Current Topics in Membranes, Volume 61 Series Editors Dale J. Benos Department of Physiology and Biophysics University of Alabama Birmingham, Alabama
Sidney A. Simon Department of Neurobiology Duke University Medical Care Durham, North Carolina
——————————————————————–
Current Topics in Membranes, Volume 61
Free Radical Effects on Membranes Edited by Sadis Matalon Department of Anesthesiology School of Medicine University of Alabama at Birmingham Birmingham, AL 35233, USA Rakesh P. Patel Division of Molecular & Cellular Pathology Department of Pathology University of Alabama at Birmingham Birmingham, AL
AMSTERDAM · BOSTON · HEIDELBERG · LONDON NEW YORK · OXFORD · PARIS · SAN DIEGO SAN FRANCISCO · SINGAPORE · SYDNEY · TOKYO Academic Press is an imprint of Elsevier
Academic Press is an imprint of Elsevier 84 Theobald’s Road, London WC1X 8RR, UK Radarweg 29, PO Box 211, 1000 AE Amsterdam, The Netherlands Linacre House, Jordan Hill, Oxford OX2 8DP, UK 30 Corporate Drive, Suite 400, Burlington, MA 01803, USA 525 B Street, Suite 1900, San Diego, CA 92101-4495, USA
First edition 2008 Copyright © 2008, Elsevier Inc. All rights reserved No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means electronic, mechanical, photocopying, recording or otherwise without the prior written permission of the publisher Permissions may be sought directly from Elsevier’s Science & Technology Rights Department in Oxford, UK: phone (+44) (0) 1865 843830; fax (+44) (0) 1865 853333; email:
[email protected]. Alternatively you can submit your request online by visiting the Elsevier web site at http://www.elsevier.com/locate/permissions, and selecting: Obtaining permission to use Elsevier material Notice No responsibility is assumed by the publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made
ISBN: 978-0-12-373879-0 ISSN: 1063-5823
For information on all Academic Press publications visit our website at books.elsevier.com
Printed and bound in USA 08 09 10 11 12
10 9 8 7 6 5 4 3 2 1
Contents Contributors ix Previous Volumes in Series xiii
I. Overview
CHAPTER 1 Structure and Functions of Biomembranes James F. Collawn and Zsuzsa Bebök
I. II. III. IV.
Cell Membrane Structure and Function 1 Overview of Membrane Functions 4 Calcium Signaling 14 Oxidative Stress and Organelle Dysfunction 15 References 19
CHAPTER 2 The Interaction of Reactive Oxygen and Nitrogen Species with Membranes Matias N. Möller, Jack R. Lancaster and Ana Denicola
I. Reactive Oxygen and Nitrogen Species 23 II. Physical Interactions: Compartmentalizing Reactivity 25 III. Chemical Effects: Lipid Peroxidation 35 References 39
II. Interaction of RONS with Channels and Pumps
CHAPTER 3 Modulation of Lung Epithelial Sodium Channel Function by Nitric Oxide Weifeng Song, Ahmed Lazrak, Shipeng Wei, Phillip McArdle and Sadis Matalon
I. Introduction 44 References 62 v
vi
Contents
CHAPTER 4 Effects of Nitrogen Oxides on Chloride Channels Benjamin Gaston
I. Overview 71 II. Introduction 72 III. Regulation by Nitrogen Oxides of Swelling-activated Cl− Channels 73 IV. Regulation of Calcium Activated Cl− Channels by Nitrogen Oxides (NOx ) 74 V. Effects of Nitrogen Oxides on CFTR 76 VI. Future Directions 82 References 83
CHAPTER 5 A Mitochondria-AOS-Kv Channel Axis in Health and Disease; New Insights and Therapeutic Targets for Vascular Disease and Cancer Gopinath Sutendra and Evangelos D. Michelakis
I. Introduction 87 II. The Components of the Mitochondria-ROS-Kv Axis 88 III. The Mitochondria-AOS-Kv Axis in Hypoxia: HPV IV. The Mitochondria-AOS-Kv Axis, Metabolism and Apoptosis 97 References 108
92
CHAPTER 6 Oxidative Modification of Ca2+ Channels, Ryanodine Receptors, and the Sarco/Endoplasmic Reticulum Ca2+ -ATPase Victor S. Sharov and Christian Schöneich
I. Introduction 114 II. Overview of Ca2+ Translocation Membrane Proteins 114 III. Ca2+ Channels 115 IV. SERCA 119 V. PMCA 124 VI. Concluding Remarks 125 References 125
CHAPTER 7 Regulation of Na,K-ATPase by Reactive Oxygen Species Guofei Zhou, Laura A. Dada and Jacob I. Sznajder
I. Na,K-ATPase 132 II. Na,K-ATPase in Alveolar Fluid Reabsorption 133
vii
Contents
III. Role of Reactive Oxygen Species in Signaling 134 IV. Regulation of Na,K-ATPase and Alveolar Fluid Reabsorption by ROS 136 V. Dopamine and β-adrenergic Agonists Improve ROS-Mediated Decrease in Alveolar Fluid Reabsorption 140 VI. Summary 141 References 141
III. RONS and Membrane Permeability CHAPTER 8 Reactive Oxygen Species and Endothelial Permeability Masuko Ushio-Fukai, Randall S. Frey, Tohru Fukai and Asrar B. Malik
I. Introduction 148 II. Generation and Metabolism of ROS 151 III. ROS Generating System in ECs (NADPH Oxidase) 151 IV. Regulation of Adherens Junctions (AJs) by Phosphorylation and by Rho GTPase 153 V. ROS-generating Stimulants which Regulate Endothelial Permeability 154 VI. ROS Reducing Factors/Proteins which Block Endothelial Permeability 165 VII. Molecular Targets of ROS Regulating Endothelial Permeability 165 VIII. Mediators/Regulators of ROS-dependent Endothelial Permeability 171 IX. Functional Significance of ROS-dependent Endothelial Permeability in Vivo 173 X. Summary and Conclusions 175 References 176
IV. RONS and Signal Transduction CHAPTER 9 Cell Signaling by Oxidants: Pathways Leading to Activation of Mitogen-activated Protein Kinases (MAPK) and Activator Protein-1 (AP-1) Arti Shukla and Brooke T. Mossman
I. Introduction 192 II. MAPK Signaling 195
viii
Contents
III. Mitogen-activated Protein Kinase Phosphatases (MKPs) 198 IV. Relationships between MAPK and Activator Protein-1 (AP-1) 199 V. Conclusions 203 References 204
CHAPTER 10 The Interaction of Mitochondrial Membranes with Reactive Oxygen and Nitrogen Species Paul S. Brookes, Andrew P. Wojtovich, Lindsay S. Burwell, David L. Hoffman and Sergiy M. Nadtochiy
I. Mitochondria as a Source of Reactive Species 212 II. Effects of ROS and RNS on Mitochondrial Respiration 217 III. Mitochondrial Membrane Lipids 221 IV. ROS, RNS & Mitochondrial Ion Transport 224 V. Complex Interactions & Concluding Remarks 230 References 232
CHAPTER 11 Oxidant Stress and Airway Epithelial Function Jenora T. Waterman and Kenneth B. Adler
I. II. III. IV. V. Index 257
Introduction 243 Sources of Reactive Oxygen Species 244 Antioxidant Defenses in Airway Epithelium 245 Oxidant-induced Airway Epithelial Responses 247 Conclusions 251 References 251
Contributors Numbers in parentheses indicate the pages on which the author’s contribution begin.
Kenneth B. Adler (245), Department of Molecular Biomedical Sciences, North Carolina State University, College of Veterinary Medicine, 4700 Hillsborough Street, Raleigh, NC 27606, USA Zsuzsa Bebök (1), Department of Cell Biology, University of Alabama at Birmingham, 1918 University Blvd, Birmingham, AL 35294-0005, USA Paul S. Brookes (213), Department of Anesthesiology, University of Rochester Medical Center Lindsay S. Burwell (213), Department of Biochemistry & Biophysics, University of Rochester Medical Center James F. Collawn (1), Department of Cell Biology, University of Alabama at Birmingham, 1918 University Avenue, Birmingham, AL 35294-0005, USA Laura A. Dada (133), Division of Pulmonary and Critical Care Medicine, Feinberg School of Medicine, Northwestern University, 240 E. Huron, McGaw Pavilion M-326, Chicago, IL 60611, USA Ana Denicola (23), Lab. Fisicoquímica Biológica, Facultad de Ciencias, Universidad de la Republica, Igua 4225, 11400 Montevideo, Uruguay David L. Hoffman (213), Department of Biochemistry & Biophysics, University of Rochester Medical Center Randall S. Frey (149), Department of Pharmacology and the Center for Lung and Vascular Biology, University of Illinois, Chicago, IL 60605, USA Tohru Fukai (149), Department of Pharmacology and the Center for Lung and Vascular Biology, University of Illinois, Chicago, IL 60605, USA Benjamin Gaston (73), University of Virginia School of Medicine, Charlottesville, VA 22908, USA Jack R. Lancaster Jr. (23), Departments of Anesthesiology, Physiology & Biophysics, and Environmental Health Sciences and Center for Free Radical Biology, University of Alabama at Birmingham, AL, USA ix
x
Contributors
Ahmed Lazrak (45), Department of Anesthesiology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35233, USA Asrar B. Malik (149), Department of Pharmacology and the Center for Lung and Vascular Biology, University of Illinois, Chicago, IL 60605, USA Sadis Matalon (45), Department of Anesthesiology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35233, USA Phillip McArdle (45), Department of Anesthesiology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35233, USA Evangelos D. Michelakis (89), Department of Medicine, University of Alberta, Edmonton, Canada Brooke T. Mossman (183), University of Vermont College of Medicine, Department of Pathology, 89 Beaumont Avenue, Burlington, VT 05405, USA Matías N. Möller (23), Lab. Fisicoquímica Biológica, Facultad de Ciencias, Universidad de la Republica, Igua 4225, 11400 Montevideo, Uruguay Sergiy M. Nadtochiy (213), Department of Anesthesiology, University of Rochester Medical Center Victor S. Sharov (115), Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS 66047, USA Christian Schöneich (115), Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS 66047, USA Arti Shukla (183), University of Vermont College of Medicine, Department of Pathology, 89 Beaumont Avenue, Burlington, VT 05405, USA Weifeng Song (45), Department of Anesthesiology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35233, USA Gopinath Sutendra (89), Department of Medicine, University of Alberta, Edmonton, Canada Jacob I. Sznajder (133), Division of Pulmonary and Critical Care Medicine, Feinberg School of Medicine, Northwestern University, 240 E. Huron, McGaw Pavilion M-326, Chicago, IL 60611, USA Masuko Ushio-Fukai (149), Department of Pharmacology and the Center for Lung and Vascular Biology, University of Illinois, Chicago, IL 60605, USA
Contributors
Jenora T. Waterman (245), Department of Molecular Biomedical Sciences, North Carolina State University, College of Veterinary Medicine, 4700 Hillsborough Street, Raleigh, NC 27606, USA Shipeng Wei (45), Department of Anesthesiology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35233, USA Andrew P. Wojtovich (213), Department of Pharmacology & Physiology, University of Rochester Medical Center Guofei Zhou (133), Division of Pulmonary and Critical Care Medicine, Feinberg School of Medicine, Northwestern University, 240 E. Huron, McGaw Pavilion M-326, Chicago, IL 60611, USA
xi
Previous Volumes in Series Current Topics in Membranes and Transport Volume 23 Genes and Membranes: Transport Proteins and Receptors∗ (1985) Edited by Edward A. Adelberg and Carolyn W. Slayman Volume 24 Membrane Protein Biosynthesis and Turnover (1985) Edited by Philip A. Knauf and John S. Cook Volume 25 Regulation of Calcium Transport across Muscle Membranes (1985) Edited by Adil E. Shamoo Volume 26 Na+ –H+ Exchange, Intracellular pH, and Cell Function∗ (1986) Edited by Peter S. Aronson and Walter F. Boron Volume 27 The Role of Membranes in Cell Growth and Differentiation (1986) Edited by Lazaro J. Mandel and Dale J. Benos Volume 28 Potassium Transport: Physiology and Pathophysiology∗ (1987) Edited by Gerhard Giebisch Volume 29 Membrane Structure and Function (1987) Edited by Richard D. Klausner, Christoph Kempf, and Jos van Renswoude Volume 30 Cell Volume Control: Fundamental and Comparative Aspects in Animal Cells (1987) Edited by R. Gilles, Arnost Kleinzeller, and L. Bolis Volume 31 Molecular Neurobiology: Endocrine Approaches (1987) Edited by Jerome F. Strauss, III, and Donald W. Pfaff Volume 32 Membrane Fusion in Fertilization, Cellular Transport, and Viral Infection (1988) Edited by Nejat Düzgünes and Felix Bronner Volume 33 Molecular Biology of Ionic Channels∗ (1988) Edited by William S. Agnew, Toni Claudio, and Frederick J. Sigworth Volume 34 Cellular and Molecular Biology of Sodium Transport∗ (1989) Edited by Stanley G. Schultz ∗ Part of the series from the Yale Department of Cellular and Molecular Physiology.
xiii
xiv
Previous Volumes in Series
Volume 35 Mechanisms of Leukocyte Activation (1990) Edited by Sergio Grinstein and Ori D. Rotstein Volume 36 Protein–Membrane Interactions∗ (1990) Edited by Toni Claudio Volume 37 Channels and Noise in Epithelial Tissues (1990) Edited by Sandy I. Helman and Willy Van Driessche
Current Topics in Membranes Volume 38 Ordering the Membrane Cytoskeleton Trilayer∗ (1991) Edited by Mark S. Mooseker and Jon S. Morrow Volume 39 Developmental Biology of Membrane Transport Systems (1991) Edited by Dale J. Benos Volume 40 Cell Lipids (1994) Edited by Dick Hoekstra Volume 41 Cell Biology and Membrane Transport Processes∗ (1994) Edited by Michael Caplan Volume 42 Chloride Channels (1994) Edited by William B. Guggino Volume 43 Membrane Protein–Cytoskeleton Interactions (1996) Edited by W. James Nelson Volume 44 Lipid Polymorphism and Membrane Properties (1997) Edited by Richard Epand Volume 45 The Eye’s Aqueous Humor: From Secretion to Glaucoma (1998) Edited by Mortimer M. Civan Volume 46 Potassium Ion Channels: Molecular Structure Function, and Diseases (1999) Edited by Yoshihisa Kurachi, Lily Yeh Jan, and Michel Lazdunski Volume 47 AmilorideSensitive Sodium Channels: Physiology and Functional Diversity (1999) Edited by Dale J. Benos Volume 48 Membrane Permeability: 100 Years since Ernest Overton (1999) Edited by David W. Deamer, Arnost Kleinzeller, and Douglas M. Fambrough Volume 49 Gap Junctions: Molecular Basis of Cell Communication in Health and Disease Edited by Camillo Peracchia
Previous Volumes in Series
xv
Volume 50 Gastrointestinal Transport: Molecular Physiology Edited by Kim E. Barrett and Mark Donowitz Volume 51 Aquaporins Edited by Stefan Hohmann, Søren Nielsen and Peter Agre Volume 52 Peptide–Lipid Interactions Edited by Sidney A. Simon and Thomas J. McIntosh Volume 53 CalciumActivated Chloride Channels Edited by Catherine Mary Fuller Volume 54 Extracellular Nucleotides and Nucleosides: Release, Receptors, and Physiological and Pathophysiological Effects Edited by Erik M. Schwiebert Volume 55 Chemokines, Chemokine Receptors, and Disease Edited by Lisa M. Schwiebert Volume 56 Basement Membrances: Cell and Molecular Biology Edited by Nicholas A. Kefalides and Jacques P. Borel Volume 57 The Nociceptive Membrane Edited by Uhtaek Oh Volume 58 Mechanosensitive Ion Channels, Part A Edited by Owen P. Hamill Volume 59 Mechanosensitive Ion Channels, Part B Edited by Owen P. Hamill Volume 60 Computational Modeling of Membrane Bilayers Edited by Scott E. Feller
Preface
Rakesh P. Patel, Sadis Matalon
Free radicals (reactive molecules with unpaired electrons in their outer orbits) are typically associated with cellular damage and death of biological organisms with perturbation of membrane integrity being key in their toxicity. Indeed, the concept that increased free radical production and the ensuing destruction of biomolecules, concomitant with depleted antioxidant defenses has shaped much thinking and efforts in elucidating the molecular mechanisms leading to a variety of disease. More recently however, with a better understanding of free radical biology, it has become apparent that the effects of free radicals (encompassing reactive oxygen species, reactive nitrogen species, reactive halogen intermediates) depend on their concentration, location, redox potential as well the biochemical composition of the target. Thus it is now clear that reactive species formation and metabolism are controlled events and central in redox-cell signaling pathways that impact diverse cellular, functions encompassing cellular, physiological and pathological responses. Interactions among reactive species and membrane components (including proteins and lipids) exemplify this paradigm. Moreover, emerging data implicate cellular membranes as critical foci for regulating the reactivity of free radical species by either regulating reactive species formation (e.g. mitochondria), determining vectorial reactive species production (e.g. respiratory burst in activated neutrophils) and providing a hydrophobic milieu which dramatically alters reactivity of various reactive species (e.g. nitric oxide). It was our goal to solicit contributions from leaders in the field that collectively discuss these concepts both in general terms and by focusing on specific examples of how reactive species interactions with specific membrane proteins can modulate cell-signaling in physiological and pathological contexts. Thus, this volume consist of eleven chapters from experts in the field that encompass free-radical effects on diverse membrane functions, ranging from selective barrier functions, controlling membrane protein function to discussing how the hydrophobic environment within membranes regulate free radical reactivity. In soliciting reviews we purposely stayed away from assembling a book on free-radicals and lipid peroxidation, a topic on which multiple research articles, xvii
xviii
R.P. Patel and S. Matalon
reviews and books have focused on and an area that remains an active focus of investigation. Instead we decided to focus on articles focused in discussing specific examples in which membranes from different cellular compartments (e.g. plasma, ER, mitochondria) and membrane proteins either regulate reactive species formation and reactivity or are specific targets of reactive species leading to alteration in function. The latter typically involves post-translation modification of specific amino acid residues resulting in selective and specific alteration of protein function. The book starts with chapters that provide overviews on biomembranes and the impact their physico-chemical properties have on reactive species reactivity (Chapters 1 and 2). This is followed by a series of chapters (Chapters 3–7) that illustrate the concept that different reactive species can modulate function of specific membrane ion channels in different tissues. This includes sodium channels, chloride channels, sodium-potassium ATPases and calcium channels in both plasma and intracellular organelle membranes. Importantly, the implications for reactive species control of ion channel function in vascular and pulmonary diseases are also discussed. We then focus on the role of reactive species in influencing a major role of membranes that being their selective barrier function and regulation of permeability (Chapter 8). In the final three chapters (Chapters 9–11) the focus is on reactive species and control of cell-signaling pathways. Specific topics that illustrate this concept include control of MAP kinases and down-stream signaling, role of the mitochondria as a source an target for reactive species signaling and finally, the role of reactive species in airway epithelial function. We would like to thank all the contributors for their efforts in compiling this book and hope that the final product provides the readership with a current-view of the how integral biological membranes are as sources, targets and transducers of reactive species biology and how a deeper understanding of this interplay is increasing our understanding of molecular mechanisms of diseases together with potentially offering new therapeutic targets.
CHAPTER 1 Structure and Functions of Biomembranes James F. Collawn and Zsuzsa Bebök Department of Cell Biology, University of Alabama at Birmingham, 1918 University Blvd, Birmingham, AL 35294-0005, USA
I. Cell Membrane Structure and Function A. Plasma Membrane B. Mitochondrial Membranes C. Peroxisomal Membranes II. Overview of Membrane Functions A. Permeability B. Ion Transport C. Signal Transduction III. Calcium Signaling IV. Oxidative Stress and Organelle Dysfunction A. Oxidative Stress and the ER B. Oxidative Stress and Peroxisomes C. Oxidative Stress and Mitochondria D. Oxidative Stress and Lysosomes E. Summary and Conclusions References
I. CELL MEMBRANE STRUCTURE AND FUNCTION Cell membrane systems provide two important functions: (1) they establish a biological barrier to the extracellular environment and (2) they compartmentalize specialized and sometimes toxic biological reactions within the cell. Although the different cellular membrane systems have diverse biological functions, they do share some common features. All membrane systems are composed of a lipid bilayer that contains a full complement of protein complexes that facilitate permeability, transport, and signaling. The focus of this chapter will be to describe recent advances in our understanding of cell membrane structure and function, and to highlight the specialized roles of mitochondria and peroxisomes. FurtherCurrent Topics in Membranes, Volume 61 Copyright © 2008, Elsevier Inc. All rights reserved
1063-5823/08 $35.00 DOI: 10.1016/S1063-5823(08)00201-9
2
J.F. Collawn and Z. Bebök
more, we will discuss how structure and function of these membrane systems are affected by oxidative stress.
A. Plasma Membrane Our contemporary view of the plasma membrane was first described more than 30 years ago by the fluid mosaic model of Singer and Nicholson (1972). Many of the features proposed by the original model still ring true today, including the basic structure. The fluid mosaic model predicted that there is a random distribution of molecular components in the membrane that have free lateral and rotational movement (Singer and Nicolson, 1972; Vereb et al., 2003). More recent studies, however, indicate that many membrane protein components are in large supramolecular complexes that are either tethered to the actin cytoskeleton or have limited lateral diffusion (Damjanovich et al., 1999; Vereb et al., 2003). Furthermore, elegant studies using single-particle tracking techniques indicate that even lipids experience transient confinement in lipid rafts (Dietrich et al., 2002). Based on these very sensitive biophysical techniques, it has become clear that the distribution of lipids and proteins in the plasma membrane is highly organized, dynamic, and nonrandom (Figure 1). Rapid advances in microscopy such as fluorescence recovery after photobleaching (FRAP), optical tracking by laser tweezers, single-particle tracking techniques, and confocal laser-scanning microscopy have aided in this revised view of the nature of the plasma membrane (reviewed in Vereb et al., 2003). Proteins, therefore, may be freely mobile or constrained by lipid rafts, by large protein complexes, or by the
FIGURE 1 Modified fluid-mosaic model of cell membrane.
1. Structure and Functions of Biomembranes
3
cytoskeleton itself. The protein organization within these large complexes is certain to affect their biological function, particularly with regard to signaling within lipid rafts. Lipid raft structures are important components of the plasma membrane and consist of ∼50–70 nm membrane patches that are enriched in sphingolipids and cholesterol. Because of the nature of the fatty acid side chains found in these sphingolipids, lipid rafts result in a thicker membrane structure where certain proteins have a tendency to accumulate, particularly signaling complexes (Simons and Toomre, 2000). Furthermore, lipid rafts change their size and protein composition in response to extracellular stimuli, resulting in the activation of various signaling cascades (Simons and Toomre, 2000). Oxidative stress and its resultant effects on lipid structure in lipid rafts can therefore have profound effects on cellular signaling cascades.
B. Mitochondrial Membranes Mitochondria consist of a double membrane system, with an extensive inner membrane surface area. The mitochondrial membrane system is second only to the endoplasmic reticulum membrane surface area, often consisting of up to 40% of the total membrane in a cell. Because of this vast membrane network, mitochondria occupy a large portion of the cytoplasmic volume of cells, and in many cell types, are constantly changing shape. Rather than the rod-like structures often depicted in textbooks, they are more often seen as elongated stringlike structures. Mitochondrial movement occurs in a number of cell types and is mediated by microtubules. The dynamic nature of these organelles is best illustrated using videomicroscopy, which demonstrates that mitochondria constantly change shape, fuse with one another, or divide in two. Although the mitochondrial genome encodes for 33 genes, the vast majority of proteins are made by the cell and are imported by the mitochondrial transporters of the outer and inner membranes, the TOM and TIM complexes. The most commonly associated function of mitochondria is in the production of ATP from oxidative phosphorylation. In this process, pyruvate and fatty acids are broken down to acetyl CoA, and in the inner matrix of the mitochondria, acetyl CoA is metabolized in the citric acid cycle, generating NADH and FADH2 . Highenergy electrons from NADH and FADH2 are then passed along the electrontransport chain on the mitochondrial inner membrane surface, generating a proton gradient across the membrane. The electro-chemical gradient across the inner membrane is then used by ATP synthase, also on the inner membrane surface, to generate ATP from ADP. The electro-chemical gradient is also important for the import of newly synthesized “mitochondrial” proteins made from the cell’s genomic DNA. Given the essential function of mitochondria, it is not surprising that a large number of seemingly unrelated disorders such as schizophrenia,
4
J.F. Collawn and Z. Bebök
Alzheimer’s disease, epilepsy, Parkinson’s disease, cardiomyopathy, and diabetes have a common component, namely the production of reactive oxygen species and mitochondrial DNA damage (reviewed in Pieczenik and Neustadt, 2007).
C. Peroxisomal Membranes Peroxisomes are small, single membrane organelles that contain a number of oxidative enzymes. This membrane system consists of only about 1% of a cell’s membrane system and functionally overlaps with mitochondria in certain biological reactions such as fatty acid β-oxidation. One unique function is in the production of plasmalogens, the most abundant lipid found in myelin. In the liver and kidney, peroxisomes also aid in the detoxification of acids, aldehydes, and alcohols via catalase and H2 O2 . The essential nature of peroxisomes is best illustrated in the human inherited disease Zellweger syndrome, a condition in which the protein import machinery in peroxisomes is defective. This loss of function leads to “empty” peroxisomes and neurological, kidney and liver abnormalities. Death occurs soon after birth.
II. OVERVIEW OF MEMBRANE FUNCTIONS All organelle membrane systems function to maintain their distinctive composition from the cytosol by providing a barrier to most polar molecules. Transport of materials (or signals) requires protein receptors/channels/transporters that span the lipid bilayer. In the following section, we will discuss how the membrane systems facilitate transport of small molecules through permeability and ion transport, and then discuss how signal transduction is facilitated through a membrane system using mechanotransduction and MAP kinases as examples.
A. Permeability The hydrophobic character of a membrane that consists of phospholipids, cholesterol, and glycolipids prevents the passive diffusion of most polar, watersoluble molecules. This critical function maintains intracellular ion concentrations, as well as organelle identity and function. The rate at which a molecule diffuses across a membrane system depends on its size and how nonpolar it is. For example, O2 and CO2 readily diffuse across membrane systems, whereas small, uncharged polar molecules such as H2 O or urea diffuse across membrane systems much more slowly. Large uncharged molecules such as glucose, and ions such as Na+ , K+ , or Cl− require carrier proteins or channels for effective transport across the bilayer.
1. Structure and Functions of Biomembranes
5
B. Ion Transport Channel or carrier proteins are required for ion transport for two different types of transport, active and passive. In passive transport, ions are transported down their concentration gradient, from high concentration to low. Since ions are charged, however, membrane potential also influences their transport. For plasma membranes, the voltage gradient places a negative potential on the inner membrane surface, and a positive on the outer surface, facilitating positive ion entry, and negative ion exit. Transport of ions against their electrochemical gradient, on the other hand, requires energy expenditure, usually in the form of ATP hydrolysis. Active transporters can be classified as uniporters, symporters, or antiporters. Uniporters transport one solute from one side of the membrane to the other, while symporters transport two solutes in the same direction, and antiporters transport two solutes in opposite directions. In the case of two solutes, one of the solutes is usually transported down its electrochemical gradient, and this free energy is used to help transport the other solute against its electrochemical gradient. The bestcharacterized example of this is in glucose transport driven by a Na+ gradient. In this case, Na+ is transported down its electrochemical gradient into the cell (from 145 outside to 10 mM inside), and glucose is co-transported in the process. The Na+ gradient is maintained by an ATP-driven Na+ pump which pumps Na+ back out of the cell to maintain this gradient. This coupled carrier system provides active transport that is driven by the Na+ gradient. A similar system is used by the Na+ –H+ exchanger, which couples Na+ influx with H+ efflux as a means of maintaining a cytosolic pH of 7.2. Another approach for controlling pH within organelles such as endosomes and lysosomes is to couple ATP hydrolysis with proton transport, as is the case with ATP-driven H+ pump. A more complicated process involves the transport of solutes across epithelial cells. In transcellular transport, co-transport of glucose and Na+ from the intestinal lumen across the epithelial cell to the blood requires pumps at the apical and basolateral surfaces. At the apical surface, Na+ and glucose is co-transported into the cell as described above. At the basolateral surface, glucose is transported out of the cell down its concentration gradient by passive transport through a carrier protein, while Na+ is transported out by active transport by the Na+ –K+ pump. The tight junctions help maintain the concentration gradients generated by the pumps.
C. Signal Transduction Signal transduction pathways provide a mechanism for transmitting signals from the extracellular environment to cells or conveying signals between cells. These signals are transmitted a number of ways, but the most common is via
6
J.F. Collawn and Z. Bebök
ligand-receptor interactions. Ligand binding “transduces” a signal across the membrane bilayer either by activating intrinsic activity of the receptor itself, or by activating an associated protein. Once activated, this sets off an activation cascade that employs a variety of intracellular signaling proteins that convey the signal to the appropriate targets within the cell. Not all ligands bind a cell surface receptor for signal transduction, and a good example of this is nitric oxide (NO). NO readily diffuses across the cell membrane and binds to iron in the active site of guanylyl cyclase, stimulating the production of cyclic GMP, and thus activating the signaling cascade. 1. Mechanotransduction In some cases, transmission of a signal across a bilayer is not mediated by ligand binding, but rather mechanotransduction. In mechanotransduction, a mechanical force exerted on the cell membrane is converted into electrical or biochemical signals (reviewed in Martinac, 2004; Orr et al., 2006). Probably the best-studied example of this is the stretch-sensitive ion channels (Martinac, 2004). The first evidence for mechanically gated channels comes from studies of mechanosensory neurons (Katz, 1950). Patch clamp analysis first allowed for measurement of single mechanosensitive channels and demonstrated that there were two types of channels: stretch-activated and stretch-inactivated ion channels (Sachs and Morris, 1998). Mechanical forces are transduced along the plane of the cell membrane (membrane tension), rather than hydrostatic pressure (Martinac, 2004). Two models have been proposed to explain channel gating, the bilayer model and the tethered model (Hamill and McBride Jr., 1997). In the bilayer model, lipid bilayer tension is all that is required for activation. Whereas in the tethered model, the channel must be in contact with the cytoskeleton or extracellular matrix before activation occurs. The two models are not mutually exclusive since the mechanism of activation may depend on the channel type. The amount of membrane tension required for half activation of most of the known mechanosensitive channels is several dynes/cm (10−3 N/m) (Martinac, 2004; Sachs, 1988), an amount easily resulting from differences in the transmembrane osmolarity of only a few milliosmols (Martinac, 2004). Mechanotransduction, much like phosphorylation, uses conformational changes in the target molecule(s) to mediate signaling events (Orr et al., 2006). The conformational changes are often associated with channels that contain linkages to the cytoskeleton or extracellular matrix, and these interactions amplify small mechanical forces into displacement of large complexes, resulting in signal transduction (Orr et al., 2006). In stretch-sensitive channels, the mechanism for signal transduction may be even simpler. Increasing tension in the lipid bilayer from 10–12 dyn/cm to 20 dyn/cm (Evans et al., 1976) increases the open-probability of the channel (Martinac and Hamill, 2002).
1. Structure and Functions of Biomembranes
7
Two possibilities have been proposed to explain how membrane tension triggers channel opening (Orr et al., 2006). In the first, if an open channel occupies a greater surface area in the bilayer than in the closed state, i.e., if it is more unfolded or expanded, then the free energy of the open state will be lower (Orr et al., 2006). In the second possibility, tension causes the bilayer to be thinner by 0.15 nm, and this triggers channel opening (Martinac and Hamill, 2002). In this scenario, the hydrophobic transmembrane domain of the channel must be thinner in the open state, and channel opening therefore would be favored in order to avoid the hydrophobic mismatch that could occur between the channel and the lipid bilayer (Orr et al., 2006). In other words, preventing the hydrophobic sidechains of the transmembrane regions of the channels from being exposed to the aqueous environment would be energetically favorable. Thus, opening the channel in the thinner bilayer lowers the free energy through the hydrophobic effect (Orr et al., 2006). Abnormalities in mechanosensitive channel function can result in neuronal, muscular, cardiac, and kidney disturbances (Chen et al., 1999; Driscoll and Chalfie, 1991; Franco Jr. and Lansman, 1990; Hansen et al., 1990). In autosomal dominant polycystic kidney disease (PKD), the defect may be due to abnormal Ca+2 signaling through polycytins, cation channels that act as mechanosensory channels (Corey, 2003). Polycystins (PKD) 1 and 2 are found in primary cilia of renal epithelial cells (Delmas, 2004), at cell–cell junctions, and a number of other cell types. Together they form a complex in which PKD1 is a regulatory/anchoring subunit and PKD2 is a mechanically regulated calcium channel (Orr et al., 2006). Loss of this signaling complex, through loss of either PKD1 or PKD2, results in the loss of cilial mechanotransduction and Ca+2 signaling. Under normal conditions, urine flow triggers signals through the cilia that modulate kidney tubule growth. However, when this signal is lost, the result is cyst formation in the kidney (Delmas, 2004; Orr et al., 2006). Loss of PKD1/2 also leads to cardiovascular and skeletal defects, as well as left-right asymmetry abnormalities (Orr et al., 2006). Mechanotransduction has also been shown to be important in modulating blood pressure changes via the myogenic response, a response that regulates rapid changes in blood vesicles and provides a mechanism for protecting capillary beds from acute blood pressure changes (Orr et al., 2006). This effect is mediated though calcium-signaling pathways (Davis et al., 2001) that are activated when nonspecific cation channels open in the stretch-sensitive smooth muscle cells. Depolarization of the membrane occurs and this activates calcium entry L-type calcium channels that regulate myogenic constriction (Orr et al., 2006). The stretch-sensitive component of arteries is mediated by integrins primarily through the action of focal adhesion kinase and MAP kinases. Mechanotransduction also plays an important role in normal lung function. Mechanical forces are constantly being applied to the lung epithelium and these forces activate the synthesis and secretion of surfactant proteins by type II epithelial cells (Gutierrez et al., 2003; Wirtz and Dobbs, 2000). Surfactant proteins
8
J.F. Collawn and Z. Bebök
are necessary for normal lung function because they lower the surface tension at the air-liquid interface. Further, a mechanotransducing mechanism has been proposed to explain c-Src activation resulting from strain on the actin cytoskeletal (Han et al., 2004). AFAP-110, an actin filament-associated protein found in lung epithelia, binds and activates c-Src, bridging changes between the actin cytoskeleton and c-Src activation (Han et al., 2004). Another mechanism to explain mechanotransduction involves growth factor shedding (Tschumperlin et al., 2004). For example, EGFR is activated in epithelial type II cells in response to cellular contraction, leading to the activation of ERK MAP kinases (see below), and the production of surfactant proteins (Correa-Meyer et al., 2002; Sanchez-Esteban et al., 2004). ERK1/2 activation requires the shedding of heparin binding-EGF into the extracellular space. Given that increasing pressure decreases the volume of the intercellular space, the heparin binding-EGF concentration increases even if the amount of shedding does not change, resulting in EGFR activation (Orr et al., 2006; Tschumperlin et al., 2004). The preceding examples illustrate that mechanotransduction is utilized by a vast array of cell types, many of which were not discussed. Two different examples of mechanotransduction were presented. In the first, membrane tension changes promote protein unfolding, and result in activation pressure-sensitive channel gating. In the second case, external forces affect large molecular complexes by either altering the individual components relative to each other or by altering the complex relative to the actin cytoskeleton or to the extracellular matrix. PKD provides an excellent example of how loss of mechanotransduction leads to dire consequences. 2. MAP Kinase The mitogen-activated protein kinase (MAPK) signaling pathways are a family of signaling cascades that are affected by receptor-ligand interactions as well as oxidative stress (reviewed in McCubrey et al., 2006). There are five families of MAPK signaling pathways (Widmann et al., 1999), although only four of them are activated by oxidative stress (McCubrey et al., 2006). These include ERK1/2 (extracellular regulated kinases), ERK3/4, JNK (Jun N-terminal kinases), p38 kinase, and the BMK1 (big mitogen-activated protein kinase 1; also known as ERK 5) signaling pathways (McCubrey et al., 2006). The JNK and p38 pathways are often grouped together as the stress-activated kinases (McCubrey et al., 2006). Oxidative stress can either activate (McCubrey et al., 2006) or inhibit (Cross and Templeton, 2004) these pathways, with the outcome depending on cell type and magnitude of the oxidative stress. MAP kinases regulate a number of cellular processes including cell growth and differentiation, gene expression, cell survival and apoptosis (Lu and Xu, 2006). In the next section, we will first review the MAPK signaling pathways and then discuss how oxidative stress affects these pathways.
1. Structure and Functions of Biomembranes
9
FIGURE 2 The MAP kinase cascade and MAP kinases activated during oxidative stress. Based on McCubrey et al. (2006).
General Features of the MAP Kinase Pathways The first MAPK signaling pathway was identified based on the ability of ERK (extracellular regulated kinases) to phosphorylate microtubule-associated protein. When it became clear that there were a large number of substrates and kinases and pathways, the name became more generally derived from the ability of these kinases to be activated by mitogens (mitogen-activated protein (MAP) kinases) (McCubrey et al., 2006). Five families of MAP kinase signaling pathways have been identified to date (Figure 2). The ERK, JNK (Jun N-terminal kinases), p38, and BMK1 pathways share two common features. First, they are all serine/threonine kinases that preferentially phosphorylate substrates with a critical Pro residue in the recognition site. Second, they all operate in a cascade in which a MAP kinase kinase kinase (MAP3K) phosphorylates and activates a MAP ki-
10
J.F. Collawn and Z. Bebök
nase kinase (MAP2K), which phosphorylates and activates a MAPK (McCubrey et al., 2006). In mammalian cells, 12 MAP kinases, 7 MAP2Ks, and 20 MAP3Ks have been identified (Lu and Xu, 2006). Each of the MAPK families can be activated by at least two MAP2Ks and by multiple MAP3Ks (Lu and Xu, 2006), illustrating the complexity and overlap of these pathways. In the following sections, a description of each of these pathways will be detailed, with a specific focus on how each is affected by oxidative stress. ERK1/2 The prototype of the MAPK pathway, ERK, is activated following receptor tyrosine kinase activation in a cascade shown in Figure 2. ERK1 and ERK2 are more than 80% identical and are expressed in all tissues (Lu and Xu, 2006). Another ERK, ERK3/4 is not activated by oxidative stress (McCubrey et al., 2006), and therefore will not be discussed further. ERK1/2 (a MAPK) is activated by MEK1/2 (MAP/ERK Kinase (MAP2K)) (McCubrey et al., 2006), which is activated by Raf (MAP3K). A number of pathways can lead to MEK1/2 activation (Figure 2), including growth factor/hormone stimulation, stress (including oxidative stress), or cytokine activation (Lu and Xu, 2006). Activation of protein kinase C either through increases in intracellular Ca+2 or by PLCγ activity results in Ras activation, leading to c-Raf /MEK/ERK activation. The RAS/RAF/MEK/ERK pathway is likely the most-studied MAPK pathway (Figure 2). ERK activation, however, is also known to occur via RAS-independent pathways as well (Burgering et al., 1993). MAP kinases are activated by a dual phosphorylation event on a conserved Thr-Xaa-Tyr motif in their activation loop by a MAP2K (Lu and Xu, 2006). MAP2Ks show remarkable specificity, whereas MAP3K can activate multiple MAP kinase cascades (Lu and Xu, 2006). As would be expected, Raf is not the only MAP3K that regulates ERK1/2. Other MAP3Ks that include Mos, TPL2 protooncogene, MLK-like mitogen-activated protein triple kinase (MLTK), and interleukin 1 receptor-associated kinase (IRAK) have been shown to activate ERK1/2 (Gotoh et al., 2001; Gotoh and Nishida, 1995; Lu and Xu, 2006; MacGillivray et al., 2000; Salmeron et al., 1996), demonstrating that there are a number of potential start points for this cascade. More than 150 substrates have been identified for ERK1/2, with a list including transcription factors, kinases, phosphatases, cytoskeletal proteins, receptors, signaling molecules, and apoptosis-related proteins (McCubrey et al., 2006). Many of the down-stream effects appear related to cell survival. Constitutively active form of RAS supports cellular transformation (Cuadrado et al., 1993; Hoyle et al., 2000), and activated forms of RAF kinases inhibit apoptosis (Hoyle et al., 2000). Further, kinases downstream of ERK have similar anti-apoptotic effects, lending credence to the idea that this pathway facilitates cell survival. ERK1/2 activate a number of anti-apoptotic proteins (Mcl-1, Bcl-XL, IEX-1, c-Flip, CREB, and CBP) and DNA repair proteins (ERCC1, XRCC1, and ATR),
1. Structure and Functions of Biomembranes
11
while at the same time inhibit a number of pro-apoptotic proteins (caspase 8, caspase 9, Bim, BAD, Hid, and STAT3/5 (reviewed in Lu and Xu, 2006). JNK In the JNK (Jun-N-terminal kinase) pathway, the TNF family receptors and/or oxidative stress starts a cascade that eventually activates MKK4/7 (MAP2K 4 and 7) that phosphorylate and activate JNK on critical threonine and tyrosine residues (Davis, 1999). MKK4/7 is activated by Ras/Rac/MEKK1/4 from oxidative stress or through the TNF family of receptors and ASK1 (apoptosis signalregulating kinase 1) activation (McCubrey et al., 2006). Both tumor necrosis factor and FAS receptors are known to activate the JNK pathway. This pathway is also activated by a number of types of cellular stress including UV light, heavy metals, and reactive oxygen intermediates, with downstream targets that include Jun, ATF-2, Elk2, and NF-E2-related factor-2 (Nrf2) (reviewed in McCubrey et al., 2006). P38 P38 MAPK is activated by MKK3 or MKK6 (MAP2Ks), which are activated by MLK3, which is in turn activated by Rac1 and cdc42. Both growth factor receptors and the TNF family of receptors activate this pathway, illustrating the overlap between the P38 and JNK pathways (McCubrey et al., 2006). TNF receptors activate this pathway via cdc42, whereas growth factor receptors activate this pathway through Ras. Targets of the p38 pathway include a number of transcription factors such as MEF2, ATF-2, Elk-1 and CREB (McCubrey et al., 2006). A unique feature of this pathway is that it does not induce an antioxidant response via Nrf2 phosphorylation (McCubrey et al., 2006), which explains its ability to promote rather than inhibit apoptosis. The balance between ERK and P38 signaling, therefore, appears to be a critical factor regulating cell survival versus apoptosis (Birkenkamp et al., 1999). BMK1 This is the most recently described MAPK pathway and therefore the least characterized. It is also referred to as the ERK5 pathway and is activated by oxidative stress, G-coupled protein receptors, and growth factor receptors such as EGF. The MAP2K in the BMK1 pathway is MEK5 and the MAP3Ks are MEKK2 and MEKK3. Activation of this pathway promotes proliferation, differentiation and cell survival, and the downstream targets include Mef2C, c-Myc, and p90Rsk (McCubrey et al., 2006). Oxidative Stress and the MAPK Signaling Pathways Oxidative stress comes from a number of sources including normal cellular respiration, activation of growth factor receptors, and activation of the tumor
12
J.F. Collawn and Z. Bebök
necrosis factor (TNF) family of receptors. Cellular stress results from the production of free radicals and reactive oxygen species (ROS), and these molecules have harmful effects on both cell membranes and cellular functions. To deal with oxidative insults, cells have developed a number of methods to protect themselves that include glutathione and thioredoxin buffering systems and catalase (McCubrey et al., 2006). Transcriptional responses to stress occur through upregulation of antioxidant genes under the control of the antioxidant response element promoter and the action of the transcription factor Nrf2 (Cho et al., 2006). Part of the cell’s response to oxidative stress includes activation of the MAPK signaling pathways. The nature of the response depends upon the level of stress and which pathways become activated. Under moderate stress conditions, the MAPK pathways promote cell viability, however, when overwhelmed, apoptosis occurs. The consequences of oxidative stress on each of the MAPK signaling pathways are described below. Oxidative stress activates the ERK1/2 signaling pathway through activation of MEK1 and 2, ERF and PDGF receptors, and certain Src kinases (McCubrey et al., 2006). Further, hydrogen peroxide treatment can activate Ca+2 channels, leading to PKC activation and MEK1/2 activation. NO can activate Ras, again leading to MEK1/2 activation, illustrating that reactive oxygen species have a number of potential targets in cells that activate the ERK1/2 pathway (see Figure 3). Although this pathway is known to provide protection against oxidative stress, it is clear that too much stress overwhelms the system. In the JNK kinase-signaling pathway, oxidative stress acts on three components of the pathway (Figure 3). In the first, ASK1 (apoptosis signal-regulating kinase), the upstream component for MKK4/7, is regulated by its direct interaction with thioredoxin. When ASK1 is bound to thioredoxin, it is inactive. When thioredoxin is oxidized, it dissociates from ASK1, allowing ASK1 to become activated (McCubrey et al., 2006). Oxidative stress can also active Rac or the TNF receptor family directly, both of which result in JNK activation. The consequences of oxidative stress on the JNK pathway depend on the kinetics of activation. Sustained activation promotes apoptosis, whereas lower levels of reactive oxygen intermediates usually do not (McCubrey et al., 2006). Hydrogen peroxide, NO, and peroxynitrite all activate the p38 pathway by activating a number of targets that include Rac, MEK1–4, MLK3, ASK1 and the TNF receptor family (McCubrey et al., 2006). NO directly increases RAS activity and this activates the p38 pathway. Since this pathway shares common components with the JNK pathway, many of the mechanisms that active JNK also activate p38. Further, the kinetics of the activation, much like the JNK pathway, influences the fate of the cell after the activation cascade. In the BMK1 pathway, oxidative stress indirectly affects MEKK3 activity, leading to the downstream effects on MEK5 and BMK1 (ERK5). The consequences of activation of this pathway and the details of the pathway are less clear than the other signaling pathways.
1. Structure and Functions of Biomembranes
13
FIGURE 3 Activation of BMK1, JNK, p38 and ERK1/2 kinases by oxidative stress through different pathways and their effects on cellular processes. Based on McCubrey et al. (2006).
Reactive oxygen species can therefore be viewed as signaling molecules since they active a number of components in the four MAPK pathways outlined above. The cellular responses are often mediated by the transcription factors that are activated, and for the most part, result in proliferation or cell survival. If, on the other hand, the oxidative stress is prolonged or more severe, the consequences are pro-apoptotic, probably because significant cellular damage from the oxidative
14
J.F. Collawn and Z. Bebök
reactions has already occurred. Understanding the balance between cell survival and apoptosis will require a complete characterization of these complicated, overlapping MAPK pathways.
III. CALCIUM SIGNALING Reactive oxygen and nitrogen species have a number of effects on normal cellular functions, but when present in excess, trigger recovery responses, or in the worst case, apoptosis. One of the first effects of oxidative stress is to activate calcium channels in the plasma membrane and ER, facilitating calcium influx (reviewed in Ermak and Davies, 2002). Under normal conditions, cytoplasmic calcium levels are tightly maintained at about 100 nM, whereas outside the cell the concentration is high (∼mM). When a signal opens calcium channels, intracellular concentrations increase 20-fold and trigger calcium-activated cellular responses. Under normal conditions, the intracellular concentration in the cell is kept low by calcium pumps at the plasma membrane and ER, by Na+ -driven Ca+2 exchangers, by Ca+2 -binding proteins in the cytoplasm, and by active Ca+2 import into mitochondria. In the later case, mitochondria use a low-affinity, high capacity Ca+2 pump in the inner membrane that utilizes the electrochemical gradient generated by oxidative phosphorylation. ER calcium release is mediated by inositol 1,4,5-triphosphosphate (IP3 ) through IP3 -gated calcium channels. IP3 is generated through the action of G-protein-linked receptors that activate phospholipase C-β, which leaves the plasma membrane and diffuses to the ER to activate calcium channels. The wave of calcium also mediates PKC translocation from the cytosol to the plasma membrane, where it is activated by calcium, by the inner leaflet of the plasma membrane, and by diacylglycerol, the other product of phospholipase C-β. These calcium fluxes and PKC activation lead directly to activation of the ERK1/2 pathway (Ca+2 -PKC-Ras-c-Raf-MEK1/2-ERK1/2). Calcium fluxes can either be highly localized or can occur throughout the cell, providing a global effect. The pulses are usually short-lived since longlived elevations in intracellular calcium are often lethal. Some of the released ER calcium is taken up by mitochondria, which act as a temporary store before the calcium is returned to the ER (Berridge et al., 1998). Temporary calcium storage is fine, but when the ER becomes calcium depleted when calcium reuptake is blocked pharmacologically, for example, there are two cellular responses. First, loss of ER calcium leads to the induction of ER stress signals. And second, the subsequent buildup of calcium of mitochondrial calcium leads to mitochondrial dysfunction and eventually apoptosis (Dolmetsch et al., 1998; Berridge et al., 1998). This suggests that any perturbation with mitochondrial function leads to dire consequences.
1. Structure and Functions of Biomembranes
15
IV. OXIDATIVE STRESS AND ORGANELLE DYSFUNCTION Oxidative stress leads to a number of changes in cell membranes and organelle function. The best-characterized examples include the effects on the ER, peroxisomes, mitochondria, and lysosomes. Oxidative stress results from the buildup of reactive oxygen species (ROS) and reactive nitrogen species (RNS). High levels of ROS damage DNA, proteins and lipids and often lead to the dysregulation of signaling pathways and pathological consequences (reviewed in Schrader and Fahimi, 2006). Oxidative stress is associated with a number of diseases including atherosclerosis, cystic fibrosis, cancer, type-2 diabetes, and a number of neurodegenerative diseases such as Parkinson’s and Alzheimer’s disease. Increased oxidative stress has also been closely associated with aging (Schrader and Fahimi, 2006; Terlecky et al., 2006), suggesting that this is a normal consequence over time, and exacerbation of this process progresses to a disease state.
A. Oxidative Stress and the ER The first response to oxidative stress probably occurs in the endoplasmic reticulum. And that is because the ER has a number of signaling pathways that are based on the oxidation status of specific proteins (reviewed in Gorlach et al., 2006). Oxidative stress from ROS causes calcium release, leading to mitochondrial calcium loading, which leads to more ROS production and more calcium release. The sarco(endo)plasmic reticulum calcium ATPases (SERCAs) which mediate calcium reuptake into the ER, are inhibited by oxidation. Inhibition of calcium reuptake inhibits protein synthesis and processing and leads to the accumulation of partially folded proteins (Gorlach et al., 2006). When left unchecked, this can lead to the unfolded protein response that either facilitates cell recovery mechanisms, or promotes apoptosis, the result depending on the magnitude and duration of the unfolded protein response.
B. Oxidative Stress and Peroxisomes ROS include the superoxide anion and hydrogen peroxide, while RNS include nitric oxide. In the respiratory pathway in peroxisomes, electrons are removed from metabolites to reduce oxygen to hydrogen peroxide. Nitric oxide is also produced in peroxisomes (Stolz et al., 2002), indicating that peroxisomes play an important role in ROS/RNS production in the cell (Schrader and Fahimi, 2006). β-oxidation of fatty acids in peroxisomes is the major pathway for the production of hydrogen peroxide. Catabolism of hydrogen peroxide occurs via a number of antioxidant enzymes including catalase. Since hydrogen peroxide is membrane permeable, antioxidant enzymes that degrade it
16
J.F. Collawn and Z. Bebök
can also be found in the cytoplasm, nucleus, and mitochondria (Schrader and Fahimi, 2006). Problems arise when the β-oxidation enzymes are dramatically increased when activators of the peroxisome proliferators activated receptors (PPARs) such as free fatty acids overload the system. This leads to oxidative stress, and when left unchecked, cancer (Schrader and Fahimi, 2006). In other cases, transition metals such as ferrous iron, which are normally found in peroxisomes in complexed form, can be released to generate the hydroxyl radical, which causes serious lipid peroxidation, damage to the peroxisomal membrane, and eventually loss of peroxisomal function (Schrader and Fahimi, 2006; Yokota et al., 2001). Peroxisomes not only participate in the generation of ROS, but also have scavenging activities to metabolize these reactive oxygen molecules. When PPARs become activated, the expression of genes involved in lipid β-oxidation is strongly enhanced (up to 10-fold), while the induction of hydrogen peroxide scavenging genes such as catalase is not (1- to 2-fold) (Rao and Reddy, 1987). Since a number of xenobiotics induce PPARs including hypolipidemic drugs, industrial chemicals, agrochemicals, and many environmental pollutants (Beier and Fahimi, 1991), it has been proposed that the tumor-promoting properties of these compounds is caused by the disproportionate production of hydrogen peroxidegenerating enzymes over scavenging enzymes, leading to oxidative stress and eventually leading to hepatic tumors in animals (Schrader and Fahimi, 2006). An excellent review on peroxisomes and their central role as generators of oxidative stress can be found in Schrader and Fahimi (2006). Although peroxisomes are important in generating reactive oxygen species for metabolic purposes, they do not generate as much as mitochondria (Beckman and Ames, 1998; Lee and Wei, 2001). However, in peroxisomes when metal ion-catalyzed conversion of hydrogen peroxide to the hydroxide radical occurs, this can result in damage to mitochondria, promoting an escalation in ROS production (Terlecky et al., 2006), and a vicious cycle that leads to apoptosis. Peroxisome function is normally kept in check with catalase maintaining the delicate balance between hydrogen peroxide formation and degradation. When this balance is upset, there is an accumulation of hydrogen peroxide and downstream reactive oxygen species (Terlecky et al., 2006). When catalase activity is compromised, as in certain disease states or after exposure to certain xenobiotics, or even during the normal aging process, there is an increase in ROS that leads to oxidative damage to cellular constituents. That this is a part of the normal aging processing should not be considered surprising. In fact, there are new potential therapies that involve increasing catalase levels that may provide a benefit in the different aging pathologies associated with oxidant-induced cellular damage (Terlecky et al., 2006).
1. Structure and Functions of Biomembranes
17
C. Oxidative Stress and Mitochondria When peroxisomal balance is compromised, mitochondrial oxidative damage starts as well. This is a critical problem because mitochondrial deficiencies directly influence a number of diseases including Parkinson’s disease, diabetes mellitus, and possibly Alzheimer’s disease (Kakkar and Singh, 2007). The cell has antioxidants inside and outside mitochondria to detoxify ROS. Inside mitochondria, the hydroperoxyl radical is converted to hydrogen peroxide by matrix manganese superoxide dismutase, and the superoxide anion is partially dismutated by CuZn superoxide dismutase (reviewed in Kakkar and Singh, 2007). When left unchecked, ROS, especially very reactive radicals, attack proteins, lipids, and mitochondrial DNA. Outside mitochondria, two systems regulate the intracellular redox environment, glutathione-S transferase and thioredoxin. Since the reduced glutathione concentration is so high, it forms the strongest protection against oxidative stress within the cell. If, however, the reduced glutathione levels become depleted, then the cell is more sensitive to apoptotic stimuli (Kakkar and Singh, 2007). Thioredoxin is a thiol-specific antioxidant that is concentrated in the ER and functions to reduce disulfide bridges of proteins that have been subjected to oxidative stress. Both glutathione-S transferase and thioredoxin are required for maintaining the proper redox environment for proteins and act as thiol-specific antioxidants. When the redox system is overwhelmed, ROS damages a number of macromolecules, including cardiolipin, a mitochondrial specific lipid. This is a critical component of mitochondrial energetics since this lipid is present on the inner mitochondrial membrane and is important for the activities of the adenine nucleotide transporter and cytochrome c oxidase (Hoch, 1992; Paradies et al., 1998). Further, it has been proposed that mitochondrial DNA may be more sensitive to oxidative damage because (1) it lacks DNA associated proteins like histones; (2) several of the proteins encoded by mitochondrial are essential for the electron transport chain; (3) its DNA is close to where ROS production occurs; and (4) it is present in many thousand copies per cell (Kakkar and Singh, 2007). Mitochondrial DNA damage occurs over a lifetime, resulting in a decline in mitochondrial function, and increased ROS production. At the extreme end, overwhelming ROS production leads to release of cytochrome c and activation of apoptosis. Overproduction of ROS also mediates the oligomerization of the proapoptotic protein Bax through the introduction of intrachain disulfide bonds. Bax oligomerization is necessary for Bax insertion into the outer mitochondrial membrane, which leads to the release of cytochrome c and other proapoptotic proteins and the initiation of the apoptotic cascade (Er et al., 2006). Cytochrome c is anchored to the inner mitochondrial membrane by its affinity to cardiolipin, and this interaction is disrupted by cardiolipid oxidation by ROS (Neuzil et al., 2006). ROS, therefore, is a central mediator in several of the steps leading to cell death.
18
J.F. Collawn and Z. Bebök
D. Oxidative Stress and Lysosomes Many of the diseases that have been associated with ROS over-production involve the CNS, probably because of the brain’s particular susceptibility to oxidative damage (reviewed in Butler and Bahr, 2006). An interesting feature of a number of CNS diseases including Alzheimer’s disease is lysosomal activation (Butler and Bahr, 2006). Lysosomal activation is a normal consequence of in the CNS during aging, and oxidative damage appears to have profound effects on this organelle. There is an important link between lysosomal function and mitochondrial function since the accumulation of oxidized material within lysosomes during oxidative stress reduces autophagic processes, including the autophagic removal and recycling of damaged mitochondria (Brunk and Terman, 2002). Oxidative damage is a critical component of Alzheimer’s disease since the amyloidogenic peptides derived from the amyloid precursor protein form free radical species (Ditaranto et al., 2001; Goodman and Mattson, 1994; Hensley et al., 1994) and produce membrane oxidative stress (Cutler et al., 2004; Ditaranto et al., 2001). Further, oxidative damage to lysosomes by free radicals not only affects autophagy, but also disruption of the lysosomal membrane integrity results in lysosomal enzyme release which includes a number of cathepsins which are known to promote ROS production and apoptosis through their effects on mitochondria (Butler and Bahr, 2006). The data indicate that most of the harmful effects of oxidative damage to lysosomes results in mitochondrial damage, with an amplification of ROS production in a vicious cycle of cellular organelle damage that eventually leads to apoptosis.
E. Summary and Conclusions Oxidative stress is a process results from an inbalance between production and catabolism of reactive oxygen species. The cell has a number of mechanisms to protect against oxidative stress since it damages cell membranes, activates signaling cascades, and promotes mitochondrial DNA damage, along with organelle dysfunction. Many of the consequences, particularly fluxes in cytosolic calcium, oxidation of lipids, disruption of ER and lysosome function lead to mitochondrial damage. Interestingly, slow loss of mitochondrial function due to oxidative damage appears to be a component of the normal aging process. Severe insults to the cell, however, result in activation of the apoptotic cascade, probably because the oxidative damage is too pronounced for the cell’s machinery to facilitate recovery. Clearly understanding this process in more detail will allow for treatments of a number of neurological diseases, and interestingly, may also be important in understanding the normal aging process. Future therapies will be directly involved with the delicate balance between ROS production and ROS catabolism.
1. Structure and Functions of Biomembranes
19
References Beckman, K.B., Ames, B.N. (1998). The free radical theory of aging matures. Physiol. Rev. 78, 547– 581. Beier, K., Fahimi, H.D. (1991). Environmental pollution by common chemicals and peroxisome proliferation: Efficient detection by cytochemistry and automatic image analysis. Progr. Histochem. Cytochem. 23, 150–163. Berridge, M.J., Bootman, M.D., Lipp, P. (1998). Calcium – a life and death signal. Nature 395, 645– 648. Birkenkamp, K.U., Dokter, W.H., Esselink, M.T., Jonk, L.J., Kruijer, W., Vellenga, E. (1999). A dual function for p38 MAP kinase in hematopoietic cells: Involvement in apoptosis and cell activation. Leukemia 13, 1037–1045. Brunk, U.T., Terman, A. (2002). The mitochondrial-lysosomal axis theory of aging: Accumulation of damaged mitochondria as a result of imperfect autophagocytosis. Eur. J. Biochem. / FEBS 269, 1996–2002. Burgering, B.M., de Vries-Smits, A.M., Medema, R.H., van Weeren, P.C., Tertoolen, L.G., Bos, J.L. (1993). Epidermal growth factor induces phosphorylation of extracellular signal-regulated kinase 2 via multiple pathways. Mol. Cell. Biol. 13, 7248–7256. Butler, D., Bahr, B.A. (2006). Oxidative stress and lysosomes: CNS-related consequences and implications for lysosomal enhancement strategies and induction of autophagy. Antioxidants & Redox Sign. 8, 185–196. Chen, X.Z., Vassilev, P.M., Basora, N., Peng, J.B., Nomura, H., Segal, Y., Brown, E.M., Reeders, S.T., Hediger, M.A., Zhou, J. (1999). Polycystin-L is a calcium-regulated cation channel permeable to calcium ions. Nature 401, 383–386. Cho, H.Y., Reddy, S.P., Kleeberger, S.R. (2006). Nrf2 defends the lung from oxidative stress. Antioxidants & Redox Sign. 8, 76–87. Corey, D.P. (2003). New TRP channels in hearing and mechanosensation. Neuron 39, 585–588. Correa-Meyer, E., Pesce, L., Guerrero, C., Sznajder, J.I. (2002). Cyclic stretch activates ERK1/2 via G proteins and EGFR in alveolar epithelial cells. Am. J. Physiol. Lung. Cell. Mol. Physiol. 282, 883–891. Cross, J.V., Templeton, D.J. (2004). Oxidative stress inhibits MEKK1 by site-specific glutathionylation in the ATP-binding domain. Biochem. J. 381, 675–683. Cuadrado, A., Bruder, J.T., Heidaran, M.A., App, H., Rapp, U.R., Aaronson, S.A. (1993). H-ras and raf-1 cooperate in transformation of NIH3T3 fibroblasts. Oncogene 8, 2443–2448. Cutler, R.G., Kelly, J., Storie, K., Pedersen, W.A., Tammara, A., Hatanpaa, K., Troncoso, J.C., Mattson, M.P. (2004). Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer’s disease. Proc. Natl. Acad. Sci. USA 101, 2070–2075. Damjanovich, S., Bene, L., Matko, J., Matyus, L., Krasznai, Z., Szabo Jr., G., Pieri, C., Gaspar Jr., R., Szollosi, J. (1999). Two-dimensional receptor patterns in the plasma membrane of cells. A critical evaluation of their identification, origin and information content. Biophys. Chem. 82, 99–108. Davis, M.J., Wu, X., Nurkiewicz, T.R., Kawasaki, J., Davis, G.E., Hill, M.A., Meininger, G.A. (2001). Integrins and mechanotransduction of the vascular myogenic response. Am. J. Physiol. 280, 1427– 1433. Davis, R.J. (1999). Signal transduction by the c-Jun N-terminal kinase. Biochem. Soc. Symp. 64, 1–12. Delmas, P. (2004). Polycystins: From mechanosensation to gene regulation. Cell 118, 145–148. Dietrich, C., Yang, B., Fujiwara, T., Kusumi, A., Jacobson, K. (2002). Relationship of lipid rafts to transient confinement zones detected by single particle tracking. Biophys. J. 82, 274–284. Ditaranto, K., Tekirian, T.L., Yang, A.J. (2001). Lysosomal membrane damage in soluble Abetamediated cell death in Alzheimer’s disease. Neurobiol. Disease 8, 19–31. Dolmetsch, R.E., Xu, K., Lewis, R.S. (1998). Calcium oscillations increase the efficiency and specificity of gene expression. Nature 392, 933–936.
20
J.F. Collawn and Z. Bebök
Driscoll, M., Chalfie, M. (1991). The mec-4 gene is a member of a family of Caenorhabditis elegans genes that can mutate to induce neuronal degeneration. Nature 349, 588–593. Er, E., Oliver, L., Cartron, P.F., Juin, P., Manon, S., Vallette, F.M. (2006). Mitochondria as the target of the pro-apoptotic protein Bax. Biochim. Biophys. Acta 1757, 1301–1311. Ermak, G., Davies, K.J. (2002). Calcium and oxidative stress, from cell signaling to cell death. Mol. Immun. 38, 713–721. Evans, E.A., Waugh, R., Melnik, L. (1976). Elastic area compressibility modulus of red cell membrane. Biophys. J. 16, 585–595. Franco Jr., A., Lansman, J.B. (1990). Calcium entry through stretch-inactivated ion channels in mdx myotubes. Nature 344, 670–673. Goodman, Y., Mattson, M.P. (1994). Secreted forms of beta-amyloid precursor protein protect hippocampal neurons against amyloid beta-peptide-induced oxidative injury. Exp. Neurol. 128, 1–12. Gorlach, A., Klappa, P., Kietzmann, T. (2006). The endoplasmic reticulum, folding, calcium homeostasis, signaling, and redox control. Antioxidants & Redox Sign. 8, 1391–1418. Gotoh, I., Adachi, M., Nishida, E. (2001). Identification and characterization of a novel MAP kinase kinase kinase, MLTK. J. Biol. Chem. 276, 4276–4286. Gotoh, Y., Nishida, E. (1995). Activation mechanism and function of the MAP kinase cascade. Mol. Repr. Dev. 42, 486–492. Gutierrez, J.A., Suzara, V.V., Dobbs, L.G. (2003). Continuous mechanical contraction modulates expression of alveolar epithelial cell phenotype. Am. J. Resp. Cell Mol. Biol. 29, 81–87. Hamill, O.P., McBride Jr., D.W. (1997). Induced membrane hypo/hyper-mechanosensitivity, a limitation of patch-clamp recording. Annu. Rev. Physiol. 59, 621–631. Han, B., Bai, X.H., Lodyga, M., Xu, J., Yang, B.B., Keshavjee, S., Post, M., Liu, M. (2004). Conversion of mechanical force into biochemical signaling. J. Biol. Chem. 279, 54793–54801. Hansen, D.E., Craig, C.S., Hondeghem, L.M. (1990). Stretch-induced arrhythmias in the isolated canine ventricle. Evidence for the importance of mechanoelectrical feedback. Circulation 81, 1094–1105. Hensley, K., Carney, J.M., Mattson, M.P., Aksenova, M., Harris, M., Wu, J.F., Floyd, R.A., Butterfield, D.A. (1994). A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide, relevance to Alzheimer disease. Proc. Natl. Acad. Sci. USA 91, 3270– 3274. Hoch, F.L. (1992). Cardiolipins and biomembrane function. Biochim. Biophys. Acta 1113, 71–133. Hoyle, P.E., Moye, P.W., Steelman, L.S., Blalock, W.L., Franklin, R.A., Pearce, M., Cherwinski, H., Bosch, E., McMahon, M., McCubrey, J.A. (2000). Differential abilities of the Raf family of protein kinases to abrogate cytokine dependency and prevent apoptosis in murine hematopoietic cells by a MEK1-dependent mechanism. Leukemia 14, 642–656. Kakkar, P., Singh, B.K. (2007). Mitochondria: A hub of redox activities and cellular distress control. Mol. Cell. Biochem. 305, 235–253. Katz, B. (1950). Depolarization of sensory terminals and the initiation of impulses in the muscle spindle. J. Physiol. 111, 261–282. Lee, H.C., Wei, Y.H. (2001). Mitochondrial alterations, cellular response to oxidative stress and defective degradation of proteins in aging. Biogerontology 2, 231–244. Lu, Z., Xu, S. (2006). ERK1/2 MAP kinases in cell survival and apoptosis. IUBMB Life 58, 621–631. MacGillivray, M.K., Cruz, T.F., McCulloch, C.A. (2000). The recruitment of the interleukin-1 (IL-1) receptor-associated kinase (IRAK) into focal adhesion complexes is required for IL-1beta-induced ERK activation. J. Biol. Chem. 275, 23509–23515. Martinac, B. (2004). Mechanosensitive ion channels, molecules of mechanotransduction. J. Cell Sci. 117, 2449–2460. Martinac, B., Hamill, O.P. (2002). Gramicidin A channels switch between stretch activation and stretch inactivation depending on bilayer thickness. Proc. Natl. Acad. Sci. USA 99, 4308–4312. McCubrey, J.A., Lahair, M.M., Franklin, R.A. (2006). Reactive oxygen species-induced activation of the MAP kinase signaling pathways. Antioxidants & Redox Sign. 8, 1775–1789.
1. Structure and Functions of Biomembranes
21
Neuzil, J., Wang, X.F., Dong, L.F., Low, P., Ralph, S.J. (2006). Molecular mechanism of ‘mitocan’induced apoptosis in cancer cells epitomizes the multiple roles of reactive oxygen species and Bcl-2 family proteins. FEBS Lett. 580, 5125–5129. Orr, A.W., Helmke, B.P., Blackman, B.R., Schwartz, M.A. (2006). Mechanisms of mechanotransduction. Developmental Cell 10, 11–20. Paradies, G., Ruggiero, F.M., Petrosillo, G., Quagliariello, E. (1998). Peroxidative damage to cardiac mitochondria, cytochrome oxidase and cardiolipin alterations. FEBS Lett. 424, 155–158. Pieczenik, S.R., Neustadt, J. (2007). Mitochondrial dysfunction and molecular pathways of disease. Exp. Mol. Pathol. 83, 84–92. Rao, M.S., Reddy, J.K. (1987). Peroxisome proliferation and hepatocarcinogenesis. Carcinogenesis 8, 631–636. Sachs, F. (1988). Mechanical transduction in biological systems. Crit. Rev. Biomed. Eng. 16, 141–169. Sachs, F., Morris, C.E. (1998). Mechanosensitive ion channels in nonspecialized cells. Rev. Physiol. Biochem. Pharmacol. 132, 1–77. Salmeron, A., Ahmad, T.B., Carlile, G.W., Pappin, D., Narsimhan, R.P., Ley, S.C. (1996). Activation of MEK-1 and SEK-1 by Tpl-2 proto-oncoprotein, a novel MAP kinase kinase kinase. EMBO J. 15, 817–826. Sanchez-Esteban, J., Wang, Y., Gruppuso, P.A., Rubin, L.P. (2004). Mechanical stretch induces fetal type II cell differentiation via an epidermal growth factor receptor-extracellular-regulated protein kinase signaling pathway. Am. J. Resp. Cell Mol. Biol. 30, 76–83. Schrader, M., Fahimi, H.D. (2006). Peroxisomes and oxidative stress. Biochim. Biophys. Acta 1763, 1755–1766. Simons, K., Toomre, D. (2000). Lipid rafts and signal transduction. Nature Rev. 1, 31–39. Singer, S.J., Nicolson, G.L. (1972). The fluid mosaic model of the structure of cell membranes. Science 175, 720–731. Stolz, D.B., Zamora, R., Vodovotz, Y., Loughran, P.A., Billiar, T.R., Kim, Y.M., Simmons, R.L., Watkins, S.C. (2002). Peroxisomal localization of inducible nitric oxide synthase in hepatocytes. Hepatology 36, 81–93. Baltimore, MD. Terlecky, S.R., Koepke, J.I., Walton, P.A. (2006). Peroxisomes and aging. Biochim. Biophys. Acta 1763, 1749–1754. Tschumperlin, D.J., Dai, G., Maly, I.V., Kikuchi, T., Laiho, L.H., McVittie, A.K., Haley, K.J., Lilly, C.M., So, P.T., Lauffenburger, D.A., Kamm, R.D., Drazen, J.M. (2004). Mechanotransduction through growth-factor shedding into the extracellular space. Nature 429, 83–86. Vereb, G., Szollosi, J., Matko, J., Nagy, P., Farkas, T., Vigh, L., Matyus, L., Waldmann, T.A., Damjanovich, S. (2003). Dynamic, yet structured: The cell membrane three decades after the Singer– Nicolson model. Proc. Natl. Acad. Sci. USA 100, 8053–8058. Widmann, C., Gibson, S., Jarpe, M.B., Johnson, G.L. (1999). Mitogen-activated protein kinase, conservation of a three-kinase module from yeast to human. Physiol. Rev. 79, 143–180. Wirtz, H.R., Dobbs, L.G. (2000). The effects of mechanical forces on lung functions. Resp. Physiol. 119, 1–17. Yokota, S., Oda, T., Fahimi, H.D. (2001). The role of 15-lipoxygenase in disruption of the peroxisomal membrane and in programmed degradation of peroxisomes in normal rat liver. J. Histochem. Cytochem. 49, 613–622.
CHAPTER 2 The Interaction of Reactive Oxygen and Nitrogen Species with Membranes Matías N. Möller∗ , Jack R. Lancaster Jr.† and Ana Denicola∗ ∗ Lab. Fisicoquímica Biológica, Facultad de Ciencias, Universidad de la Republica, Igua 4225, 11400 Montevideo, Uruguay † Departments of Anesthesiology, Physiology & Biophysics, and Environmental Health Sciences and Center for Free Radical Biology, University of Alabama at Birmingham, AL, USA
I. Reactive Oxygen and Nitrogen Species II. Physical Interactions: Compartmentalizing Reactivity A. Nitric Oxide and Oxygen B. Superoxide C. Hydrogen Peroxide D. Hydroxyl Radical E. Peroxynitrite and Nitrogen Dioxide F. Carbonate Radical G. Permeability of Ionic Species and Their Conjugate Acids H. Solubility of ·NO and O2 in Membranes I. Diffusion of ·NO and O2 in Membranes III. Chemical Effects: Lipid Peroxidation A. Nitric Oxide B. Nitrogen Dioxide C. Peroxynitrite and Carbonate Radical D. Superoxide E. Hydrogen Peroxide and Hydroxyl Radical F. Biophysical Effects of Lipid Peroxidation in Membranes References
I. REACTIVE OXYGEN AND NITROGEN SPECIES The term reactive oxygen–nitrogen species (RONS) is used to group a number of molecules derived from and including molecular oxygen and nitric oxide (·NO). Most RONS are oxidizing species, free radicals (like O2 , ·NO) but some are still reactive although not radicals (like hydrogen peroxide or peroxynitrite). Current Topics in Membranes, Volume 61 Copyright © 2008, Elsevier Inc. All rights reserved
1063-5823/08 $35.00 DOI: 10.1016/S1063-5823(08)00202-0
24
M.N. Möller et al.
FIGURE 1 Reaction network of oxygen and nitrogen reactive species. It can be appreciated how RNS arise from the interaction of ·NO with ROS, either by the autoxidation of ·NO, or by the reaction of ·NO with superoxide to yield peroxynitrite. The formation of the conjugate acids of superoxide and peroxynitrite has been included because it is the neutral form of the molecule that can cross the biomembrane by simple diffusion. Furthermore, the formation of radical species from peroxynitrous acid or from nitrosoperoxycarboxylate (ONOOCO− 2 ) may participate in membrane permeation and oxidation. The metal-dependent reduction of H2 O2 (Fenton reaction) generates hydroxyl radical, a good initiator of membrane lipoperoxidation.
They are reactive towards several biomolecules, most of the times oxidizing, damaging and leading to deleterious effects on their function, although some important exceptions exist and some RONS are endogenously produced with specific physiological roles. The final effect of RONS in a biological environment will greatly depend on their interactions with biomembranes, which is the focus of the present chapter. But first, let’s overview some of the main RONS formed in vivo (Figure 1): Nitric oxide is an important intercellular messenger produced enzymatically from the oxidation of L-arginine by nitric oxide synthases (NOS) (Stuehr et al., 2004). It is involved in vasodilation, neurotransmission, and also in immune response (Beckman and Koppenol, 1996). It switches from cell signaling to cell damaging by significantly increasing the amount of ·NO produced and reacting with other molecules to form more reactive species (Beckman and Koppenol, 1996). It can react with superoxide (O·− 2 ) at diffusion-limited rates to form the more oxidizing species peroxynitrite (Radi et al., 2000). Peroxynitrite (ONOO− ) is an oxidizing species with a complex chemistry (Radi et al., 2000), that is illustrated in Figure 1. It is relevant to note its pKa = 6.8 close to physiological pH,
2. The Interaction of Reactive Oxygen and Nitrogen Species with Membranes
25
its ability to form radicals nitrogen dioxide (·NO2 ) and hydroxyl radical (·OH) in a 30% yield or rearrange to nitrate (70%), and its reactivity with CO2 to also form ·NO and carbonate radical (CO·− ) in a 35% yield. 2 3 Alternatively, ·NO can react with O2 , to yield primarily ·NO2 and then dinitrogen trioxide (N2 O3 ), important nitrating and nitrosating species, in a reaction that is accelerated by lipid membranes (Liu et al., 1998; Möller et al., 2007a, 2007b). There are several sources of superoxide, which include NADPH oxidase, xanthine oxidase, mitochondrial electron leakage and xenobiotic metabolism (Radi et al., 2000). The superoxide anion can form its conjugate acid, the perhydroxyl radical (HOO·) with a pKa = 4.8 and it can also be reduced to hydrogen peroxide (H2 O2 ) (Green and Hill, 1984). The antioxidant enzyme responsible for O·− 2 detoxification is superoxide dismutase (SOD), a metal-dependent enzyme that catalyzes O·− 2 disproportionation to O2 and H2 O2 (Brunori and Rotilio, 1984). Hydrogen peroxide is relatively stable, but reacts with reduced metals via Fenton reaction to yield the most oxidizing species: hydroxyl radical (·OH) (Buettner, 1993). Because of this and its role in cell signaling, there are additional antioxidant enzymes to deal with H2 O2 , including metal-dependent (catalase), selenium-dependent (glutathione peroxidase), and thiol-dependent peroxidases (peroxiredoxins) (Rhee et al., 2005). All the RONS interact with biomembranes, either by directly reacting with membrane components and modifying its structure and function, or just crossing them to react with targets on the other side of the membrane. In the next section we will be mainly concerned with the ability of these different species to permeate through the lipid membrane, and then deal with chemical effects on membrane components. The chemical effects will be focused on lipids, the common building blocks of biomembranes, since the effect of RONS on membrane proteins will depend on the particular membrane studied, and will be dealt with in subsequent chapters.
II. PHYSICAL INTERACTIONS: COMPARTMENTALIZING REACTIVITY One of the main functions of biomembranes is to delimit and separate cell and organelles components and functions. In a similar way, the site of action of some RONS can be restricted by biomembranes (additional chemical reactions can also limit the site of action). Therefore, the reactivity of some RONS can be compartmentalized, according to the ability of RONS to traverse a biomembrane. As a general rule, uncharged nonelectrolytes can diffuse through the lipid part of the membrane, while charged species need either to form its conjugate acid, or need a protein channel to permeate a membrane at significant rates. Another important rule is that the smaller and less polar the molecule, the higher permeability through membranes. The order of permeability across pure lipid membranes is: ·NO, O ONOOH, ·NO , HOO·, H O O·− , ONOO− , CO·− (Figure 2). 2 2 2 2 3
26
M.N. Möller et al.
FIGURE 2 Classification of reactive species according to their lipid membrane permeation capacity. Pm /Pw is the ratio between membrane permeability and the permeability through an equivalent layer of water. Lipid membranes are not barriers to the passage of ·NO or O2 , while it offers a moderate barrier to the permeation of hydrophilic polar nonelectrolytes, similar to that of water. The permeability of charged molecules is too low to be significant, and will not occur at significant rates unless protein channels are present.
It should be noted that Overton’s rule, that states that the permeability is directly related to solubility in an organic solvent, is not strictly followed by small molecules (nonelectrolytes with mass <50 Da) which show a higher than expected permeability (Lieb and Stein, 1986; Walter and Gutknecht, 1986). It is not necessary for a molecule to be lipophilic (i.e. to be more soluble in the hydrophobic interior of membranes than in water) to permeate a membrane. Polar non-charged molecules like H2 O can enter and cross the membrane even though their solubility is 1000 times lower in the membrane than in water (Figure 2). However, charged molecules find a much higher barrier to permeation, and can traverse membranes only at very low rates (see Cl− in Figure 2), unless protein channels are present. For comparing the ability of different RONS to permeate lipid membranes, we will use reported permeability coefficients (Pm ) that indicate the speed at which the molecule moves across the membrane (Stein, 1986), and relates the flux of the molecule across the membrane (Jm ) to the difference in concentration at both sides of the membrane (C, Eq. (1)). Pm is determined by the diffusion coefficient of the molecule in the membrane (Dm ), the partition coefficient of the molecule between the membrane and water (KP ), and the thickness of the mem-
2. The Interaction of Reactive Oxygen and Nitrogen Species with Membranes
27
brane (δ, Eq. (2)). Jm = Pm .C
(1)
Pm = Dm .KP /δ
(2)
To compare the barrier effect of membranes to the transport of RONS, we compare Pm values with the calculated permeability through an equally thick layer of water, Pw (Eq. (3)) Pw = Dw /δ
(3)
Table 1 summarizes the reported Pm values for different RONS and the calculated Pm /Pw ratios. A. Nitric Oxide and Oxygen The barrier to ·NO and O2 membrane permeation is very low. It is so low that direct measurements of ·NO or O2 transport across membranes cannot be done, because the aqueous layer at both sides of the membrane offers a higher resistance to ·NO or O2 transport than the membrane itself (see below). However, the permeability through membranes could be determined from the interaction of these molecules with spin- or fluorescent probes located at different depths in the lipid membrane, yielding Pm values 10–100 cm/s. For comparison, the permeability of membranes to H2 O or other polar non-charged species is 3–6 orders of magnitude lower (Pm = 10−2 –10−4 cm/s, see Table 1). Thus, biomembranes are not barriers to ·NO and O2 transport. The differences in the calculated Pm /Pw ratios by different authors (Table 1) arise mainly from considering different experimentally determined Dw . As general considerations, it can be seen that the addition of cholesterol to egg yolk phosphatidylcholine (EYPC) leads to slight decrease in ·NO permeability (Subczynski et al., 1996), and also that the lowest permeability is observed in red blood cell membranes (Denicola et al., 1996), but is only 1/5 that through water. According to the assays using probes at different depths of the membrane bilayer, the main permeation barrier is located in the region of the polar headgroups of the phospholipids or in the water interface, while transport is maximal in the mid-bilayer (Denicola et al., 1996; Subczynski et al., 1996). The permeability of membranes to O2 has been studied in a wide range of conditions, and thus we can generalize some observations. As for ·NO, the main barrier to permeation in the membrane lies in the polar headgroups/water interface region, the permeability decreases when cholesterol is added and increases with temperature (Table 1 and references therein). The plasma membrane from Chinese hamster ovary and human red blood cells exhibit the lowest permeability to O2 (Subczynski et al., 1992; Denicola et al., 1996), but even in these cases the permeability of the membrane is just 1/3 that of water (Table 1).
28
M.N. Möller et al.
TABLE 1 Permeability coefficients of reactive oxygen and nitrogen species across different lipid membranes Molecule Membrane
T (°C) Pm (cm/s) Pm /Pw b
Ref.
·NO ·NO ·NO ·NO
EYPC EYPC:Chol (30% Chol) EYPC RBC (human)
20 20 20 20
73 66 47a 18a
1.28 1.17 0.36 0.2
(Subczynski et al., 1996) (Subczynski et al., 1996) (Denicola et al., 1996) (Denicola et al., 1996)
O2 O2 O2 O2 O2 O2 O2 O2 O2 O2 O2 O2 O2
EYPC RBC (human) EYPC EYPC:Chol (30% Chol) CHO CHO DMPC DMPC DOPC DOPC Lens Lipid POPC:Chol (50% Chol) POPC
20 20 20 20 20 37 18 29 10 30 35 35 35
87a 38a 62 56 21 42 12 125 33 114 51 50 157
0.62 0.42 1.08 0.85 0.34 0.45 0.4 1.8 0.8 1.6 0.96 0.94 3.0
(Denicola et al., 1996) (Denicola et al., 1996) (Subczynski et al., 1996) (Subczynski et al., 1996) (Subczynski et al., 1992) (Subczynski et al., 1992) (Subczynski et al., 1989) (Subczynski et al., 1989) (Subczynski et al., 1989) (Subczynski et al., 1989) (Widomska et al., 2007) (Widomska et al., 2007) (Widomska et al., 2007)
H2 O H2 O
EYPC RBC (human)
25 25
2 × 10−4 ∼10−5 1.2 × 10−3 ∼5 × 10−5
(Gennis, 1989) (Lieb and Stein, 1986)
H 2 O2 H 2 O2 H 2 O2 H 2 O2 H 2 O2 H 2 O2 H 2 O2 H 2 O2 O·− 2 O·− 2 O·− 2 HOO·
RBC (rat) PC12 HUVEC IMR-90 Peroxisome (rat liver) E. coli Chara chorallina Jurkat T-Cell DODAC SBPC EYPC EYPC
37 45 25 23 23
1.2 × 10−2 4 × 10−4 1.6 × 10−3 1.1 × 10−3 3 × 10−3 1.6 × 10−3 3.6 × 10−4 2 × 10−4 10−6 2.1 × 10−6 7.6 × 10−8 4.9 × 10−4
∼5 × 10−4 ∼2 × 10−5 ∼6 × 10−5 ∼4 × 10−5 ∼10−4 ∼6 × 10−5 ∼10−5 ∼10−5 ∼4 × 10−8 ∼10−7 ∼10−9 ∼2 × 10−5
(Mathai and Sitaraman, 1994) (Makino et al., 2004) (Makino et al., 2004) (Makino et al., 2004) (Makino et al., 2004) (Makino et al., 2004) (Makino et al., 2004) (Antunes and Cadenas, 2000) (Gomes et al., 1993) (Takahashi and Asada, 1983) (Gus’kova et al., 1984) (Gus’kova et al., 1984)
ONOOH ONOOH ONOOH ONOOH
DMPC EYPC DMPC DPPC
23 21 21 21
8 × 10−4 1.3 × 10−3 6.3 × 10−4 4 × 10−4
∼3 × 10−5 ∼5 × 10−5 ∼2.5 × 10−5 ∼1.6 × 10−5
(Marla et al., 1997) (Khairutdinov et al., 2000) (Khairutdinov et al., 2000) (Khairutdinov et al., 2000)
Na+
EYPC
25
10−14
∼10−16
(Gennis, 1989)
25
10−11
∼10−13
(Gennis, 1989)
Cl−
EYPC
Abbreviations: PC: phosphatidylcholine; EYPC: egg yolk PC; Chol: cholesterol; RBC: red blood cell membrane; CHO: Chinese hamster ovary plasma membrane; DMPC: dimyristoyl PC; DOPC: dioleoyl PC; POPC: palmitoyloleoyl PC; DODAC: dioctadecyldimethylammonium chloride; SBPC: soy bean PC; DPPC: dipalmitoyl PC. a Calculated from data in the reference, P = (average D m app )/d ; where d is 3.2 and 5.0 nm for EYPC and RBC membrane, respectively. b Except for O and ·NO, the rest of the P /P are estimated values using P = 25 cm/s, corresponding to a m w w 2 typical Dw = 1 × 10−5 cm2 /s and δ = 4 nm.
2. The Interaction of Reactive Oxygen and Nitrogen Species with Membranes
29
Why are there problems measuring the permeability of membranes to ·NO or O2 then, if they are just 1/5 to 1/3 that of on equivalent layer of water? Because there is normally a water layer much thicker than the membrane. For directly measuring permeability through the membrane it is necessary to make the transport across the membrane the rate limiting step. However, even with the most vigorous stirring or turbulent flow, due to hydrodynamic effects, cells (or liposomes) are surrounded by an “unstirred layer” of unmixed water, where transport is limited by diffusion (Liu et al., 1998). Thus, in any experimental condition, ·NO usually spends more time traveling through the aqueous solution than crossing the membrane. This can be illustrated by considering the total “resistance” to permeability (PT−1 ), which is the sum of membrane resistance (Pm−1 ) and the unstirred water layer resistance (Pw−1 ) (Figure 3)1 : PT−1 = Pw−1 + Pm−1
(4)
Note that a 12 nm-thick aqueous layer offers a resistance equal to that imposed by red blood cell membranes to ·NO (using Dw = 2.2 × 10−5 cm2 s−1 ) (Zacharia and Deen, 2005), while unstirred layers are usually thicker than 1 µm (1000 nm!) (Liu et al., 1998).
B. Superoxide Ions face a much higher barrier to membrane permeation than nonelectrolytes. The permeability coefficient for chloride across an EYPC membrane is 10−11 cm/s, several orders of magnitude slower than for O2 or water. To cross the membrane, the ion must lose the water hydration shell before entering the membrane and then move into a nonpolar medium. This process is energetically very unfavorable, so membranes are effective barriers to passive ion transport (Gennis, 1989). In cellular membranes, this is compensated by the presence of protein channels in the membrane that facilitate ion transport. Using anion channels (band 3), superoxide can easily cross the red blood cell membrane, and this was demonstrated by blocking O·− 2 transport with the band 3 inhibitors DIDS and SITS (Lynch and Fridovich, 1978b). The decrease in O·− 2 efflux by band 3 inhibitors indicates that basal (passive) permeability is low. It has been estimated that the permeability through a pure soy bean PC membrane (no ion channels) is 2.1 × 10−6 cm/s (Takahashi and Asada, 1983), similar to the estimated permeability through dioctadecyldimethylammonium chloride membranes (DODAC) in the liquid crystalline state (10−6 cm/s, Table 1, Gomes et al., 1993). This permeability coefficient is still too high for a ionic species like superoxide anion. In fact, Gus’kova et al. showed that O·− 2 permeation was insensitive 1 For interpretation of the references to color in this figure legend, the reader is referred to the web version of this book.
30
M.N. Möller et al.
FIGURE 3 Membrane resistance to ·NO permeation, compared with an aqueous layer of variable thickness. The resistance to ·NO permeation through an aqueous layer Pw−1 was calculated using Eq. (3) and DNO = 2.2 × 109 nm2 /s and increases linearly with layer thickness (red line). The resistance to ·NO permeation through the red blood cell membrane (5.6 × 10−9 s/nm, Table 1) and through EYPC membranes (1.4 × 10−9 s/nm, Table 1) are indicated in green. It can be appreciated that a 12.2 nm thick aqueous layer offers the same resistance than a red blood cell membrane, and an even narrower layer of water is equivalent to an EYPC membrane. Unstirred layers are usually thicker than 1 µm, offering a resistance 100 times greater than the membrane itself.
to transmembrane potential, indicating that the permeating species could not be charged, and should be the conjugated acid HOO· instead (Gus’kova et al., 1984). They estimated a permeability coefficient of 4.9 × 10−4 cm/s for HOO·, while −7 cm/s (Table 1). Pm for O·− 2 ∼10
C. Hydrogen Peroxide Hydrogen peroxide (H2 O2 ) is a hydrophilic molecule (KP between ether and water is 0.07 at 26 °C, Mathai and Sitaraman, 1994) that can cross lipid membranes in a similar manner to water. Most of the reported permeability coefficients in different cell membranes lie between 1 × 10−3 and 2 × 10−4 cm/s, very similar to the values reported for water (Table 1). Therefore, the membrane offers an intermediate barrier to H2 O2 transport. The permeability has been observed to vary according to the lipid composition of the membrane (Mathai and Sitaraman, 1994), and even more, Saccharomyces cerevisiae can regulate its membrane composition to decrease H2 O2 permeation (Branco et al., 2004). It was recently
2. The Interaction of Reactive Oxygen and Nitrogen Species with Membranes
31
TABLE 2 Partition coefficients for ·NO and O2 in different lipid systems O
Lipid system
T (°C)
KPNO
KP 2
Ref.
EYPC DLPC LDL Triton X-100 DMPC DMPC RBC DMPC DMPC DMPC
25 25 25 25 35 20
3.6 ± 0.3 3.6 ± 0.6 3.0 ± 0.4 3.1 ± 0.5
3.2 ± 0.3 3.2 2.6 ± 0.3 2.6 4.1 ± 0.6 1.0 ± 0.5 5±4 1.3 3.1 3.3
(Möller et al., 2005, 2007b) (Möller et al., 2007b) (Möller et al., 2005, 2007b) (Möller et al., 2007b) (Smotkin et al., 1991) (Smotkin et al., 1991) (Power and Stegall, 1970) (Subczynski and Hyde, 1983) (Subczynski and Hyde, 1983) (Subczynski and Hyde, 1983)
20 30 37
Abbreviations: as in Table 1, DLPC: dilauroyl PC.
demonstrated that H2 O2 can also use aquaporins (membrane water channels), which increases its permeation through membranes (Bienert et al., 2007).
D. Hydroxyl Radical This radical can be formed from ONOOH homolysis, or from metal-mediated H2 O2 reduction (Figure 1). It is a small polar nonelectrolyte, so it would be expected to permeate like water. However, ·OH is so reactive that will react with the first molecule it finds, within a few nm of the site of formation (Halliwell and Gutteridge, 2000). Facing a membrane, it will react not only with inner fatty acids, but also with the polar headgroups, which are unreactive towards other RONS. Therefore, ·OH will not traverse but react with the membrane.
E. Peroxynitrite and Nitrogen Dioxide Both peroxynitrite and its conjugate acid, peroxynitrous acid, can permeate biological membranes, but through different routes. Peroxynitrous acid can cross lipid bilayers by simple diffusion (Denicola et al., 1998; Khairutdinov et al., 2000; Marla et al., 1997), with a permeability coefficient similar to water (1.3–0.8 × 10−3 cm/s, Khairutdinov et al., 2000; Marla et al., 1997), while peroxynitrite uses anion channels like the band 3 of red blood cells membrane (Denicola et al., 1998). Although it is hard to differentiate between ONOOH and ·NO2 permeation, Khairutdinov et al. showed that ·NO2 could permeate phospholipids membranes as much as ONOOH (Khairutdinov et al., 2000).
32
M.N. Möller et al.
However, additional experiments suggest that ONOOH is even more permeable than ·NO2 . Using lipophilic tyrosine analogs, or tyrosine containing transmembrane peptides, Kalyanaraman et al. showed that intramembrane tyrosine nitration by peroxynitrite (that homolyzes to ·NO2 ) was more efficient than nitration of tyrosine in solution (Zhang et al., 2001). Moreover, the tyrosine residues located closer to the center of the bilayer resulted more nitrated by peroxynitrite, but when myeloperoxidase-derived ·NO2 was used, the nitration yields increased in the opposite direction, favoring the tyrosine residues closer to the surface (Zhang et al., 2003).
F. Carbonate Radical Peroxynitrite reacts very fast with CO2 to yield an unstable intermediate that decays to ·NO2 and carbonate radical (CO·− 3 ) (Figure 1). Carbonate radical is a more selective oxidant than ·OH, is more bulky and is negatively charged. As already discussed, the charge prevents the molecule from entering into the nonpolar lipid interior, and considerably limits its permeability. Furthermore, the pKa of carbonate radical is close to 0, so it will never form the conjugate acid that may permeate the membrane, as ONOOH or HOO· do (Augusto et al., 2002). In agreement with expected results, carbonate radical is very inefficient in crossing pure phospholipids membranes (Khairutdinov et al., 2000), and also in crossing red blood cell membranes (Romero et al., 1999). In theory, it could cross through anion channels, but its reactions with other molecules may preclude its permeation.
G. Permeability of Ionic Species and Their Conjugate Acids As mentioned above, CO·− 3 will always be ionic because of its low pKa , while ·− − ONOO and O2 can form their conjugate acids because their pKa are closer to the physiological pH. In the protonated form, both ONOOH and HOO· show similar transport properties across membranes, however, at pH 7.4, these species are mostly in the ionic state. The proportion of protonated species relative to the total species can be calculated as: −1 [HA]/ [HA] + [A− ] = 1 + 10(pH-pKa ) (5) So that using the reported pKa (6.8 and 4.8, for peroxynitrite and superoxide, respectively) we can calculate that 20% of peroxynitrite will be present as ONOOH, while only 0.16% of superoxide will be protonated. Therefore, at pH 7.4, mem− branes will restrict more the transport of O·− 2 than that of ONOO (∼100 times − more). This is why it is argued that the sites of ONOO formation are dictated mainly by the sites of O·− 2 formation (Radi et al., 2000).
2. The Interaction of Reactive Oxygen and Nitrogen Species with Membranes
33
H. Solubility of ·NO and O2 in Membranes The solubility of gases in liquids is expressed in many different units, and care should be taken when interpreting solubility data. For convenience, we will use the partition coefficient (KP ), that is the ratio between the molar concentrations of the molecule in the membrane and in the aqueous solution (KP = Cm /Cw ) at equilibrium and at a defined temperature (25 °C, unless specified). For many years it was considered that ·NO solubility in membranes should be higher than in water because of the ∼9 times higher solubility of ·NO in organic solvents compared to water (Shaw and Vosper, 1976). Malinski et al. used 1octanol as a better model of the solvent properties of the lipid membrane and found that the partition coefficient for ·NO between 1-octanol and water was 6.5 (Malinski et al., 1993). More recently, we have shown that the solubility of ·NO in phospholipid membranes is actually ∼3 times greater than in water (Table 2) (Möller et al., 2005, 2007b). Likewise, O2 is approximately 3 times more soluble in membranes than in water (Table 2). The difference with model organic solvents can be explained based on the ordered and packed structure of lipid bilayers that is not randomly distributed as organic solvent molecules (De Young and Dill, 1990). Furthermore, this effect can be explained thermodynamically in terms of the Scaled Particle Theory (Pierotti, 1976; Pollack, 1991). According to this theory, the energies involved in dissolving a molecule in a solvent include not only the interaction between the molecule and the solvent (attractive), but also the work required to create a cavity in the solvent to accommodate the solute (repulsive). This work depends on the surface tension of the solvent, and due to the dense packing of lipids, membranes would be expected to offer a greater resistance to cavity creation and thus lower solubility of ·NO and O2 in the membrane compared with organic solvents. Furthermore, it has been shown that the solubility of O2 changes according to the physical state of the membrane (Table 2, Smotkin et al., 1991; Subczynski and Hyde, 1983), which supports the solute exclusion by lipid packing. On the other hand, the same theory predicts a significant solubility due to the small size of both ·NO and O2 compared with other bigger molecules. Another significant difference with organic solvents is that ·NO is not homogeneously distributed across the membrane, but prefers the acyl chain interior of the lipid bilayer. Molecular-dynamics calculations show that ·NO solubility increases towards the center of the bilayer (Figure 4). The overall solubility of ·NO in the membrane calculated using Sugii et al. data is one order of magnitude higher than experimentally determined values (Sugii et al., 2005), while the solubility calculated from Jedlovszky et al. is similar to experimental values (Jedlovszky and Mezei, 2003). Nitric oxide is mostly excluded from the polar headgroups region of the membrane, while it accumulates in the less polar, more mobile center of the lipid bilayer. This uneven distribution complicates the determination of experimental KP , since different hydrophobic volumes may be considered (Möller
34
M.N. Möller et al.
FIGURE 4 Distribution of ·NO along the lipid bilayer. The partition coefficient for ·NO at different depths of the membrane were calculated using energetic data from Sugii et al. (2005) and from Jedlovszky and Mezei (2003), according to KP = exp−(G/RT ) . The calculated solubility profiles were then scaled to yield an overall KP = 3.6 over the membrane width (40 Å). The square profile corresponds to an homogeneous membrane distribution. The regions 1, 2, 3 and 4 indicate the bulk water region (blue), the high polar headgroups density region (yellow), the high acyl chain density region (orange) and the low acyl chain density, mid bilayer (red), respectively. It can be appreciated how ·NO prefers the lipid acyl chain region over the polar headgroups region, and even more, the less dense and more flexible bilayer lipid interior.
et al., 2005). For convenience, most people use the volume defined by the partial specific volume of the membrane, although it may include some aqueous volume contribution. This is illustrated in Figure 4 by the square profile corresponding to the experimentally determined solubility. The distribution of O2 across the lipid bilayer is essentially the same to that of ·NO, so it will not be discussed in detail. I. Diffusion of ·NO and O2 in Membranes Another important factor regulating reaction rates in membranes, and transport across the membrane is diffusion. Diffusion controls how fast molecules can move within the membrane. It is a random process, with molecules moving in every direction and changing direction every time. If a concentration difference in space exists, then, there will be a net transport of molecules. The diffusion coefficient (D) can be used to calculate how far will a molecule travel (x) in a given time t
2. The Interaction of Reactive Oxygen and Nitrogen Species with Membranes
35
(in three dimensions): x = (6D.t)1/2
(6)
The diffusion coefficient for both ·NO and O2 in phosphate buffer is 2.2–4.5 × 10−5 cm2 s−1 (Denicola et al., 1996; Zacharia and Deen, 2005), while in the center of EYPC membranes is 3.1 × 10−6 for ·NO and 6.6 × 10−6 cm2 s−1 for O2 (Denicola et al., 1996; Möller et al., 2005), approximately 10 times slower than in water. Note that the Stokes–Einstein model of diffusion, where diffusion is inversely dependent on solvent viscosity, is not applicable to membranes and small molecules such as ·NO and O2 where the assumption of solute size greater than solvent size is violated (Lieb and Stein, 1986; Möller et al., 2005). There is still no definitive theory about diffusion in membranes, but the steep dependence of permeability on molecular volume suggests that cavities (or “free volume”) are again involved (as in solubility) (Lieb and Stein, 1986). The diffusion process would occur through a series of jumps from an occupied to a free cavity after it forms from molecular fluctuations. The diffusion coefficient would then be proportional to the probability of finding a cavity with an equal or greater volume than the molecule that is diffusing (Lieb and Stein, 1986).
III. CHEMICAL EFFECTS: LIPID PEROXIDATION As mentioned above, membranes could represent a barrier to the transport of some RONS, while others can easily permeate the membrane and react with targets inside the cell, depending on the available targets, their reactivity and quantity. However, the membrane itself is not inert towards these RONS and could be chemically modified in the transport process. Next, we will focus on the chemical effects of RONS on lipids of the membrane. The prototypical effect of reactive species on membrane lipids is lipid peroxidation. Lipid peroxidation affects mainly polyunsaturated fatty acids (2 or more double bonds in the fatty acid chain), and leads to the formation of lipid hydroperoxides, lipid alcohols, and aldehydes. It all begins with an oxidant producing a lipid radical (L·, Figure 5, Initiation). The intermediate radical is stabilized by the addition of oxygen to form the lipid-peroxyl radical (LOO·). This lipid-peroxyl radical is an oxidant and will oxidize nearby lipids, which will add O2 and continue the oxidation cycle chain reaction (Figure 5, Propagation). Therefore, O2 contributes to propagate the oxidation damage, leading to the formation of lipid hydroperoxides (LOOH). These LOOH alter the structure of the lipid bilayer, and can also lead to new oxidant species. In the presence of metal ions, the hydroperoxides can be decomposed to the lipid alkoxyl radical (LO·), which is even more oxidizing and keeps on propagating the oxidative damage (Figure 5, Branching). Lipid hydroperoxides are relatively long lived but break down spontaneously to
36
M.N. Möller et al.
FIGURE 5 The different stages in lipid peroxidation. Lipid peroxidation starts after a one electron oxidation of polyunsaturated fatty acid (LH), followed by a propagation phase, where O2 is added and new radicals are formed from neighboring lipids, accumulating lipid hydroperoxides. The chain reaction is stopped in termination reactions, either by reduction by α-tocopherol, or by radical–radical reactions. Additional lipid radicals can be generated from branching reactions involving lipid hydroperoxide reaction with reduced metal ions, or with superoxide.
yield aldehydes, end-products of lipoperoxidation. In biomembranes, lipid peroxidation stops because the main antioxidant in membranes, α-tocopherol, reduces the propagating LOO· to LOOH (Figure 5, Termination). After seeing the general mechanism of lipid peroxidation, we can now evaluate the potential participation of the different reactive species.
A. Nitric Oxide Nitric oxide (·NO) mostly inhibits the propagation of lipid oxidative damage. is a free radical that contains one unpaired electron. Similarly to O2 , ·NO
·NO
2. The Interaction of Reactive Oxygen and Nitrogen Species with Membranes
37
is not very reactive, reacting only with other free radicals or with metal centers (another unpaired electron is a must). Differently to O2 , the reaction with a lipid radical yields a non-oxidizing species and terminates lipid peroxidation. The very fast reaction with lipid peroxyl radicals, close to the diffusion limit (Padmaja and Huie, 1993; Goldstein et al., 2004), added to the high solubility of ·NO within the membrane (Möller et al., 2005), make ·NO an extremely efficient lipid antioxidant, even more effective than vitamin E (Rubbo et al., 2000). The reaction products of ·NO with lipid radicals have been identified as nitrated lipids with potent anti-inflammatory properties currently under investigation, thus suggesting that this process not only acts to terminate oxidative damage but also initiates specific signaling processes (Rubbo et al., 1994; Baker et al., 2004; Cui et al., 2006). In addition to inhibiting propagation, ·NO may also react with the initiator oxidant, making it a very ample and powerful antioxidant.
B. Nitrogen Dioxide Nitrogen dioxide is a common oxidant emerging from different possible routes and can enter lipid membranes (Khairutdinov et al., 2000). In addition to peroxynitrite homolysis, it can be formed from ·NO autoxidation and from H2 O2 dependent nitrite oxidation by hemeperoxidases (Augusto et al., 2002). ·NO2 can perform hydrogen atom abstraction leading to lipid peroxidation or lipid nitration, and also add to lipid double bonds generating a radical nitrolipid intermediate that may follow different paths. Another ·NO2 can add to form the non-radical dinitrolipid, it can add O2 and generate a propagating nitrolipid peroxyl radical (Pryor et al., 1982), or it can detach from the lipid leading to double bond isomerization from cis to trans conformation (Augusto et al., 2002; Jiang et al., 1999). Because of its H atom abstraction and addition to double bonds, it can be considered an initiator of lipid peroxidation. However, it can also react with lipid peroxyl radicals in a termination reaction at diffusion-limited rates (Goldstein et al., 2004), so it may even act as an antioxidant under certain conditions. The roles that RONS play in lipid peroxidation are complex and very dependent on the system under study. For instance, the high solubility of both ·NO and O2 in the membrane, leads to a higher rate of ·NO autoxidation, forming ·NO2 and N2 O3 (Liu et al., 1998; Möller et al., 2007a, 2007b). ·NO2 will act as as oxidant, or even as antioxidant while ·NO will inhibit oxidation. N2 O3 (equivalent to nitrous acid) could react with unsaturated fatty acids to yield nitroso-lipids, or with lipid hydroperoxides to yield nitro-lipids, lipid nitrates and nitrites (O’Donnell et al., 1999). These reagents may have little impact on membrane functionality, but the secondary products formed like nitrated lipids may have large effects on the cell physiology (Cui et al., 2006). Furthermore, ·NO2 and N2 O3 may well react with proteins associated to the membrane, specially with reactive cysteine residues, and
38
M.N. Möller et al.
lead to S-nitrosated or some other thiol oxidation product of the protein, resulting in an altered function and signaling (Möller et al., 2007a).
C. Peroxynitrite and Carbonate Radical It is not peroxynitrite itself but the radicals derived from it that can oxidize membrane lipids (Radi et al., 1991). Peroxynitrous acid can penetrate the membrane and yield ·NO2 and ·OH, which can both initiate lipid peroxidation (Radi et al., 1991). Alternatively, peroxynitrite-derived radicals can also enter the membrane and initiate lipid peroxidation, and this may be the most important route of oxidation (Botti et al., 2005). The effects of these radicals are dealt in separate sections. The addition of CO2 to the system protects the membrane from oxidation, because carbonate radical can not get into the membrane, and reactions in the aqueous phase consume the oxidant species (Khairutdinov et al., 2000; Romero et al., 1999). The lipid oxidation of low density lipoprotein (LDL) by peroxynitrite is also prevented by CO2 , and reactivity is then focused on exposed protein Apo-B, resulting in enhanced tyrosine nitration (Botti et al., 2005), and this will probably also occur in membranes.
D. Superoxide Superoxide has been associated with lipid peroxidation and cell lysis (Lynch and Fridovich, 1978a). However, it is not involved in initiating lipid peroxidation but rather in propagating it. Preformed lipid hydroperoxides (LOOH) are needed, · which are reduced by O·− 2 generating propagating LO (Lynch and Fridovich, 1978a; Aikens and Dix, 1991). In the experiments performed by Lynch and Fridovich, it was observed that external superoxide dismutase could inhibit cell lysis, indicating that internally generated O·− 2 that could cross the membrane was responsible for cell lysis (Lynch and Fridovich, 1978a). Furthermore, singlet oxygen (1 O2 ) scavengers also protected cell from lysis, indicating that it played an important role in this system, forming additional LOOH. The proposed reactions are shown in Eqs. (7)–(9). · − LOOH + O·− 2 → LO + OH + O2
(7)
+ 1 LO· + O·− 2 + H → LOH + O2
(8)
LH + 1 O2 → LOOH
(9)
2. The Interaction of Reactive Oxygen and Nitrogen Species with Membranes
39
E. Hydrogen Peroxide and Hydroxyl Radical Hydrogen peroxide is not directly reactive to membrane lipids, but can generate hydroxyl radical able to react with most molecules, and initiate lipid peroxidation by H atom abstraction or addition to double bonds. Hydroxyl radical is one of the most oxidizing molecules (Buettner, 1993), and it can react with most organic molecules at practically diffusion-limited rates (Halliwell and Gutteridge, 2000).
F. Biophysical Effects of Lipid Peroxidation in Membranes Lipid peroxidation introduces a bulky and polar group (–OOH) to a phospholipid acyl chain (Buettner, 1993; Wong-ekkabut et al., 2007), altering the tight packing of the lipid bilayer. The oxidized acyl chains occupy a higher area per molecule than non-oxidized molecules and they are more hydrophilic, with the hydroxy- and hydroperoxy-groups more exposed to the aqueous phase (Abousalham et al., 2000; Wong-ekkabut et al., 2007). Although a looser membrane structure would be expected, several biophysical determinations indicate that lipid peroxidation results in a more rigid and less fluid membrane (Richter, 1987), with a higher leakiness and general permeability (Mandal and Chatterjee, 1980). It is also observed a diminished electrical resistance and an increased flip-flop of phospholipids (Richter, 1987). The effect of lipoperoxidation on membrane proteins is to decrease their mobility, both by forming lipid–protein adducts and protein–protein covalent aggregates (Richter, 1987; Soszynski and Bartosz, 1996). Even though the direct reaction of RONS with membrane lipids yields an altered membrane structure with higher permeability, the most important biological consequences of membrane lipoperoxidation may be due to the formation of secondary more reactive species (like aldehydes, peroxides, nitrolipids) capable of modulating signal cascades or develop cellular damage. References Abousalham, A., Fotiadu, F., Buono, G., Verger, R. (2000). Surface properties of unsaturated nonoxidized and oxidized free fatty acids spread as monomolecular films at an argon/water interface. Chem. Phys. Lipids 104, 93–99. Aikens, J., Dix, T.A. (1991). Perhydroxyl radical (HOO.) initiated lipid peroxidation. The role of fatty acid hydroperoxides. J. Biol. Chem. 266, 15091–15098. Antunes, F., Cadenas, E. (2000). Estimation of H2 O2 gradients across biomembranes. FEBS Letters 475, 121–126. Augusto, O., Bonini, M.G., Amanso, A.M., Linares, E., Santos, C.C.X., De Menezes, S.L. (2002). Nitrogen dioxide and carbonate radical anion: Two emerging radicals in biology. Free Radic. Biol. Med. 32, 841–859. Baker, P.R.S., Schopfer, F.J., Sweeney, S., Freeman, B.A. (2004). Red cell membrane and plasma linoleic acid nitration products: Synthesis, clinical identification, and quantitation. Proc. Natl. Acad. Sci. USA 10, 11577–11582.
40
M.N. Möller et al.
Beckman, J.S., Koppenol, W.H. (1996). Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and the ugly. Am. J. Physiol. Cell Physiol. 271, 1424–1437. Bienert, G.P., Moller, A.L.B., Kristiansen, K.A., Schulz, A., Moller, I.M., Schjoerring, J.K., Jahn, T.P. (2007). Specific aquaporins facilitate the diffusion of hydrogen peroxide across membranes. J. Biol. Chem. 282, 1183–1192. Botti, H., Trostchansky, A., Batthyany, C., Rubbo, H. (2005). Reactivity of peroxynitrite and nitric oxide with LDL. IUBMB Life 57, 407–412. Branco, M.R., Marinho, H.S., Cyrne, L., Antunes, F. (2004). Decrease of H2 O2 plasma membrane permeability during adaptation to H2 O2 in Saccharomyces cerevisiae. J. Biol. Chem. 279, 6501– 6506. Brunori, M., Rotilio, G. (1984). Biochemistry of oxygen radical species. Methods Enzymol. 105, 22– 35. Buettner, G.R. (1993). The pecking order of free radicals and antioxidants: Lipid peroxidation, α-tocopherol, and ascorbate. Arch. Biochem. Biophys. 300, 535–543. Cui, T., Schopfer, F.J., Zhang, J., Chen, K., Ichikawa, T., Baker, P.R., Batthyany, C., Chacko, B.K., Feng, X., Patel, R.P., Agarwal, A., Freeman, B.A., Chen, Y.E. (2006). Nitrated fatty acids: Endogenous anti-inflammatory signaling mediators. J. Biol. Chem. 281, 35686–35698. De Young, L.R., Dill, K.E. (1990). Partitioning of nonpolar solutes into bilayers and amorphous n-alkanes. J. Phys. Chem. 94, 801–809. Denicola, A., Souza, J.M., Radi, R. (1998). Diffusion of peroxynitrite across erythrocyte membranes. Proc. Natl. Acad. Sci. USA 95, 3566–3571. Denicola, A., Souza, J.M., Radi, R., Lissi, E. (1996). Nitric oxide diffusion in membranes determined by fluorescence quenching. Arch. Biochem. Biophys. 328, 208–212. Gennis, R.B. (1989). Biomembranes, Molecular Structure and Function. Springer-Verlag, Harrisonburg. Goldstein, S., Lind, J., Merenyi, G. (2004). Reaction of organic peroxyl radicals with NO2 and NO in aqueous solution: Intermediacy of organic peroxynitrate and peroxynitrite species. J. Phys. Chem. A 108, 1719–1725. Gomes, L.F., Cuccovia, I.M., Chaimovich, H., Barbieri, D.H.G.P., Politi, M.J. (1993). Permeation of superoxide anion through the bilyer of vesicles of a synthetic amphiphile. Biochim. Biophys. Acta 1152, 78–82. Green, M.J., Hill, A.O. (1984). Chemistry of dioxygen. Methods Enzymol. 105, 3–22. Gus’kova, R.A., Ivanov, I.I., Kol’tover, V.K., Akhobadze, V.V., Rubin, A.B. (1984). Permeability of bilayer lipid membranes for superoxide (O− 2 ) radicals. Biochim. Biophys. Acta 778, 579–585. Halliwell, B., Gutteridge, J.M.C. (2000). Free Radicals in Biology and Medicine. Oxford University Press, New York. Jedlovszky, P., Mezei, M. (2003). Effects of cholesterol on the properties of phospholipid membranes. 2. Free energy profile of small molecules. J. Phys. Chem. B 107, 5322–5332. Jiang, H., Kruger, N., Lahiri, D.R., Wang, D., Vatele, J.M., Balazy, M. (1999). Nitrogen dioxide induces cis-trans-isomerization of arachidonic acid within cellular phospholipids. J. Biol. Chem. 274, 16235–16241. Khairutdinov, R.F., Coddington, J.W., Hurst, J.K. (2000). Permeation of phospholipid membranes by peroxynitrite. Biochemistry 39, 14238–14249. Lieb, W.R., Stein, W.D. (1986). Non-stokesian nature of transverse diffusion within human red cell membranes. J. Memb. Biol. 92, 111–119. Liu, X., Miller, M.J., Joshi, M.S., Thomas, D.D., Lancaster Jr., J.R. (1998). Accelerated reaction of nitric oxide with O2 within the hydrophobic interior of biological membranes. Proc. Natl. Acad. Sci. USA 95, 2175–2179. Liu, X., Miller, M.J.S., Joshi, M.S., Sadowska-Krowicka, H., Clarka, D.A., Lancaster Jr., J.R. (1998). Diffusion-limited reaction of free nitric oxide with erythrocytes. J. Biol. Chem. 273, 18709–18713. Lynch, R.E., Fridovich, I. (1978a). Effects of superoxide on the erythrocyte membrane. J. Biol. Chem. 253, 1838–1845.
2. The Interaction of Reactive Oxygen and Nitrogen Species with Membranes
41
Lynch, R.E., Fridovich, I. (1978b). Permeation of the erythrocyte stroma by superoxide radical. J. Biol. Chem. 253, 4697–4699. Makino, N., Sasaki, K., Hashida, K., Sakakura, Y. (2004). A metabolic model describing the H2 O2 elimination by mammalian cells including H2 O2 permeation through cytoplasmic and peroxisomal membranes, comparison with experimental data. Biochim. Biophys. Acta 1673, 149–159. Malinski, T., Zaha, S., Grunfeld, S., Patton, M., Kapturczak, M., Tomboulian, P. (1993). Diffusion of nitric oxide in the aorta wall monitored in situ by porphyrinic microsensors. Biochem. Biophys. Res. Comm. 193, 1076–1082. Mandal, T.K., Chatterjee, S.N. (1980). Ultraviolet- and sunlight-induced lipid peroxidation in liposomal membrane. Radiat. Res. 83, 290–302. Marla, S.S., Lee, J., Groves, J.T. (1997). Peroxynitrite rapidly permeates phospholipid membranes. Proc. Natl. Acad. Sci. USA 94, 14243–14248. Mathai, J.C., Sitaraman, V. (1994). Stretch sensitivity of transmembrane mobility of hydrogen peroxide through voids in the bilayer. J. Biol. Chem. 269, 17784–17793. Möller, M., Botti, H., Batthyany, C., Rubbo, H., Radi, R., Denicola, A. (2005). Direct measurement of nitric oxide and oxygen partitioning into liposomes and low density lipoprotein. J. Biol. Chem. 280, 8850–8854. Möller, M.N., Li, Q., Lancaster, J.R.J., Denicola, A. (2007a). Acceleration of nitric oxide autoxidation and nitrosation by membranes. IUBMB Life 59, 1–6. Möller, M.N., Li, Q., Vitturi, D.A., Robinson, J.M., Lancaster, J.R.J., Denicola, A. (2007b). Membrane “lens” effect: Focusing the formation of reactive nitrogen oxides from the NO/O2 reaction. Chem. Res. Toxicol. 20, 709–714. O’Donnell, V.B., Eiserich, J.P., Chumley, P.H., Jablonsky, M.J., Krishna, N.R., Kirk, M., Barnes, S., Darley-Usmar, V.M., Freeman, B.A. (1999). Nitration of unsaturated fatty acids by nitric oxidederived reactive species peroxynitrite, nitrous acid, nitrogen dioxide, and nitronium ion. Chem. Res. Toxicol. 12, 83–92. Padmaja, S., Huie, R.E. (1993). The reaction of nitric oxide with organic peroxyl radicals. Biochem. Biophys. Res. Comm. 195, 539–544. Pierotti, R.A. (1976). A scaled particle theory of aqueous and nonaqueous solutions. Chem. Rev. 76, 717–726. Pollack, G.L. (1991). Why gases dissolve in liquids. Science 251, 1323–1330. Power, G.G., Stegall, H. (1970). Solubility of gases in human red blood cell ghosts. J. Appl. Physiol. 29, 145–149. Pryor, W.A., Lightsey, J.W., Church, D.F. (1982). Reaction of nitrogen dioxide with alkenes and polyunsaturated fatty acids: Addition and hydrogen abstraction mechanisms. J. Am. Chem. Soc. 104, 6685–6692. Radi, R., Beckman, J.S., Bush, K.M., Freeman, B.A. (1991). Peroxynitrite-induced membrane lipid peroxidation: The cytotoxic potential of superoxide and nitric oxide. Arch. Biochem. Biophys. 288, 481–487. Radi, R., Denicola, A., Alvarez, B., Ferrer-Sueta, G., Rubbo, H. (2000). The biological chemistry of peroxynitrite. In: Ignarro, L.J. (Ed.), Nitric Oxide Biology and Pathobiology. Academic Press, San Diego, pp. 57–82. Rhee, S.G., Yang, K.S., Kang, S.W., Woo, H.A., Chang, T.S. (2005). Controlled elimination of intracellular H2 O2 : Regulation of peroxiredoxin, catalase, and glutathione peroxidase via posttranslational modification. Antiox. Redox Signal. 7, 619–626. Richter, C. (1987). Biophysical consequences of lipid peroxidation in membranes. Chem. Phys. Lipids 44, 175–189. Romero, N., Denicola, A., Souza, J.M., Radi, R. (1999). Diffusion of peroxynitrite in the presence of carbon dioxide. Arch. Biochem. Biophys. 368, 23–30. Rubbo, H., Radi, R., Trujillo, M., Telleri, R., Kalyanaraman, B., Barnes, S., Kirk, M., Freeman, B.A. (1994). Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives. J. Biol. Chem. 269, 26066–26075.
42
M.N. Möller et al.
Rubbo, H., Radi, R., Anselmi, D., Kirk, M., Barnes, S., Butler, J., Eiserich, J.P., Freeman, B.A. (2000). Nitric oxide reaction with lipid peroxyl radicals spares a-tocopherol during lipid peroxidation. J. Biol. Chem. 275, 10812–10818. Shaw, A.W., Vosper, A.J. (1976). Solubility of nitric oxide in aqueous and nonaqueous solvents. J. Chem. Soc. Faraday Trans. 1 8, 1239–1244. Smotkin, E.S., Moy, F.T., Plachy, W.Z. (1991). Dioxygen solubility in aqueous phosphatidylcholine dispersions. Biochim. Biophys. Acta 1061, 33–38. Soszynski, M., Bartosz, G. (1996). Effect of peroxynitrite on erythrocytes. Biochim. Biophys. Acta 1291, 107–114. Stein, W.D. (1986). Transport and Diffusion across Cell Membranes. Academic Press, Orlando, FL. Stuehr, D.J., Santolini, J., Wang, Z.Q., Wei, C.C., Adak, S. (2004). Update on mechanism and catalytic regulation in the NO synthases. J. Biol. Chem. 279, 36167–36170. Subczynski, W.K., Hyde, J.S. (1983). Concentration of oxygen in lipid bilayers using a spin-label method. Biophys. J. 41, 283–286. Subczynski, W.K., Hyde, J.S., Kusumi, A. (1989). Oxygen permeability of phosphatidylchilinecholesterol membranes. Proc. Natl. Acad. Sci. USA 86, 4474–4478. Subczynski, W.K., Hopwood, L.E., Hyde, J.S. (1992). Is the mammalian cell plasma membrane a barrier to oxygen transport? J. Gen. Physiol. 100, 69–87. Subczynski, W.K., Lomnicka, M., Hyde, J.S. (1996). Permeability of nitric oxide through lipid bilayer membranes. Free Rad. Res. 24, 343–349. Sugii, T., Takagi, S., Matsuoka, Y. (2005). A molecular dynamics study of lipid bilayers: Effects of the hydrocarbon chain length on permeability. J. Chem. Phys. 123, 184714. Takahashi, M., Asada, K. (1983). Superoxide anion permeability of phospholipid membranes and chloroplast thylakoids. Arch. Biochem. Biophys. 226, 558–566. Walter, A., Gutknecht, J. (1986). Permeability of small nonelectrolytes through lipid bilayer membranes. J. Memb. Biol. 90, 207–217. Widomska, J., Raguz, M., Subczynski, W.K. (2007). Oxygen permeability of the lipid bilayer membrane made of calf lens lipids. Biochim. Biophys. Acta 1768, 2635–2645. Wong-ekkabut, J., Xu, Z., Triampo, W., Tang, I.M., Tieleman, D.P., Monticelli, L. (2007). Effect of lipid peroxidation on the properties of lipid bilayers: A molecular dynamics study. Biophys. J. 93, 4225–4236. Zacharia, I.G., Deen, W.M. (2005). Diffusivity and solubility of nitric oxide in water and saline. Ann. Biomed. Eng. 33, 214–222. Zhang, H., Joseph, J., Feix, J., Hogg, N., Kalyanaraman, B. (2001). Nitration and oxidation of a hydrophobic tyrosine probe by peroxynitrite in membranes: Comparison with nitration and oxidation of tyrosine by peroxynitrite in aqueous solution. Biochemistry 40, 7675–7686. Zhang, H., Bhargava, K., Keszler, A., Feix, J., Hogg, N., Joseph, J., Kalyanaraman, B. (2003). Transmembrane nitration of hydrophobic tyrosyl probes. J. Biol. Chem. 278, 8969–8978.
CHAPTER 3 Modulation of Lung Epithelial Sodium Channel Function by Nitric Oxide Weifeng Song, Ahmed Lazrak, Shipeng Wei, Phillip McArdle and Sadis Matalon Department of Anesthesiology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35233, USA
I. Introduction A. Molecular Structure of Amiloride-sensitive Epithelial Sodium Channels B. Molecular Properties of Na+ Channels of Lung Distal Epithelial Cells C. Biophysical Properties of Na+ Channels in Lung Epithelial Cells D. Importance of Na+ Transport in Lung Fluid Balance E. Interactions of NO and RONS with Biological Targets F. Reactive Intermediates Decrease Ion Transport Across the Aveolar Epithelium in Vivo G. Reactive Intermediates Decrease Vectorial Na+ Transport Across ATII Cells in Vitro H. Regulation of Lung Epithelial Na+ Channels by cGMP References
Abstract Alveolar epithelial cells of mammalian lungs actively transport sodium (Na+ ) and chloride (Cl− ) ions and these processes are important in fluid homeostasis. Sodium ions enter the apical membranes of both type I and type II alveolar epithelial cells through sodium selective, cation and cyclic nucleotide gated ion channels and are extruded across the basolateral membrane by the ouabain-sensitive Na,K-ATPase. This vectorial transport of Na+ ions (and concomitant movement of Cl− ions to maintain electroneutrality) creates an oncotic force leading to the reabsorption of fluid across both normal and damaged lungs. Nitric oxide and reactive oxygen nitrogen intermediates (formed by the reactions of nitric oxide with partially reduced oxygen species), generated in close proximity of epithelial cell membranes by activated inflammatory cells, modulate the activity of sodium channels via signal transduction mechanisms (such as increasing PKG and PKC) or by post-translational oxidative modifications of sodium channel proteins and their chaperons. Channel activity (and vectorial sodium transport) may be either Current Topics in Membranes, Volume 61 Copyright © 2008, Elsevier Inc. All rights reserved
1063-5823/08 $35.00 DOI: 10.1016/S1063-5823(08)00203-2
44
W. Song et al.
increased or decreased depending on levels of reactive intermediates and length of exposure. Better understanding of these interactions would offer considerable new insights into the mechanisms leading to pulmonary edema in a number of pathological conditions.
I. INTRODUCTION For gas exchange to occur optimally, the alveoli of the adult mammalian lungs must remain open and free from fluid. In utero, gas exchange occurs across the placenta and the fetal lung is filled with fluid which enters the trachea and distal lung epithelia because of the osmotic gradient created by the active secretion of chloride (Cl− ) ions (Olver and Strang, 1974). Although this fluid is essential for lung growth and development (Bland and Nielson, 1992), it must be rapidly removed shortly after birth to allow for gas exchange to occur. Various studies in rats, sheep, guinea pigs and other species established that just prior to birth, the distal alveolar epithelium converts from Cl− secretion to sodium (Na+ ) absorption and this active transport of Na+ ions across distal lung epithelial cells is essential for the clearance of fetal fluid (Brown et al., 1983; Olver et al., 1986; O’Brodovich et al., 1990; O’Brodovich, 1991). Studies showing reabsorption of intratracheally instilled isotonic fluid or plasma from the alveolar spaces of adult anesthetized animals and resected human lungs, and its near complete inhibition by elimination of the Na,K-ATPase or by replacement of Na+ ions in the alveolar epithelial fluid by large cations, indicate that adult alveolar epithelial cells are capable of actively transporting sodium (Na+ ) ions (Matthay et al., 1982, 1985, 2002; Sakuma et al., 1994). Based on the results of a large number of studies on anesthetized and conscious animals, human lungs as well as isolated epithelial cells, we know that the distal lung epithelial cells (Clara, alveolar type I and II cells) actively transport Na+ ions in a vectorial fashion from the alveolar to the interstitial sides (Figure 1). Na+ ions diffuse passively down their electrochemical gradient (created by the action of the basolaterally located Na,K-ATPase) into alveolar epithelial cells through apically located amiloride-sensitive channels [ENaC; (Cheek et al., 1989; Yue et al., 1995; Jain et al., 2001; Johnson et al., 2006)] or cyclic nucleotide gated ion channels (Kemp et al., 2001) and are extruded across the basolateral cell membranes by the ouabain-sensitive Na+ ,K+ -ATPase (Factor et al., 1998; Ridge et al., 2003). Movement of Na+ ions from the alveolar to the interstitial space necessitates the simultaneous movement of an anion (such as Cl− ) to preserve electro-neutrality. A number of in vivo studies suggested the movement of Cl− ion occurs via both trans-cellular Cl− channels (such as CFTR) as well as para-cellular pathways (Nielsen et al., 1998; Fang et al., 2002). More recent studies have provided convincing evidence of the presence of functional CFTR in both fetal (Lazrak et al., 2002) and adult ATII cells (Brochiero et al., 2004) and showed
3. Nitric Oxide and Sodium Channels
45
FIGURE 1 Model of ion transport across alveolar epithelial cells. Na+ ions enter the apical membranes of alveolar epithelial (both type II or type I cells) via a variety of ENaC and non-ENaC cation channels (see Table 1), down a favorable electrochemical gradient created by the action of the electrogenic ouabain sensitive-ATP Na,K-ATPase. K+ ions, brought into the cells by the pump in exchange of Na+ ions, leave the cells passively through basolarerally located K+ channels. To maintain neutrality, Cl− ions enter cells through CFTR type channels and exit basolaterally via a Na,K, Cl cotransporter. The combined movement of Na+ and Cl− ions creates an oncotic gradient leading to the reabsorption of alveolar fluid.
that functional CFTR was necessary for the increase of vectorial Na+ transport by β2 -agonists (Fang et al., 2002). Thus in summary, although the vectorial movement of Na+ ions across epithelial cells requires the presence of both passive (channels) and energy consuming (Na,K-ATPAse) basolateral transporters, ion channels constitute the rate-limiting step in this process, offering more than 90% of the resistance to trans-cellular Na+ transport.
A. Molecular Structure of Amiloride-sensitive Epithelial Sodium Channels A complementary DNA (cDNA) encoding an amiloride-sensitive Na+ channel was cloned from the colon of salt-deprived rats using functional expression cloning techniques (Canessa et al., 1993). This clone, termed αrENaC (for the α subunit of the rat epithelial Na+ channel) contains a 2094-nt open reading frame corresponding to 698 amino acids with a predicted molecular mass of 79 kDa. Furthermore, it shares significant homology with mec-4 and deg-1, members of a family of Caenorhabditis elegans genes involved in sensory touch expres-
46
W. Song et al.
sion. Channels formed by the expression of αrENaC in Xenopus oocytes, are highly selective for Na+ over K+ ions, have much higher affinity to amiloride (Ki = 0.1 µM) than EIPA (Ki = 10 µM) and high permeability to Li+ ions (PLi /PNa = 1.6). Subsequently Canessa et al. (1994b) identified and cloned two additional subunits of this channel, named βrENaC and γ rENaC, with molecular masses of 72 kDa and 75 kDa, respectively. Co-expression of all three subunits in oocytes generated 100-fold higher amiloride-sensitive currents than αrENaC alone. Each subunit has two putative trans-membrane domains, yielding a protein with a large (∼50 kDa) hydrophilic loop and short hydrophilic NH2 and COOH termini. αrENaC spans the membrane twice with the short terminal ends on the cytoplasmic side and a large hydrophilic loop in the extracellular space (Canessa et al., 1994a). The αrENaC message was identified only in organs known to contain epithelial Na+ channels, such as kidney medulla and cortex, distal colon and lungs. Experiments utilizing point mutations suggest that all three subunits are involved in pore formation (Schild et al., 1997), although the exact stochiometry varies. Five ENaC subunits, namely α, β, γ , δ and ε ENaC have been cloned to date, although ε ENaC is not found in mammalian cells. Combinations of the various subunits form channels with varying unitary conductances, ion selectivities and regulatory properties (Snyder et al., 1998). In general the β and γ subunits regulate the channel activity of the conducting α, δ and ε ENaC subunits when they are heterologously expressed in oocytes and cell lines. As mentioned above, heterologous expression of α, β, γ ENaC in Xenopus oocytes or mammalian cells form Na+ channels with unitary conductances of about 4–5 pS which are highly permeable to Na+ but poorly permeable to K+ (PNa+ /PK+ > 20) and inhibited by nanomolar concentrations of amiloride. Channels formed by heterologous expression of αβ, αγ ENaC in Xenopus oocytes, exhibit variant amiloride sensitivities, conductances, and Na+ permeabilities (McNicholas and Canessa, 1997; Fyfe and Canessa, 1998). Kizer et al. (1997) reported that expression of the α rENaC from osteoblasts into a null cell line resulted in 24 pS cation channel with equal permeability to Na+ over K+ ions. Expression of αcRNA alone into Xenopus oocytes results in small currents with little sensitivity to amiloride (Canessa et al., 1994b; Chen et al., 2004a). Furthermore, the presence of δENaC significantly alters the biophysical properties of these channels. δβγ ENaC channels have a Na+ conductance of 12 pS (vs. 4 pS for αβγ ENaC) and are less sensitive to amiloride (IC50 : 26 µM vs. 0.1 µM for αβγ ENaC) (Ji et al., 2006); δ but not α ENaC channel activity is gated by extraoocyte protons (Ji et al., 2006) and cGMP (Ji et al., 2007). These studies provide the molecular basis of the wide diversity of ion channels found in a number of epithelia including the lung alveolar epithelium, as discussed below.
3. Nitric Oxide and Sodium Channels
47
B. Molecular Properties of Na+ Channels of Lung Distal Epithelial Cells Voilley et al. (1994) used a fragment of the rat colon Na+ channel cDNA to screen a human lung cDNA library. One of the hybridizing clones contained a 2007-bp open reading frame, encoding a 699-amino acid protein with a mass of 76 kDa. When injected into oocytes, the cloned channel exhibited sensitivity to amiloride. The sequence shares 81% identity with αrENaC, if methionine-27 of the rat colon sequence is aligned with the first methionine of the human sequence, and is identical with αhENaC cloned from a human kidney cDNA library (McDonald et al., 1994). When total RNA is extracted from whole lungs, there are very low levels of αENaC mRNA during early stages of fetal rat (O’Brodovich et al., 1993), mouse (Dagenais et al., 1997), and human (Voilley et al., 1994) development. Although αrENaC mRNA does increases prior to birth (O’Brodovich et al., 1993), β and γ rENaC subunits are differentially regulated with maximal expression shortly after birth (Tchepichev et al., 1995). Expression of αrENaC mRNA in adult rat ATII cells was also demonstrated by Northern blot analysis (Yue et al., 1995), PCR (Farman et al., 1997) and in situ hybridization (Matsushita et al., 1996; Farman et al., 1997). Additional in situ studies indicate that although β and γ mRNAs are detected in large and small airways they are less abundant in ATII cells as compared to αrENaC (Farman et al., 1997). In early studies, antibodies, raised against the α, β and γ subunits, labeled surface epithelial cells on the rat trachea, bronchi and bronchioles but not on normal alveoli (Renard et al., 1995). However, more recent studies have shown the presence of α, β and γ -ENaC in both isolated and cultured ATII (Jain et al., 1999, 2001; Thome et al., 2003; Hardiman et al., 2004), ATI (Johnson et al., 2002, 2006) as well as in situ (Matthay et al., 2002). A recent study also reported the presence of δENaC in human Clara cell like lines (Ji et al., 2006), although its presence in alveolar epithelial cells has not been confirmed as yet. Antibodies raised against a purified epithelial sodium channel protein isolated from kidney papillae immunostained alveolar epithelial cells both in vitro and in vivo (Matalon et al., 1992; Yue et al., 1995). Finally various subunits of the Na,K-ATPase have been identified by immunofluorescent and electron microscopy techniques in the basolateral membranes of both ATI and ATII cells (Schneeberger and McCarthy, 1986; Ridge et al., 1997, 2003; Johnson et al., 2002). In short, it is now clear that alveolar epithelial cells contain the necessary machinery for vectorial Na+ transport.
C. Biophysical Properties of Na+ Channels in Lung Epithelial Cells Patch clamp measurements of either isolated ATII cells, or ATI and ATII cells in situ have shown the existence of a variety of Na+ channels (summarized in
48
W. Song et al. TABLE 1 Biophysical properties of cation channels based on patch clamp measurements AT II(rat)
Days in cult
g (pS) PNa+ /PK+ Amil(IC50 uM) Regulation
1–4 1–4
20.4 27
1.15 NM
<1 NM
Ca2+ Terbut.; hyperoxia
1–4 1–4 1.5–2 1–4 1–4 1–4 2 and Lung slices 1–4 1–4 2 and Lung slices
25 21 25 20.6 20.6 21 21
7 1 2.08 0.97 0.97 1 1
<1 <1 >1 <1 <1 <1 NM
6 6 6
>80 >80 >40
<1 <1 NM
cAMP/PKA steroids EGF cGMP/PKG NM cAMP/PKA Ca2+ cardiogenic pulmonary edema fluid steroids cAMP/PKA Ca2+ cardiogenic pulmonary edema fluid
Reference
(Feng et al., 1993) (Yue et al., 1994, 1995) (Yue et al., 1995) (Jain et al., 2001) (Kemp et al., 1999) (Jain et al., 1998) (Jain et al., 1999) (Chen et al., 2002) (Gandhi et al., 2007) (Jain et al., 2001) (Chen et al., 2002) (Gandhi et al., 2007)
AT I cells (rat) Lung slices 8.2
NM
<1
Dopamine
Lung slices 22
NM
<1
Dopamine
(Johnson et al., 2006) (Johnson et al., 2006)
AT I/AT II 0–1
21
1
>1
NM
0–1
9
4
<1
NM
0–1
4–5
>40
<1
NM
(Johnson et al., 2006; Helms et al., 2006) (Johnson et al., 2006) (Johnson et al., 2006; Helms et al., 2006)
Table 1) with diverse biophysical properties (single channel conductance, relative permeability for Na+ vs. K+ , amiloride sensitivity), and response to a variety of signal transduction and pharmacological agents). As seen in Table 1, a number of different group of channels have been identified: (1) non-selective (i.e. equally permeable to Na+ and K+ ions), Ca2+ -activated cation channels (Feng et al., 1993) with unknown ENaC subunit composition; (2) highly selective Na+ channels composed of α, β, and γ -ENaC subunits (Jain et al., 2001;
3. Nitric Oxide and Sodium Channels
49
FIGURE 2 Measurements of alveolar fluid clearance (AFC) in anesthetized, ventilated C57BL/6 mice. AFC was calculated from changes in instilled BSA concentration during a 30-min period. Data are means 6 SD (n ∼ 6 animals for each group). In all cases, the instillate contained 5% fat-free BSA in NaCl or N -methyl-D-glucamine chloride (NMDG-Cl) as indicated. The osmolality was adjusted to that of the plasma for the appropriate group. Amiloride (amil; 1.5 mM) and/or ouabain (forsk; 50 µM) were also added to the instillate as indicated. ∗ P , 0.05 compared with the corresponding control (adapted from Figure 1 of Hardiman et al. (2001) with permission).
Johnson et al., 2006), which are inhibited by an increase of intracellular Ca2+ ; (3) moderately selective or non-selective cation channels consisting of either αENaC alone or combinations of α with β or γ -ENaC (Yue et al., 1994, 1995; Jain et al., 1999, 2001); (4) cGMP-activated cation channels inhibited by Zn+2 (Kemp et al., 2001), which may contain δ-ENaC. A number of factors (including the culture substratum, the presence or absence of steroids, the presence of an air–liquid interface etc.), determine the biophysical properties and subunit composition of these channels (Jain et al., 1999, 2001; Lazrak et al., 2000b). So the question is which type of channels are present in the alveolar epithelium in vivo? Measurements of Na+ dependent alveolar fluid clearance across anesthetized animals are consistent with the presence of a variety of both highly selective and non-selective Na+ channels on alveolar cells. For example, as shown in Figure 2 instilled amiloride blocks between 50–80% of Na+ driven AFC while substitution of Na+ with NMDG totally abolishes it (Matthay et al., 1996; Hardiman et al., 2001; Hickman-Davis et al., 2006); the higher than expected K+ concentrations in the alveolar lining fluid of anesthetized rabbits and the lowering of these values following application of amiloride (Nielson and Lewis, 1990), are consistent with K+ efflux through non-selective or poorly selective cation channels in alveolar epithelial cells. This diversity has to be kept in
50
W. Song et al.
mind when one tries to assess the effects of various agents on Na+ -driven alveolar fluid clearance in vivo. D. Importance of Na+ Transport in Lung Fluid Balance A variety of studies have provided unequivocal evidence that active Na+ transport plays an essential role in the reabsorption of fetal fluid and the established of fluid free air spaces. Instillation of amiloride or benzamil into the fluid filled airspaces of newborn guinea pigs prior to their first breath, resulted in decreased clearance of the fetal fluid and the development of respiratory distress and arterial hypoxemia (O’Brodovich et al., 1990). Neonatal mice, in which αENaC gene was inactivated by gene targeting, were unable to clear the fetal lung fluid and died within 40 h of birth (Hummler et al., 1996). Transgenic expression of α-rENaC driven by a cytomegalovirus promoter in αmENaC(−/−) knockout mice rescued the perinatal lethal pulmonary phenotype and partially restored Na+ transport in renal, colonic, and pulmonary epithelia (Hummler et al., 1997). In addition, studies showing that newborn infants with either transient tachypnea (Gowen et al., 1988) or neonatal respiratory distress syndrome (Barker et al., 1997) had more negative nasal trans-epithelial potential differences (PD) that were poorly inhibited by amiloride, suggesting that impairment of Na+ absorption across the respiratory epithelia of very premature infants may be one of the factors contributing to the pathogenesis of RDS. In contrast βENaC (−/−) mice showed normal prenatal development but on low-salt diets developed type 1 pseudohypoaldosteronism (Pradervand et al., 1999). While it remains unclear whether active Na+ transport plays an important role in keeping alveolar spaces free of fluid in the normal lung, a variety of studies have clearly established that active Na+ transport plays an important role in limiting the degree of alveolar edema in adult mammalian lungs following acute or chronic injury to the alveolar epithelium. For example, intratracheal instillation of a Na+ channel blocker in rats exposed to hyperoxia, increased the amount of extravascular lung water (Yue and Matalon, 1997). Conversely, intratracheal instillation of adenoviral vectors expressing the Na+ ,K+ -ATPase genes increased survival of rats exposed to hyperoxia (Factor et al., 2000). Moreover, patients with acute lung injury who are still able to concentrate alveolar protein (as a result of active Na+ reabsorption) have a better prognosis than those that cannot (Matthay and Wiener-Kronish, 1990; Ware and Matthay, 2001). Finally, decreased Na+ reabsorption predisposes mountaineers to pulmonary edema (Sartori et al., 2002). In addition, abnormalities in ENaC channel number and opening have been linked to the pathogenesis of cystic fibrosis (Stutts et al., 1995) and Liddle’s syndrome (Pradervand et al., 1999). Thus, lung Na+ transport is highly relevant to human lung disease, and it is important to understand the factors which decrease alveolar fluid clearance in vivo.
3. Nitric Oxide and Sodium Channels
51
Because nitric oxide (NO) and reactive oxygen nitrogen intermediates (RONS) are produced by activated inflammatory cells, in close proximity to the alveolar epithelium and epithelial Na+ channels, a number of studies have been conducted to understand how they may damage epithelial Na+ channels and how this injury can be reversed. Below we review briefly the sources of NO and RONS in the alveolar space and current studies documenting NO and RONS modification of Na+ channel structure function relationships both in vivo and in vitro.
E. Interactions of NO and RONS with Biological Targets NO is generated from three enzymes (eNOS, cNOs and iNOS) which catalyze the oxidative deamination of L-arginine. Potential sources of NO in the lung include both rat and human activated alveolar macrophages (Laskin et al., 1996; Hickman-Davis et al., 2002), neutrophils, alveolar type II cells (Punjabi et al., 1994; Weinberger et al., 1999), and airway cells (Asano et al., 1994). Increased iNOS levels have been found in airway cells and human lung tissue obtained from patients with ARDS (Haddad et al., 1994; Kobayashi et al., 1998; Sittipunt et al., 2001) and other inflammatory lung diseases. The biological effects of NO depend on its concentration, the biochemical composition of the target, and the presence of other radicals (Figure 3). NO may bind to the heme group of soluble guanylate cyclase resulting in increased cellular cGMP levels and activation of PKGs (Ignarro, 1992); it may react with superoxide (O2 •− ) at diffusion limited rates (6.7 × 109 M−1 × s−1 ) to produce peroxynitrite (ONOO− ) (Beckman et al., 1990) and higher oxides of nitrogen; or, in the presence of an electron acceptor, it may react with thiols to form nitrosothiols (RS-NO) (Stamler et al., 1992a, 1992b, 1992c). In spite of the numerous beneficial effects of NO (such as vasodilation, inhibition
FIGURE 3 Generation of reactive oxygen nitrogen intermediates.
52
W. Song et al.
of platelet and neutrophil adherence in endothelial cells, termination of selfpropagation reactions), at high concentrations, NO itself has been shown to inactivate critical enzymes by interacting with their iron-sulfur centers (Molina y Vedia et al., 1992), causing DNA strand breaks which result in the activation of the nuclear enzyme, poly-ADP-ribosyl transferase (Molina y Vedia et al., 1992), and inhibiting both DNA and protein synthesis (Curran et al., 1991; Delaney et al., 1993). However, at physiological concentrations, the reactivity and toxicity of NO is mild, and most of its toxicity has been attributed to either ONOO− or higher oxides of nitrogen. Peroxynitrite is a potent oxidizing and nitrating agent which oxidizes thiols at rates at least 1000-fold greater than H2 O2 at pH 7 (Radi et al., 1991a), causes iron-independent lipid peroxidation of lipids and human low density lipoproteins (Radi et al., 1991b; Graham et al., 1993), nitrates phenolics including tyrosine residues in proteins (Beckman et al., 1992; Greis et al., 1996) and oxidizes proteins (Pryor et al., 1994). Because of this diverse reactivity, ONOO− has been shown to damage a wide spectrum of biological targets such as DNA (Inoue and Kawanishi, 1995), the mitochondria electron transport chain (Radi et al., 1994), lung ion channels (Hu et al., 1994; Duvall et al., 1998; Guo et al., 1998) and the pulmonary surfactant system (Haddad et al., 1993, 1996). Furthermore, ONOO− , because of its very high reactivity, will attack biological targets even in the presence of antioxidant substances (van der Vliet et al., 1994). A number of reports (Denicola et al., 1996; Gow et al., 1996) indicate that physiological concentrations of carbon dioxide and bicarbonate enhance the reactivity of ONOO− via the formation of the nitrosoperoxycarbonate anion, which by decomposing to carbonate radicals and nitrogen dioxide (NO2 ), increases nitration of important physiological targets both in vitro (Zhu et al., 2000) and in vivo (Lang et al., 2005). Highly reactive oxygen nitrogen intermediates are also formed by heme per• oxidase catalyzed reaction of NO− 2 and H2 O2 to form nitrogen dioxide ( NO2 ) which oxidizes and nitrates phenolics (tyrosine and tryptophan) and unsaturated fatty acids (van der Vliet et al., 1995, 1997). The physiological relevance of these reactions were first demonstrated in vitro using neutrophils or monocytes as the source of MPO and H2 O2 (Davis et al., 1991). However, the extent to which these species can nitrate, chlorinate, oxidize specific target proteins and inhibit their function in vivo during lung inflammation was not clarified until very recently. MacPherson et al. (2001) identified eosinophils and eosinophil peroxidase (EPO) as a major source of oxidants during asthma. Finally, elegant studies by Brennan et al. (2002) show that the extent to which EPO- and MPO-catalyzed reactions contribute to tyrosine nitration in vivo is very much dependent on the underlying cause of the inflammatory response, and that nitrogen dioxide (• NO2 ), which is the one-electron oxidation product of NO− 2 , may be involved in these nitration reactions.
3. Nitric Oxide and Sodium Channels
53
FIGURE 4 Contribution of reactive oxygen nitrogen species to M. pulmonis-mediated alterations of AFC in vivo. MPO(+/+) and littermate MPO(−/−) mice were infected with 107 CFU M. pulmonis and AFC measured at 48 hours later. AFC measurements were performed on ventilated mice and percent clearance was calculated from changes in instilled BSA concentration during a 30 min period. Data are means ± SE, n = 5 to 9 animals for each group. In all cases the instillate contained 5% fat-free BSA in NaCl with the osmolality adjusted to that of murine plasma (322 mosmol/kgH2 O). Amiloride (1.5 mM) was added to the instillate as indicated. ∗ Significant difference from uninfected same strain control; † Significant difference from 48 h infected group, p = 0.04. (Adapted from Hickman-Davis et al. (2006) (Figure 3) with permission.)
F. Reactive Intermediates Decrease Ion Transport Across the Aveolar Epithelium in Vivo Several studies have investigated the possible association between RONS and Na+ transport across the alveolar epithelium in both animals with acute lung injury and patients with cardiogenic edema. Pittet et al. (2001) showed that reabsorption of isotonic fluid (secondary to vectorial transport of Na+ ions) was inhibited during prolonged hemorrhagic shock. Instillation of aminoguanidine, an inhibitor of iNOS, restored fluid re-absorption to normal levels. HickmanDavis et al. (2006) showed mycoplasma infection of C57Bl/6 mice resulted in significant decrease of both Na+ -dependent alveolar fluid clearance and inhibition of amiloride sensitive Na+ currents across alveolar type II cells isolated from these mice and patched in the whole cell mode. However, normal levels of AFC were seen when myeloperoxidase deficient mice, were infected with mycoplasmas (Hickman-Davis et al., 2006), suggesting that reactive species generated by MPO catalyzed contributed to the decrease of AFC by damagina apical and basolateral transporters (Figure 4). Zhu et al. (2001) showed that increased levels of nitrate and nitrite (the stable by-products of NO and RONS) in edema fluid samples of patients with acute lung injury were associated with slower rates of AFC across the lungs of patients with acute lung injury (Figure 5). Reactive oxygen–
54
W. Song et al.
FIGURE 5 Increased levels of nitrate/nitrite in the edema fluid of patients with ARDS are associated with lower levels of AFC. Box-plot summary of mean interval edema fluid nitrate and nitrite concentration versus two categories of alveolar fluid clearance in patients with Acute Lung Injury/Adult Respiratory Distress Syndrome. Maximal alveolar fluid clearance is 1%/h. Impaired/Sub-maximal alveolar fluid clearance is <14%/h. Horizontal line represents the median, the box encompasses the 25th to 75th percentile and the error bars encompass the 10th to 90th percentile. ∗ p < 0.05 by Mann Whitney U-test. From Zhu et al. (2001) (Figure 2) with permission.
nitrogen intermediates have also been shown to decrease ATII cell Na,K-ATPase in thrombin and oleic acid injury by promoting endocytosis from the basolateral plasma membrane via a mechanism involving phosphorylation of PKCζ (Vadasz et al., 2005, 2004). On the other hand, iNOS (−/−) mice as well as alveolar epithelial cells treated with iNOS inhibitors lack amiloride sensitive transport and have lower levels of α and γ ENaC proteins (Hardiman et al., 2004). Thus although increase levels of RONS damage ion transport, basal levels of NO are necessary for the proper function of the amiloride sensitive channels. G. Reactive Intermediates Decrease Vectorial Na+ Transport Across ATII Cells in Vitro More definitive conclusions concerning the effects of NO and RONS on ion channels on alveolar epithelial cells were drawn from studies measuring ion transport across alveolar epithelial cells. Hu et al. (1994) showed that micromolar concentrations of ONOO− decreased amiloride-inhibitable 22 Na+ uptake across
3. Nitric Oxide and Sodium Channels
55
freshly isolated rabbit ATII cells by at least 40%. Compeau et al. (1994) reported that incubation of confluent monolayers of fetal lung epithelial cells with LPS activated alveolar macrophages for 16 h resulted in a 60% reduction in amiloridesensitive short circuit current (Isc ) and 60% decrease in the density of a 25-pS non-selective cation, Ca2+ activated channel present in the apical membrane of these cells. These effects were abrogated by blocking the ability of alveolar macrophages to generate NO and were associated with a decrease in ENaC mRNA levels. Guo et al. (1998) also reported that NO, generated by a variety of NO donor decreased Isc across confluent monolayers of rat ATII cells with an IC50 of 0.4 µM without affecting transepithelial resistance. NO also inhibited ∼60% of the amiloride-sensitive Isc across ATII cell monolayers following permeabilization of the basolateral membranes, providing strong evidence of down-regulation of amiloride sensitive ENaC channels. Incubation of ATII monolayers with a cell-permeable form of cGMP (8-bromo-cGMP; 400 µM) did not decrease Isc , indicating that at least under these conditions, the inhibitory effects of NO were not mediated by increasing cGMP levels. These findings are in agreement with the original report of Goodman and Crandall also showed that Br-cGMP did not alter dome formation (a parameter for active salt and water transport) by ATII cells (Goodman et al., 1984) and suggest that the effects of NO are mediated through cGMP-independent mechanisms, such as post-translational modifications of either ENaC per se, or structural proteins (such as actin and fondrin) which are necessary for proper action of ENaC. Indeed, 3-morpholinosydnonimine (SIN-1), a generator of ONOO− profoundly inhibited the amiloride-sensitive whole-cell conductance in Xenopus oocytes injected with α, β, γ -rENaC (Duvall et al., 1998) (Figure 6). On the other hand, even supraphysiological concentrations of NO, generated by a variety of NO donors, had no effect on the amiloride-sensitive current of Xenopus oocytes injected with α, β and γ ENaC. ONOO− may exert its effects by oxidizing, nitrating or nitrosylation critical amino acid residues in either ENaC or other structural proteins necessary for its proper function. The α-rENaC subunit has two membrane-spanning domains and an extracellular loop that is rich in tyrosine residues. Mutations or deletions within the extracellular loop of α-rENaC (residues 278–283) affect the ability of amiloride to block α-rENaC channels as well as their open probability (Ismailov et al., 1997). Furthermore, selected mutations within this region of αENaC or within the corresponding region of γ ENaC altered the channel’s response to external Ni+2 and to changes in extracellular Na+ (Sheng et al., 2004). Chen et al. (2004a) generated α-rENaC mutant proteins, where tyrosine residues at positions 279 (mutation α Y279A ), and 283 (mutation α Y283A ) were replaced with alanine, and expressed these mutants, either alone or in combination with wild-type β and γ -rENaC in Xenopus oocytes. Exposure of oocytes to SIN-1 (1 mM) for five minutes decreased both total Na+ and amiloride-sensitive currents across wt- and α Y279A but not α Y283A β, γ -rENaC. Furthermore, exposure to SIN-1 increased the Ki for amiloride across wt but not α Y279A β, γ -rENaC injected oocytes. These
56
W. Song et al.
FIGURE 6 Peroxynitrite decreases amiloride-sensitive currents in Xenopus oocytes. Current-voltage (I–V) relationships from Xenopus oocytes expressing α, β, γ -rENaC. The upper panel shows currents while membrane potentials were stepped from the resting potential to −100 and +100 mV in the absence and presence of amiloride (10 µM). Measurements were then repeated after oocytes were incubated with SIN-1 (1 mM) for 120 min. Amiloride sensitive currents were then calculated as the difference currents. The solid circles are values from oocytes expressing rENaC, but not exposed to SIN-1 (X ± SEM; n = 6). The open circles are values from oocytes expressing rENaC and exposed to SIN-1 (1 mM) for 2 h (X ± SEM; n = 7). The conductance (slope of I–V relationship) was significantly different from zero in the control oocytes (P < 0.01), but not in oocytes exposed to SIN-1 (modified from Duvall et al. (1998) with permission).
3. Nitric Oxide and Sodium Channels
57
data indicate that both tyrosines are important for proper ENaC function and their oxidative modifications contribute to altered ENaC function. Both the extracellular and trans-membrane segments of ENaC subunits contains domains rich in cysteine residues. Cysteine residues not involved in disulfide formation may become oxidized or nitrosylated which may alter ENaC function. Reactive species (such as superoxide, hydrogen peroxide and hydroxyl radicals) produced by xanthine and xanthine oxidase, decreased amiloride sensitive currents across toad ventral skin mounted in Ussing chambers when added in the apical but not in the basolateral sides, indicating that these reactive species damaged epithelial Na+ channels (Matalon et al., 1989). Furthermore, intracellular oxidizing agents reduced amiloride-sensitive currents in Xenopus oocytes injected with α, β and γ ENaC (Kellenberger et al., 2005). RONS may be downregulating ENaC activity via activation of PKC, which has been shown to reduce ENaC activity and modify its subunit composition. Inhibition of PKC rapidly increased Po and appearance of new channels in patches of A6 (Ling and Eaton, 1989), and lung ATII cells (Chen et al., 2004b) as well in Xenopus oocytes heterologously expressing α, β and γ ENaC (Awayda et al., 1996). In contrast, stimulation of PKC inhibited whole-cell currents in Xenopus oocytes (Awayda et al., 1996). Likewise, PKC activation decreased expression of both β and γ ENaC levels in A6 cells, the activity of single channels and transepithelial Na+ reabsorption (Stockand et al., 2000). ENaC channels are constitutively open at the plasma membrane and do not appear to require additional activation (Canessa et al., 1994b). ENaC activity is regulated by two fundamental mechanisms: changes in the open probability (Po ) of the preexisting channels, or changes in the number of channels at the cell plasma membrane. In the long run, factors that influence both ENaC mRNA and protein levels can potentially modulate amiloride-sensitive Na+ transport in the lung. In the short term, the number of channels at the cell membrane is controlled by a number of mechanisms that involve on one hand the synthesis of new proteins and their exocytosis, on the other hand their removal by endocytosis and their degradation in the proteasome. The ubiquitin-proteasome pathway is an important regulator of ENaC function. The half-life of ENaC in mammalian cell membranes is short (less than 1 hour). ENaC is ubiquitinated in vivo on the α and γ , but not in the β subunits (Staub et al., 1997). Inhibition of ubiquitination or the proteasome results in increased channel activity, due to an increase in the number of channels present at the plasma membrane (Malik et al., 2001). Ubiquitination (ATPdependent serial addition of ubiquitin monomers to lysine residues on proteins), which targets proteins for rapid degradation by the proteasome, is catalyzed by the sequential action of ubiquitin-activating, ubiquitin-conjugating, and ubiquitin protein ligase enzymes (Hochstrasser, 1995). Neural precursor cell-expressed developmentally downregulated protein 4 (Nedd4-2) is the ubiquitin-protein ligase required for ubiquitination of ENaC (Staub et al., 2000). Nedd4-2 is homologous to the ubiquitin ligase and contains three WW domains (Staub and Rotin, 1996;
58
W. Song et al.
Staub et al., 1996) that bind to the PPXY regions of β and γ ENaC subunits. It is assumed that during the interaction of WW domains of Nedd4 with the PPXY domains of ENaC subunits, an E6-AP carboxyl terminus in Nedd4-2 act as a ubiquitin ligase and conjugates ubiquitin to the amino termini of α, β, γ ENaC subunits (Zhou et al., 2007). Ubiquitin binding to α and γ ENaC subunits occurs in MDCK cells and Hek293 cells transfected with the three ENaC subunits (Staub et al., 2000). The co- expression of ENaC subunits and Nedd4-2 in Xenopus oocytes leads to the reduction of ENaC half life at the cell surface and simultaneous decrease in the whole cell amiloride sensitive current was observed (Abriel et al., 1999). Nedd4-2 directly regulates basal ENaC activity by modulating channel stability at the cell surface. In the lung, Nedd4 is mainly expressed in the epithelia lining the airways and in the distal respiratory epithelium, a pattern of expression similar to that of ENaC (Hochstrasser, 1995). Interestingly, the interaction between ENaC and Nedd4-2 is disrupted in Liddle Syndrome, a hereditable form of salt-sensitive hypertension (Snyder et al., 1995). Truncations of the COOH-terminus or mutations in conserved COOH-terminal PY motif abolish the interaction between ENaC and Nedd4-2 resulting in a longer ENaC half-life at the plasma membrane and lower levels of internalization and degradation. This leads to increased amiloride-sensitive current at the apical membrane and increased salt absorption (Snyder et al., 2004, 2005; Knight et al., 2006). The link between PKC and the ubiquitin-proteasome pathway has just recently been made clear. In A6 cells, PKC has been shown to activate the mitogenactivated protein (MAP) kinase kinase kinase Raf-1, and the MAP kinase kinases MAPK/ERK (MEK) 1 and 2. Activation of MEK 1 and 2 was shown to enhance phosphorylation of β and γ , but not αENaC (Shimkets et al., 1998). This phosphorylation event facilitates binding of Nedd4-2 to ENaC, which may then promote ENaC internalization and removal from the cell surface (Staub et al., 2000). Reactive oxygen-nitrogen intermediates have also been shown to decrease ATII cell Na,K-ATPase in thrombin and oleic acid injury by promoting endocytosis from the basolateral plasma membrane via a mechanism involving phosphorylation of PKCζ (Vadasz et al., 2004, 2005).
H. Regulation of Lung Epithelial Na+ Channels by cGMP In contrast to the results cited above, other studies clearly show that • NO modulates cation channel activity in both renal and alveolar epithelial cells by increasing cGMP levels. (Light et al., 1990) demonstrated the presence of a 28 pS cation channel in rat renal inner-medullary collecting duct cells, the activity of which was decreased both by cGMP per se and via cGMP kinase (PKG)-induced phosphorylation. • NO, released from bradykinin stimulated endothelial cells, or NO donors decreased net 22 Na+ flux across isolated perfused cortical collecting
3. Nitric Oxide and Sodium Channels
59
© 1998 American Physiological Society FIGURE 7 GSNO decreases the open probability (Po ) of cation channels in ATII cells. Acute exposure of AT II cells to S-nitrosoglutathione (GSNO) inhibits non-selective cation channel activity in apical cell-attached patches. Channel activity was measured as open probability (Po ) before and 2 min after addition of 100 µM GSNO to bath. Each Po was calculated from at least 3 min of consecutive recording. Individual data and means + SE from 7 cell-attached patch experiments showing reversibility of effect of GSNO after washout. Each symbol represents a different patch; lines connect data points from the same patch. (Reprinted from Jain et al. (1998) with permission.)
ducts (Stoos et al., 1995) and decreased Na+ short-circuit current across a cortical collecting duct cell line while increasing their cGMP content (Stoos et al., 1995). Helms et al. (2005) reported that NO released from PAPANONOate decreased amiloride sensitive Na+ current across confluent monolayers of Xenopus kidney distal nephron A6 and M1 cortical collecting duct cells mounted in Ussing chambers; furthermore when these cells were patched in the cell attached mode, PAPANOate decreased the open probability of the 4 pS ENaC channels without altering their unitary conductance. In vitro studies on the regulation of Na+ transport by cGMP across confluent monolayers of cultured rat type II alveolar cells (AT2) have led to contradictory results. As mentioned above, cGMP did not alter Isc across rat AT2 monolayers (Guo et al., 1998). In contrast, cGMP, as well as NO, increased Isc and 22 Na influx in tracheal and distal lung epithelial cells (Schwiebert et al., 1997; Rafii et al., 2002). Jain et al. reported that cell permeable forms of cGMP and nitrosoglutathione (GSNO) significantly decreased single channel activity in rat AT2 cells (Figure 7) (Jain et al., 1998). However, Kemp et al. showed that Br-
60 W. Song et al.
FIGURE 8 • NO decreases amiloride sensitive currents in A549 cells through cGMP-dependent mechanisms. (A) Time course recording of whole-cell inward (Na+ ) current, evoked by −100 mV voltage pulses every 10 s before, during and after perfusion of an A549 cell with SES containing 100 µM PAPANONOate. The pipette was filled with the SIS. Whole-cell I–V relations before (B) and five min post PAPANONOate perfusion, when the steady state currents were seen (C). The whole-cell current inhibited by • NO (• NO sensitive) was calculated by digitally subtracting the currents at the steady state effect of • NO (as shown in C) from the current before the perfusion with • NO containing SES (as shown in B). Mean I–V relationships for the total and • NO-sensitive currents are shown in panel D. For panel D, values are means ±1 SEM (n = 6). (From Lazrak et al. (2000a) with permission.)
3. Nitric Oxide and Sodium Channels
61
cGMP increased cation conductance in rat ATII cells which was totally abolished by Zn2+ (Kemp et al., 2001). Different responses of whole-cell Na+ conductance to cGMP and GSNO in A549 cells were reported by three independent groups (Xu et al., 1999; Kamosinska et al., 2000; Lazrak et al., 2000a) (Figure 8). The most likely explanation for these contradictory responses are the existence of multiple families of Na+ channels in ATII cells (most likely with different ENaC subunit composition than the 4 pS ENaC channels), the properties of which may be modified by culture conditions (Matalon and O’Brodovich, 1999; Jain et al., 2001; Matalon et al., 2002). For example, cell permeable forms of cGMP activated a sodium conductance in Xenopus oocytes following heterologous expression of α, β, γ and δ ENaC but not α, β, γ ENaC alone (Ji et al., 2007). Expression of δ ENaC has been documented by both indirect immunofluorescence and RT-PCR in a variety of human lung epithelial cell lines (Ji et al., 2006). In addition to amiloride sensitive channels, lung epithelial cells contain cyclic nucleotide-gated (CNG) cation channels on their apical membranes (Norlin et al., 2001). The biochemical composition of the cGMP-activated, non-αENaC Na+ channels in lung epithelial cells is not known. In a recent study, Kaestle et al. (2007) report that endogenous nitric oxide, generated by eNOS following a transient increase of left atrial pressure, decreased sodium reabsorption by epithelial cells. This effect was mimicked by intratracheal instillation of high doses of Br-cGMP (1 mM) and ameliorated by agents that inhibited either eNOS or soluble guanylate cyclase. Furthermore, eNOS (−/−) mice were protected from this effect. These data clearly support the hypothesis that cGMP decreases alveolar Na+ reapsorption. It must be stressed that in this study, the authors measured bi-directional fluxes across the alveolar epithelium, so their results cannot be attributed to an increase of Cl− secretion, as previously reported (Chen et al., 2006). Based on these data one may conclude that increased levels of NO will increase the amount of fluid in the lungs of patients with cardiogenic edema. Indeed at least one study has suggested that this is the case (Bocchi et al., 1994). Thus, use of inhaled NO or agents that activate cGMP production (in an effort to reduce pulmonary vasoconstriction) may have to be carefully considered since inhibition of alveolar fluid transport has been correlated with worsening clinical outcome in patients with acute lung injury (Matthay and Wiener-Kronish, 1990; Ware and Matthay, 2001). However, it is important to remember that the experiments of Kaestle et al. were conducted in isolated perfused rats (which lack lymph flow) and these results apply only to an acute increase of left atrial pressure. Also, a recent report indicates that cardiogenic edema fluid (but not plasma) increases amiloride sensitive Na+ transport in both adult ATII cells and across the alveolar epithelium (Gandhi et al., 2007). Thus, additional factors may come into play to prevent the NO decrease of alveolar fluid clearance and prevent fluid accumulation into the alveolar spaces.
62
W. Song et al.
In summary, reactive oxygen nitrogen species play important role in the regulation of cation and ENaC type channels by a activating signal transduction pathways (such as PKC, cGMP, MAPK) and via post-translational modifications of a variety of critical aminoacids (such as cysteines and tyrosines). These changes in structure lead to changes in function which may have important implications in lung fluid clearance during inflammation. Acknowledgements This work was supported by grants HL075540, HL31197, HL51173 and 1U01ES015676. The authors acknowledge the expert editorial assistance of Ms. Teri Potter.
References Abriel, H., Loffing, J., Rebhun, J.F., Pratt, J.H., Schild, L., Horisberger, J.D., Rotin, D., Staub, O. (1999). Defective regulation of the epithelial Na+ channel by Nedd4 in Liddle’s syndrome. J. Clin. Invest. 103 (5), 667–673. Asano, K., Chee, C.B., Gaston, B., Lilly, C.M., Gerard, C., Drazen, J.M., Stamler, J.S. (1994). Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells. Proc. Natl. Acad. Sci. USA 91 (21), 10089–10093. Awayda, M.S., Ismailov, I.I., Berdiev, B.K., Fuller, C.M., Benos, D.J. (1996). Protein kinase regulation of a cloned epithelial Na+ channel. J. Gen. Physiol. 108 (1), 49–65. Barker, P.M., Gowen, C.W., Lawson, E.E., Knowles, M.R. (1997). Decreased sodium ion absorption across nasal epithelium of very premature infants with respiratory distress syndrome. J. Pediatrics 130 (3), 373–377 (see comments). Beckman, J.S., Beckman, T.W., Chen, J., Marshall, P.A., Freeman, B.A. (1990). Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA 87 (4), 1620–1624. Beckman, J.S., Ischiropoulos, H., Zhu, L., van der Woerd, M., Smith, C., Chen, J., Harrison, J., Martin, J.C., Tsai, M. (1992). Kinetics of superoxide dismutase- and iron-catalyzed nitration of phenolics by peroxynitrite. Arch. Biochem. Biophys. 298 (2), 438–445. Bland, R.D., Nielson, D.W. (1992). Developmental changes in lung epithelial ion transport and liquid movement. Annu. Rev. Physiol. 54, 373–394. Bocchi, E.A., Bacal, F., Auler Jr., J.O., Carmone, M.J., Bellotti, G., Pileggi, F. (1994). Inhaled nitric oxide leading to pulmonary edema in stable severe heart failure. Am. J. Cardiol. 74 (1), 70–72. Brennan, M.L., et al. (2002). A tale of two controversies: Defining both the role of peroxidases in nitrotyrosine formation in vivo using eosinophil peroxidase and myeloperoxidase-deficient mice, and the nature of peroxidase-generated reactive nitrogen species. J. Biol. Chem. 277 (20), 17415– 17427. Brochiero, E., Dagenais, A., Prive, A., Berthiaume, Y., Grygorczyk, R. (2004). Evidence of a functional CFTR Cl(−) channel in adult alveolar epithelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 287 (2), L382–L392. Brown, M.J., Olver, R.E., Ramsden, C.A., Strang, L.B., Walters, D.V. (1983). Effects of adrenaline and of spontaneous labour on the secretion and absorption of lung liquid in the fetal lamb. J. Physiol. (Lond.) 344, 137–152. Canessa, C.M., Horisberger, J.D., Rossier, B.C. (1993). Epithelial sodium channel related to proteins involved in neurodegeneration. Nature 361 (6411), 467–470 (see comments). Canessa, C.M., Merillat, A.M., Rossier, B.C. (1994a). Membrane topology of the epithelial sodium channel in intact cells. Am. J. Physiol. 267, C1682–C1690. Canessa, C.M., Schild, L., Buell, G., Thorens, B., Gautschi, I., Horisberger, J.D., Rossier, B.C. (1994b). Amiloride-sensitive epithelial Na+ channel is made of three homologous subunits. Nature 367 (6462), 463–467.
3. Nitric Oxide and Sodium Channels
63
Cheek, J.M., Kim, K.J., Crandall, E.D. (1989). Tight monolayers of rat alveolar epithelial cells: Bioelectric properties and active sodium transport. Am. J. Physiol. 256, C688–C693. Chen, L., Patel, R.P., Teng, X., Bosworth, C.A., Lancaster Jr., J.R., Matalon, S. (2006). Mechanisms of cystic fibrosis transmembrane conductance regulator activation by s-nitrosoglutathione. J. Biol. Chem. 281 (14), 9190–9199. Chen, X.J., Eaton, D.C., Jain, L. (2002). Beta-adrenergic regulation of amiloride-sensitive lung sodium channels. Am. J. Physiol. Lung Cell Mol. Physiol. 282 (4), L609–L620. Chen, L., Fuller, C.M., Kleyman, T.R., Matalon, S. (2004a). Mutations in the extracellular loop of alpha-rENaC alter sensitivity to amiloride and reactive species. Am. J. Physiol Renal Physiol. 286 (6), F1202–F1208. Chen, X.J., Seth, S., Yue, G., Kamat, P., Compans, R.W., Guidot, D., Brown, L.A., Eaton, D.C., Jain, L. (2004b). Influenza virus inhibits ENaC and lung fluid clearance. Am. J. Physiol. Lung Cell Mol. Physiol. 287 (2), L366–L373. Compeau, C.G., Rotstein, O.D., Tohda, H., Marunaka, Y., Rafii, B., Slutsky, A.S., O’Brodovich, H. (1994). Endotoxin-stimulated alveolar macrophages impair lung epithelial Na+ transport by an L-Arg-dependent mechanism. Am. J. Physiol. 266, C1330–C1341. Curran, R.D., Ferrari, F.K., Kispert, P.H., Stadler, J., Stuehr, D.J., Simmons, R.L., Billiar, T.R. (1991). Nitric oxide and nitric oxide-generating compounds inhibit hepatocyte protein synthesis. FASEB J. 5, 2085–2092. Dagenais, A., Kothary, R., Berthiaume, Y. (1997). The alpha subunit of the epithelial sodium channel in the mouse: Developmental regulation of its expression. Pediatric Res. 42 (3), 327–334. Davis, J.K., Davidson, M., Schoeb, T.R. (1991). Murine respiratory mycoplasmosis: A model to study effects of oxidants. Res. Rep. Health Eff. Inst. 47, 1–29. Delaney, C.A., Green, M.H., Lowe, J.E., Green, I.C. (1993). Endogenous nitric oxide induced by interleukin-1 beta in rat islets of Langerhans and HIT-T15 cells causes significant DNA damage as measured by the ‘comet’ assay. FEBS Lett. 333 (3), 291–295. Denicola, A., Freeman, B.A., Trujillo, M., Radi, R. (1996). Peroxynitrite reaction with carbon dioxide/bicarbonate: Kinetics and influence on peroxynitrite-mediated oxidation. Arch. Biochem. Biophys. 333 (1), 49–58. Duvall, M.D., Zhu, S., Fuller, C.M., Matalon, S. (1998). Peroxynitrite inhibits amiloride-sensitive Na+ currents in Xenopus oocytes expressing α, β, γ rENaC. Am. J. Physiol. 274 (5), C1417–C1423. Pt 1. Factor, P., Dumasius, V., Saldias, F., Brown, L.A., Sznajder, J.I. (2000). Adenovirus-mediated transfer of an Na+ /K+ -ATPase beta1 subunit gene improves alveolar fluid clearance and survival in hyperoxic rats. Hum. Gene Ther. 11 (16), 2231–2242. Factor, P., Senne, C., Dumasius, V., Ridge, K., Jaffe, H.A., Uhal, B., Gao, Z., Sznajder, J.I. (1998). Overexpression of the Na+ ,K+ -ATPase alpha1 subunit increases Na+ ,K+ -ATPase function in A549 cells. Am. J. Resp. Cell Mol. Biol. 18 (6), 741–749. Fang, X., Fukuda, N., Barbry, P., Sartori, C., Verkman, A.S., Matthay, M.A. (2002). Novel role for CFTR in fluid absorption from the distal airspaces of the lung. J. Gen. Physiol. 119 (2), 199–208. Farman, N., Talbot, C.R., Boucher, R., Fay, M., Canessa, C., Rossier, B., Bonvalet, J.P. (1997). Noncoordinated expression of alpha-, beta-, and gamma-subunit mRNAs of epithelial Na+ channel along rat respiratory tract. Am. J. Physiol. 272 (1), C131–C141. Pt 1. Feng, Z.P., Clark, R.B., Berthiaume, Y. (1993). Identification of nonselective cation channels in cultured adult rat alveolar type II cells. Am. J. Resp. Cell Mol. Biol. 9 (3), 248–254. Fyfe, G.K., Canessa, C.M. (1998). Subunit composition determines the single channel kinetics of the epithelial sodium channel. J. Gen. Physiol. 112 (4), 423–432. Gandhi, S.G., et al. (2007). Effects of cardiogenic edema fluid on ion and fluid transport in the adult lung. Am. J. Physiol. Lung Cell Mol. Physiol. 293 (3), L651–L659. Goodman, B.E., Brown, S.E., Crandall, E.D. (1984). Regulation of transport across pulmonary alveolar epithelial cell monolayers. J. Appl. Physiol. 57 (3), 703–710.
64
W. Song et al.
Gow, A., Duran, D., Thom, S.R., Ischiropoulos, H. (1996). Carbon dioxide enhancement of peroxynitrite-mediated protein tyrosine nitration. Arch. Biochem. Biophys. 333, 42–48. Gowen, C.W.J., Lawson, E.E., Gingras, J., Boucher, R.C., Gatzy, J.T., Knowles, M.R. (1988). Electrical potential difference and ion transport across nasal epithelium of term neonates: correlation with mode of delivery, transient tachypnea of the newborn, and respiratory rate. J. Pediatrics 113, 121–127. Pt 1. Graham, A., Hogg, N., Kalyanaraman, B., O’Leary, V., Darley-Usmar, V., Moncada, S. (1993). Peroxynitrite modification of low-density lipoprotein leads to recognition by the macrophage scavenger receptor. FEBS Lett. 330 (2), 181–185. Greis, K.D., Zhu, S., Matalon, S. (1996). Identification of nitration sites on surfactant protein A by tandem electrospray mass spectrometry. Arch. Biochem. Biophys. 335 (2), 396–402. Guo, Y., Duvall, M.D., Crow, J.P., Matalon, S. (1998). Nitric oxide inhibits Na+ absorption across cultured alveolar type II monolayers. Am. J. Physiol. 274 (3), L369–L377. Pt 1. Haddad, I.Y., Ischiropoulos, H., Holm, B.A., Beckman, J.S., Baker, J.R., Matalon, S. (1993). Mechanisms of peroxynitrite-induced injury to pulmonary surfactants. Am. J. Physiol. 265, L555–L564. Haddad, I.Y., Pataki, G., Hu, P., Galliani, C., Beckman, J.S., Matalon, S. (1994). Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury. J. Clin. Invest. 94 (6), 2407–2413. Haddad, I.Y., Zhu, S., Ischiropoulos, H., Matalon, S. (1996). Nitration of surfactant protein A results in decreased ability to aggregate lipids. Am. J. Physiol. 270, L281–L288. Hardiman, K.M., Lindsey, J.R., Matalon, S. (2001). Lack of amiloride-sensitive transport across alveolar and respiratory epithelium of iNOS(−/−) mice in vivo. Am. J. Physiol. Lung Cell Mol. Physiol. 281 (3), L722–L731. Hardiman, K.M., Nicholas-Bevensee, C.M., Fortenberry, J., Myles, C.T., Malik, B., Eaton, D.C., Matalon, S. (2004). Regulation of amiloride-sensitive Na(+) transport by basal nitric oxide. Am. J. Respir. Cell Mol. Biol. 30 (5), 720–728. Helms, M.N., Self, J., Bao, H.F., Job, L.C., Jain, L., Eaton, D.C. (2006). Dopamine activates amiloridesensitive sodium channels in alveolar type I cells in lung slice preparations. Am. J. Physiol. Lung Cell Mol. Physiol. 291 (4), L610–L618. Helms, M.N., Yu, L., Malik, B., Kleinhenz, D.J., Hart, C.M., Eaton, D.C. (2005). Role of SGK1 in nitric oxide inhibition of ENaC in Na+ -transporting epithelia. Am. J. Physiol. Cell Physiol. 289 (3), C717–C726. Hickman-Davis, J.M., Nicholas-Bevensee, C., Davis, I.C., Ma, H.P., Davis, G.C., Bosworth, C.A., Matalon, S. (2006). Reactive species mediate inhibition of alveolar type II sodium transport during mycoplasma infection. Am. J. Respir. Crit. Care Med. 173 (3), 334–344. Hickman-Davis, J.M., O’Reilly, P., Davis, I.C., Peti-Peterdi, J., Davis, G., Young, K.R., Devlin, R.B., Matalon, S. (2002). Killing of Klebsiella pneumoniae by human alveolar macrophages. Am. J. Physiol. Lung Cell Mol. Physiol. 282 (5), L944–L956. Hochstrasser, M. (1995). Ubiquitin, proteasomes, and the regulation of intracellular protein degradation. Curr. Opin. Cell Biol. 7 (2), 215–223. Hu, P., Ischiropoulos, H., Beckman, J.S., Matalon, S. (1994). Peroxynitrite inhibition of oxygen consumption and sodium transport in alveolar type II cells. Am. J. Physiol. 266, L628–L634. Hummler, E., Barker, P., Gatzy, J., Beermann, F., Verdumo, C., Schmidt, A., Boucher, R., Rossier, B.C. (1996). Early death due to defective neonatal lung liquid clearance in αENaC-deficient mice. Nat. Genet. 12, 325–328. Hummler, E., et al. (1997). A mouse model for the renal salt-wasting syndrome pseudohypoaldosteronism. Proc. Natl. Acad. Sci. USA 94 (21), 11710–11715. Ignarro, L.J. (1992). Haem-dependent activation of cytosolic guanylate cyclase by nitric oxide: A widespread signal transduction mechanism. Biochem. Soc. Trans. 20 (2), 465–469. Inoue, S., Kawanishi, S. (1995). Oxidative DNA damage induced by simultaneous generation of nitric oxide and superoxide. FEBS Lett. 371, 86–88.
3. Nitric Oxide and Sodium Channels
65
Ismailov, I.I., et al. (1997). Identification of an amiloride binding domain within the alpha-subunit of the epithelial Na+ channel. J. Biol. Chem. 272 (34), 21075–21083. Jain, L., Chen, X.J., Brown, L.A., Eaton, D.C. (1998). Nitric oxide inhibits lung sodium transport through a cGMP-mediated inhibition of epithelial cation channels. Am. J. Physiol. 274 (4), L475– L484. Pt 1. Jain, L., Chen, X.J., Malik, B., Al Khalili, O., Eaton, D.C. (1999). Antisense oligonucleotides against the alpha-subunit of ENaC decrease lung epithelial cation-channel activity. Am. J. Physiol. 276 (6), L475–L484. Pt 1. Jain, L., Chen, X.J., Ramosevac, S., Brown, L.A., Eaton, D.C. (2001). Expression of highly selective sodium channels in alveolar type II cells is determined by culture conditions. Am. J. Physiol. Lung Cell Mol. Physiol. 280 (4), L646–L658. Ji, H.L., Chen, L., Shrestha, K., Song, W., Su, X.F., Smith, P.R., Sorscher, E.J., Benos, D.J., Matalon, S. (2007). Guanosine nucleotides activate sodium transport in human respiratory epithelial cells. FASEB J. 21 (5), A553. Ref Type: Abstract. Ji, H.L., Su, X.F., Kedar, S., Li, J., Barbry, P., Smith, P.R., Matalon, S., Benos, D.J. (2006). Deltasubunit confers novel biophysical features to alpha beta gamma-human epithelial sodium channel (ENaC) via a physical interaction. J. Biol. Chem. 281 (12), 8233–8241. Johnson, M.D., Bao, H.F., Helms, M.N., Chen, X.J., Tigue, Z., Jain, L., Dobbs, L.G., Eaton, D.C. (2006). Functional ion channels in pulmonary alveolar type I cells support a role for type I cells in lung ion transport. Proc. Natl. Acad. Sci. USA 103 (13), 4964–4969. Johnson, M.D., Widdicombe, J.H., Allen, L., Barbry, P., Dobbs, L.G. (2002). Alveolar epithelial type I cells contain transport proteins and transport sodium, supporting an active role for type I cells in regulation of lung liquid homeostasis. Proc. Natl. Acad. Sci. USA 99 (4), 1966–1971. Kaestle, S.M., Reich, C.A., Yin, N., Habazettl, H., Weimann, J., Kuebler, W.M. (2007). Nitric oxidedependent inhibition of alveolar fluid clearance in hydrostatic lung edema. Am. J. Physiol. Lung Cell Mol. Physiol. 293 (4), L859–L869. Kamosinska, B., Radomski, A., Man, S.F., Radomski, M.W., Duszyk, M. (2000). Role of inducible nitric-oxide synthase in regulation of whole-cell current in lung epithelial cells. J. Pharmacol. Exp. Ther. 295 (2), 500–505. Kellenberger, S., Gautschi, I., Pfister, Y., Schild, L. (2005). Intracellular thiol-mediated modulation of epithelial sodium channel activity. J. Biol. Chem. 280 (9), 7739–7747. Kemp, P.J., Borok, Z., Kim, K.J., Lubman, R.L., Danto, S.I., Crandall, E.D. (1999). Epidermal growth factor regulation in adult rat alveolar type II cells of amiloride-sensitive cation channels. Am. J. Physiol. 277 (6), C1058–C1065. Pt 1. Kemp, P.J., Kim, K.J., Borok, Z., Crandall, E.D. (2001). Re-evaluating the Na(+) conductance of adult rat alveolar type II pneumocytes: evidence for the involvement of cGMP-activated cation channels. J. Physiol. 536, 693–701. Pt 3. Kizer, N., Guo, X.L., Hruska, K. (1997). Reconstitution of stretch-activated cation channels by expression of the alpha-subunit of the epithelial sodium channel cloned from osteoblasts. Proc. Natl. Acad. Sci. USA 94 (3), 1013–1018 [published erratum appears in Proc. Natl. Acad. Sci. USA 94 (8) (1997 April 15) 4233]. Knight, K.K., Olson, D.R., Zhou, R., Snyder, P.M. (2006). Liddle’s syndrome mutations increase Na+ transport through dual effects on epithelial Na+ channel surface expression and proteolytic cleavage. Proc. Natl. Acad. Sci. USA 103 (8), 2805–2808. Kobayashi, A., Hashimoto, S., Kooguchi, K., Kitamura, Y., Onodera, H., Urata, Y., Ashihara, T. (1998). Expression of inducible nitric oxide synthase and inflammatory cytokines in alveolar macrophages of ARDS following sepsis. Chest 113 (6), 1632–1639 (see comments). Lang, J.D., Figueroa, M., Sanders, K.D., Aslan, M., Liu, Y., Chumley, P., Freeman, B.A. (2005). Hypercapnia via reduced rate and tidal volume contributes to lipopolysaccharide-induced lung injury. Am. J. Respir. Crit. Care Med. 171 (2), 147–157. Laskin, J.D., Heck, D.E., Laskin, D.L. (1996). Nitric oxide production in the lung and liver following inhalation of the pulmonary irritant ozone. Adv. Exp. Med. Biol. 387, 141–146.
66
W. Song et al.
Lazrak, A., Samanta, A., Matalon, S. (2000a). Biophysical properties and molecular characterization of amiloride-sensitive sodium channels in A549 cells. Am. J. Physiol. Lung Cell Mol. Physiol. 278 (4), L848–L857. Lazrak, A., Samanta, A., Venetsanou, K., Barbry, P., Matalon, S. (2000b). Modification of biophysical properties of lung epithelial Na(+) channels by dexamethasone. Am. J. Physiol. Cell Physiol. 279 (3), C762–C770. Lazrak, A., Thome, U., Myles, C., Ware, J., Chern, L., Venglarik, C.J., Matalon, S. (2002). cAMP regulation of Cl(−) and HCO(−)(3) secretion across rat fetal distal lung epithelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 282 (4), L650–L658. Light, D.B., Corbin, J.D., Stanton, B.A. (1990). Dual ion-channel regulation by cyclic GMP and cyclic GMP-dependent protein kinase. Nature 344 (6264), 336–339. Ling, B.N., Eaton, D.C. (1989). Effects of luminal Na+ on single Na+ channels in A6 cells, a regulatory role for protein kinase C. Am. J. Physiol. 256 (6), F1094–F1103. Pt 2. MacPherson, J.C., Comhair, S.A., Erzurum, S.C., Klein, D.F., Lipscomb, M.F., Kavuru, M.S., Samoszuk, M.K., Hazen, S.L. (2001). Eosinophils are a major source of nitric oxide-derived oxidants in severe asthma: Characterization of pathways available to eosinophils for generating reactive nitrogen species. J. Immun. 166 (9), 5763–5772. Malik, B., Schlanger, L., Al Khalili, O., Bao, H.F., Yue, G., Price, S.R., Mitch, W.E., Eaton, D.C. (2001). Enac degradation in A6 cells by the ubiquitin-proteosome proteolytic pathway. J. Biol. Chem. 276 (16), 12903–12910. Matalon, S., Beckman, J.S., Duffey, M.E., Freeman, B.A. (1989). Oxidant inhibition of epithelial active sodium transport. Free Radical Biol. Med. 6, 557–564. Matalon, S., Kirk, K.L., Bubien, J.K., Oh, Y., Hu, P., Yue, G., Shoemaker, R., Cragoe Jr., E.J., Benos, D.J. (1992). Immunocytochemical and functional characterization of Na+ conductance in adult alveolar pneumocytes. Am. J. Physiol. 262, C1228–C1238. Matalon, S., Lazrak, A., Jain, L., Eaton, D.C. (2002). Invited review: Biophysical properties of sodium channels in lung alveolar epithelial cells. J. Appl. Physiol. 93 (5), 1852–1859. Matalon, S., O’Brodovich, H. (1999). Sodium channels in alveolar epithelial cells: Molecular characterization, biophysical properties, and physiological significance. Annu. Rev. Physiol. 61, 627–661. Matsushita, K., McCray, P.B.J., Sigmund, R.D., Welsh, M.J., Stokes, J.B. (1996). Localization of epithelial sodium channel subunit mRNAs in adult rat lung by in situ hybridization. Am. J. Physiol. 271 (2), L332–L339. Pt 1. Matthay, M.A., Berthiaume, Y., Staub, N.C. (1985). Long-term clearance of liquid and protein from the lungs of unanesthetized sheep. J. Appl. Physiol. 59 (3), 928–934. Matthay, M.A., Folkesson, H.G., Clerici, C. (2002). Lung epithelial fluid transport and the resolution of pulmonary edema. Physiol. Rev. 82 (3), 569–600. Matthay, M.A., Folkesson, H.G., Verkman, A.S. (1996). Salt and water transport across alveolar and distal airway epithelia in the adult lung. Am. J. Physiol. 270 (4), L487–L503. Pt 1. Matthay, M.A., Landolt, C.C., Staub, N.C. (1982). Differential liquid and protein clearance from the alveoli of anesthetized sheep. J. Appl. Physiol. 53 (1), 96–104. Matthay, M.A., Wiener-Kronish, J.P. (1990). Intact epithelial barrier function is critical for the resolution of alveolar edema in humans. Am. Rev. Respir. Dis. 142, 1250–1257. McDonald, F.J., Snyder, P.M., McCray Jr., P.B., Welsh, M.J. (1994). Cloning, expression, and tissue distribution of a human amiloride-sensitive Na+ channel. Am. J. Physiol. 266, L728–L734. McNicholas, C.M., Canessa, C.M. (1997). Diversity of channels generated by different combinations of epithelial sodium channel subunits. J. Gen. Physiol. 109 (6), 681–692. Molina y Vedia, L., McDonald, B., Reep, B., Brune, B., Di Silvio, M., Billiar, T.R., Lapetina, E.G. (1992). Nitric oxide-induced S-nitrosylation of glyceraldehyde-3-phosphate dehydrogenase inhibits enzymatic activity and increases endogenous ADP-ribosylation. J. Biol. Chem. 267, 24929– 24932 [published erratum appears in J. Biol. Chem. (1993 February 5) 268 (4), 3016]. Nielsen, V.G., Duvall, M.D., Baird, M.S., Matalon, S. (1998). cAMP activation of chloride and fluid secretion across the rabbit alveolar epithelium. Am. J. Physiol. 275 (6), L1127–L1133. Pt 1.
3. Nitric Oxide and Sodium Channels
67
Nielson, D.W., Lewis, M.B. (1990). Effects of amiloride on alveolar epithelial PD and fluid composition in rabbits. Am. J. Physiol. 258, L215–L219. Norlin, A., Lu, L.N., Guggino, S.E., Matthay, M.A., Folkesson, H.G. (2001). Contribution of amiloride-insensitive pathways to alveolar fluid clearance in adult rats. J. Appl. Physiol. 90 (4), 1489–1496. O’Brodovich, H. (1991). Epithelial ion transport in the fetal and perinatal lung. Am. J. Physiol. 261, C555–C564. O’Brodovich, H., Canessa, C., Ueda, J., Rafii, B., Rossier, B.C., Edelson, J. (1993). Expression of the epithelial Na+ channel in the developing rat lung. Am. J. Physiol. 265, C491–C496. O’Brodovich, H., Hannam, V., Seear, M., Mullen, J.B. (1990). Amiloride impairs lung water clearance in newborn guinea pigs. J. Appl. Physiol. 68, 1758–1762. Olver, R.E., Ramsden, C.A., Strang, L.B., Walters, D.V. (1986). The role of amiloride-blockable sodium transport in adrenaline- induced lung liquid reabsorption in the fetal lamb. J. Physiol. (Lond) 376, 321–340. Olver, R.E., Strang, L.B. (1974). Ion fluxes across the pulmonary epithelium and the secretion of lung liquid in the foetal lamb. J. Physiol. (Lond.) 241 (2), 327–357. Pittet, J.F., Lu, L.N., Morris, D.G., Modelska, K., Welch, W.J., Carey, H.V., Roux, J., Matthay, M.A. (2001). Reactive nitrogen species inhibit alveolar epithelial fluid transport after hemorrhagic shock in rats. J. Immun. 166 (10), 6301–6310. Pradervand, S., et al. (1999). Salt restriction induces pseudohypoaldosteronism type 1 in mice expressing low levels of the beta-subunit of the amiloride-sensitive epithelial sodium channel. Proc. Natl. Acad. Sci. USA 96 (4), 1732–1737. Pryor, W.A., Jin, X., Squadrito, G.L. (1994). One- and two-electron oxidations of methionine by peroxynitrite. Proc. Natl. Acad. Sci. USA 91, 11173–11177. Punjabi, C.J., Laskin, J.D., Pendino, K.J., Goller, N.L., Durham, S.K., Laskin, D.L. (1994). Production of nitric oxide by rat type II pneumocytes: Increased expression of inducible nitric oxide synthase following inhalation of a pulmonary irritant. Am. J. Respir. Cell Mol. Biol. 11, 165–172. Radi, R., Beckman, J.S., Bush, K.M., Freeman, B.A. (1991a). Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J. Biol. Chem. 266, 4244–4250. Radi, R., Beckman, J.S., Bush, K.M., Freeman, B.A. (1991b). Peroxynitrite-induced membrane lipid peroxidation: The cytotoxic potential of superoxide and nitric oxide. Arch. Biochem. Biophys. 288, 481–487. Radi, R., Rodriguez, M., Castro, L., Telleri, R. (1994). Inhibition of mitochondrial electron transport by peroxynitrite. Arch. Biochem. Biophys. 308, 89–95. Rafii, B., Gillie, D.J., Sulowski, C., Hannam, V., Cheung, T., Otulakowski, G., Barker, P.M., O’Brodovich, H. (2002). Pulmonary oedema fluid induces non-alpha-ENaC-dependent Na(+) transport and fluid absorption in the distal lung. J. Physiol. 544, 537–548. Pt 2. Renard, S., Voilley, N., Bassilana, F., Lazdunski, M., Barbry, P. (1995). Localization and regulation by steroids of the alpha, beta and gamma subunits of the amiloride-sensitive Na+ channel in colon, lung and kidney. Pflugers Arch. Eur. J. Physiol. 430, 299–307. Ridge, K., et al. (1997). Alpha-2 Na,K-ATPase contributes to lung liquid clearance. Ann. NY Acad. Sci. 834, 651–652. Ridge, K.M., Olivera, W.G., Saldias, F., Azzam, S., Horowitz, S., Rutschman, V., Dumasius, V., Factor, P., Sznajder, J.I. (2003). Alveolar type 1 cells express the a2 Na,K-ATPase which contributes to lung liquid clearance. Circ. Res. Sakuma, T., Okaniwa, G., Nakada, T., Nishimura, T., Fujimura, S., Matthay, M.A. (1994). Alveolar fluid clearance in the resected human lung. Am. J. Respir. Crit. Care Med. 150, 305–310 (see comments). Sartori, C., et al. (2002). Salmeterol for the prevention of high-altitude pulmonary edema. N. Engl. J. Med. 346 (21), 1631–1636.
68
W. Song et al.
Schild, L., Schneeberger, E., Gautschi, I., Firsov, D. (1997). Identification of amino acid residues in the alpha, beta, and gamma subunits of the epithelial sodium channel (ENaC) involved in amiloride block and ion permeation. J. Gen. Physiol. 109 (1), 15–26. Schneeberger, E.E., McCarthy, K.M. (1986). Cytochemical localization of Na+ –K+ -ATPase in rat type II pneumocytes. J. Appl. Physiol. 60 (5), 1584–1589. Schwiebert, E.M., Potter, E.D., Hwang, T.H., Woo, J.S., Ding, C., Qiu, W., Guggino, W.B., Levine, M.A., Guggino, S.E. (1997). cGMP stimulates sodium and chloride currents in rat tracheal airway epithelia. Am. J. Physiol. 272 (3), C911–C922. Pt 1. Sheng, S., Bruns, J.B., Kleyman, T.R. (2004). Extracellular histidine residues crucial for for Na+ self-inhibition of epithelial Na+ channels. J. Biol. Chem. 279 (11), 9743–9749. Shimkets, R.A., Lifton, R., Canessa, C.M. (1998). In vivo phosphorylation of the epithelial sodium channel. Proc. Natl. Acad. Sci. USA 95 (6), 3301–3305. Sittipunt, C., Steinberg, K.P., Ruzinski, J.T., Myles, C., Zhu, S., Goodman, R.B., Hudson, L.D., Matalon, S., Martin, T.R. (2001). Nitric oxide and nitrotyrosine in the lungs of patients with acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 163 (2), 503–510. Snyder, P.M. (2005). Minireview: regulation of epithelial Na+ channel trafficking. Endocrinology 146 (12), 5079–5085. Snyder, P.M., Cheng, C., Prince, L.S., Rogers, J.C., Welsh, M.J. (1998). Electrophysiological and biochemical evidence that DEG/ENaC cation channels are composed of nine subunits. J. Biol. Chem. 273 (2), 681–684. Snyder, P.M., Olson, D.R., Kabra, R., Zhou, R., Steines, J.C. (2004). cAMP and serum and glucocorticoid-inducible kinase (SGK) regulate the epithelial Na(+) channel through convergent phosphorylation of Nedd4-2. J. Biol. Chem. 279 (44), 45753–45758. Snyder, P.M., Price, M.P., McDonald, F.J., Adams, C.M., Volk, K.A., Zeiher, B.G., Stokes, J.B., Welsh, M.J. (1995). Mechanism by which Liddle’s syndrome mutations increase activity of a human epithelial Na+ channel. Cell 83 (6), 969–978. Stamler, J.S., Simon, D.I., Jaraki, O., Osborne, J.A., Francis, S., Mullins, M., Singel, D., Loscalzo, J. (1992a). S-nitrosylation of tissue-type plasminogen activator confers vasodilatory and antiplatelet properties on the enzyme. Proc. Natl. Acad. Sci. USA 89 (1), 8087–8091. Stamler, J.S., Simon, D.I., Osborne, J.A., Mullins, M.E., Jaraki, O., Michel, T., Singel, D.J., Loscalzo, J. (1992b). S-nitrosylation of proteins with nitric oxide: Synthesis and characterization of biologically active compounds. Proc. Natl. Acad. Sci. USA. 89, 444–448. Stamler, J.S., Singel, D.J., Loscalzo, J. (1992c). Biochemistry of nitric oxide and its redox-activated forms. Science 258, 1898–1902 (see comments). Staub, O., Abriel, H., Plant, P., Ishikawa, T., Kanelis, V., Saleki, R., Horisberger, D.J., Schild, L., Rotin, D. (2000). Regulation of the epithelial Na+ channel by Nedd4 and ubiquitination. Kidney Int. 57 (3), 809–815. Staub, O., Dho, S., Henry, P., Correa, J., Ishikawa, T., McGlade, J., Rotin, D. (1996). WW domains of Nedd4 bind to the proline-rich PY motifs in the epithelial Na+ channel deleted in Liddle’s syndrome. EMBO J. 15 (10), 2371–2380. Staub, O., Gautschi, I., Ishikawa, T., Breitschopf, K., Ciechanover, A., Schild, L., Rotin, D. (1997). Regulation of stability and function of the epithelial Na+ channel (ENaC) by ubiquitination. EMBO J. 16 (21), 6325–6336. Staub, O., Rotin, D. (1996). WW domains. Structure 4 (5), 495–499. Stockand, J.D., Bao, H.F., Schenck, J., Malik, B., Middleton, P., Schlanger, L.E., Eaton, D.C. (2000). Differential effects of protein kinase C on the levels of epithelial Na+ channel subunit proteins. J. Biol. Chem. 275 (33), 25760–25765 (in process citation). Stoos, B.A., Garcia, N.H., Garvin, J.L. (1995). Nitric oxide inhibits sodium reabsorption in the isolated perfused cortical collecting duct. J. Am. Soc. Nephrol. 6, 89–94. Stutts, M.J., Canessa, C.M., Olsen, J.C., Hamrick, M., Cohn, J.A., Rossier, B.C., Boucher, R.C. (1995). CFTR as a cAMP-dependent regulator of sodium channels. Science 269 (5225), 847–850 (see comments).
3. Nitric Oxide and Sodium Channels
69
Tchepichev, S., Ueda, J., Canessa, C., Rossier, B.C., O’Brodovich, H. (1995). Lung epithelial Na channel subunits are differentially regulated during development and by steroids. Am. J. Physiol. 269, C805–C812. Thome, U.H., Davis, I.C., Nguyen, S.V., Shelton, B.J., Matalon, S. (2003). Modulation of sodium transport in fetal alveolar epithelial cells by oxygen and corticosterone. Am. J. Physiol. Lung Cell Mol. Physiol. 284 (2), L376–L385. Vadasz, I., Morty, R.E., Kohstall, M.G., Olschewski, A., Grimminger, F., Seeger, W., Ghofrani, H.A. (2004). Oleic acid inhibits alveolar fluid reabsorption: A role in acute respiratory distress syndrome? Am. J. Respir. Crit. Care Med. Vadasz, I., Morty, R.E., Olschewski, A., Konigshoff, M., Kohstall, M.G., Ghofrani, H.A., Grimminger, F., Seeger, W. (2005). Thrombin impairs alveolar fluid clearance by promoting endocytosis of Na+ ,K+ -ATPase. Am. J. Resp. Cell Mol. Biol. 33 (4), 343–354. van der Vliet, A., Eiserich, J.P., Halliwell, B., Cross, C.E. (1997). Formation of reactive nitrogen species during peroxidase-catalyzed oxidation of nitrite. A potential additional mechanism of nitric oxide-dependent toxicity. J. Biol. Chem. 272 (12), 7617–7625. van der Vliet, A., Eiserich, J.P., O’Neill, C.A., Halliwell, B., Cross, C.E. (1995). Tyrosine modification by reactive nitrogen species: A closer look. Arch. Biochem. Biophys. 319, 341–349. van der Vliet, A., Hu, M.L., O’Neill, C.A., Cross, C.E., Halliwell, B. (1994). Interactions of human blood plasma with hydrogen peroxide and hypochlorous acid. J. Lab. Clin. Med. 124, 701–707. Voilley, N., Lingueglia, E., Champigny, G., Mattei, M.G., Waldmann, R., Lazdunski, M., Barbry, P. (1994). The lung amiloride-sensitive Na+ channel: Biophysical properties, pharmacology, ontogenesis, and molecular cloning. Proc. Natl. Acad. Sci. USA 91, 247–251. Ware, L.B., Matthay, M.A. (2001). Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 163 (6), 1376–1383. Weinberger, B., Heck, D.E., Laskin, D.L., Laskin, J.D. (1999). Nitric oxide in the lung: Therapeutic and cellular mechanisms of action. Pharmacol. Ther. 84 (3), 401–411. Xu, W., Leung, S., Wright, J., Guggino, S.E. (1999). Expression of cyclic nucleotide-gated cation channels in airway epithelial cell. J. Membr. Biol. 171 (2), 117–126. Yue, G., Matalon, S. (1997). Mechanisms and sequelae of increased alveolar fluid clearance in hyperoxic rats. Am. J. Physiol. 272 (3), L407–L412. Pt 1. Yue, G., Russell, W.J., Benos, D.J., Jackson, R.M., Olman, M.A., Matalon, S. (1995). Increased expression and activity of sodium channels in alveolar type II cells of hyperoxic rats. Proc. Natl. Acad. Sci. USA 92, 8418–8422. Yue, G., Shoemaker, R.L., Matalon, S. (1994). Regulation of low-amiloride-affinity sodium channels in alveolar type II cells. Am. J. Physiol. 267, L94–L100. Zhou, R., Patel, S.V., Snyder, P.M. (2007). Nedd4-2 catalyzes ubiquitination and degradation of cell surface ENaC. J. Biol. Chem. 282 (28), 20207–20212. Zhu, S., Basiouny, K.F., Crow, J.P., Matalon, S. (2000). Carbon dioxide enhances nitration of surfactant protein A by activated alveolar macrophages. Am. J. Physiol. Lung Cell Mol. Physiol. 278 (5), L1025–L1031. Zhu, S., Ware, L.B., Geiser, T., Matthay, M.A., Matalon, S. (2001). Increased levels of nitrate and surfactant protein a nitration in the pulmonary edema fluid of patients with acute lung injury. Am. J. Respir. Crit. Care Med. 163 (1), 166–172.
CHAPTER 4 Effects of Nitrogen Oxides on Chloride Channels Benjamin Gaston University of Virginia School of Medicine, Charlottesville, VA 22908, USA
I. Overview II. Introduction III. Regulation by Nitrogen Oxides of Swelling-activated Cl− Channels IV. Regulation of Calcium Activated Cl− Channels by Nitrogen Oxides (NOx ) V. Effects of Nitrogen Oxides on CFTR A. The Effects of NOx on Wild-type (Wt) CFTR Function B. Wild-type CFTR Inhibition C. Wild-type CFTR Degradation D. Effects or Expression and Maturation of F508 CFTR VI. Future Directions References
I. OVERVIEW
Abnormal chloride (Cl− ) channel activity underlies the pathophysiology of several human diseases. Recently, it has been appreciated that nitric oxide synthase (NOS) activation and/or treatment with exogenous nitrogen oxides (NOx ) can modify the expression, maturation and/or function of a variety of Cl− channel proteins, including the cystic fibrosis (CF) transmembrane regulatory protein (CFTR). Mechanisms underlying these effects are both cyclic GMP (cGMP)dependent and cGMP-independent. A more detailed molecular understanding of these mechanisms may enable targeting of Cl− channels in the development of new therapies. Current Topics in Membranes, Volume 61 Copyright © 2008, Elsevier Inc. All rights reserved
1063-5823/08 $35.00 DOI: 10.1016/S1063-5823(08)00204-4
72
B. Gaston
II. INTRODUCTION Chloride (Cl− ) channels represent a heterogenous group of proteins. The proteins associated with some Cl− transport functions have not been characterized (Jentsch et al., 2002; Do and Civan, 2004; Suzuki et al., 2006). Stratified according to conductance, there are three broad categories of characterized Cl− channels: small (<10 pico siemens [pS]), middle-sized (10–100 pS) and large (>100 pS; or maxi-Cl− ) (Jentsch et al., 2002; Do and Civan, 2004; Suzuki et al., 2006). Functionally, Cl− channels have also been classified by Suzuki and coworkers to include those involved in 1) ligand-gated transmission in post-synaptic membranes; 2) effects on resting membrane potential in muscle; 3) de-polarization of cells, particularly including smooth muscle cells and retinal epithelial cells; 4) cell volume regulation; 5) fluid transport in epithelia; and 6) ion balance in acidified intracellular vesicles. Many of the functional roles of Cl− channel proteins have been identified in knock-out animals (Jentsch et al., 2002; Suzuki et al., 2006). Abnormalities of Cl− channel proteins in humans are associated with a broad spectrum of diseases, including cystic fibrosis (CF), myotonia congenita, Bartter’s syndrome, Dent’s disease, vitelliform macular dystrophy (Best’s disease) and osteopetrosis (Jentsch et al., 2002; Suzuki et al., 2006). There are five general classes of proteins that are established to represent Cl− channels. The largest family is the CLC family, of which there are at least nine members (Jentsch et al., 2002). Other Cl− channel proteins include the CF transmembrane conductance regulator (CFTR), swelling-activated Cl− channels (ICl swell ), calcium activated Cl− channels (CaCC), and the γ -amino buteric acid/glycine (GABA)- and glycine-receptor ligand-gated Cl− channels (Jentsch et al., 2002; Novak, 2003; Do and Civan, 2004; Suzuki et al., 2006). Cl− channel function, in general, is highly regulated by phosphorylation and/or by the intracellular or intravesicular concentrations of a variety of ions, including protons, Cl− itself, calcium and bicarbonate. For example, CaCCs in airway epithelial cells can be activated by Ca2+ flux and following P2 Y2 -purenergic receptor activation stimulated by ATP; and CFTR activation is coupled to A2b purenergic receptors activated by adenosine (Novak, 2003; Tarran et al., 2006a, 2006b). Additionally, recent evidence suggests that products downstream from nitric oxide synthase (NOS) activation also affect Cl− channel expression and function. These recent observations regarding nitrogen oxide (NOx )-mediated regulation are the subject of the current review. Activation of NOS results in the formation of nitric oxide (NO) and Snitrosothiols (Mayer et al., 1998; Gow et al., 2002; Gaston et al., 2006). These compounds cause both cyclic GMP (cGMP)-dependent and cGMP-independent effects, though it is increasingly apparent that these mechanistic classifications are not mutually exclusive (Mayer et al., 1998; Gow et al., 2002; Gaston et al., 2006; Chen et al., 2006; Sayed et al., 2007; Whalen et al., 2007). Classically, NOSderived NOx activate guanylyl cyclase and, through cGMP, downstream protein
4. Chloride Channels
73
kinases to cause cellular effects. Additional functional protein modifications, including tyrosine nitration and cysteine S-nitrosylation, mediate important effects downstream from NOS activation (Ricciardolo et al., 2004). Tyrosine nitration is a cytotoxic reaction associated with increased coproduction (or administration) of NO and superoxide, resulting in NO+ 2 addition to tyrosine. This tyrosine modification appears to be relatively irreversible in cellular systems. Cysteine Snitrosylation classically occurs through NO+ (nitrosonium) transfer, in which a proton is lost from a cysteine thiolate and replaced with the NO+ . Over 100 proteins have been identified that are post-translationally modified by S-nitrosylation (Hess et al., 2005). It is important to note that the concentration of the NOS product or exogenous NOx is a critical determinant of effect in biological systems (Ricciardolo et al., 2004; Gaston et al., 2006). For example, low µM concentrations of the endogenous compound, S-nitrosoglutathione (GSNO), cause certain effects through S-nitrosylation and/or guanylyl cyclase activation that are relevant to physiology; whereas high µM or mM concentrations can cause opposite—often toxic—effects through NO radical liberation, tyrosine nitration or even through glutathionylation (Jilling et al., 1999; Bebok et al., 2002; Zaman et al., 2004, 2006; Que et al., 2005; Wang et al., 2005; Gaston et al., 2006; Sayed et al., 2007). In this regard, it is often ill-advised to think of S-nitrosothiols as “NO donors”: they are physiological signaling molecules in physiological concentrations, working through NO+ transfer reactions (transnitrosylations); and NO radical “donors” only in high (toxic) concentrations (Ricciardolo et al., 2004; Gaston et al., 2006). A number of enzyme systems have been characterized that are involved in nitrosylation and denitrosylation processes; these likely affect NOS-dependent Cl− channel regulation as well (Lipton et al., 2001; Hess et al., 2005; Que et al., 2005; Gaston et al., 2006; Zaman et al., 2006). Recently, it has also become apparent that phosphorylation and S-nitrosylation can operate in tandem as reversible, physiological signaling mechanisms (Hess et al., 2005; Gaston et al., 2006; Carver et al., 2007; Whalen et al., 2007). Each of these mechanisms downstream from NOS activation—guanylyl cyclase activation, tyrosine nitration and cysteine S-nitrosylation—is relevant to regulation of Cl− channel expression and/or function. Each will be reviewed in the sections that follow.
III. REGULATION BY NITROGEN OXIDES OF SWELLING-ACTIVATED Cl− CHANNELS Swelling-activated Cl− transport may be mediated by small, intracellular proteins that, typically, can migrate from cytosol to the cell membrane during cell swelling induced by extracellular hypotonia challenge (Ellershaw et al., 2000; Jentsch et al., 2002; Fürst et al., 2005). Though controversial, evidence suggests that these proteins can interact with, and be phosphorylated by, cGMP-dependent
74
B. Gaston
protein kinase type 2 (Fürst et al., 2005) downstream from NOS activation. In one study, the S-nitrosothiol, S-nitroso-N-acetyl penicillamine (SNAP), inhibited swelling-induced increases in Cl− conductance in about half of the rabbit portal vein smooth muscle cells analyzed. In other cells, however, SNAP augmented this conductance; and the effect was recapitulated by the cell permeable cGMP analog, 8-bromo cGMP; further, it was inhibited by the guanylyl cyclase inhibitor, ODQ (Ellershaw et al., 2000). Strikingly, there was also a subpopulation of these rabbit portal vein smooth muscle cells in which SNAP inhibited swelling-induced Cl− transport in a cGMP-independent fashion. Thus, both cGMP dependentand independent-effects may be operative under different conditions in the regulation of swelling-dependent Cl− transport by S-nitrosothiols. Dose, location, cell-specific metabolism and condition appear to be critical determinants of these differential effects. However, a great deal more work needs to be done to understand the precise molecular mechanisms underlying these effects under physiological conditions. IV. REGULATION OF CALCIUM ACTIVATED Cl− CHANNELS BY NITROGEN OXIDES (NOx ) In 1997, Kamonsinska and coworkers showed that apical DIDS-sensitive Cl− transport in human lung epithelial cells is inhibited by NOS inhibition; and that this effect of NOS inhibition could be overcome with 100 µM GSNO (Kamonsinska et al., 1997) (Figure 1). This observation was consistent with subsequent work suggesting that NOS inhibition could modify stimulated Cl− transport in the colonic epithelium (Reddix et al., 2000; Stoner et al., 2000). The effect was proposed to represent an effect on CaCC. However, since these publications, additional Cl− channels have been identified and additional information has been discovered regarding sensitivity to DIDS and other agents of Cl− channels (Jentsch et al., 2002; Do and Civan, 2004; Suzuki et al., 2006); more specific pharmacological identification of CFTR- and non-CFTR-mediated epithelial cell apical Cl− transport is now possible. Calcium activated Cl− channels are widely distributed in nature. Hirakawa et al. (1999) found that high concentrations (mM range) of SNAP could activate these channels in aortic smooth muscle cells by causing an increase in intracellular calcium. Consistent with this observation, Kito and Suzuki showed that sodium nitroprusside could increase CaCC activity by increasing intracellular calcium concentrations in pacemaker cells of the guinea pig gastric antrum (Kito and Suzuki, 2003), and Garcia-Mata et al. (2003) showed that SNAP (10 µM) increases calcium-sensitive Cl− conductance in guard cells of higher plant (Vicia) leaves. Of note, the effect observed by Garcia-Mata proved to be cGMPindependent. Paradoxically, Sakagami et al. (2001) showed that sodium nitroprusside can inhibit CaCC currents in retinal contracting pericytes in a cGMP-
4. Chloride Channels
75
FIGURE 1 Inhibition of whole-cell Cl− current by N G -monomethyl-L-arginine (L-NMMA) and its reversal by GSNO. A: typical recordings showing effects of 100 µM L-NMMA and 100 µM GSNO on whole-cell current. B: current-voltage relationships for recordings shown in A. C: histogram showing effects of L-NMMA and GSNO on whole-cell current. Data are represented as means SD (n = 5). Control value (100%) is shown as dotted line. ∗ P < 0.05 and ∗∗ P < 0.01 compared with control value. (From Kamonsinska et al., 1997; with permission.)
dependent fashion. Importantly, NOS inhibition in these microvascular cells increased CaCC current. Of note in this regard, Parai and Tabrizchi (2005) have observed that CaCC—studied using the inhibitor, niflumic acid—may be involved in regulation of vascular smooth muscular tone downstream from NOS activation. NOS inhibition (with L-NAME) augmented the increase in vascular resistance associated with Cl− -free buffer perfusion during α agonist stimulation. Classically, there are two Cl− channel proteins on the basolateral side of epithelial cells: CLC2 and bestrophin. Bestrophin, so named because its absence is associated with Best’s disease, is a recently discovered protein, believed to function as a CaCC (Duta et al., 2006; Suzuki et al., 2006). Duta et al. (2006) have shown that iNOS activation and exposure GSNO activate bestrophin on the basolateral side of Calu-3 cells through a cGMP-dependent process, likely mediated by PKG-dependent phosphorylation. They hypothesize that GSNO augments transcellular Cl− transport by activating both apical CFTR (Chen et al., 2006) and basolateral bestrophin. Taken together, these data reveal the complexity of NOx signaling: it is not strictly a cGMP-dependent process, and the effect of varying concentrations of different NOx on different cell types—and at different intracellular locations— can be dramatically different; even opposing. These observations underscore the
76
B. Gaston
possibility that NOS does not behave simply to generate a gaseous free radical, the bioactivities of which are limited by its diffusion and free radical reactivity. These various data regarding dose, agent, calcium-dependence and cGMP-dependence of NOS and of various NOx on CaCC transport will not likely be comprehensively understood until the specific molecular mechanisms involved in these effects are characterized.
V. EFFECTS OF NITROGEN OXIDES ON CFTR Cystic fibrosis is a common and often fatal disease. The effects of NOS products and other exogenous NOx on the expression and function of CFTR have received substantially more attention than the interaction of NOx with any other Cl− channel. NOS products can effect CFTR expression, maturation, degradation and function; cyclic GMP-dependent signaling, nitration chemistry and Snitrosylation signaling are each involved in various ways in these diverse effects.
A. The Effects of NOx on Wild-type (Wt) CFTR Function Building on evidence that NO increases Cl− secretion from airway epithelial cells in vitro (Duszyk, 2001), elegant studies have now established that low µM concentrations of GSNO increase wt CFTR function in Calu-3 cell monolayers (Chen et al., 2006) (Figure 2). There appear to be both cGMP-dependent and cGMP-independent mechanisms by which this occurs (Seidler et al., 1997; Chen et al., 2006). The cGMP-dependent effect is robust and appears to involve G-protein coupled phosphorylation. The mechanism that underlies the cGMPindependent effect is still unknown. Of note, several “corrector” therapies, including GSNO itself (see below) appear to have the potential to increase cell surface expression of the most common human clinical mutant CFTR form, F508. F508 CFTR expressed on the cell surface has the potential to be functional, but it is not yet known whether GSNO increase Cl− conductance through F508 CFTR that has been “corrected” to cell surface.
B. Wild-type CFTR Inhibition S-Nitrosoglutathione at doses 200 µM applied to the cytosolic side of a apical cell membrane can inhibit wt CFTR function, an effect caused by glutathionylation of cysteine 1344 (Wang et al., 2005). However, this effect is unlikely to be of substantial clinical relevance because GSNO concentrations of 200 µM have not previously been reported in vivo, particularly not in the intracellular environment.
4. Chloride Channels
77
FIGURE 2 GSNO promotes the maturation and function of F508 CFTR but has no effect on wild type CFTR maturation. mIMCD cells were infected with either F508 or wild type CFTR recombinant adenovirus. Cells were left untreated or were treated with 10 µM GNSO for 1 or 2 h prior to cell lysis. Equal amounts of total protein were separated by SDS-PAGE, and CFTR expression was determined by Western blot. A, F508 CFTR: lane 1, mock-infected parental cells; lane 2, F508 CFTR expressing cells, untreated; lane 3, 1-h treatment of 10 µM GSNO; lane 4, 2-h treatment with 10 µM GSNO. B, wild type CFTR: lane 1, mock-infected parental cells; lane 2, wt CFTR expressing cells, untreated; lane 3, 1-h treatment of 10 µM GSNO; lane 4, 2-h treatment with 10 µM GSNO. C, representative recordings of currents elicited by voltage steps (from −100 mV to +40 mV) in F508 CFTR-infected mIMCD cells after stimulation with 20 µM forskolin. Very small currents were recorded in untreated cells. Treatments with GSNO resulted in forskolin-stimulated time- and voltage-independent currents. D, current-voltage relations of currents recorded in C. Open circles, untreated cells; filled circles, GSNO-treated cells. E, specific conductance (Gm ) for GSNO-treated and untreated F508 CFTR- or mock-infected mIMCD cells. GSNO-treated F508 CFTR-infected cells showed a significantly higher Gm (p = 0.033, factorial ANOVA). (From Howard et al., 2003.)
78
B. Gaston
C. Wild-type CFTR Degradation In stably transfected HELA cells, as well as Calu-3 and murine epithelial cells, 100 µM DETA NONOate decreases CFTR expression, both intracellularly and on the apical surface of polarized cells in culture (Jilling et al., 1999; Bebok et al., 2002; Matalon et al., 2003). The NONOate generates NO radical, which reacts with superoxide to form peroxynitrous acid, nitrating CFTR tyrosines (Bebok et al., 2002). This CFTR nitration leads to increased targeting of the protein for degradation before it reaches full maturation (Jilling et al., 1999; Bebok et al., 2002; Matalon et al., 2003).
D. Effects or Expression and Maturation of F508 CFTR On the other hand, evidence in the last decade has suggested that cysteine nitrosylation—particularly of ubiquitin ligase enzymes—can prevent targeted degradation of specific proteins (Yao et al., 2004; Palmer et al., 2007). Because CFTR maturation is regulated, in part, by degradation, there has been interest in determining whether GSNO or other nitrosylating agents would augment CFTR maturation. Surprisingly, several groups have now reported evidence that GSNO increases expression, maturation and function of F508 CFTR (Zaman et al., 2001, 2004, 2007; Howard et al., 2003; Servetnyk et al., 2006). For example, Howard and coworkers (2003) have shown that exposure of murine renal medullary collecting cells overexpressing F508 CFTR to 10 µM GSNO results in increased CFTR maturation and increased forskolin-driven Cl− transport (Figure 3). This effect of GSNO has features that suggest that the biochemistry involves transnitrosylation (NO+ transfer) reactions (Zaman et al., 2001, 2004, 2006; Howard et al., 2003). Specifically, 1) it is reversed by dithiothreitol; 2) it is inhibited by oxyhemoglobin, but not by N-ethyl-maleimide-pretreated oxyhemoglobin, suggesting that a reduced cysteine of hemoglobin, depleting NO+ — rather than loss of NO radical to the heme porphyrin group—is responsible for the hemoglobin-mediated inhibition; 3) it is not recapitulated by 8-bromo-cGMP; 4) GSNO is only one of a class of nitrosylating agents that increase wild type and F508 CFTR expression and maturation; and 5) this class compounds ethyl nitrite, which produces little NO (Zaman et al., 2006). Indeed, the potency of nitrosylating agents in increasing the CFTR expression and maturation is not related to the ability of these agents to serve as unstable “NO radical donors” (Zaman et al., 2006). The effects of these agents on CFTR expression and maturation are both transcriptional and post-translational. Low µM levels of GSNO increase CFTR transcription by differential effects on the stabilization of transcription factors Sp1 and Sp3; higher GSNO concentrations (especially those close to 1 mM) actually
4. Chloride Channels
79
FIGURE 3 Effect of GSNO on Sp3/Sp1–DNA-binding activity. (A) EMSA using a consensus Sp3/Sp1 oligonucleotide as probe and nuclear extracts from control (lane 1) and GSNO-treated cells at concentrations of 0.5–500 mM (lanes 2–6). Physiological GSNO concentrations increased Sp3/Sp1–DNA binding. Supraphysiological GSNO concentrations inhibited Sp3 binding but augmented Sp1 binding. (B) Nuclear protein extracts were prepared from A549 cells treated with 1, 5, 10 and 100 mM GSNO for 6 h and then subjected to immunoblot analysis using anti-Sp1, Sp3 and a-tubulin antibodies. Molecular masses of Sp1 and Sp3 were 112 and 90–112 kDa respectively. Results are representative of three separate experiments. (C) The induction of Sp1/Sp3–DNA-binding activities by 10 mM GSNO was confirmed by supershift analysis. Antibodies recognizing Sp1 and Sp3 were added after the addition of radiolabelled oligonucleotide to the nuclear-binding reaction. Results are representative of three separate experiments; Ab, antibody. (D) EMSA was performed on nuclear extracts from A549 cells, with 5 mg of nuclear extracts from control and GSNO-treated cells (10 mM) in the presence or absence of 10 mM oxyHb, or oxyHb pretreated with 10 mM NEM for 4 h. Results are representative of three experiments. (From Zaman et al., 2004, with permission.)
80
B. Gaston
FIGURE 4 GSNO increases Isc across Calu-3 cells. Confluent monolayers of Calu-3 cells were mounted in an Ussing chamber. Upper panel, GSNO (10 µM) was added into the apical compartment. Isc (left axis) and Rt (right axis) were measured as described in the text. Once Isc stabilized, three boluses of glibenclamide (0.1 mM each) were added into the apical compartment. Results are shown of typical experiments. See Table 1 for mean values. Middle panel, CFTRinh-172 inhibits the GSNO-induced Isc in Calu-3 cells. Following addition of GSNO (10 µM) into the apical compartment, addition of the specific CFTR inhibitor CFTRinh-172 inhibited Isc in a dose-response fashion. Results are shown for a typical experiment. Lower panel, dose-dependent increase of Isc by GSNO. GSNO (0.05–200 µM) were added sequentially into the apical compartments of Ussing chambers containing Calu-3 cells. The percentage of maximum GSNO-induced current (y-axis) was calculated as follows: % = [(Ix − I0 )/(I200 − I0 )] × 100, where I0 is the current obtained without GSNO, Ix is the steady-state current with a given concentration of GSNO (in µM), and I200 is the current measured during with 200 µM GSNO. ki was calculated by fitting the data with the equation, Y = I200 × (ki hc)/[ki hc + Ix ], where hc is the Hill coefficient using Microcal Origin Version 6. Each point represents the mean ±1 S.E. of measurements obtained in six different monolayers. (From Chen et al., 2006, with permission.)
4. Chloride Channels
81
FIGURE 5 GSNO exposure results in SNO trafficking through, and altered F508 CFTR association of proteins in, the ER and Golgi. A. SNO-modified proteins were immunoprecipitated with CFTR from the ER and Golgi fractions at various times following exposure to 10 µM GSNO in polarized human bronchial epithelial CFBE41o− cells. SNO concentration was assayed by Cu/cys reduction-chemiluminescence (22,114,138). B. Immunoblots of cysteine string proteins (Csp’s) 1 & 2 from cytosolic, ER and Golgi fractions after immunoprecipitation with anti-CFTR antibody at different timepoints after exposure to 10 µM GSNO. C. Immunoblots showing the effect of 10 µM GSNO on heat shock cognate (Hsc) 70 associated with CFTR in cytosolic, ER and Golgi fractions. 50 µg of protein was loaded per lane (from Ref. 22; Appendix A). (Adapted from Zaman et al., 2006, with permission.)
inhibit CFTR transcription by increasing the expression and DNA-binding of Sp1 (Zaman et al., 2004). Again, differential effects reflect differential chemistry and localization of the targets of GSNO (Figure 4). The post-transcriptional effects observed following a whole-cell pulse of GSNO can be followed by studying nitrosothiol-modified proteins that coimmunoprecipitate with CFTR as it trafficks through the endoplasmic reticulum and Golgi during maturation. The cysteine nitrosylation of these chaperone pro-
82
B. Gaston
teins in the CFTR interactome (Wang et al., 2006) ultimately favor full maturation of F508 CFTR (Zaman et al., 2006; Figure 5). The molecular targets of GSNO that co-immunoprecipitate with CFTR include both heat shock cognate (Hsc) 70 and heat shock protein 70-heat shock protein 90 organizing protein (Hop). In the case of Hsc 70, it appears that S-nitrosylation of a single cysteine in the ATP binding domain is likely to inhibit the function of Hsc 70 as a chaperone, preventing it from targeting misfolded CFTR for degradation (Zaman et al., 2006). In the case of Hop, S-nitrosylation may alter Hop-CFTR interaction to favor full maturation (Zaman et al., 2007). GSNO appears to have additional effects on CFTR through post-translational modifications that are not fully clarified, including an effect on cysteine string protein expression (Zaman et al., 2006). Importantly, the cellular metabolism of GSNO and other nitrosothiols is tightly regulated at the level of synthesis, degradation and localization (Que et al., 2005; Gaston et al., 2006). The study of nitrosylation signaling in general, and as it relates to CFTR maturation and function in particular, is still in its infancy. There is interest in using inhaled GSNO as a corrector therapy for CF. This is particularly appealing because GSNO is an endogenous compound (Gaston et al., 1993), levels of which are low in the CF airway (Grasemann et al., 1999), that may have the added beneficial affects of increasing ciliary beat frequency (Li et al., 2000), relaxing human airway smooth muscle (Gaston et al., 1993; Gaston et al., 1994), improving ventilation perfusion matching (Moya et al., 2001; Snyder et al., 2002), inhibiting the growth of certain microbial agents that colonize the CF airway (Yoon et al., 2006), and, potentially, inhibiting amiloride-sensitive sodium transport (Jain et al., 1998).
VI. FUTURE DIRECTIONS Several core questions remain to be answered. 1. Which Cl− channels are affected by NOx ? In addition to the Cl− channels discussed in this paper, there may be other channels affected by products of NOS activation and other NOx . In particular, channels that may be nitrosothiol-sensitive include channels that are functionally 1) sensitive to modulation by mecuric chloride—which breaks nitrosothiol bonds; 2) acid-responsive, because acid conditions can favor formation of nitrosothiols; and 3) inhibited by dithiothreitol, which reduces nitrosothiol bonds (Jentsch et al., 2002; Do and Civan, 2004; Suzuki et al., 2006; Gow et al., 2007). 2. Molecular characterization of the effects of NOx on Cl− channel expression and function. The structures of many Cl− channels have not been discovered. Indeed, specific proteins associated with some Cl− channel activities remain to be identified.
4. Chloride Channels
83
Molecular features of these proteins by which they would be modified by cGMPdependent protein kinases and/or by nitrosylation are incompletely understood. Exploiting NOS-Cl− channel interactions for the purpose of pharmacological modification of Cl− function in medicine will likely require a substantially more detailed molecular understanding of these interactions. This is also true for the interactome of these proteins. For example, in the case of CFTR, the design and optimization of pharmacological agents that increase F508 CFTR maturation and function will require a good deal more information about the CFTR interactome and its modification by nitrosylating agents. 3. Improved assays. In the case of nitrosothiol modifications, assays for specific NOx effects remain cumbersome and subject to substantial error (Hausladen et al., 2007; Gow et al., 2007). In particular, because of the lability of S-nitrosothiol bonds, it is difficult to extract nitrosylated proteins from cells and subcellular fractions without modifying the protein and S-NO bond during the process. It is particularly important that the so-called triple iodide method not be used for S-nitrosothiol assays (Hausladen et al., 2007). Indeed, any S-nitrosothiol assay should be paired, in the context of the protein or low mass nitrosothiol being assayed, to other complementary assays that use a different technology (Lancaster and Gaston, 2004; Gow et al., 2007). Fortunately, assays more sensitive and specific than those currently in use are in development. For example there is a recent report of an extremely sensitive new mass spectrometry instrument for measuring plasma GSNO concentrations (Taubert et al., 2007). These types of systems may make the path forward substantially easier to navigate. Once these technical obstacles begin to be cleared, moving forward to study NOS-dependent Cl− channel modifications will likely be extremely rewarding. Treatment for a substantial number of diseases may be facilitated by this new information. References Bebok, Z., Varga, K., Hicks, J.K., Venglarik, C.J., Kovacs, T., Chen, L., Hardiman, K.M., et al. (2002). Reactive oxygen nitrogen species decrease cystic fibrosis transmembrane conductance regulator expression and cAMP-mediated Cl− secretion in airway epithelia. J. Biol. Chem. 277, 43041– 43049. Carver, D.J., Gaston, B., deRonde, K., Palmer, L.A. (2007). Akt-mediated activation of HIF-1 in pulmonary vascular endothelial cells by S-nitrosoglutathione. Am. J. Respir. Cell Mol. Biol. 37, 255–263. Chen, L., Patel, R.P., Teng, A. (2006). Mechanisms of cystic fibrosis transmembrane conductance regulator activation by S-nitrosoglutathione. J. Biol. Chem. 281, 9190–9199. Do, C.W., Civan, M.M. (2004). Basis of chloride transport in ciliary epithelium. J. Membrane Biol. 200, 1–13. Duszyk, M. (2001). Regulation of anion secretion by nitric oxide in human airway epithelial cells. Am. J. Physiol. 281, L450–L457. Duta, V., Duta, F., Puttagunta, L., Befus, A.D., Duszyk, M. (2006). Regulation of basolateral Cl− channels in airway epithelial cells: The role of nitric oxide. J. Membrane Biol. 213, 165–174.
84
B. Gaston
Ellershaw, D.C., Greenwood, I.A., Large, W.A. (2000). Dual modulation of swelling-activated chloride current by NO and NO donors in rabbit portal vein myocytes. J. Physiol. 528, 15–24. Fürst, J., Schedlbauer, A., Grandini, R., Garavaglia, M.L., Saino, S., Gschwentner, M., Sarg, B., et al. (2005). Icln159 folds into a plecstrin homology domain-like structure. J. Biol. Chem. 280, 31276–31282. Garcia-Mata, C., Gay, R., Sokolovski, S., Hills, A., Lamattina, L., Blatt, M.R. (2003). Nitric oxide regulates K+ and Cl− channels in guard cells through a subset of abscisic acid-evoked signaling pathways. Proc. Natl. Acad. Sci. USA 100, 1116–1121. Gaston, B., Reilly, J., Drazen, J.M., Fackler, J., Ramdev, P., Arnelle, D., Mullins, M., et al. (1993). Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways. Proc. Natl. Acad. Sci. USA 90, 10957–10961. Gaston, B., Drazen, J.M., Jansen, A., Sugarbaker, D.A., Loscalzo, J., Stamler, J.S. (1994). Relaxation of human bronchial smooth muscle by S-nitrosothiols in vitro. J. Pharmacol. Exp. Ther. 268, 978– 984. Gaston, B., Singel, D., Doctor, A., Stamler, J.S. (2006). S-nitrosothiol signaling in respiratory biology. Am. J. Respir. Crit. Care Med. 173, 1186–1193. Gow, A.J., Chen, Q., Hess, D.T., Day, B.J., Ischiropoulos, H., Stamler, J.S. (2002). Basal and stimulated protein S-nitrosylation in multiple cell types and tissues. J. Biol. Chem 277, 9637–9640. Gow, A., Doctor, A., Mannick, J., Gaston, B. (2007). S-nitrosothiol measurements in biological systems. J. Chromatog. B 851, 140–151. Grasemann, H., Gaston, B., Fang, K., Ratjen, F. (1999). Decreased levels of nitrosothiols in the lower airways of patients with cystic fibrosis and normal pulmonary function. J. Pediatr. 135, 770–772. Hausladen, A., Rafikov, R., Angelo, M., Singel, D.J., Nudler, E., Stamler, J.S. (2007). Assessment of nitric oxide signals by triiodide chemiluminescence. Proc. Natl. Acad. Sci. USA 104, 2157–2162. Hess, D.T., Matsumoto, A., Kim, S.O., Marshall, H.F., Stamler, J.S. (2005). Protein S-nitrosylation: Purview and parameters. Nat. Rev. Mol. Cell Biol. 6, 150–166. Hirakawa, Yl., Gericke, M., Cohen, R.A., Bolotina, V.M. (1999). Ca(2+)-dependent Cl(−) channels in mouse and rabbit aortic smooth muscle cells: Regulation by intracellular Ca(2+) and NO. Am. J. Physiol. 277, 1732–1744. Howard, M., Fischer, H., Roux, J., Santos, B., Gullans, S., Yancey, P., Welch, W. (2003). Mammalian osmolytes and S-nitrosoglutathione promote F508 CFTR protein maturation and function. J. Biol. Chem. 278, 35159–35167. Jain, L., Chen, X.J., Brown, L.A., Eaton, D.C. (1998). Nitric oxide inhibits lung sodium transport through a cGMP-mediated inhibition of epithelial cation channels. Am. J. Physiol. 274, 475–484. Jentsch, T.J., Stein, V., Weinreich, F., Zdebik, A.A. (2002). Molecular structure and physiological function of chloride channels. Physiol. Rev. 82, 503–568. Jilling, T., Haddad, I.Y., Cheng, S.H., Matalon, S. (1999). Nitric oxide inhibits heterologous CFTR expression in polarized epithelial cells. Am. J. Physiol Lung Cell Mol. Physiol. 277, L89–L96. Kamonsinska, B., Radomski, M.W., Duszyk, M., Radomski, A., Man, S.F.P. (1997). Nitric oxide activates chloride currents in human lung epithelial cells. Am. J. Physiol. 272, 1098–1104. Kito, Y., Suzuki, H. (2003). Pacemaker frequency is increased by sodium nitroprusside in the guinea pig gastric antrum. J. Physiol. 546, 191–205. Lancaster, J., Gaston, B. (2004). NO and nitrosothiols: Spatial confinement and free diffusion. Am. J. Physiol. Lung Cell Mol. Physiol. 287, 465–466. Li, D., Shirakami, G., Zhan, X., Johns, R.A. (2000). Regulation of ciliary beat frequency by the nitric oxide-cyclic guanosine monophosphate signaling pathway in rat airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 23, 175–181. Lipton, A., Johnson, M., Macdonald, T., Lieberman, M., Gozal, D., Gaston, B. (2001). S-nitrosothiols signal the ventilatory response to hypoxia. Nature 413, 171–174. Matalon, S., Hardiman, K.M., Jain, L., Eaton, D.C., Kotlikoff, M., Eu, J.P., Sun, J., et al. (2003). Regulation of ion channel structure and function by reactive oxygen–nitrogen species. Am. J. Physiol. Lung Cell Mol. Physiol. 285, 1184–1189.
4. Chloride Channels
85
Mayer, B., Pfeiffer, S., Schrammel, A., Koesling, D., Schmidt, K., Brunner, F. (1998). A new pathway of nitric oxide/cyclie GMP signaling involving S-nitrosoglutathione. J. Biol. Chem. 273, 3264– 3270. Moya, M.P., Gow, A.J., McMahon, T.J., Toone, E.J., Cheifetz, I.M., Goldberg, R.N., Stamler, J.S. (2001). S-nitrosothiol repletion by an inhaled gas regulates pulmonary function. Proc. Natl. Acad. Sci. USA 98, 5792–5797. Novak, I. (2003). ATP regulation of epithelial Cl− channels-new challenges? J. Physiol. 547, 1113. Parai, K., Tabrizchi, R. (2005). Effects of chloride substitution in isolated mesenteric blood vessels from Dahl normotensive and hypertensive rats. J. Cardiovasc. Pharmacol. 46, 105–114. Palmer, L., Doctor, A., Chhabra, P., Sheram, M.L., Laubach, V., Karlinsey, M.Z., Forbes, M., Macdonald, T., Gaston, B. (2007). S-Nitrosothiols signal hypoxia-mimetic vascular pathology. J. Clin. Invest. 117, 2592–2601 Que, L.G., Liu, L., Yan, Y., Whitehead, G.S., Gavett, S.H., Schwartz, D.A., Stamler, J.S. (2005). Protection from experimental asthma by an endogenous bronchodilator. Science 308, 1618–1621. Reddix, R.A., Liu, X., Miller, M.J., Niu, X., Powell, A. (2000). Constitutive nitric oxide release modulates neurally-evoked chloride secretion in guinea pig colon. Auton. Neurosci. 86, 47–57. Ricciardolo, F., Sterk, P., Gaston, B., Folkerts, G. (2004). Nitric oxide in health and disease of the respiratory system. Physiol. Rev. 84, 731–765. Sakagami, K., Kawamura, H., Wu, D.M., Puro, D.G. (2001). Nitric oxide/cGMP-induced inhibition of calcium and chloride currents in retinal pericytes. Microvasc. Res. 62, 196–203. Sayed, N., Baskaran, P., Ma, X., van den Akker, F., Beuve, A. (2007). Desensitization of soluble guanylyl cyclase, the NO receptor, by S-nitrosylation. Proc. Nat. Acad. Sci. 104, 12312–12317. Seidler, U., Blumenstein, I., Kretz, A., Viellard-Baron, D., Rossmann, H., Colledge, W.H., Evans, M., et al. (1997). A functional CFTR protein is required for mouse intestinal cAMP-, cGMP- and Ca(2+)-dependent HCO3-secretion. J. Physiol. 505, 411–423. Servetnyk, Z., Krjukova, J., Gaston, B., Zaman, K., Hjelte, L., Roomans, G.M., Dragomir, A. (2006). Activation of chloride transport in CF airway epithelial cell lines and primary CF nasal epithelial cells by S-nitrosoglutathione. Respir. Res. 7, 124. Snyder, A., McPherson, M.E., Hunt, J.F., Johnson, M., Stamler, J.S., Gaston, B. (2002). Acute effects of aerosolized S-nitrosoglutathione in cystic fibrosis. Am. J. Respir. Crit. Care Med. 165, 922–926. Stoner, M.C., Scherr, A.M., Lee, J.A., Wolfe, L.G., Kellum, J.M. (2000). Nitric oxide is a neurotransmitter in the chloride secretory response to serotonin in rat colon. Surgery 128, 240–245. Suzuki, M., Morita, T., Iwamoto, T. (2006). Diversity of Cl− channels. Cell Mol. Life Sci. 63, 12–24. Tarran, R., Button, B., Boucher, R.C. (2006a). Regulation of normal and cystic fibrosis airway surface liquid volume by phasic shear stress. Annu. Rev. Physiol. 68, 543–561. Tarran, R., Trout, L., Donaldson, S.H., Boucher, R.C. (2006b). Soluble mediators, not cilia, determine airway surface liquid volume in normal and cystic fibrosis superficial airway epithelia. J. Gen. Physiol. 127, 591–604. Taubert, D., Roesen, R., Lehmann, C., Jung, N., Schömig, E. (2007). Effects of low habitual cocoa intake on blood pressure and bioactive nitric oxide. JAMA 298, 49–60. Wang, W., Oliva, C., Li, G., Holmgren, A., Lillig, C.H., Kirk, K.L. (2005). Reversible silencing of CFTR chloride channels by glutathionylation. J. Gen. Physiol. 125, 127–141. Wang, X., Venable, J., LaPointe, P., Hutt, D.M., Koulov, A.V., Coppinger, J., Gurkan, C., et al. (2006). Hsp90 cochaperone aha1 downregulation rescues misfolding of CFTR in cystic fibrosis. Cell 127, 803–815. Whalen, E.J., Foster, M.W., Matsumoto, A., Ozawa, K., Violin, J.D., Que, L.G., Nelson, C.D. (2007). Regulation of beta-adrenergic receptor signaling by S-nitrosylation of G-protein-coupled receptor kinase 2. Cell 129, 511–522. Yao, D., Gu, Z., Nakamura, T., Shi, Z.Q., May, Y., Gaston, B., Palmer, L.A. (2004). Nitrosative stress linked to sporadic Parkinson’s disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity. Proc. Natl. Acad. Sci. USA 101, 10810–10814.
86
B. Gaston
Yoon, S.S., Coakley, R., Lau, G.W., Lymar, S.V., Gaston, B., Karabulut, A.C., Hennigan, R.F. (2006). Anaerobic killing of mucoid Pseudomonas aeruginosa by acidified nitrite derivatives under cystic fibrosis airway conditions. J. Clin. Invest. 116, 436–446. Zaman, K., McPherson, M., Vaughan, J., Hunt, J., Mendes, F., Gaston, B., Palmer, L. (2001). Snitrosoglutathione increases cystic fibrosis transmembrane regulator maturation. Biochem. Biophys. Res. Commun. 284, 65–70. Zaman, K., Palmer, L.A., Doctor, A., Hunt, J.F., Gaston, B. (2004). Concentration-dependent effects of endogenous S-nitrosoglutathione on gene regulation by specificity proteins Sp3 and Sp1. Biochem. J. 380, 67–74. Zaman, K., Carraro, S., Doherty, J., Henderson, E.M., Lendermon, E., Verghese, G., Zigler, M., Ross, M., Park, E., Palmer, L.A., Doctor, A., Stamler, J.S., Gaston, B. (2006). A novel class of compounds that increase CFTR expression and maturation in epithelial cells. Mol. Pharmacol. 70, 1435–1442. Zaman, K., Borowitz, M., Henderson, E.M., Mantri, S., Gaston, B. (2007). The role of Hsp70/Hsp90 organizing protein (Hop) as a target of S-nitrosoglutathione (GSNO) relevant to augmented deltaF508 CFTR maturation in human airway epithelial cells. In: Conference of the Am. Thorac. Soc. A931.
CHAPTER 5 A Mitochondria-AOS-Kv Channel Axis in Health and Disease; New Insights and Therapeutic Targets for Vascular Disease and Cancer Gopinath Sutendra and Evangelos D. Michelakis Departments of Medicine, University of Alberta, Edmonton, Canada
I. Introduction II. The Components of the Mitochondria-ROS-Kv Axis A. Mitochondria (Sensor) B. AOS (Mediator) C. Kv Channels (Effector) III. The Mitochondria-AOS-Kv Axis in Hypoxia: HPV IV. The Mitochondria-AOS-Kv Axis, Metabolism and Apoptosis A. The Metabolism of Cancer Cells B. DCA Reverses the Mitochondrial Remodeling, Normalizes the MitochondriaAOS-Kv Axis, Unlocking the Cancer Cells from a State of Apoptosis Resistance C. Pulmonary Arterial Hypertension: Intriguing Parallels with Cancer D. Conclusion References
I. INTRODUCTION Mitochondria, activated oxygen species (AOS) and voltage-dependent potassium channels (Kv) have been in the center of multiple signaling pathways in diverse cell types in both health and disease. In addition to production of energy, mitochondria are now recognized as important sensors of cellular metabolic demand; for example, they are important oxygen sensors and major regulators of cell death (apoptosis). This allows the mitochondria to regulate supply and demand of energy, promoting cell death when the energy production cannot keep up with energy demands. In addition, mitochondria are major producers of AOS, and Current Topics in Membranes, Volume 61 Copyright © 2008, Elsevier Inc. All rights reserved
1063-5823/08 $35.00 DOI: 10.1016/S1063-5823(08)00205-6
88
G. Sutendra and E.D. Michelakis
thus regulate many redox-sensitive cellular functions. Some of these AOS, like H2 O2 , are relatively stable with long effective radius, reaching “remote” targets, like Kv channels in the plasma membrane. In turn, the regulation of Kv channels results in changes in both intracellular calcium and potassium, which can then regulate mitochondrial function and apoptosis as well. Thus, feedback loops are completed, strengthening and sustaining the effects of an axis involving a sensor (mitochondria), mediator (AOS) and effector (Kv channels). There is now evidence that this axis is involved in many important functions in health and disease. For example, this axis and its coordinated response during hypoxia, can provide the basis for Hypoxic Pulmonary Vasoconstriction (HPV), a mechanism critical for the life in all mammals. Furthermore, the axis appears to be regulating apoptosis and proliferation in an identical manner in a variety of seemingly unrelated diseases, like pulmonary arterial hypertension (PAH) and cancer. Not only does this axis provide new insights in diseases characterized by suppressed apoptosis and increased cellular proliferation, but it provides novel therapeutic targets for these diseases. Normalization of this axis in PAH and cancer leads to reversal of the disease. Here, we describe the components of this axis and its role in health (HPV) and disease (PAH and cancer).
II. THE COMPONENTS OF THE MITOCHONDRIA-ROS-KV AXIS A. Mitochondria (Sensor) The mitochondria are traditionally known as the energy generating centers of the cell (Duchen, 1999). Glucose and free fatty acids (FFA) are the main energy sources of the cell and fuels of mitochondria. Glucose enters the glycolytic pathway in the cytoplasm, where it eventually becomes pyruvate. Pyruvate can remain in the cytoplasm and, in the presence of lactic dehydrogenase (LDH), can become lactic acid and complete glycolysis (Gly). However, in the presence of activated pyruvate dehydrogenase (PDH) on the mitochondrial membranes, pyruvate becomes acetyl-CoA, which in the inner mitochondrial space enters the Krebs’ cycle to complete glucose oxidation (GO). Similarly, FFAs enter the mitochondria to undergo β-oxidation in which acetyl-CoA is produced. The acetyl-CoA from both GO and β-oxidation enters the Krebs’ cycle, where the electron donors NADH and FADH2 are produced. These electron donors can “donate” their electrons to the electron transport chain (ETC). The ETC is comprised of five mega-complexes (I–V) which transfer electrons down a redox gradient. The final acceptor of electrons, at complex IV of the ETC, is molecular oxygen, forming H2 O (respiration). As the electrons flow, H+ are generated and are transferred out of the internal mitochondrial membrane, creating the mitochondrial membrane potential (Ψ m), which is quite negative (more than −200 mV). The ATP synthase (complex V) at the end of the ETC brings H+ back into the inner membrane (thus using the
5. A Mitochondria-AOS-Kv Channel Axis
89
stored energy of the Ψ m) and phosphorylates ADP, producing ATP. Therefore respiration is coupled to oxidative phosphorylation. A small percentage of the electrons flowing down the ETC, results in the production of AOS (superoxide), mostly in complexes I and III. In the presence of the mitochondrial manganese superoxide dismutase (MnSOD) superoxide can be dismutated to the more stable H2 O2 , which can diffuse out of the mitochondria relatively easily and regulate remote redox-sensitive targets; thus providing a means of communication between mitochondria and important cellular structures like the cell membrane. Therefore the mitochondria, as sensors of metabolic supply and demand (for example, sensors of hypoxia), via the production of a mediator (AOS, H2 O2 ) can regulate the function of effectors in order to match sensing with a cellular response (Duchen, 1999). An example of an acute response is the modulation of redox-sensitive Kv channels in the membrane and, as discussed below, regulation of vascular tone. This regulation, strategically controlled throughout the body can result in more supply of oxygen in hypoxic tissues by either dilating systemic arteries or constricting pulmonary arteries (PA). Because the production of AOS is proportional to the flow or electrons down the ETC, the signaling ability of the mitochondria is proportional to their overall function, an important requirement for any sensormediator-effector system. Since the efflux of H+ from the inner mitochondrial space is also proportional to the electron flow, the Ψ m correlates with production of AOS and overall mitochondrial function. The fact that Ψ m can easily be quantified and monitored in living cells (using positively charged rhodaminebased fluorescent dyes that are selectively uptaken by the negative mitochondria in proportion to the Ψ m (Duchen, 1999)) has allowed for a more comprehensive understanding of the role of this mitochondria-AOS-Kv channel axis and its role in both health and disease. More sustained chronic responses can also be regulated by the mitochondria, through their “communication” with the nucleus. Mitochondrial activity can also regulate intracellular Ca++ (by changing Ψ m, the buffering of the positively charged cytosolic Ca++ can be regulated (Duchen, 1999)) and again, via the production of AOS, can regulate the activity of Ca++ - and redox-sensitive transcription factors, that can be translocated to the nucleus where they can regulate the expression of a number of genes, potentiating, maintaining or suppressing mitochondrial function. This can achieve long-term control of this sensing system. The vast majority of the proteins required for mitochondrial function are produced by nuclear genes. A mitochondria-regulated transcription factor can therefore regulate both mitochondrial but also membrane (i.e. Kv channels) function allowing for the feedback loops necessary for the plasticity of this important sensing system. As will be discussed below, an example of such a transcription factor is the nuclear factor of activated T cells (NFAT) (Bonnet et al., 2007b; Macian, 2005). Such feedback loops can be activated or inhibited further by therapeutic interventions, which result in the activation or inhibition of the whole
90
G. Sutendra and E.D. Michelakis
mitochondria-AOS-Kv axis and might have multiple, but co-ordinated and comprehensive effects in many disease states. Such diseases, PAH and cancer, are examples that we discuss below.
B. AOS (Mediator) The source of AOS production in mitochondria is mostly complex I and III (Duchen, 1999). In some tissues or conditions the primary source of AOS is complex I while in others is complex III (Barrientos and Moraes, 1999; Ide et al., 1999; Chandel et al., 2000; Vanden Hoek et al., 1998). The ETC complexes consist of many subunits. For example, complex I consists of 42 subunits, only 7 of which are encoded by mitochondrial DNA (mtDNA) (Duchen, 1999). Inhibition of the complex (and thus the flow of electrons) proximal to the site of AOS production site would cause a decrease in AOS production. Inhibition of the complex distal to this site would disrupt the flow of electron down the respiratory chain, diverting them to react with O2 and generate AOS. Mutations in several subunits of complex I have been described in many human muscular and neurodegenerative diseases that are associated with increased neuronal AOS production, including Parkinson’s disease. Fibroblast mitochondria from patients with complex I and complex III deficiency show increased superoxide production, but not mitochondria from patients with complex IV deficiency (Pitkanen and Robinson, 1996). Barrientos and Moraes used a genetic model (40% complex I-inhibited human-ape xenomitochondrial hybrids) and a drug-induced model (0–100% complex I-inhibited cells using different concentrations of rotenone) and showed a direct quantitative correlation between the level of complex I function, cell respiration, AOS production and Ψ m (Barrientos and Moraes, 1999). The inhibition of complex I results in collapse of the proton gradient (decreased Ψ m) and therefore a decrease in the mitochondrial activity: decreased complex I activity → decreased respiration + decreased Ψ m+ increased superoxide production (Barrientos and Moraes, 1999). Unlike the other two SODs (the CuSOD and the extracellular SOD), MnSOD undergoes significant regulation. Dynamic induction of MnSOD occurs through a redox-sensitive mediator (Pitkanen and Robinson, 1996). As expected, many patients with complex I (but not complex IV) deficiency have increased MnSOD levels (Pitkanen and Robinson, 1996). This is a defensive mechanism of the mitochondria to the stress induced by the increased superoxide production that the patients display. It is possible therefore that differences in a cell’s redox status might result in different levels of expressed MnSOD. Furthermore, diversity in the function/expression of MnSOD among different tissues is not surprising given the fact that diversity in mitochondria function has been described not only among different organs or tissues (for example pulmonary versus systemic arter-
5. A Mitochondria-AOS-Kv Channel Axis
91
ies (Michelakis et al., 2002a)) but even within a single cell (for example, within a cardiomyocyte) (reviewed in McMurtry and Michelakis, 2004). These data further support the importance of approaching the AOS production (and their downstream effects) as part of a comprehensive and fine-tuned sensing and feedback system and directly relating them to overall mitochondrial function and metabolism. It also means that the production of AOS is not a simple or an allor none phenomenon and should always be interpreted in the context of the model, tissue or disease state, in which they are measured. Findings in one tissue or one disease state cannot be extrapolated to others. Unfortunately this has contributed to several conflicts in the literature, some of which are discussed below (Weir and Archer, 2006).
C. Kv Channels (Effector) Potassium channels are transmembrane proteins that selectively conduct potassium and have the ability to alter membrane potential, intracellular ion concentration ([K+ ]i ; [Ca++ ]i ), cell volume and impact multiple functions of the cell such as contractile state, size, proliferation and apoptosis. Kv channels evolved from proteins with two transmembrane domains, such as the Kir channels (Gallin W.J, 2001). Many Kv channels are enriched in cysteine and methionine groups in critical points of the protein and are redox-sensitive making them ideal targets of AOS. Oxidation or reduction of these critical cysteine or methionine groups can alter the conformational structure of the pore of the channel, altering its conduction properties; generally oxidation promotes whereas reduction inhibits the open state of the channel. The intracellular concentration of K+ is much higher than the extracellular (145 mM compared to 4.5 mM) resulting in a spontaneous outward current. The equilibrium potential for K+ (EK ) determined by the Nernst equation is approximately −91 mV and illustrates the prominent contribution of K+ to the cell’s resting membrane potential (EM ), which in smooth muscle cells (SMC) is approximately −60 mV. At resting EM , L-type voltage-sensitive Ca++ channels (a major pathway for Ca++ entry) are closed. Inhibition of Kv channels results in decreased K+ efflux from the cell and propels the cell interior to be more positive. This leads to depolarization of the EM and subsequent activation of L-type Ca++ channels. Therefore, inhibition of Kv channels increases both intracellular K+ and Ca++ levels. Increased [K+ i ] exhibits tonic inhibition on the formation of the apoptosome (Cain et al., 2001) and caspases of several cell types including pulmonary artery smooth muscle cells (PASMC) (Remillard and Yuan, 2004), thereby inhibiting apoptosis. Potassium ions are also influential in regulating many enzymes; one such metabolic enzyme pyruvate dehydrogenase kinase (PDK), which phosphorylates and inhibits the pyruvate dehydrogenase (PDH) has recently been suggested to show dependence on K+ ions (Knoechel et al., 2006).
92
G. Sutendra and E.D. Michelakis
Increased [Ca++ i ] not only increases vasoconstriction but also contributes to proliferation (Platoshyn et al., 2000). Not surprisingly, inhibition or downregulation of Kv channel function has been described in HPV, PAH and cancer. Specific redox-sensitive Kv channels, like Kv1.5 and Kv2.1, have not only be shown to directly regulate PASMC EM (Archer et al., 1998) but regulate apoptosis and be directly involved in the mechanisms of HPV, PAH (Bonnet et al., 2007b; McMurtry et al., 2005, 2004; Michelakis et al., 2002b) and cancer (Bonnet et al., 2007a). The production of AOS typically promotes a tonic activation of Kv channels. Hyperpolarized mitochondria are associated with a decreased AOS production and inhibited Kv channels. As it will be discussed below, hyperpolarized mitochondria are also associated with a state of resistance to apoptosis. Therefore, it is not surprising that hyperpolarized mitochondria-decreased AOS—inhibited Kv channels are seen in seemingly unrelated diseases characterized by suppressed apoptosis and increased proliferation, like PAH and cancer (Bonnet et al., 2007a, 2006, 2007b; McMurtry et al., 2005, 2004; Michelakis et al., 2002b). More importantly, drugs that primarily target mitochondria, reversing the mitochondrial hyperpolarization (like the PDK inhibitor Dichloroacetate, DCA), also increase AOS and up-regulate and activate Kv channels, reversing established PAH and cancer in vivo in animal models (Bonnet et al., 2007a, 2006, 2007b; McMurtry et al., 2004; Michelakis et al., 2002b). Once again, these observations underline the importance of a comprehensive approach to this axis in many different conditions and diseases.
III. THE MITOCHONDRIA-AOS-KV AXIS IN HYPOXIA: HPV Anoxic pulmonary vasoconstriction was first described in 1894 in the dog (Bradford and Dean, 1894). Von Euler and Liljestrand published the first detailed studies of HPV in 1946, in the cat (von Euler and Liljestrand, 1946). They described the opposite effects of hypoxia on the systemic and pulmonary circulations and went on to say, “oxygen want and carbon dioxide accumulation. . . call forth a contraction of the lung vessels, which leads to improved conditions for the utilization of the alveolar air.” We now refer to this critical function for the optimization of oxygenation in the body as enhanced ventilation/perfusion (V/Q) matching. In the following year, Motley, Cournand et al observed that breathing 10% oxygen in nitrogen almost doubled pulmonary vascular resistance in man (Motley et al., 1947). After birth, HPV plays an important role in V/Q matching. In the fetus, however, the lungs are not ventilated and the result of the high pulmonary vascular resistance is to direct relatively oxygenated blood returning from the placenta to cross from the right side to the left side of the circulation through the foramen
5. A Mitochondria-AOS-Kv Channel Axis
93
ovale and the ductus arteriosus. The observation that an increase in oxygen tension at birth, right after the first few breaths, causes both pulmonary vasodilatation and contraction of the ductus arteriosus (Born et al., 1956) has fascinated physiologists for half a century. The characteristics of HPV have been established. The basic mechanism of HPV exists within the lungs, as it is present in the isolated perfused lung and isolated resistance PAs as well as isolated PASMC, occurs immediately and is reversible upon return to normoxia. In addition, maximal HPV is observed in the small, resistance pulmonary arteries, as opposed to the larger, conduit, proximal pulmonary arteries (Michelakis et al., 2004; Weir et al., 2005). Regarding the O2 sensor in HPV, although somewhat controversial, there is agreement that the list of the redox-based candidate O2 sensors is limited to primarily two, i.e. the PASMC mitochondrial electron transport chain (ETC) versus PASMC NAD(P)H and novel oxidases (NOX) and that the redox mediator from these sensors is either AOS or reducing/oxidizing couples in the cytoplasm (Michelakis et al., 2004; Weir et al., 2005). Although the relative importance of these two candidate oxygen sensors might vary between tissues or disease states, the fact that knockout mice lacking critical components of the NADPH oxidase have intact HPV, suggests that the mitochondria might be the primary oxygen sensor at least in the healthy pulmonary circulation (Archer et al., 1999). The recent interest in the effector of HPV has resulted in more controversy regarding its identity, i.e. the intracellular Ca++ machinery versus PASMC K+ channels, and even further, the molecular identity of the leading K+ channel candidates (Michelakis et al., 2004; Weir et al., 2005). The reason for the significant interest in the identification of the main effector of HPV is also related to the possibility that the PA vasoconstriction that initiates HPV might, if sustained, also initiate the process leading to PA remodeling and PAH. This would mean that the HPV effector might also be the target of pharmacologic or gene therapy approaches to treat PAH (Archer and Rich, 2000). The impressive similarities of the O2 sensing effector mechanisms between several O2 sensitive tissues is supportive of a leading role of O2 sensitive Kv channels as the effectors of HPV. For example, the effector in the response to O2 in the PAs, ductus arteriosus, carotid body, neuroepithelial body and adrenomeddulary cells involves redox mediated inhibition of Kv channels (Michelakis et al., 2004; Weir et al., 2005). At the same time, evidence from both humans and animal models suggests that a selective downregulation of Kv channels that occurs in PAH, might be etiologically associated with the development of PAH (Archer and Rich, 2000). Physiologists have been puzzled by the fact that the resistance PAs constrict to hypoxia while systemic arteries dilate. What is the mechanism by which HPV is intrinsic only in the resistance PASMC? We have shown that the resistance PASMC are different from the systemic arterial SMC in that they have different
94
G. Sutendra and E.D. Michelakis
FIGURE 1 Hypoxic pulmonary vasoconstriction (HPV) is intrinsic to the pulmonary circulation: hypoxia causes pulmonary artery constriction and systemic arterial dilatation. This might be due to the differences in the oxygen sensor in these tissues (i.e. the mitochondria). Perfusing pressures of a rat lung and kidney, perfused in series, shows a simultaneous increase in the pulmonary artery pressure and decrease in the renal artery pressure during hypoxia. Freshly isolated pulmonary and renal artery smooth muscle cells (handled and imaged under identical conditions) show that mitochondrial membrane potential (Ψ m, an index of mitochondrial function) is lower in the pulmonary artery compared to the renal artery smooth muscle cell mitochondria.
mitochondria (HPV sensors) and are endowed with more O2 -sensitive Kv channels (HPV effectors) (Michelakis et al., 2002a). Mitochondria are attractive candidate O2 sensors since they consume the majority of the cell’s O2 . They are also the major regulators of the cell’s redox status, since they are the major producers of AOS and form large and diffuse networks throughout the cytoplasm, that are sometimes only obvious when mitochondria are imaged in live cells with confocal microscopy (Figure 1). This allows close proximity to critical regulators of the intracellular Ca++ homeostasis, including the endoplasmic reticulum and the membrane ion channels. In addition, PASMC mitochondria, as will be discussed below, are particularly endowed
5. A Mitochondria-AOS-Kv Channel Axis
95
with manganese superoxide dismutase (MnSOD), compared with mitochondria from systemic vascular SMC (Michelakis et al., 2002a). This results in immediate dismutation of the ETC-produced superoxide to H2 O2 . Superoxide is a very unstable molecule, although it has been proposed to play a role in the response to hypoxia; mitochondrial-derived superoxide initiates the stabilization of hypoxiainducible factor 1α (Chandel et al., 2000), which in turn induces the expression of several genes important in hypoxia, such as erythropoietin. In contrast, the more stable mitochondrial-derived H2 O2 (Boveris and Chance, 1973), has a much longer effective diffusion radius than superoxide (Wolin, 2000), can diffuse to the cytoplasm and activate the soluble guanylate cyclase (Burke and Wolin, 1987; Wolin and Burke, 1987) or activate sarcolemmal K+ channels (Barlow and White, 1998; Hayabuchi et al., 1998; Wang et al., 1996) in vascular SMC thus causing vasodilatation. The concept of a “mitochondrial-derived effector” is not new. Mitochondria can also release other mediators, such as glutamate, that can affect sarcolemmal proteins and mediate glucose sensing and insulin secretion in betacells of the pancreas (Maechler and Wollheim, 1999). The mitochondrial ETC was proposed to be the O2 sensor in the carotid body in 1972 (Mills and Jobsis, 1972). Since then multiple studies have supported the role of the mitochondrial ETC as O2 sensor in the carotid body (reviewed in LopezBarneo et al., 2001). The involvement of the PASMC mitochondria in O2 sensing and HPV was proposed in 1993 (Archer et al., 1993b) and since then their role was confirmed in a more definitive manner by the same (Michelakis et al., 2004; Weir et al., 2005) and other groups (Waypa et al., 2001). The role of mitochondria as universal oxygen sensors allows them to match and couple energy (or oxygen) demand with oxygen delivery in the whole body, either by optimizing ventilationperfusion matching (through HPV in the PAs) or oxygen delivery (through the activation of the respiration center in the brain by the carotid body). The evidence suggesting that the mitochondrial ETC could be important in O2 sensing is based in part on the concordant effects of certain ETC inhibitors and hypoxia. In fact, proximal ETC inhibitors are the only class of drugs that can mimic hypoxia in a variety of O2 sensitive tissues. Inhibitors of complex I (rotenone) and complex III (antimycin), but not inhibitors of complex IV (cyanide) mimic hypoxia’s effect in the pulmonary circulation (Archer et al., 1993a; Waypa et al., 2001). Inhibitors of the mitochondrial ETC mimic hypoxia’s effects on the carotid body (e.g. increase sinus nerve activity (Mulligan et al., 1981)) and PA (cause vasoconstriction) (Archer et al., 1993a; Rounds and McMurtry, 1981). Like hypoxia, rotenone and antimycin inhibit Kv current in PASMCs and decrease the production of AOS (Archer et al., 1993b). The mitochondrial uncoupler, carbonyl cyanide p-trifluoromethoxyphenyl-hydrazone (FCCP), also decreases PASMC Kv current (Yuan et al., 1996). Buckler et al made similar observations in the carotid body, noting that both mitochondrial uncouplers, FCCP and 2,4-dinitrophenol (DNP), excite the carotid body by inhibiting an outward K+ current and inducing
96
G. Sutendra and E.D. Michelakis
a small inward current. This leads to membrane depolarization of the type 1 cell and voltage-gated Ca++ entry (Buckler and Vaughan-Jones, 1998). Mitochondrial Diversity Explains the Localization of HPV Within the Resistance PAs The critical role of mitochondria in O2 sensing is further supported by the fact that the responses of both hypoxia and proximal ETC inhibitors are opposing in PA versus RA (Michelakis et al., 2002a). Rotenone and antimycin decrease Kv current in isolated PASMC while they increase K+ current in isolated RA SMC. This explains the effects of hypoxia, rotenone and antimycin in endothelium-free isolated arteries and perfused organs (isolated perfused rat lung perfused in series with isolated rat kidney, Figure 1): they all constrict the PAs and dilate the renal arteries. In contrast, both vascular beds constrict to Angiotensin II and 4aminopyridine, a Kv channel blocker (Michelakis et al., 2002a). This suggests that the reason for these opposing effects lies within the vascular SMC and that it involves the sensor-mediator, rather than the effector. This is further supported by the fact that the production of mitochondrial AOS and H2 O2 at baseline and in response to hypoxia and ETC inhibitors is differentially regulated between PA and renal arteries (RA). We measured the baseline levels of AOS production (during normoxia) as well as the effects of hypoxia and ETC inhibitors in isolated, denuded, resistance PA and RA rings using 3 independent methods: Lucigenin-enhanced chemiluminescence, which preferentially detects superoxide anion levels (Choi et al., 1998) and the AmplexRed and DCF (2 ,7 -dichlorofluorescin diacetate) fluorescence assays, which are specific for H2 O2 . The data from all these assays are concordant and they show that the production of H2 O2 is higher in the PA versus the RA at baseline (Michelakis et al., 2002a). Once again, proximal ETC inhibitors (rotenone and antimycin A, 50 µM) mimic hypoxia and they both decease the production of H2 O2 in the PA. However, neither hypoxia nor the proximal ETC blockers alter the production of H2 O2 in the RA. Cyanide 1 µM (a distal ETC, complex IV) blocker does not affect H2 O2 production in either artery (Michelakis et al., 2002a). Evidence that the differences of the AOS production are intrinsic to the mitochondria, comes from experiments with isolated lung versus kidney mitochondria. The production of AOS and H2 O2 from isolated mitochondria was measured with lucigenin-enhanced chemiluminescence and AmplexRed. Once again, the lung mitochondria make more AOS and H2 O2 than the kidney and while hypoxia and proximal ETC inhibitors decrease AOS and H2 O2 in the lung, they do not in the kidney mitochondria (Michelakis et al., 2002a). Since the AOS production is directly linked to mitochondrial respiration, we studied O2 consumption in both lung and kidney mitochondria. Lung mitochondria have significantly lower rates of respiration, compared to kidney mitochondria, and quality control assays show that this is not due to differential damage during isolation (Michelakis et al., 2002a). As discussed above, the AOS produc-
5. A Mitochondria-AOS-Kv Channel Axis
97
tion correlates with Ψ m and respiration, in that lower respiration is associated with depolarized Ψ m and higher AOS levels. We used two different Ψ msensitive dyes (JC-1 and TMRM) and showed that mitochondria from RASMC have significantly higher Ψ m than mitochondria from PASMC under identical loading and imaging conditions, when studied in situ (Michelakis et al., 2002a) (Figure 1). When the SMC were superfused with a hypoxic solution, the PASMC mitochondria hyperpolarized whereas the RASMC mitochondria depolarized. Lastly, PA mitochondrial express less complex I and III subunits but more MnSOD compared to the RA mitochondria (Michelakis et al., 2002a). The Model for the Molecular Basis of HPV (Figure 2) The findings discussed support many of the known features of vascular O2 sensing. The high level of H2 O2 production at baseline in the PAs, could explain the relatively vasodilated (low-pressure) state of the pulmonary, compared to the systemic, circulation. Tonically produced H2 O2 from the proximal ETC can diffuse to the cytoplasm and cause Kv channel activation, PASCM hyperpolarization, decreased opening of the voltage-gated Ca++ channels, decreased [Ca++ ]i levels and vasodilatation. During acute hypoxia, the tonic production of this mitochondrial-derived vasodilator (H2 O2 ) decreases, thus promoting Ik inhibition and vasoconstriction, i.e. HPV. In contrast a hypoxia-induced increase in AOS would increase Ik (Gebremedhin et al., 1994) and promote systemic arterial vasodilatation. Controversy remains as to whether hypoxia decreases or increases AOS production. Other groups have indicated that hypoxia increases mitochondrialderived ROS production (Liu et al., 2003; Waypa et al., 2001, 2002). This is more likely due to differences in techniques and preparations used to study AOS. However all groups involved identify that the mitochondria and ROS account for the hemodynamic effects of hypoxia. A recent summary of the controversy on this issue can be found at Weir and Archer (2006). IV. THE MITOCHONDRIA-AOS-KV AXIS, METABOLISM AND APOPTOSIS A shift of the metabolism away from mitochondria (oxidative phosphorylation) and towards the energetically less efficient glycolysis (GO generates 36 moles ATP per mole of glucose whereas Gly generates only 2) has now been shown to be associated with a resistance to apoptosis. As expected, this metabolic shift is associated with a suppression of the mitochondria-AOS-Kv axis (hyperpolarized mitochondria, suppressed AOS, inhibited Kv channels). This characterizes proliferative diseases like PAH and cancer and at first appears paradoxical; why are these proliferative and energy-hungry states associated with the switch to an energetically inefficient metabolism? Is this switch causally related to these diseases? Recent work attempts to explain this fascinating “paradox”, also known in history as the “Warburg effect”.
98 G. Sutendra and E.D. Michelakis
FIGURE 2 The mechanism of HPV. Vasodilatation requires the production of H2 O2 (redox mediator) from the mitochondria (sensor), which oxidizes and opens Kv channels, leading to hyperpolarization of the plasma membrane. This inhibits voltage-gated calcium channels, decreasing calcium entry. A hypoxia-induced decrease in the production of AOS in complexes I and III of the mitochondria ETC, results in decreased H2 O2 production, reduction and inhibition of Kv channels; this results in depolarized plasma membrane potential (EM ), opening of the voltage-gated Ca++ channels, influx of Ca++ and pulmonary vasoconstriction, i.e. HPV.
5. A Mitochondria-AOS-Kv Channel Axis
99
A. The Metabolism of Cancer Cells Most cancers are characterized by aerobic Gly, i.e. they use glycolysis for energy production, despite the fact that oxygen is present. In 1929, Warburg first observed this and suggested it resulted from mitochondrial dysfunction, preventing the mitochondria-based glucose oxidation (GO) (Warburg, 1930). Because Gly is far less efficient in generating ATP compared to GO, the glycolytic cancer cells up-regulate glucose receptors and significantly increase glucose uptake in an attempt to “catch up”. Positron emission tomography (PET) imaging, the most sensitive way to diagnose cancer, has now confirmed that most solid tumors have significantly increased glucose uptake and metabolism, compared to noncancerous tissues. This bio-energetic difference between cancer and normal cells, might offer a very selective therapeutic target, as glycolysis is not typically seen in normal tissues apart from skeletal muscle during strenuous exercise. However, this area of experimental oncology had remained controversial; the glycolytic profile has traditionally been viewed as a result of cancer progression, not a cause and therefore the interest in targeting tumor metabolism has been low. The glycolytic profile of cancer is difficult to understand, using an evolutionary model of carcinogenesis. First, why would these highly proliferating and energy-demanding cells rely on glycolysis rather than the much more efficient GO? Second, Gly results in significant lactic acidosis, which might cause significant toxicity to the surrounding tissues and the cancer cells themselves. Recent advances have caused a rekindling of the metabolic hypothesis of cancer suggesting that these facts are not as conflicting as they appear at first (Gatenby and Gillies, 2004): Glycolysis Offers an Early Adaptation to the Hypoxic Microenvironment in Carcinogenesis Gatenby and Gillies recently proposed that since early carcinogenesis often occurs in a hypoxic microenvironment, the transformed cells have to rely on anaerobic glycolysis for energy production (Gatenby and Gillies, 2004). Hypoxiainducible factor (HIF) is activated in hypoxic conditions and it has been shown to induce the expression of several glucose transporters and most of the enzymes required for Gly (Robey et al., 2005). For example, HIF induces the expression of pyruvate dehydrogenase kinase (PDK) (Kim et al., 2006), a gate-keeping enzyme that regulates the flux of carbohydrates (pyruvate) into the mitochondria. In the presence of activated PDK, pyruvate dehydrogenase (PDH) is inhibited, limiting the entry of pyruvate into the mitochondria, where GO can take place. In other words, activated PDK promotes completion of Gly in the cytoplasm with metabolism of pyruvate into lactate; inhibited PDK ensures an efficient coupling between Gly and GO. Initially, tumors compensate by increasing glucose uptake into the cells. Furthermore, Gatenby and Gillies list a number of mechanisms through which lactic acidosis facilitates tumor growth: breakdown of extra-cellular matrix al-
100
G. Sutendra and E.D. Michelakis
lowing expansion, increased cell mobility/metastatic potential and (along with HIF) activation of angiogenesis (Gatenby and Gillies, 2004). While tumors eventually become vascularized and are not significantly hypoxic anymore (although some tumors remain hypoxic at the core because the quality of the neo-vessel formation is poor) the aerobic glycolytic profile persists This suggests that the (initially adaptive) metabolic remodeling confers a survival advantage to cancer cells. Indeed, recent evidence suggests that transformation to a glycolytic phenotype offers resistance to apoptosis (Plas and Thompson, 2002; Kim and Dang, 2005, 2006). Gly is Associated with Resistance to Apoptosis Several of the enzymes involved in Gly are also important regulators of apoptosis and gene transcription, suggesting that links between metabolic sensors, cell death and gene transcription are established directly through the enzymes that control metabolism (Kim and Dang, 2005). For example, hexokinase activation leads to a significant suppression of apoptosis; activated hexokinase translocates from the cytoplasm to the mitochondrial membranes where it interacts with and suppresses several key components of mitochondria-dependent apoptosis (Kim and Dang, 2005; Pastorino and Hoek, 2003). It is therefore not surprising that hexokinase is upregulated and activated in many cancers (Kim and Dang, 2005; Pastorino and Hoek, 2003). How does this occur? The promoter of hexokinase contains both p53 and HIF response elements and both mutated p53 and activated HIF increase hexokinase expression (Mathupala et al., 1997, 2001). In addition, the oncogenic protein Akt is upregulated in many cancers and induces a glycolytic metabolic profile via a number of mechanisms (Elstrom et al., 2004; Osaki et al., 2004). Akt increases both the expression and activity of hexokinase (Elstrom et al., 2004; Gottlob et al., 2001). The gene that normally antagonizes Akt, PTEN, is mutated (loss of function mutation) in a large number of cancers. Very recent data revealed even more links between p53 and metabolism: p53 regulates the expression of a critical enzyme of Gly via the production of TIGAR and is also directly regulating the expression of a subunit of cytochrome c oxidase, an important element of complex IV of the ETC in mitochondria (reviewed in Pan and Mak, 2007). In other words, the most common molecular abnormality in cancer, i.e. the loss of p53 function, induces metabolic and mitochondrial changes, compatible with the glycolytic phenotype. Similarly, the c-myc transcription factor increases the expression of many enzymes of Gly and can induce this same metabolic phenotype (Kim and Dang, 2005, 2006). In summary, an evolutionary theory of carcinogenesis identifies metabolism and Gly as a critical and early adaptive mechanism of cancer cells against hypoxia, that persist because it offers resistance to apoptosis in cancer cells (Gatenby and Gillies, 2004). The genetic theory on carcinogenesis, also identifies Gly and metabolism as an end-result of activation of many diverse oncogenes, including c-myc, Akt/PTEN and p53 (Pan and Mak, 2007). Therefore, it is possible that
5. A Mitochondria-AOS-Kv Channel Axis
101
this metabolic phenotype is centrally involved in the pathogenesis of cancer and is not simply a “by-product” of carcinogenesis. Although it is not clear whether this metabolic phenotype directly induces malignancy, it certainly “facilitates” carcinogenesis (Kim and Dang, 2006). In addition, this metabolic signature is the common denominator of multiple and diverse pathways; which means that if it is therapeutically targeted it might offer selectivity for malignant cells of diverse cellular and molecular origins. Mitochondria, Cancer and Apoptosis Shifting metabolism away from mitochondria (GO) and towards the cytoplasm (Gly), will suppress apoptosis, a form of cell death that is dependent on mitochondrial energy production. Pro-apoptotic mediators, like cytochrome c and apoptosis-inducing factor, are protected inside the mitochondria. When the voltage- and redox-sensitive mitochondrial transition pore (MTP) opens, they are released in the cytoplasm and induce apoptosis. Mitochondrial depolarization and increased AOS are associated with opening of the MTP (Zamzami and Kroemer, 2001). As discussed above, Ψ m and AOS production are dependent on the flux of electrons down the ETC, which in turn are dependent on the production of electron donors (NADH, FADH2 ) from the Krebs’ cycle. Suppressing the entry of pyruvate to the mitochondria and thus the production of acetyl-CoA, will suppress both the Krebs’ cycle and the ETC and thus MTP opening and apoptosis. The decreased flow of electrons will also result in a decrease in AOS and thus an inhibition of Kv channels, depolarizing the cells and eventually resulting in increased intracellular Ca++ and K+ . In turn, these will promote proliferation and further suppress apoptosis. In summary, suppression of mitochondrial function will result in suppression of the mitochondria-AOS-Kv axis and in suppression of apoptosis at two levels: first at the level of mitochondria, where the increased Ψ m is shifted away from the apoptosis threshold and opening of MTP and second at the level of Kv channels, where the increased levels of intracellular K+ will inhibit caspases. Remarkably, all of these abnormalities are reversed, leading to reversal of cancer growth, by a mitochondria-targeting drug, DCA (Bonnet et al., 2007a).
B. DCA Reverses the Mitochondrial Remodeling, Normalizes the Mitochondria-AOS-Kv Axis, Unlocking the Cancer Cells from a State of Apoptosis Resistance We recently showed that several cancer cell lines (non-small cell lung cancer, breast cancer and glioblastoma) had hyperpolarized mitochondria, compared to non-cancer cell lines (Bonnet et al., 2007a), a finding that was first described (but remained unappreciated) by Dr Chen at the Dana Farber Institute in the 80s (Chen, 1988). We also showed that this was associated with suppressed levels of
102 G. Sutendra and E.D. Michelakis
FIGURE 3 A glycolytic environment is associated with an anti-apoptotic and pro-proliferative state, characterizing PAH and cancer. Increased entry of pyruvate into the mitochondria by dichloroacetate or LDH inhibition promotes glucose oxidation, increased apoptosis and decreased proliferation (see text for discussion).
5. A Mitochondria-AOS-Kv Channel Axis
103
mitochondria-derived AOS and decreased activity and expression of Kv channels (Bonnet et al., 2007a). The Ca++ -sensitive transcription factor NFAT was also active (i.e. nuclear) in the cancer cells (Bonnet et al., 2007a). NFAT is a transcription factor that has been show to increase the levels of the anti-apoptotic mitochondrial bcl-2 and decrease the levels of the Kv channel Kv1.5 (Bonnet et al., 2007b; Macian, 2005). All of these features are compatible with an anti-apoptotic state and could be secondary to suppressed mitochondrial activity (Figure 3): decrease entry of pyruvate would eventually result in decrease flux of electrons in the ETC and therefore decreased AOS production, closing of the existing redox-sensitive Kv channels and increased intracellular Ca++ . The decreased AOS could also contribute to closure of the redox-sensitive MTP and mitochondrial hyperpolarization. The decreased entry of pyruvate into the mitochondria (and therefore the decreased GO) would result in compensatory Gly. Increased hexokinase levels would contribute to the hyperpolarization of the mitochondria; increased hexokinase in a glycolytic environment is known to be translocated to the mitochondrial membrane, inhibiting the voltage-dependent anion channel (a component of the MTP), resulting in hyperpolarization and suppression of apoptosis (Pastorino et al., 2005). By inhibiting PDK (Figure 4), DCA activated the pyruvate dehydrogenase, which resulted in an increased delivery of pyruvate into the mitochondria. As predicted, DCA increased GO and depolarized the mitochondria, returning the Ψ m towards the levels of the non-cancer cells, without affecting the mitochondria of non-cancerous cells. Remarkably, all the above features of the cancer cells were “normalized” following the increase in GO and the mitochondrial depolarization: AOS increased, NFAT was inactivated and function/expression of Kv channels was increased. Most importantly, apoptosis was induced in the cancer cells with both cyt c and apoptosis inducing factor efflux from the mitochondria (Figure 3). This resulted in a decrease in tumor growth both in vitro and in vivo in xenotransplant models. It is important here to clarify that simply inhibiting Gly (particularly at proximal stages), will not promote pyruvate entry into the mitochondria, i.e. will not re-activate mitochondria. It will also be toxic to several non-cancerous tissues that depend on Gly for energy production. Inhibiting Gly (which has previously been tested as a potential treatment for cancer) typically results in necrosis, not apoptosis, since apoptosis is an energy-consuming process, requiring active mitochondria. The “trick” is to enhance the Gly to GO coupling, not just inhibit Gly. One of the ways that this can happen is by activating PDH, or inhibiting LDH, bringing pyruvate into the mitochondria and enhancing GO. This hypothesis is also supported by the recently published work that inhibition of LDH (by siRNA), which promotes the transfer of pyruvate into the mitochondria (in that sense mimicking DCA), also promotes cancer apoptosis and decreases tumor growth in vitro and in mice xenotransplants (Fantin et al., 2006) (Figure 3).
104 G. Sutendra and E.D. Michelakis
FIGURE 4 Structure of human pyruvate dehydrogenase kinase 2 (PDK2) bound with dichloroacetate (DCA). (A) Ribbon representation of PDK2 with DCA bound. (B) Surface representation of PDK2 bound with DCA. The carboxylate group of DCA forms a salt bridge (dashed white line) with Arginine 154 of PDK2. (C) Structure of DCA. The structures were generated using visual molecular dynamics (VMD) version 1.8.6 with the coordinates acquired from Protein Data Bank (PDB#2BU8).
5. A Mitochondria-AOS-Kv Channel Axis
105
DCA has been used clinically to treat inherited mitochondrial disorders over 30 years (Stacpoole, 1989; Stacpoole et al., 2003). It is a very small molecule (Figure 4), orally available and cheap (it is a generic drug) and the recent findings suggest that it might be a promising selective therapy for cancer. Indeed, clinical phase I and II clinical trials in patients with several forms of cancer have now started at the University of Alberta. Intriguingly, DCA reverses PAH with an identical mechanism, again normalizing the mitochondrial-AOS-Kv axis and promoting apoptosis.
C. Pulmonary Arterial Hypertension: Intriguing Parallels with Cancer Since its first description (Dresdale et al., 1951; Romberg, 1891) PAH has fascinated scientists and, despite the recent progress, remains an intriguing and mysterious disease. PAH pathology spreads through the whole spectrum of vascular disease: there are well-described abnormalities involving the endothelium, the smooth muscle cells, the fibroblasts and the interstitial matrix in the vascular wall as well as abnormalities in platelets and circulating inflammatory cells. These abnormalities result in an obliterative remodeling of the pulmonary circulation, characterized by lumen occlusion in medium and small-sized pulmonary arteries (PA) due to excessive cellular proliferation in the vascular wall (Figure 5); the right ventricular (RV) afterload increases, resulting in RV failure and premature death (Voelkel et al., 2006). Systemic arteries are typically normal in PAH and this represents a major challenge since candidate therapies will have to reverse the vascular remodeling in the PAs without affecting the systemic arteries. Therapies are limited in effectiveness, typically suffer form severe adverse effects and the mortality in PAH remains very high (Archer and Michelakis, 2006). Recent evidence suggests that many features of cancer are also present in PAH. For example, PAs from patients and animals with PAH express cancer markers, like the mitochondrial apoptosis inhibitory protein survivin (McMurtry et al., 2005) and are characterized by a remarkable resistance to apoptosis (Michelakis, 2006). Like in cancer, there is a great need for effective and selective disease-modifying therapies (Archer and Michelakis, 2006). The mitochondria-AOS-Kv axis is an attractive target for novel PAH therapies. As discussed above, the differences in the PA compared to the systemic arterial mitochondria might provide the basis of pulmonary artery-selective therapies. Since the axis is involved in the regulation of both vascular tone and proliferation/apoptosis, its targeting might have several beneficial effects. The mitochondria-AOS-Kv axis is significantly suppressed in PAH, including human and PAH in several animal models. Hyperpolarized mitochondria, decreased AOS and inhibited/downregulated Kv channels have been described in PASMC from patients with clinical PAH and in several rat models of the disease (Bonnet et al., 2006, 2007b; McMurtry et al., 2005, 2004; Michelakis et al.,
106
G. Sutendra and E.D. Michelakis
FIGURE 5 PAH pathology: immunohistochemistry in a human sample from a patient with PAH; staining with an antibody against smooth muscle actin shows the impressive proliferation of the PASMC in the media, essentially obliterating the PA lumen. As discussed in text, the PA media in PAH is characterized by suppressed apoptosis and increased proliferation, resembling a neoplastic tissue. Like in cancer, this is associated with a suppressed mitochondria-AOS-Kv channel axis.
2002b). In addition, this axis remains suppressed even in isolated PASMC in culture. This phenotype likely contributes significantly to the resistance in apoptosis that underlines the pathology of PAH. Even more remarkable is the fact that DCA, reverses all animal models of established PAH by the exact and identical mechanism that it inhibits cancer growth (Figure 6 and Table 1) (Bonnet et al., 2007a; McMurtry et al., 2004). Both in vivo and in vitro DCA decreases and normalizes the mitochondrial Ψ m, increases H2 O2 production and acutely activates Kv channels. Like in cancer, PAH is also associated with an activated NFAT, explaining in part the down-regulation of Kv channels and the regulation of several mitochondrial enzymes, in order to produce a mitochondrial remodeling similar to that of cancer (Bonnet et al., 2007b).
5. A Mitochondria-AOS-Kv Channel Axis
107
FIGURE 6 The mitochondria acting Dichloroacetate reverses cancer (Bonnet et al., 2007a) and PAH (McMurtry et al., 2004) by an identical mechanism including mitochondrial depolarization, activation of K+ channels, induction of apoptosis, resulting in normalization of hemodynamics in rat PAH and decrease in cancer growth in a xenotransplant model of non-small cell lung cancer in nude rats. Representative pictures of the effects of DCA in PASMC and cancer mitochondrial Ψ m (TMRM staining) and outward K+ current (patch claming) are shown. These result in induction of apoptosis, measured by TUNEL (green: TUNEL, blue: nuclear staining by DAPI) and reversal of the disease: the decreased PA pressure (measured by catheterization of anesthetized rats via the jugular vein) and the decreased in tumor growth (measured by a rat microCT). (For colors see the web version of this book.)
108
G. Sutendra and E.D. Michelakis TABLE 1
A Normal PASMC PAH PASMC PAH PASMC + DCA B Normal Epithelial Cell Cancer Cell Cancer Cell + DCA
Mitochondrial Ψ m
AOS Production
K+ Current
↓ ↑ ↓
↑ ↓ ↑
↑ ↓ ↑
Mitochondrial Ψ m
ROS Production
K+ Current
↓ ↑ ↓
↑ ↓ ↑
↑ ↓ ↑
DCA results in reversal of the AOS- and calcium-activated NFAT, leading to the reversal of the Kv channel downregulation as well (McMurtry et al., 2004). Like in cancer, DCA has no effects whatsoever in the non-diseased pulmonary arteries and in the normal systemic arteries (McMurtry et al., 2004). One would expect that the vascular wall in PAH would be characterized by a glycolytic phenotype, like in cancer’s Warburg effect. Although direct measurements of metabolism within the PA wall in PAH are not yet available, it is intriguing that a recent report describes high glucose uptake within the PA wall in patients with PAH, using PET imaging (Xu et al., 2007). This raises the intriguing possibility that the anti-apoptotic glycolytic environment in the remodeled PA wall in PAH is associated with compensatory increased uptake of glucose, exactly like in cancer. D. Conclusion These recent observations on the mitochondria-AOS-Kv axis in PAH and cancer open a new window in our understanding of these diseases, their therapy and even their diagnosis with metabolic-based molecular imaging techniques. These fascinating parallels between a vascular remodeling disease like PAH and cancer suggest that the mitochondria-AOS-Kv axis and metabolism might play an important role in other vascular disorders characterized by a proliferative remodeling (like restenosis or transplant vasculopathy) and that therapies that target this axis might be effective in those diseases as well. Molecular medicine calls for a look into mechanisms of disease without the traditional limits of medical specialties and suggests that comprehensive signaling systems like the mitochondriaAOS-Kv axis should be studied and therapeutically targeted in many seemingly unrelated diseases. References Archer, S., Rich, S. (2000). Primary pulmonary hypertension: A vascular biology and translational research “Work in Progress”. Circulation 102, 2781–2791.
5. A Mitochondria-AOS-Kv Channel Axis
109
Archer, S.L., Huang, J., Henry, T., Peterson, D., Weir, E.K. (1993a). A redox based oxygen sensor in rat pulmonary vasculature. Circ. Res. 73, 1100–1112. Archer, S.L., Huang, J., Henry, T., Peterson, D., Weir, E.K. (1993b). A redox-based O2 sensor in rat pulmonary vasculature. Circ. Res. 73, 1100–1112. Archer, S.L., Michelakis, E.D. (2006). An evidence-based approach to the management of pulmonary arterial hypertension. Curr. Opin. Cardiol. 21, 385–392. Archer, S.L., Reeve, H.L., Michelakis, E., Puttagunta, L., Waite, R., Nelson, D.P., Dinauer, M.C., Weir, E.K. (1999). O2 sensing is preserved in mice lacking the gp91 phox subunit of NADPH oxidase. Proc. Natl. Acad. Sci. USA 96, 7944–7949. Archer, S.L., Souil, E., Dinh-Xuan, A.T., Schremmer, B., Mercier, J.C., El Yaagoubi, A., NguyenHuu, L., Reeve, H.L., Hampl, V. (1998). Molecular identification of the role of voltage-gated K+ channels, Kv1.5 and Kv2.1, in hypoxic pulmonary vasoconstriction and control of resting membrane potential in rat pulmonary artery myocytes. J. Clin. Invest. 101, 2319–2330. Barlow, R.S., White, R.E. (1998). Hydrogen peroxide relaxes porcine coronary arteries by stimulating BKCa channel activity. Am. J. Physiol. 275, H1283–H1289. Barrientos, A., Moraes, C. (1999). Titrating the effects of mitochondrial complex I impairment in the cell physiology. J. Biol. Chem. 274, 16188–16197. Bonnet, S., Archer, S.L., Allalunis-Turner, J., Haromy, A., Beaulieu, C., Thompson, R., Lee, C.T., Lopaschuk, G.D., Puttagunta, L., Bonnet, S., Harry, G., Hashimoto, K., Porter, C.J., Andrade, M.A., Thebaud, B., Michelakis, E.D. (2007a). A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell 11, 37–51. Bonnet, S., Michelakis, E.D., Porter, C.J., Andrade-Navarro, M.A., Thebaud, B., Bonnet, S., Haromy, A., Harry, G., Moudgil, R., McMurtry, M.S., Weir, E.K., Archer, S.L. (2006). An abnormal mitochondrial-hypoxia inducible factor-1alpha-Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats: Similarities to human pulmonary arterial hypertension. Circulation 113, 2630–2641. Bonnet, S., Rochefort, G., Sutendra, G., Archer, S.L., Haromy, A., Webster, L., Hashimoto, K., Bonnet, S.N., Michelakis, E.D. (2007b). The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted. Proc. Natl. Acad. Sci. USA 104, 11418–11423. Born, G.V.R., Dawes, G.S., Mott, J.C., Rennick, B.R. (1956). The constriction of the ductus arteriosus caused by oxygen and by asphyxia in newborn lambs. J. Physiol. 132, 304–342. Boveris, A., Chance, B. (1973). The mitochondrial generation of hydrogen peroxide. Biochem. J. 134, 707–716. Bradford, J., Dean, H. (1894). The pulmonary circulation. J. Physiol. 16, 34–96. Buckler, K.J., Vaughan-Jones, R.D. (1998). Effects of mitochondrial uncouplers on intracellular calcium, pH and membrane potential in rat carotid body type I cells. J. Physiol. 513, 819–833. Burke, T., Wolin, M. (1987). Hydrogen peroxide elicits pulmoary arterial relaxation and guanylate cyclase activation. Am. J. Physiol. 252, H721–H732. Cain, K., Langlais, C., Sun, X.M., Brown, D.G., Cohen, G.M. (2001). Physiological concentrations of K+ inhibit cytochrome c-dependent formation of the apoptosome. J. Biol. Chem. 276, 41985– 41990. Chandel, N.S., McClintock, D.S., Feliciano, C.E., Wood, T.M., Melendez, J.A., Rodriguez, A.M., Schumacker, P.T. (2000). Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: A mechanism of O2 sensing. J. Biol. Chem. 275, 25130–25138. Chen, L.B. (1988). Mitochondrial membrane potential in living cells. Annu. Rev. Cell. Biol. 4, 155– 181. Choi, J.W., Haigh, W.G., Lee, S.P. (1998). Caveat: Mycoplasma arginine deiminase masquerading as nitric oxide synthase in cell cultures. Biochim. Biophys. Acta 1404, 314–320. Dresdale, D., Schultz, M., Michtom, R. (1951). Primary pulmonary hypertension. Clinical and hemodynamic study. Am. J. Med. 11, 686–705.
110
G. Sutendra and E.D. Michelakis
Duchen, M.R. (1999). Contributions of mitochondria to animal physiology: From homeostatic sensor to calcium signalling and cell death. J. Physiol. (Lond.) 516, 1–17. Elstrom, R.L., Bauer, D.E., Buzzai, M., Karnauskas, R., Harris, M.H., Plas, D.R., Zhuang, H., Cinalli, R.M., Alavi, A., Rudin, C.M., Thompson, C.B. (2004). Akt stimulates aerobic glycolysis in cancer cells. Cancer Res. 64, 3892–3899. Fantin, V.R., St-Pierre, J., Leder, P. (2006). Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell 9, 425–434. Gallin W.J, S.A.N. (2001). Evolution of potassium channel proteins. In: Potassium Channels in Cardiovascular Biology. Kluwer Academic/Plenum Publishers, New York. Chapter 1. Gatenby, R.A., Gillies, R.J. (2004). Why do cancers have high aerobic glycolysis? Nat. Rev. Cancer 4, 891–899. Gebremedhin, D., Bonnet, P., Greene, A.S., England, S.K., Rusch, N.J., Lombard, J.H., Harder, D.R. (1994). Hypoxia increases the activity of Ca2+ -sensitive K+ channels in cat cerebral arterial muscle cell membranes. Pflügers Arch. 428, 621–630. Gottlob, K., Majewski, N., Kennedy, S., Kandel, E., Robey, R.B., Hay, N. (2001). Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. Genes Dev. 15, 1406–1418. Hayabuchi, Y., Nakaya, Y., Matsuoka, S., Kuroda, Y. (1998). Hydrogen peroxide-induced vascular relaxation in porcine coronary arteries is mediated by Ca2+ -activated K+ channels. Heart Vessels 13, 9–17. Ide, T., Tsutsui, H., Kinugawa, S., Utsumi, H., Kang, D., Hattori, N., Uchida, K., Arimura, K., Egashira, K., Takeshita, A. (1999). Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium. Circ Res. 85, 357–363. Kim, J.W., Dang, C.V. (2005). Multifaceted roles of glycolytic enzymes. Trends Biochem. Sci. 30, 142–150. Kim, J.W., Dang, C.V. (2006). Cancer’s molecular sweet tooth and the Warburg effect. Cancer Res. 66, 8927–8930. Kim, J.W., Tchernyshyov, I., Semenza, G.L., Dang, C.V. (2006). HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia. Cell Metab. 3, 177–185. Knoechel, T.R., Tucker, A.D., Robinson, C.M., Phillips, C., Taylor, W., Bungay, P.J., Kasten, S.A., Roche, T.E., Brown, D.G. (2006). Regulatory roles of the N-terminal domain based on crystal structures of human pyruvate dehydrogenase kinase 2 containing physiological and synthetic ligands. Biochemistry 45, 402–415. Liu, J.Q., Sham, J.S., Shimoda, L.A., Kuppusamy, P., Sylvester, J.T. (2003). Hypoxic constriction and reactive oxygen species in porcine distal pulmonary arteries. Am. J. Physiol. Lung. Cell Mol. Physiol. 285, L322–L333. Lopez-Barneo, J., Pardal, R., Ortega-Saenz, P. (2001). Cellular mechanism of oxygen sensing. Annu. Rev. Physiol. 63, 259–287. Macian, F. (2005). NFAT proteins: Key regulators of T-cell development and function. Nat. Rev. Immunol. 5, 472–484. Maechler, P., Wollheim, C. (1999). Mitochondrial glutamate acts as a messenger in glucose-induced insulin exocytosis. Nature 402, 685–689. Mathupala, S.P., Heese, C., Pedersen, P.L. (1997). Glucose catabolism in cancer cells. The type II hexokinase promoter contains functionally active response elements for the tumor suppressor p53. J. Biol. Chem. 272, 22776–22780. Mathupala, S.P., Rempel, A., Pedersen, P.L. (2001). Glucose catabolism in cancer cells: Identification and characterization of a marked activation response of the type II hexokinase gene to hypoxic conditions. J. Biol. Chem. 276, 43407–43412. McMurtry, M.S., Archer, S.L., Altieri, D.C., Bonnet, S., Haromy, A., Harry, G., Bonnet, S., Puttagunta, L., Michelakis, E.D. (2005). Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension. J. Clin. Invest. 115, 1479–1491.
5. A Mitochondria-AOS-Kv Channel Axis
111
McMurtry, M.S., Bonnet, S., Wu, X., Dyck, J.R., Haromy, A., Hashimoto, K., Michelakis, E.D. (2004). Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis. Circ Res. 95, 830–840. McMurtry, S., Michelakis, E. (2004). Mitochondrial diversity in the vasculature: Implications for vascular oxygen sensing. In: Yuan, J. (Ed.), Hypoxic Pulmonary Vasoconstriction: Cellular and Molecular Mechanisms. Kluwer, New York (Chapter 17). Michelakis, E.D. (2006). Spatio-temporal diversity of apoptosis within the vascular wall in pulmonary arterial hypertension: Heterogeneous BMP signaling may have therapeutic implications. Circ. Res. 98, 172–175. Michelakis, E.D., Hampl, V., Nsair, A., Wu, X., Harry, G., Haromy, A., Gurtu, R., Archer, S.L. (2002a). Diversity in mitochondrial function explains differences in vascular oxygen sensing. Circ. Res. 90, 1307–1315. Michelakis, E.D., McMurtry, M.S., Wu, X.C., Dyck, J.R., Moudgil, R., Hopkins, T.A., Lopaschuk, G.D., Puttagunta, L., Waite, R., Archer, S.L. (2002b). Dichloroacetate, a metabolic modulator, prevents and reverses chronic hypoxic pulmonary hypertension in rats: Role of increased expression and activity of voltage-gated potassium channels. Circulation 105, 244–250. Michelakis, E.D., Thebaud, B., Weir, E.K., Archer, S.L. (2004). Hypoxic pulmonary vasoconstriction: Redox regulation of O2 -sensitive K+ channels by a mitochondrial O2 -sensor in resistance artery smooth muscle cells. J. Mol. Cell Cardiol. 37, 1119–1136. Mills, E., Jobsis, F.F. (1972). Mitochondrial respiratory chain of carotid body and chemoreceptor response to changes in oxygen tension. J. Neurophsiol. 35, 405–428. Motley, H.L., Cournand, A., Werko, L., Himmelstein, A., Dresdale, D. (1947). Influence of short periods of induced acute anoxia upon pulmonary artery pressure in man. Am. J. Physiol. 150, 315–320. Mulligan, E., Lahiri, S., Storey, B.T. (1981). Carotid body O2 chemoreception and mitochondrial oxidative phosphorylation. J. Appl. Physiol. 51, 438–446. Osaki, M., Oshimura, M., Ito, H. (2004). PI3K-Akt pathway: Its functions and alterations in human cancer. Apoptosis 9, 667–676. Pan, J.G., Mak, T.W. (2007). Metabolic targeting as an anticancer strategy: Dawn of a new era? Sci. STKE 2007, pe14. Pastorino, J.G., Hoek, J.B. (2003). Hexokinase II: The integration of energy metabolism and control of apoptosis. Curr. Med. Chem. 10, 1535–1551. Pastorino, J.G., Hoek, J.B., Shulga, N. (2005). Activation of glycogen synthase kinase 3beta disrupts the binding of hexokinase II to mitochondria by phosphorylating voltage-dependent anion channel and potentiates chemotherapy-induced cytotoxicity. Cancer Res. 65, 10545–10554. Pitkanen, S., Robinson, B.H. (1996). Mitochondrial complex I deficiency leads to increased production of superoxide radicals and induction of superoxide dismutase. J. Clin. Invest. 98, 345–351. Plas, D.R., Thompson, C.B. (2002). Cell metabolism in the regulation of programmed cell death. Trends Endocrinol. Metab. 13, 75–78. Platoshyn, O., Golovina, V.A., Bailey, C.L., Limsuwan, A., Krick, S., Juhaszova, M., Seiden, J.E., Rubin, L.J., Yuan, J.X. (2000). Sustained membrane depolarization and pulmonary artery smooth muscle cell proliferation. Am. J. Physiol. Cell Physiol. 279, C1540–C1549. Remillard, C.V., Yuan, J.X. (2004). Activation of K+ channels: An essential pathway in programmed cell death. Am. J. Physiol. Lung. Cell Mol. Physiol. 286, L49–L67. Robey, I.F., Lien, A.D., Welsh, S.J., Baggett, B.K., Gillies, R.J. (2005). Hypoxia-inducible factor1alpha and the glycolytic phenotype in tumors. Neoplasia 7, 324–330. Romberg, E. (1891). Ueber slerose der lungenarterien. Deutsch Arch. Klin. Med. 48, 197. Rounds, S., McMurtry, I. (1981). Inhibitors of oxidative ATP production cause transient vasoconstriction and block subsequent pressor responses in rat lungs. Circ. Res. 48, 393–400. Stacpoole, P.W. (1989). The pharmacology of dichloroacetate. Metabolism 38, 1124–1144. Stacpoole, P.W., Nagaraja, N.V., Hutson, A.D. (2003). Efficacy of dichloroacetate as a lactate-lowering drug. J. Clin. Pharmacol. 43, 683–691.
112
G. Sutendra and E.D. Michelakis
Vanden Hoek, T.L., Becker, L.B., Shao, Z., Li, C., Schumacker, P.T. (1998). Reactive oxygen species released from mitochondria during brief hypoxia induce preconditioning in cardiomyocytes. J. Biol. Chem. 273, 18092–18098. Voelkel, N.F., Quaife, R.A., Leinwand, L.A., Barst, R.J., McGoon, M.D., Meldrum, D.R., Dupuis, J., Long, C.S., Rubin, L.J., Smart, F.W., Suzuki, Y.J., Gladwin, M., Denholm, E.M., Gail, D.B. (2006). Right ventricular function and failure: Report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. Circulation 114, 1883–1891. von Euler, U., Liljestrand, G. (1946). Observations on the pulmonary arterial blood pressure in the cat. Acta Physiol. Scand. 12, 301–320. Wang, D., Youngson, C., Wong, V., Yeger, H., Dinauer, M.C., Vega-Saenz Miera, E., Rudy, B., Cutz, E. (1996). NADPH-oxidase and a hydrogen peroxide-sensitive K+ channel may function as an oxygen sensor complex in airway chemoreceptors and small cell lung carcinoma cell lines. Proc. Natl. Acad. Sci. USA 93, 13182–13187. Warburg, O. (1930). Ueber den stoffwechsel der tumoren. Constable, London. Waypa, G.B., Chandel, N.S., Schumacker, P.T. (2001). Model for hypoxic pulmonary vasoconstriction involving mitochondrial oxygen sensing. Circ Res. 88, 1259–1266. Waypa, G.B., Marks, J.D., Mack, M.M., Boriboun, C., Mungai, P.T., Schumacker, P.T. (2002). Mitochondrial reactive oxygen species trigger calcium increases during hypoxia in pulmonary arterial myocytes. Circ. Res. 91, 719–726. Weir, E.K., Archer, S.L. (2006). Counterpoint: Hypoxic pulmonary vasoconstriction is not mediated by increased production of reactive oxygen species. J. Appl. Physiol. 101, 995–998. Discussion 998. Weir, E.K., Lopez-Barneo, J., Buckler, K.J., Archer, S.L. (2005). Acute oxygen-sensing mechanisms. N. Engl. J. Med. 353, 2042–2055. Wolin, M., Burke, T. (1987). Hydrogen peroxide elicits activation of bovine pulmonary arterial soluble guanylate cyclase by a mechanism associated with its metabolism by catalase. Biochem. Biophys. Res. Comm. 143, 20–25. Wolin, M.S. (2000). Interactions of oxidants with vascular signaling systems. Arterioscler. Thromb. Vasc. Biol. 20, 1430–1442. Xu, W., Koeck, T., Lara, A.R., Neumann, D., DiFilippo, F.P., Koo, M., Janocha, A.J., Masri, F.A., Arroliga, A.C., Jennings, C., Dweik, R.A., Tuder, R.M., Stuehr, D.J., Erzurum, S.C. (2007). Alterations of cellular bioenergetics in pulmonary artery endothelial cells. Proc. Natl. Acad. Sci. USA 104, 1342–1347. Yuan, X.J., Sugiyama, T., Goldman, W.F., Rubin, L.J., Blaustein, M.P. (1996). A mitochondrial uncoupler increases KCa currents but decreases KV currents in pulmonary artery myocytes. Am. J. Physiol. 270, C321–C331. Zamzami, N., Kroemer, G. (2001). The mitochondrion in apoptosis: How Pandora’s box opens. Nat. Rev. Mol. Cell Biol. 2, 67–71.
CHAPTER 6 Oxidative Modification of Ca2+ Channels, Ryanodine Receptors, and the Sarco/ Endoplasmic Reticulum Ca2+-ATPase Victor S. Sharov and Christian Schöneich Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS 66047, USA
I. Introduction II. Overview of Ca2+ Translocation Membrane Proteins III. Ca2+ Channels A. Voltage-gated Channels B. Ligand-gated Channels IV. SERCA V. PMCA VI. Concluding Remarks References
Abstract This paper reviews our current knowledge on the oxidative modifications of membrane proteins implicated in Ca2+ transport. The high sensitivity of some Ca2+ handling proteins, such as the L-type voltage-gated channel, the ryanodine receptor, and the sarco/endoplasmic reticulum Ca2+ -ATPase (SERCA) to oxidative modifications renders them important targets for oxidative regulation/modulation endowing a crosstalk between redox signaling and calcium transients in the cell. The main focus of this review is to correlate either loss or gain of protein function under conditions of oxidative stress to selective, potentially reversible, modifications of specific amino acids. Among those special emphasis will be placed on S-nitrosation, S-glutathiolation, disulfide formation, and Tyr nitration, as potential mechanism of redox-dependent signaling in the cell. Current Topics in Membranes, Volume 61 Copyright © 2008, Elsevier Inc. All rights reserved
1063-5823/08 $35.00 DOI: 10.1016/S1063-5823(08)00206-8
114
V.S. Sharov and C. Schöneich
I. INTRODUCTION Changes in subcellular, cellular or tissue Ca2+ levels have been reported for various conditions of oxidative stress (reviewed by Annunziato et al., 2002; Camello-Almaraz et al., 2006; Davidson and Duchen, 2006; Mattson, 2007; Beccafico et al., 2007; Hool, 2008). Such modulation of Ca2+ levels can be the result of activation/inactivation and/or post-translational modification of multiple proteins involved in the regulation of Ca2+ metabolism. Generally, conditions of oxidative stress are characterized by increased levels of some but not necessarily by all types of reactive oxygen species (ROS), which may include superoxide anion radical, peroxides, peroxynitrite, hypochlorous acid, and others. Each of these species will show distinct reactivities and selectivities in their reactions with given proteins, and frequently the actual parameters controlling these reactivities and selectivities are not completely understood. Fact is, however, that some of these ROS are involved in very selective reversible modifications of specific proteins, associated with a change in activity, so that these modifications can be considered regulatory in nature. In this paper, we will not provide an overview over all ROS and/or free radicals, which could potentially modify calcium channels and transporters (for reviews, see Stark, 2005; Camello-Almaraz et al., 2006; Hool and Corry, 2007). Rather, we will describe studies demonstrating either loss or gain of protein function when Ca2+ channels and transporters are exposed to specific oxidants and/or biologic conditions. Among these Ca2+ transporting proteins we will focus on the L-type voltagegated channel, the sarco/endoplasmic reticulum Ca2+ -ATPase (SERCA), and the plasma membrane Ca2+ -ATPase (PMCA), where specifically SERCA and PMCA are somehow underrepresented in recent reviews (Hool and Corry, 2007; Hidalgo and Donoso, 2008), which concentrate more on voltage- and ligand-gated Ca2+ channels. II. OVERVIEW OF Ca2+ TRANSLOCATION MEMBRANE PROTEINS To understand the role of redox regulation of Ca2+ channels and transporters (Davidson and Duchen, 2006; Hool and Corry, 2007; Mattson, 2007), we shall briefly classify the proteins involved in Ca2+ translocation through membranes, and their specific functions. Generally, cells maintain low cytoplasmic concentrations of Ca2+ (below 10−7 M) through ATP-dependent translocation of Ca2+ ions across the plasma membrane by PMCA and the Ca2+ /Na+ exchanger, and into intracellular stores by SERCA, the mitochondrial Ca2+ uniporter (MCU) or ion exchangers. Since extracellular Ca2+ concentrations are usually 3 to 4 orders of magnitude higher, the opening of plasma membrane Ca2+ channels can rapidly elevate intracellular calcium levels. Similarly, Ca2+ release channels located in the membranes of intracellular organelles can generate fast Ca2+ fluxes into the
6. Oxidative Modification of Ca2+ -Transporting Proteins
115
cytoplasm and into other cellular compartments. Often the influx of extracellular Ca2+ serves as an external signal triggering massive release of Ca2+ from intracellular stores, especially in excitable cells. The mitochondrial membrane harbors the MCU, a channel, which transports Ca2+ into mitochondria using an electrogenic membrane potential (Kirichok et al., 2004). Instead, the Na+ /Ca2+ exchanger releases Ca2+ from mitochondria through exchange with Na+ ions. Inside the cell, Ca2+ serves as a second messenger to regulate the activity of diverse proteins and cellular functions, such as cell signaling, gene expression, cell motility, apoptosis, etc.; in specific tissues, Ca2+ is involved in physiological processes such as muscle contraction, neurotransmitter secretion, neuron excitability, and action potential generation. Hence, the maintenance of Ca2+ homeostasis through the various calcium handling mechanisms is very important, specifically because high intracellular calcium concentrations are toxic and may lead to cell death via apoptotic and necrotic pathways (Waring, 2005). III. Ca2+ CHANNELS A. Voltage-gated Channels Ca2+ channels are classified as voltage-gated channels, associated with the plasma membrane, and ligand-gated channels, which reside in different types of membranes (Catterall et al., 2005; Hool and Corry, 2007). Voltage-gated channels are expressed in muscle, neuronal, endocrine, and receptor cells and further classified based on mechanisms of activation and inactivation as L-type (high voltage activated, long lasting, inhibited by dihydropyridines, phenylalkylamines, and benzothiazepines), and T-type (low voltage and transiently activated with only pacemaking function and unknown antagonists). Additionally, N-type, P/Q-type, and R-type channels have been identified in neurons based on specific functions and sensitivity to toxins, where N-type channels are sensitive to ω-conotoxinGVIA, P/Q-type channels are sensitive to ω-agatoxin IVA, and R-type channels are sensitive to SNX-482. Voltage-gated Ca2+ channels are implicated, among others, in excitation-contraction coupling, action potential generation, hormone and neurotransmitter release, pacemaking (repetitive fire activity), and sensing (Catterall et al., 2005). A large effort was placed on the evaluation of the role of nitric oxide (NO) on Ca2+ channel activity and intracellular Ca2+ levels. Experimentally, this was achieved through the use of NO synthase (NOS) inhibitors, NO scavengers and NO donors specifically in brain and muscle tissues and cultured cells. As both soluble guanylate cyclase (sGC) and S-nitrosation (cGMP-independent) pathways may be involved in the NO-dependent modulation of Ca2+ currents, specific inhibitors of both NO pathways were applied for further analysis. Early observations that NO inhibits an L-type Ca2+ current in carotid body sensory cells via a cGMP-independent mechanism were
116
V.S. Sharov and C. Schöneich
based on experiments with N-ethylmaleimide (NEM), which prevented the Snitrosation of calcium channels (Summers et al., 1999). Channel-type specificity was assessed by the influence of specific inhibitors on the effect of NO on the Ca2+ current. Recent data support a role of S-nitrosation in the inhibitory effect of NO on L-type Ca2+ channels, in addition to an sGC-dependent mechanism in vestibular hair cells (Almanza et al., 2007), cultured rat hippocampal neurons, and rat hippocampal slices in the CA1 region (Jian et al., 2007; Tjong et al., 2007). Chemical evidence for an S-nitrosation mechanism was obtained through the reversal of NO-dependent inhibition by ascorbate, which reduces S-nitrosothiols but not disulfides. Importantly, reactive molecules, such as, e.g., the oxidant hydrogen peroxide or the Michael acceptor 4-hydroxynonenal, modulated L-type Ca2+ channel activity in the opposite direction compared to NO, for example, selectively enhancing the nifedipine-sensitive Ca2+ current in dentate granule cells (Akaishi et al., 2004a, 2004b). Unfortunately, however, these conclusions are based on functional studies only and suffer from the lack of a direct demonstration of S-nitrosation of Ca2+ channels (it could well be that the observed Ca2+ levels are the result of modification of regulatory proteins upstream from the Ca2+ channels). No data are available on the structural and functional modification by either NO or other reactive species of Ca2+ channels other than L-type channels. An indirect mechanism of NO-dependent inhibition has been reported for N- and P/Q-types of Ca2+ channels in rat insulinoma and human neuroblastoma cells, likely mediated through sGC (Grassi et al., 1999; D’Ascenzo et al., 2002). Together, these data would suggest that L-type Ca2+ channels could be selectively targeted by reactive oxygen species and that their activity could be regulated through oxidation. In such case oxidative protein modification appears physiologically important instead of damaging. Interestingly, CA1 hippocampal neurons, which are specifically vulnerable to oxidative stress elicited by ischemiareperfusion, exhibited a selective downregulation of L-type calcium-channel activity after the ischemic insult, whereas non-vulnerable CA3 neurons did not (Li et al., 2007). This result could be interpreted such that physiologic oxidative regulation of a protein requires an environment, which tolerates periodic increased levels of ROS. This is the case for CA3 but not for CA1 neurons. Based on selective effects of hypoxia, thiol-reducing and alkylating reagents, and reactive oxygen and nitrogen species on L-type Ca2+ channels, a typespecific pore-forming α1 subunit of the channel was suggested as a target for oxidative modification and redox regulation implicated in aging and diseases (Annunziato et al., 2002; Waring, 2005; Zima and Blatter, 2006; Mattson, 2007; Hool, 2008). Here, Cys residues are the most probable oxidation sensitive sites on this protein subunit; for example, the human cardiac α1C subunit contains 43 Cys residues, and out of them, three are localized to the specific sequence 1786 RERHVPVCEDLELRRDSGSAGTQAHCLLLRRANPSRCHSR1825 , which is responsible for its sensitivity to hypoxia in cultured HEK cells (Fearon et al.,
6. Oxidative Modification of Ca2+ -Transporting Proteins
117
2000). Importantly, other Cys residues in the channel, e.g., those involved in the formation of inter-unit disulfide bridges may also contribute structurally to the overall calcium channel activity (Hool, 2008). In addition, the oxidation of Met residues may directly affect the structure of the Ca2+ channel, or indirectly affect the activity of the channel through modification of regulatory proteins, such as calmodulin (reviewed by Bigelow and Squier, 2005). A sequence-specific analysis of oxidative post-translational modifications in voltage-gated Ca2+ channels is still needed. However, one obstacle pertaining to the correlation of such modifications with structure is the lack of atomic resolution structural information about any Ca2+ channel; to date, most of our knowledge is based on the molecular structure and function of other voltage-gated channels, such as the potassium channel (Hool and Corry, 2007).
B. Ligand-gated Channels Three isoforms of the inositol triphosphate (IP3 ) receptor and the ryanodine receptor (RyR) represent the most common types of a ligand-gated calcium release channel. More recently, two additional members of this class of calcium-release channels have been described: (i) the inner nuclear membrane inositol tetrakisphosphate (IP4 ) receptor, which releases Ca2+ from the nuclear envelope lumen to the nucleoplasm (Mishra and Delivoria-Papadopoulos, 2002; Mishra et al., 2003), and (ii) the calcium release-activated current (CRAC) channel, which is located in the plasma membrane of non-excitable cells, such as T-lymphocytes, and which is dependent on extracellular calcium (Zweifach and Lewis, 1996; Zhang et al., 2005). Different types and isoforms of release channels for storeoperated calcium (SOC), which are activated at different calcium concentrations, are usually co-expressed and a combination of these receptors serves to maintain intracellular Ca2+ levels and regulate Ca2+ responses (Zheng et al., 2005; Hool and Corry, 2007). In addition to calcium, SOC release channels are sensitive to specific protein and low molecular weight ligands. Here, we shall briefly review data on the redox regulation of Ca2+ release channels. The RyR is probably one of the best characterized Ca2+ release channel with regard to redox regulation despite of its dimensions (a homotetrameric RyR contains over 20,000 amino acids with a total mass of ca. 2.3 MDa) and complete lack of atomic resolution structural information. Experimental evidence suggests that oxidative modifications of Cys are involved in the alteration of channel activity. Each monomer of RyR contains ca. 100 Cys residues, and approximately half of them are available for covalent modification (Dulhunty et al., 2000; Xia et al., 2004). The pharmacological effects of different classes of sulfhydryl-modifying reagents and oxidants demonstrate the existence of “hyperreactive” Cys residues on RyRs, which could play a role in the regulation of normal contractile function (for skeletal and cardiac muscle tissues) and rationalize alterations in excitation-contraction
118
V.S. Sharov and C. Schöneich
coupling during pathological conditions (Feng et al., 1999; Anzai et al., 2000; Goldhaber and Qayyum, 2000; Morad and Suzuki, 2000; Salama et al., 2000; Fabisiak et al., 2000; Pessah and Feng, 2000; Bidasee et al., 2003a, 2003b; Xia et al., 2000, 2004; Martinez-Burgos et al., 2006; Mochizuki et al., 2007; Cheong et al., 2005; Hidalgo, 2005). In fact, the term “redox sensor” has been applied to the RyR. This term has multiple meanings ranging from a simple correlation of a number of free Cys residues with Ca2+ permeability of the channel to a more specific susceptibility to reversible S-nitrosation, S-glutathiolation, and disulfide formation of selected Cys residues, that control channel activity depending on oxygen tension and/or overall cellular GSH/GSSG ratio (Xu et al., 1998; Eu et al., 1999; Meissner, 2004; Hidalgo and Donoso, 2008). Albeit physiological effects of thiol modifications may vary depending on cell and RyR type, and reagent concentrations, oxidizing conditions generally favor channel opening, whereas reducing conditions have the opposite effect. In addition to direct effects on the RyR properties, thiol modifications alter the channel response to other modifiers and physiological ligands, such as Ca2+ , Mg2+ , ATP, and cADP ribose, and several proteins, which modulate channel activity, such as protein kinases, CaM, junctophilin, and the immunophilin, FK506-binding protein (FKBP12), an essential component of RyR1 and RyR2 in muscle tissues (Zhang et al., 1999; Hamilton and Reid, 2000; Oba et al., 2002, 2008; Meissner, 2004; Aracena et al., 2005; Zissimopoulos and Lai, 2006; Camello-Almaraz et al., 2006; Bull et al., 2007; Phimister et al., 2007; Zissimopoulos et al., 2007). Again, potential oxidative modification of regulatory proteins, e.g., calmodulin, should be taken into consideration (Boschek et al., 2008). An interesting hypothesis suggests that all non-thiol channel modulators may affect RyR through a single mechanism, changing the reduction potential of the channel according to their electron donor/acceptor characteristics (Marinov et al., 2007). The identification of Cys residues responsible for the redox regulation of RyR was an open question until the recent development of sequence-specific mass spectrometry techniques. Based on limited proteolysis of skeletal muscle RyR1 and N-terminal amino acid sequencing, together with the analysis of the distribution of [3 H]NEM labeling, it was initially demonstrated that Cys3635 is rapidly labeled by NEM and that this labeling is blocked by association with calmodulin (Moore et al., 1999). The authors suggested that Cys3635 is located at an intersubunit contact site that is close to or within a calmodulin binding site. By means of cleavable isotopecoded affinity tag (ICAT) labeling of Cys residues, coupled to MALDI-TOF peptide fingerprinting, an additional 8 Cys sites were identified, which are endogenously modified in RyR1 (i.e., Cys at positions 36, 315, 811, 906, 1591, 2326, 2363, 3193, and 3635) and another three Cys residues, which could be modified only exogenously with redox-active reagents (Cys253, Cys1040, and Cys1303) (Aracena-Parks et al., 2006). Recently, combining fluorescent derivatization of Cys residues for quantitative analysis with tandem MS analysis of tryptic digests, two research groups successfully identified functionally important Cys residues
6. Oxidative Modification of Ca2+ -Transporting Proteins
119
(“hyperreactive cysteines”) that can be labeled by thiol-reactive probes under physiological conditions. Seven of them were identified as 7-diethylamino-3(4 -maleimidylphenyl)-4-methylcoumarin adducts (Cys1040, Cys1303, Cys2436, Cys2565, Cys2606, Cys2611, and Cys3635) after in-gel tryptic digestion and reversed-phase HPLC of the resulting peptides followed by MALDI-TOF/TOF and ESI-MS/MS analysis (Voss et al., 2004). The application of another Cys label, monobromobimane, coupled to MALDI-TOF and MALDI-TOF/TOF mass spectrometry analysis yielded only one redox-sensitive Cys residue, Cys2327 (Petrotchenko et al., 2006). These experimental differences may be the results of different analytical procedures and mass spectrometry equipment used in the latter studies. To date, the lack of 3-D atomic resolution structures of RyR does not permit any structure-function relationship analysis of the sequence-specific modification of redox-sensitive Cys residues. IV. SERCA The sarco/endoplasmic reticulum Ca-ATPase (SERCA) constitutes an essential Ca2+ -pump responsible for maintaining and/or restoring cytosolic Ca2+ levels during various physiological processes such as, e.g., muscle relaxation, signal transduction, and neuronal activity. SERCA is responsible for the transport of Ca2+ into the endoplasmic or sarcoplasmic reticulum (ER/SR) thereby maintaining high Ca2+ concentrations in the intracellular store, which is used for triggering muscle contraction, cell signaling and apoptosis (MacLennan et al., 1997; East, 2000; Dremina et al., 2004, 2006). The nomenclature of SERCA is based on three genes (SERCA1, SERCA2, SERCA3) and different isoforms, which are expressed in tissue-specific and developmentally regulated patterns (Bobe et al., 2004; Dode et al., 2002). The fast-twitch muscle isoform SERCA1 is restricted to fast-twitch skeletal muscle, while SERCA2a is expressed in cardiac and slow-twitch skeletal muscle. The isoforms SERCA2b and SERCA3a-3f are expressed ubiquitously in muscle and non-muscle cells. A special isoform of SERCA2, the secretory pathway Ca2+ /Mn2+ -ATPase 2 (SPCA) is a Golgilocalized pump with high affinity for Ca2+ ions presented in various types of secretory cells (Vanoevelen et al., 2005). Importantly, a reduced activity or expression of SERCA appears to correlate with various pathologies, including genetic diseases and cancer (MacLennan et al., 1997; Prasad et al., 2004). SERCA activity is modulated through specific post-translational modifications, such as oxidation and/or S-glutathiolation (Viner et al., 1999b, 2000; Adachi et al., 2004). SERCA isoforms differ in their sensitivity to oxidative modifications in vivo and in vitro. Earlier, we had demonstrated that biological aging leads to the accumulation of significant levels of 3-nitrotyrosine (3-NT) on the SERCA2a isoform, i.e., ca. 4 mol 3-NT/mol SERCA2a in skeletal muscle (Viner et al., 1996, 1999a), and ca. 3 mol 3-NT/mol SERCA2a in the heart (Knyushko et al., 2005). Such high yields of 3-NT on SERCA2a may not come as a surprise considering the
120
V.S. Sharov and C. Schöneich
close location of SERCA and nitric oxide synthase (nNOS) (Kobzik et al., 1994; Xu et al., 1999). What is surprising, though, is the apparent selectivity of nitration for SERCA2a even in fast-twitch skeletal muscle, which contains large quantities of the SERCA1 isoform that is ca. 84% homologous to SERCA2a. Mass spectrometry analysis revealed that in vivo aging leads to nitration of predominantly Tyr residues at positions 294 and 295 in rat skeletal muscle SERCA2a (Viner et al., 1999a). This sequence-specific information was utilized to generate sequence-specific antibodies against SERCA2a containing 3-NT at positions 294 and 295, which were then successfully applied for immunohistochemistry of SERCA2 nitration (Xu et al., 2006). Similar observations of a higher sensitivity of SERCA2 to modification by peroxynitrite in vitro (Grover et al., 2003; Kaplan et al., 2003) and in vivo (Li et al., 2006; Fugere et al., 2006) compared to other isoforms have been reported. SERCA2 activity is regulated in part through the NO-dependent reversible S-glutathiolation of Cys residues at positions 669 and/or 674 (Adachi et al., 2004). These sites were identified through a proteomic method, where cells were incubated with biotinylated glutathione prior to affinity enrichment of S-glutathiolated peptides. The redox state of specific SERCA Cys residues is important for enzymatic function, and modifications of different SERCA Cys residues may result in both inhibition and activation of the protein (Viner et al., 1999b, 2000; Adachi et al., 2004; Li and Camacho, 2004). Earlier studies on the role of Cys modifications in the regulation of SERCA activity were based on either selective labeling or site-directed mutagenesis of Cys residues that resulted in a significant change of protein activity. Though these approaches specifically addressed modifications of selected Cys residues, they are less relevant to oxidative modifications of SERCA in vivo. Besides, the oxidative modification of amino acids can lead to a variety of oxidation products, which may differentially affect protein structure and function. Proteolytic mapping of SERCA and HPLC-MS analysis detected several specific Cys-containing peptides with a mass increase fitting to Cys oxidation, Cys S-nitrosation and S-glutathiolation, and quantified the loss of some Cys residues upon oxidation in vitro using reactive thiol labeling (Viner et al., 2000; Adachi et al., 2004). However, all previous studies suffered from both incomplete Cys labeling in SERCA and the use of peptide masses only (MS1 mode) for the identification of labeled peptides. Moreover, these earlier studies did not use modification-resistant peptides as internal standards for digestion yields of Cys-containing peptides. Recently, we addressed these problems when labeling of SERCA1 within the sarcoplasmic reticulum (SR) preparation with ThioGlo1 (TG1=methyl-10-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-9-methoxy3-oxo-3H-benzo[f]chromene-2-carboxylate) in 2% SDS resulted in a virtually complete derivatization of reduced Cys residues of SERCA1 (Sharov et al., 2006). In-gel processing (reduction, alkylation and digestion) of the protein allowed the recovery of most Cys-containing peptides, and of additional peptides, which were used to normalize the yields of the labeled peptides by quantitative HPLC-ESI-
6. Oxidative Modification of Ca2+ -Transporting Proteins
121
TABLE 1 Content of ThioGlo1-labeled Cys residues in SERCA1 after the exposure of rat skeletal muscle sarcoplasmic reticulum (SR) to different concentrations of peroxynitrite or tryptophan peroxide in vitro, and in the SR isolated from 34-months-old rats relative to control, untreated 6 months old animals. Total loss of Cys residues per SERCA monomer is calculated as sum of losses of individual Cys residues (Sharov et al., 2006; Dremina et al., 2007) Cys sequence position 525 561 636 471 674,675 498 614 364 12 377 268 417,420 938 774 Total loss
TG1-labeled Cys content in SERCA1 (ratio to control) Peroxynitrite (mM) 0.3
1
3
0.1
DL-Trp peroxide (mM) 0.2
Aging (34 months)
0.66 ± 0.13∗ – – – – – – – – – – – – – 0.34
0.74 ± 0.07∗ – – – – 0.77 ± 0.08∗ – 0.65 ± 0.03∗ – – – 0.55 ± 0.05∗∗ – – 1.29
0.69 ± 0.07∗ – – – 0.63 ± 0.05∗ 0.56 ± 0.04∗ – 0.41 ± 0.07∗∗ – – – 0.49 ± 0.01∗∗ 0.35 ± 0.10∗∗ – 2.87
– – – – 0.92 ± 0.05∗ – – – 0.81 ± 0.15∗ – 0.89 ± 0.10∗ 0.83 ± 0.10∗ 0.66 ± 0.29∗ 0.33 ± 0.14∗∗ 1.56
– – – – 0.73 ± 0.11∗∗ – – – 0.66 ± 0.12∗∗ 0.64 ± 0.14∗∗ 0.60 ± 0.21∗∗ 0.67 ± 0.14∗∗ 0.39 ± 0.15∗∗ 0.29 ± 0.15∗∗ 3.02
0.73 ± 0.12∗ 0.55 ± 0.16∗∗ 0.65 ± 0.10∗∗ 0.60 ± 0.20∗∗ 0.69 ± 0.27∗ 0.54 ± 0.07∗∗ – 0.61 ± 0.11∗∗ – – 0.63 ± 0.21∗∗ 0.70 ± 0.22∗ 3.30
∗ Statistically significant results with P > 0.90. ∗∗ Statistically significant results with P > 0.95.
tandem MS. The quantitative analysis of the TG1-labeled sequences provides a differential display of 16 out of 20 reduced Cys residues in SERCA1 available for oxidative modification. Importantly, quantification of total Cys losses by HPLC-MS analysis of SERCA1 digests is in agreement with the data obtained by fluorescence spectroscopy of the intact TG1-labeled protein, validating the approach and permitting the analysis of a role of specific Cys residues in the control of SERCA activity. In vitro, the incubation of SR with different oxidants led to the inactivation of the ATPase function with concomitant loss of TG1-reactive Cys residues. Peroxynitrite, a biologically relevant oxidant, targeted specific SERCA Cys residues at position 364, 417, 420, 498, 525, 674, 675, and 938 (Table 1). A comparative analysis shows that not all the oxidation-sensitive Cys residues are equally important for SERCA function. Peroxynitrite concentration-dependent loss of individual Cys residues coincided with the loss of SERCA activity only for the residues at positions 674/675 and 938 (Sharov et al., 2006). No other Cys residue shows the characteristic lag phase correlating with protein inactivation. It is likely that some of the earlier targeted Cys residues, i.e., at positions 525, 498,
122
V.S. Sharov and C. Schöneich
417, 420, and 364 actually protect functionally important Cys residues from oxidation and could be considered intramolecular antioxidants similar to the function ascribed to protein methionine residues (Levine et al., 1996). Based on peroxynitrite data, we cannot state whether the oxidation of individual Cys674, Cys675 or Cys938 residues alone serve as a “redox switch” for SERCA1 activity, or the loss of the protein activity is due to a combination of multiple Cys oxidation events and/or additional modifications such as Met oxidation and Tyr nitration (Alvarez and Radi, 2003). Considering the importance of selected Cys residues for the NO-dependent activation of SERCA, the sensitivity of SERCA against amino acid peroxides was investigated (Dremina et al., 2007). Such amino acid peroxides form under conditions of oxidative stress and are ca. 100-fold more reactive towards SERCA compared to hydrogen peroxide. Out of 16 SERCA1 Cys residues quantifiable through TG1-labeling, 9 are reactive towards peroxides derived from Trp (Table 1). Among those Cys residues, Cys774 and Cys938 were most reactive, both located in the transmembrane domain of SERCA. A lower reactivity was observed for Cys residues present at positions 12, 268, 377, 417, 420, 674, and 675. The rather high reactivity of the Trp-derived peroxides towards Cys residues located in the transmembrane domain (Cys268, Cys774 and Cys938) is remarkable. The crystal structures of SERCA1 in the absence and presence of Ca2+ (Toyoshima et al., 2000; Toyoshima and Nomura, 2002) show that Cys938 is more exposed on the surface of the protein compared to Cys774 and Cys268, which rather point towards the interior of the transmembrane domain (Figure 1). Hence, the observed reactivity of Trp-derived peroxides with Cys residues of the transmembrane domain is not consistent with their surface exposure. On the other hand, specifically the more buried Cys residues may participate in hydrogen bonding, resulting in partial negatively charged sulfur, which should be easier to oxidize. Interestingly, Cys938, but not Cys774, represents also a target for the water-soluble anion peroxynitrite (Table 1). With such a manifold of targets it is difficult to correlate the oxidation of one specific Cys residue with SERCA inactivation: it is likely, that oxidation of each of the individual Cys residues is associated with a degree of inactivation, and that the measured SERCA inactivation represents the sum of all the partial inactivations caused by the oxidation of individual Cys residues. In addition, at least 4 Cys residues could not be quantified by TG1-labeling and oxidation of the latter may contribute to the overall SERCA inactivation (Li and Camacho, 2004). Biological aging leads to a ca. 40% loss of SERCA1 activity in rat skeletal muscle in vivo (Sharov et al., 2006), and a molecular rationale for this phenomenon could be the age-dependent oxidation of specific Cys residues by peroxynitrite, amino acid peroxides, and/or other endogenous oxidants. Interestingly, the affected residues in vivo do not completely match those targeted by peroxynitrite and Trp peroxide in vitro (Table 1 and Figure 1). Both peroxynitrite in vitro and aging in vivo target Cys residues at positions 498, 525, 674/675 and 938, whereas
6. Oxidative Modification of Ca2+ -Transporting Proteins
123
FIGURE 1 Crystal structure of SERCA1 (PDB: 1su4) showing the location of Cys residues sensitive to oxidation by Trp peroxide and peroxynitrite in vitro and to in vivo aging in rat skeletal muscle SR. Cys residues are represented in the spacefill view using elemental (CPK) color palette, Ca2+ ions attached to the high-affinity binding sites in the transmembrane calcium translocation channel are shown as blue balls, and the phosphorylated aspartic acid residue (Asp351∼P) in the active site is shown as a spacefill residue in magenta. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this book.)
Trp peroxide in vitro and aging in vivo target Cys at positions 377, 674/675, 774, and 938. Hence, if we suggest an existence of specific Cys residue(s), which is(are) required in a reduced state for an active conformation and unrestricted
124
V.S. Sharov and C. Schöneich
ATPase activity of SERCA1, Cys residues at positions 674/675 and 938 represent the most probable candidates. Aging additionally affects Cys at positions 561 and 614, while Trp peroxide additionally targets Cys12, Cys268, Cys344 and Cys349, and peroxynitrite additionally targets Cys364. The Cys oxidation pattern observed as a result of aging likely reflects the occurrence and reaction of additional oxidants in vivo, which target, for example, Cys561 and Cys614. Also, the conformation of SERCA in vitro may not be completely identical with that in vivo, a feature, which may lead to some differential reaction kinetics of Cys residues. Moreover, not only the loss of a specific Cys residue, but also the nature of its specific Cys oxidation product will determine its ultimate effect on protein function. At present, we cannot definitely conclude, which Cys residue is more important for the loss of SERCA1 ATPase activity observed in aging rat skeletal muscle. A notable observation is the oxidative modification of Cys674/675 by different oxidants in vitro and in vivo, given that in smooth muscle SERCA2 (which shares more than 80% homology with SERCA1) Cys674 is reversibly modified through S-glutathiolation induced by NO, resulting in SERCA activation, whereas removal of this Cys residue results in a loss of NO-dependent activation (Adachi et al., 2004). Ligand binding studies do not show significant changes in either the Ca2+ or ATP affinity of SERCA1 in aging SR, suggesting that the effect of Cys oxidation on Ca2+ -ATPase function may not be due to modification of specific ligand binding sites on the protein but, rather, through more general effects on protein structure, potentially uncoupling ATP hydrolysis from Ca2+ translocation. In contrast, the inactivation of SERCA by peroxynitrite in vitro is accompanied by a decrease in Ca2+ affinity (Sharov et al., 2006). These data, again, demonstrate that SERCA Cys modification in vitro does not completely simulate the age-dependent modification.
V. PMCA Since observations of an age-associated decrease in PMCA activity in the rat brain (Qin et al., 1998; Zaidi et al., 1998), attempts have been made to link the elevated Ca2+ levels in aging neurons with oxidative modifications of the plasma membrane Ca2+ -ATPase. The sensitivity of PMCA to oxidation in vitro was tested in synaptic plasma membranes exposed to azo-initiators, hydrogen peroxide, and peroxynitrite. All these reactive species markedly changed the kinetic parameters of PMCA enzymatic activity and caused aggregation of the protein in a concentration-dependent manner, suggesting that this protein may represent a target to oxidative stress in aging brain (Zaidi and Michaelis, 1999). Analysis of oxidative post-translational modifications in purified PMCA exposed to hydrogen peroxide, which caused a ca. 50% inactivation of the enzyme and significant structural alterations (partially reversible by DTT), did not reveal significant changes
6. Oxidative Modification of Ca2+ -Transporting Proteins
125
in amino acid composition, except for a loss of ca. 2.5 mol Cys/mol protein (Zaidi et al., 2003). In addition, a protective effect of calmodulin bound to PMCA before the exposure to oxidants was documented. The latter effect can be attributed to either a structural change in PMCA upon calmodulin binding that renders PMCA less oxidation-sensitive (Lushington et al., 2005), or an “antioxidant” effect of calmodulin, which contains highly oxidizible Met residues, particularly the C-terminal Met144 and Met145 (reviewed by Bigelow and Squier, 2005). Conformations of a PMCA-calmodulin complex were probed by single-molecule polarization modulation spectrometry and it was found that oxidative modification of either PMCA or CaM in the complex results in an increased coupling of an autoinhibitory/CaM binding domain to the ATP-binding core of PMCA, thereby stabilizing the enzyme in an inactive conformation (Osborn et al., 2004, 2005). Specific Cys targets for PMCA oxidative modifications are still to be identified.
VI. CONCLUDING REMARKS The high sensitivity of some Ca2+ handling proteins, such as the L-type voltage-gated channel, the ryanodine receptor, and SERCA renders them important targets for oxidative regulation/modulation endowing a crosstalk between redox signaling and calcium transients in the cell. With the development of sensitive mass spectrometry and proteomic methodologies, there is no doubt that specific sequences targeted by oxidation in vivo may soon be identified. Acknowledgements This work was supported by the NIH (AG12993, HL31607).
References Adachi, T., Weisbrod, R.M., Pimentel, D.R., Ying, J., Sharov, V.S., Schöneich, C., Cohen, R.A. (2004). S-glutathiolation by peroxynitrite activates SERCA during arterial relaxation by nitric oxide. Nat. Med. 10, 1200–1207. Akaishi, T., Nakazawa, K., Sato, K., Saito, H., Ohno, Y., Ito, Y. (2004a). Modulation of voltage-gated Ca2+ current by 4-hydroxynonenal in dentate granule cells. Biol. Pharm. Bull. 27, 174–179. Akaishi, T., Nakazawa, K., Sato, K., Saito, H., Ohno, Y., Ito, Y. (2004b). Hydrogen peroxide modulates whole cell Ca2+ currents through L-type channels in cultured rat dentate granule cells. Neurosci. Lett. 356, 25–28. Almanza, A., Navarrete, F., Vega, R., Soto, E. (2007). Modulation of voltage-gated Ca2+ current in vestibular hair cells by nitric oxide. J. Neurophysiol. 97, 1188–1195. Alvarez, B., Radi, R. (2003). Peroxynitrite reactivity with amino acids and proteins. Amino Acids 25, 295–311. Annunziato, L., Pannaccione, A., Cataldi, M., Secondo, A., Castaldo, P., Di Renzo, G., Taglialatela, M. (2002). Modulation of ion channels by reactive oxygen and nitrogen species: A pathophysiological role in brain aging? Neurobiol. Aging 23 (5), 819–834. Anzai, K., Ogawa, K., Ozawa, T., Yamamoto, H. (2000). Oxidative modification of ion channel activity of ryanodine receptor. Antioxid. Redox. Signal. 2, 35–40.
126
V.S. Sharov and C. Schöneich
Aracena, P., Tang, W., Hamilton, S.L., Hidalgo, C. (2005). Effects of S-glutathionylation and Snitrosylation on calmodulin binding to triads and FKBP12 binding to type 1 calcium release channels. Antiox. Redox Signal. 7, 870–881. Aracena-Parks, P., Goonasekera, S.A., Gilman, C.P., Dirksen, R.T., Hidalgo, C., Hamilton, S.L. (2006). Identification of cysteines involved in S-nitrosylation, S-glutathionylation, and oxidation to disulfides in ryanodine receptor type 1. J. Biol. Chem. 281, 40354–40368. Beccafico, S., Puglielli, C., Pietrangelo, T., Bellomo, R., Fano, O.G., Fulle, S. (2007). Age-dependent effects on functional aspects in human satellite cells. Ann. NY Acad. Sci. 1100, 345–352. Bidasee, K.R., Nallani, K., Besch Jr., H.R., Dincer, U.D. (2003a). Streptozotocin-induced diabetes increases disulfide bond formation on cardiac ryanodine receptor (RyR2). J. Pharmacol. Exp. Ther. 305, 989–998. Bidasee, K.R., Nallani, K., Yu, Y., Cocklin, R.R., Zhang, Y., Wang, M., Dincer, U.D., Besch Jr., H.R. (2003b). Chronic diabetes increases advanced glycation end products on cardiac ryanodine receptors/calcium-release channels. Diabetes 52, 1825–1836. Boschek, C.B., Jones, T.E., Smallwood, H.S., Squier, T.C., Bigelow, D.J. (2008). Loss of the calmodulin-dependent inhibition of the RyR1 calcium release channel upon oxidation of methionines in calmodulin. Biochemistry 47, 131–142. Bigelow, D.J., Squier, T.C. (2005). Redox modulation of cellular signaling and metabolism through reversible oxidation of methionine sensors in calcium regulatory proteins. Biochim. Biophys. Acta 1703, 121–134. Bobe, R., Bredoux, R., Corvazier, E., Andersen, J.P., Clausen, J.D., Dode, L., Kovacs, T., Enouf, J. (2004). Identification, expression, function, and localization of a novel (sixth) isoform of the human sarco/endoplasmic reticulum Ca2+ ATPase 3 gene. J. Biol. Chem. 279, 24297–24306. Bull, R., Finkelstein, J.P., Humeres, A., Behrens, M., Hidalgo, C. (2007). Effects of ATP, Mg2+ , and redox agents on the Ca2+ dependence of RyR channels from rat brain cortex. Am. J. Physiol. Cell Physiol. 293, C162–C171. Camello-Almaraz, C., Gomez-Pinilla, P.J., Pozo, M.J., Camello, P.J. (2006). Mitochondrial reactive oxygen species and Ca2+ signaling. Am. J. Physiol. Cell Physiol. 291, C1082–C1088. Catterall, W.A., Perez-Reyes, E., Snutch, T.P., Striessnig, J. (2005). International Union of Pharmacology. XlVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels. Pharmacol. Rev. 57, 411–425. Cheong, E., Tumbev, V., Abramson, J., Salama, G.S., Stoyanovsky, D.A. (2005). Nitroxyl triggers Ca2+ release from skeletal and cardiac sarcoplasmic reticulum by oxidizing ryanodine receptors. Cell Calcium 37, 87–96. D’Ascenzo, M., Martinotti, G., Azzena, G.B., Grassi, C. (2002). cGMP/protein kinase G-dependent inhibition of N-type Ca2+ channels induced by nitric oxide in human neuroblastoma imr32 cells. J. Neurosci. 22, 7485–7492. Davidson, S.M., Duchen, M.R. (2006). Calcium microdomains and oxidative stress. Cell Calcium 40 (5–6), 561–574. Dode, L., Vilsen, B., Van Baelen, K., Wuytack, F., Clausen, J.D., Andersen, J.P. (2002). Dissection of the functional differences between sarco(endo)plasmic reticulum Ca2+ -ATPase (SERCA) 1 and 3 isoforms by steady-state and transient kinetic analyses. J. Biol. Chem. 277, 45579–45591. Dremina, E.S., Sharov, V.S., Kumar, K., Zaidi, A., Michaelis, E.K., Schöneich, C. (2004). Antiapoptotic protein Bcl-2 interacts with and destabilizes the sarcoplasmic/endoplasmic reticulum Ca2+ -ATPase (SERCA). Biochem. J. 383, 361–370. Dremina, E.S., Sharov, V.S., Schöneich, C. (2006). Displacement of SERCA from SR lipid caveolaerelated domains by Bcl-2: A possible mechanism for SERCA inactivation. Biochemistry 45, 175– 184. Dremina, E.S., Sharov, V.S., Davies, M.J., Schöneich, C. (2007). Oxidation and inactivation of SERCA by selective reaction of cysteine residues with amino acid peroxides. Chem. Res. Toxicol. 20, 1462–1469.
6. Oxidative Modification of Ca2+ -Transporting Proteins
127
Dulhunty, A., Haarmann, C., Green, D., Hart, J. (2000). How many cysteine residues regulate ryanodine receptor channel activity? Antioxid. Redox Signal. 2, 27–34. East, J.M. (2000). Sarco(endo)plasmic reticulum calcium pumps: Recent advances in our understanding of structure/function and biology (review). Mol. Memb. Biol. 17, 189–200. Eu, J.P., Xu, L., Stamler, J.S., Meissner, G. (1999). Regulation of ryanodine receptors by reactive nitrogen species. Biochem. Pharmacol. 57, 1079–1084. Fabisiak, J.P., Ritov, V.B., Kagan, V.E. (2000). Reversible thiol-dependent activation of ryanodinesensitive Ca2+ release channel by etoposide (VP-16) phenoxyl radical. Antioxid. Redox Signal. 2, 73–82 Fearon, I.M., Varadi, G., Koch, S., Isaacsohn, I., Ball, S.G., Peers, C. (2000). Splice variants reveal the region involved in oxygen sensing by recombinant human L-type Ca2+ channels. Circ. Res. 87 (7), 537–539. Feng, W., Liu, G., Xia, R., Abramson, J.J., Pessah, I.N. (1999). Site-selective modification of hyperreactive cysteines of ryanodine receptor complex by quinones. Mol. Pharmacol. 55, 821–831. Fugere, N.A., Ferrington, D.A., Thompson, L.V. (2006). Protein nitration with aging in the rat semimembranosus and soleus muscles. J. Gerontol. A Biol. Sci. Med. Sci. 61, 806–812. Goldhaber, J.I., Qayyum, M.S. (2000). Oxygen free radicals and excitation-contraction coupling. Antioxid. Redox Signal. 2, 55–64. Grassi, C., D’Ascenzo, M., Valente, A., Battista Azzena, G. (1999). Ca2+ channel inhibition induced by nitric oxide in rat insulinoma RINM5F cells. Pflügers Arch. 437, 241–247. Grover, A.K., Kwan, C.-Y., Samson, S.E. (2003). Effects of peroxynitrite on sarco/endoplasmic reticulum Ca2+ pump isoforms SERCA2b and SERCA3a. Am. J. Physiol. Cell Physiol. 285, C1537– C1543. Hamilton, S.L., Reid, M.B. (2000). RyR1 modulation by oxidation and calmodulin. Antioxid. Redox Signal. 2, 41–45. Hidalgo, C. (2005). Cross talk between Ca2+ and redox signaling cascades in muscle and neurons through the combined activation of ryanodine receptors/Ca2+ release channels. Philos. Trans. R. Soc. Lond. B Biol. Sci. 360, 2237–2246. Hidalgo, C., Donoso, P. (2008). Crosstalk between calcium and redox signaling: From molecular mechanisms to health implications. Antioxid. Redox. Signal. Mar 31; (Epub ahead of print). Hool, L.C., Corry, B. (2007). Redox control of calcium channels: From mechanisms to therapeutic opportunities. Antiox. Redox Signal. 9, 409–435. Hool, L.C. (2008). Evidence for the regulation of L-type Ca2+ channels in the heart by reactive oxygen species: Mechanism for mediating pathology. Clin. Exp. Pharmacol. Physiol. 35, 229–234. Jian, K., Chen, M., Cao, X., Zhu, X.-H., Fung, M.-L., Gao, T.-M. (2007). Nitric oxide modulation of voltage-gated calcium current by S-nitrosylation and cGMP pathway in cultured rat hippocampal neurons. Biochem. Biophys. Res. Commun. 359 (3), 481–485. Kaplan, P., Babusikova, E., Lehotsky, J., Dobrota, D. (2003). Free radical-induced protein modification and inhibition of Ca2+ -ATPase of cardiac sarcoplasmic reticulum. Mol. Cell. Biochem. 248, 41–47. Kirichok, Y., Krapivinsky, G., Clapham, D.E. (2004). The mitochondrial calcium uniporter is a highly selective ion channel. Nature 427, 360–364. Knyushko, T.V., Sharov, V.S., Williams, T.D., Schöneich, C., Bigelow, D.J. (2005). 3-nitrotyrosine modification of SERCA2a in the aging heart: A distinct signature of the cellular redox environment. Biochemistry 44, 13071–13081. Kobzik, L., Reid, M.B., Bredt, D.S., Stamler, J.S. (1994). Nitric oxide in skeletal muscle. Nature 372, 546–548. Levine, R.L., Mosoni, L., Berlett, B.S., Stadtman, E.R. (1996). Methionine residues as endogenous antioxidants in proteins. Proc. Natl. Acad. Sci. USA 93, 15036–15040. Li, Y., Camacho, P. (2004). Ca2+ -dependent redox modulation of SERCA2b by Erp57. J. Cell Biol. 164, 35–46.
128
V.S. Sharov and C. Schöneich
Li, S.Y., Yang, X., Ceylan-Isik, A., Du, M., Sreejayan, N., Ren, J. (2006). Cardiac contractile dysfunction in Lep/Lep obesity is accompanied by NADPH oxidase activation, oxidative modification of sarco(endo)plasmic reticulum Ca2+ -ATPase and myosin heavy chain isozyme switch. Diabetologia 49, 1434–1446. Li, X.-M., Yang, J.-M., Hu, D.-H., Hou, F.-Q., Zhao, M., Zhu, X.-H., Wang, Y., Li, J.-G., Hu, P., Chen, L., Qin, L.-N., Gao, T.-M. (2007). Contribution of downregulation of L-type calcium currents to delayed neuronal death in rat hippocampus after global cerebral ischemia and reperfusion. J. Neurosci. 27, 5249–5259. Lushington, G.H., Zaidi, A., Michaelis, M.L. (2005). Theoretically predicted structures of plasma membrane Ca2+ -ATPase and their susceptibilities to oxidation. J. Mol. Graph. Model. 24, 175– 185. MacLennan, D.H., Rice, W.J., Green, N.M. (1997). The mechanism of Ca2+ transport by sarco(endo)plasmic reticulum Ca2+ -ATPases. J. Biol. Chem. 272, 28815–28818. Marinov, B.S., Olojo, R.O., Xia, R., Abramson, J.J. (2007). Non-thiol reagents regulate ryanodine receptor function by redox interactions that modify reactive thiols. Antiox. Redox. Signal. 9, 609– 621. Martinez-Burgos, M.A., Granados, M.P., Gonzalez, A., Rosado, J.A., Yago, M.D., Salido, G.M., Martinez-Victoria, E., Manas, M., Pariente, J.A. (2006). Involvement of ryanodine-operated channels in tert-butylhydroperoxide-evoked Ca2+ mobilisation in pancreatic acinar cells. J. Exp. Biol. 209, 2156–2164. Mattson, M.P. (2007). Calcium and neurodegeneration. Aging Cell 6, 337–350. Meissner, G. (2004). Molecular regulation of cardiac ryanodine receptor ion channel. Cell. Calcium 35, 621–628. Mishra, O.P., Delivoria-Papadopoulos, M. (2002). Nitric oxide-mediated Ca++ -influx in neuronal nuclei and cortical synaptosomes of normoxic and hypoxic newborn piglets. Neurosci. Lett. 318, 93–97. Mishra, O.P., Qayyum, I., Delivoria-Papadopoulos, M. (2003). Hypoxia-induced modification of the inositol triphosphate receptor in neuronal nuclei of newborn piglets: Role of nitric oxide. J. Neurosci. Res. 74, 333–338. Mochizuki, M., Yano, M., Oda, T., Tateishi, H., Kobayashi, S., Yamamoto, T., Ikeda, Y., Ohkusa, T., Ikemoto, N., Matsuzaki, M. (2007). Scavenging free radicals by low-dose carvedilol prevents redox-dependent Ca2+ leak via stabilization of ryanodine receptor in heart failure. J. Am. Coll. Cardiol. 49, 1722–1732. Moore, C.P., Zhang, J.-Z., Hamilton, S.L. (1999). A role for cysteine 3635 of RyR1 in redox modulation and calmodulin binding. J. Biol. Chem. 274, 36831–36834. Morad, M., Suzuki, Y.J. (2000). Redox regulation of cardiac muscle calcium signaling. Antioxid. Redox Signal. 2, 65–71. Oba, T., Maeno, Y., Nagao, M., Sakuma, N., Murayama, T. (2008). Cellular redox state protects acetaldehyde-induced alteration in cardiomyocyte function by modifying Ca2+ release from sarcoplasmic reticulum. Am. J. Physiol. Heart Circ. Physiol. 294, H121–H133. Oba, T., Murayama, T., Ogawa, Y. (2002). Redox states of type 1 ryanodine receptor alter Ca2+ release channel response to modulators. Am. J. Physiol. Cell Physiol. 282, C684–C692. Osborn, K.D., Bartlett, R.K., Mandal, A., Zaidi, A., Urbauer, R.J.B., Urbauer, J.L., Galeva, N., Williams, T.D., Johnson, C.K. (2004). Single-molecule dynamics reveal an altered conformation for the autoinhibitory domain of plasma membrane Ca2+ -ATPase bound to oxidatively modified calmodulin. Biochemistry 43, 12937–12944. Osborn, K.D., Zaidi, A., Urbauer, R.J.B., Michaelis, M.L., Johnson, C.K. (2005). Single-molecule characterization of the dynamics of calmodulin bound to oxidatively modified plasma-membrane Ca2+ -ATPase. Biochemistry 44, 11074–11081. Pessah, I.N., Feng, W. (2000). Functional role of hyperreactive sulfhydryl moieties within the ryanodine receptor complex. Antioxid. Redox Signal. 2, 17–25.
6. Oxidative Modification of Ca2+ -Transporting Proteins
129
Petrotchenko, E.V., Pasek, D., Elms, P., Dokholyan, N.V., Meissner, G., Borchers, C.H. (2006). Combining fluorescence detection and mass spectrometric analysis for comprehensive and quantitative analysis of redox-sensitive cysteines in native membrane proteins. Anal. Chem. 78, 7959–7966. Phimister, A.J., Lango, J., Lee, E.H., Ernst-Russell, M.A., Takeshima, H., Ma, J., Allen, P.D., Pessah, I.N. (2007). Conformation-dependent stability of junctophilin 1 (jp1) and ryanodine receptor type 1 (RyR1) channel complex is mediated by their hyper-reactive thiols. J. Biol. Chem. 282, 8667– 8677. Prasad, V., Okunade, G.W., Miller, M.L., Shull, G.E. (2004). Phenotypes of SERCA and PMCA knockout mice. Biochem. Biophys. Res. Commun. 322, 1192–1203. Qin, Z., Zaidi, A., Gao, J., Krainev, A.G., Michaelis, M.L., Squier, T.C., Bigelow, D.J. (1998). Decrease in Ca2+ -ATPase activity in aged synaptosomal membranes is not associated with changes in fatty acyl chain dynamics. Mech. Ageing Dev. 105, 291–300. Salama, G., Menshikova, E.V., Abramson, J.J. (2000). Molecular interaction between nitric oxide and ryanodine receptors of skeletal and cardiac sarcoplasmic reticulum. Antioxid. Redox Signal. 2, 5–16. Sharov, V.S., Dremina, E.S., Galeva, N.A., Williams, T.D., Schöneich, C. (2006). Quantitative mapping of oxidation-sensitive cysteine residues in SERCA in vivo and in vitro by HPLCElectrospray-Tandem MS: Selective protein oxidation during biological aging. Biochem. J. 394, 605–615. Stark, G. (2005). Functional consequences of oxidative membrane damage. J. Membr. Biol. 205, 1–16. Summers, B.A., Overholt, J.L., Prabhakar, N.R. (1999). Nitric oxide inhibits L-type Ca2+ current in glomus cells of the rabbit carotid body via a cGMP-independent mechanism. J. Neurophysiol. 81, 1449–1457. Tjong, Y.-W., Jian, K., Li, M., Chen, M., Gao, T.-M., Fung, M.-L. (2007). Elevated endogenous nitric oxide increases Ca2+ flux via L-type Ca2+ channels by S-nitrosylation in rat hippocampal neurons during severe hypoxia and in vitro ischemia. Free Radic. Biol. Med. 42, 52–63. Toyoshima, C., Nakasako, M., Nomura, H., Ogawa, H. (2000). Crystal structure of the calcium pump of sarcoplasmic reticulum at 2.6 Å resolution. Nature 405, 647–655. Toyoshima, C., Nomura, H. (2002). Structural changes in the calcium pump accompanying the dissociation of calcium. Nature 418, 605–611. Vanoevelen, J., Dode, L., Van Baelen, K., Fairclough, R.J., Missiaen, L., Raeymaekers, L., Wuytack, F. (2005). The secretory pathway Ca2+ /Mn2+ -ATPase 2 is a Golgi-localized pump with high affinity for Ca2+ ions. J. Biol. Chem. 280, 22800–22808. Viner, R.I., Ferrington, D.A., Hühmer, A.F., Bigelow, D.J., Schöneich, C. (1996). Accumulation of nitrotyrosine on the SERCA2a isoform of SR Ca-ATPase of rat skeletal muscle during aging: A peroxynitrite-mediated process? FEBS Lett. 379, 286–290. Viner, R.I., Ferrington, D.A., Williams, T.D., Bigelow, D.J., Schöneich, C. (1999a). Protein modification during biological aging: Selective tyrosine nitration of the SERCA2a isoform of the sarcoplasmic reticulum Ca2+ -ATPase in skeletal muscle. Biochem. J. 340, 657–669. Viner, R.I., Williams, T.D., Schöneich, C. (1999b). Peroxynitrite modification of protein thiols: Oxidation, nitrosylation, and S-glutathiolation of functionally important cysteine residue(s) in the sarcoplasmic reticulum Ca2+ -ATPase. Biochemistry 38, 12408–12415. Viner, R.I., Williams, T.D., Schöneich, C. (2000). Nitric oxide-dependent modification of the sarcoplasmic reticulum Ca2+ -ATPase: Localization of cysteine target sites. Free Radic. Biol. Med. 29, 489–496. Voss, A.A., Lango, J., Ernst-Russell, M., Morin, D., Pessah, I.N. (2004). Identification of hyperreactive cysteines within ryanodine receptor type 1 by mass spectrometry. J. Biol. Chem. 279, 34514– 34520. Waring, P. (2005). Redox active calcium ion channels and cell death. Arch. Biochem. Biophys. 434, 33–42.
130
V.S. Sharov and C. Schöneich
Xia, R., Stangler, T., Abramson, J.J. (2000). Skeletal muscle ryanodine receptor is a redox sensor with a well defined redox potential that is sensitive to channel modulators. J. Biol. Chem. 275, 36556–36561. Xia, R., Ganther, H.E., Egge, A., Abramson, J.J. (2004). Selenium compounds modulate the calcium release channel/ryanodine receptor of rabbit skeletal muscle by oxidizing functional thiols. Biochem. Pharmacol. 67, 2071–2079. Xu, L., Eu, J.P., Meissner, G., Stamler, J.S. (1998). Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation. Science 279, 234–237. Xu, K.Y., Huso, D.L., Dawson, T.M., Bredt, D.S., Becker, L.C. (1999). Nitric oxide synthase in cardiac sarcoplasmic reticulum. Proc. Natl. Acad. Sci. USA 96, 657–662. Xu, S., Ying, J., Jiang, B., Guo, W., Sharov, V., Lazar, H., Menzoian, J., Bigelow, D., Schöneich, C., Cohen, R. (2006). Detection of sequence-specific tyrosine nitration of manganese SOD and SERCA in cardiovascular disease and aging. Am. J. Physiol. Heart Circ. Physiol. 290, H2220– H2227. Zaidi, A., Gao, J., Squier, T.C., Michaelis, M.L. (1998). Age-related decrease in brain synaptic membrane Ca2+ -ATPase in F344/BN F1 rats. Neurobiol. Aging 19, 487–495. Zaidi, A., Michaelis, M.L. (1999). Effects of reactive oxygen species on brain synaptic plasma membrane Ca2+ -ATPase. Free Radic. Biol. Med. 27, 810–821. Zaidi, A., Barron, L., Sharov, V.S., Schöneich, C., Michaelis, E.K., Michaelis, M.L. (2003). Oxidative inactivation of purified plasma membrane Ca2+ -ATPase by hydrogen peroxide and protection by calmodulin. Biochemistry 42, 12001–12010. Zhang, J.-Z., Wu, Y., Williams, B.Y., Rodney, G., Mandel, F., Strasburg, G.M., Hamilton, S.L. (1999). Oxidation of the skeletal muscle Ca2+ release channel alters calmodulin binding. Am. J. Physiol. Cell Physiol. 276, C46–C53. Zhang, S.L., Yu, Y., Roos, J., Kozak, J.A., Deerinck, T.J., Ellisman, M.H., Stauderman, K.A., Cahalan, M.D. (2005). STIM1 is a Ca2+ sensor that activates CRAC channels and migrates from the Ca2+ store to the plasma membrane. Nature 437, 902–905. Zheng, Y.-M., Wang, Q.-S., Rathore, R., Zhang, W.-H., Mazurkiewicz, J.E., Sorrentino, V., Singer, H.A., Kotlikoff, M.I., Wang, Y.-X. (2005). Type-3 ryanodine receptors mediate hypoxia-, but not neurotransmitter-induced calcium release and contraction in pulmonary artery smooth muscle cells. J. Gen. Physiol. 125, 427–440. Zima, A.V., Blatter, L.A. (2006). Redox regulation of cardiac calcium channels and transporters. Cardiovasc. Res. 71, 310–321. Zissimopoulos, S., Lai, F.A. (2006). Redox regulation of the ryanodine receptor/calcium release channel. Biochem. Soc. Trans. 34, 919–921. Zissimopoulos, S., Docrat, N., Lai, F.A. (2007). Redox sensitivity of the ryanodine receptor interaction with FK506-binding protein. J. Biol. Chem. 282, 6976–6983. Zweifach, A., Lewis, R.S. (1996). Calcium-dependent potentiation of store-operated calcium channels in T lymphocytes. J. Gen. Physiol. 107 (5), 597–610.
CHAPTER 7 Regulation of Na,K-ATPase by Reactive Oxygen Species Guofei Zhou, Laura A. Dada and Jacob I. Sznajder Division of Pulmonary and Critical Care Medicine, Feinberg School of Medicine, Northwestern University, 240 E. Huron, McGaw Pavilion M-326, Chicago, IL 60611, USA
I. Na,K-ATPase II. Na,K-ATPase in Alveolar Fluid Reabsorption III. Role of Reactive Oxygen Species in Signaling A. Mitochondrial ROS B. NADPH Oxidase ROS Production C. ROS as Signaling Molecules IV. Regulation of Na,K-ATPase and Alveolar Fluid Reabsorption by ROS A. Hypoxia B. Hyperoxia C. Other Stimuli V. Dopamine and β-adrenergic Agonists Improve ROS-Mediated Decrease in Alveolar Fluid Reabsorption VI. Summary References
Abstract Pulmonary edema occurs in patients with acute respiratory distress syndrome (ARDS) and congestive heart failure. Effective edema clearance is critical for these patients to survive. The edema clearance is carried out mostly by the coordination of the apical Na+ channels and the basolateral Na,K-ATPase effecting active Na+ transport. Downregulation of Na+ transport occurs frequently in ARDS patients and results in impaired edema clearance. Hypoxia, hyperoxia, particulate matter and thrombin inhibit edema clearance. Reactive oxygen species (ROS) generated from the electron transport chain in the mitochondria and/or NADPH oxidase appears to be critical for the impaired edema clearance under these stress conditions. During hypoxia, ROS activate PKCζ , which in turn phosphorylates Na,K-ATPase α1 subunit at Ser-18, leading to the endocytosis of Na,K-ATPase from the plasma membrane. The endocytosis of Na,K-ATPase results in decreased Current Topics in Membranes, Volume 61 Copyright © 2008, Elsevier Inc. All rights reserved
1063-5823/08 $35.00 DOI: 10.1016/S1063-5823(08)00207-X
132
G. Zhou et al.
Na,K-ATPase activity and can be prevented by antioxidants. We propose that ROS act as signaling molecules regulating the activity of Na,K-ATPase, which is important for alveolar fluid reabsorption. Further studies into the mechanisms by which Na,K-ATPase is regulated will be of importance for development of novel strategies for the treatment of edema patients.
I. NA,K-ATPase The Na,K-ATPase is a membrane-bound protein which belongs to the P-type ATPase protein family, where a phosphorylated enzymatic intermediate is formed during the catalytic cycle (Kaplan, 2002). Plasma membrane Na,K-ATPase utilizes the energy released from ATP hydrolysis to pump 3 Na+ out of cells and exchange 2 K+ into cells simultaneously, generating the Na+ and K+ gradients across the plasma membrane (Blanco and Mercer, 1998). These gradients are crucial to maintain cell volume, membrane potential and to provide a secondary energy source for nutrient uptake, maintaining intracellular pH and Ca2+ concentration. Na,K-ATPase is a heterodimer consisting of α and β subunits, and both are necessary for its activity. It is believed that α and β subunits are synthesized independently and then assembled into a dimer in the endoplasmic reticulum and delivered to the plasma membrane (Therien and Blostein, 2000; Kaplan, 2002). The α subunit is a transmembrane protein that catalyzes ATP hydrolysis and contains the binding sites for Na+ , K+ and its inhibitor ouabain (Blanco and Mercer, 1998). Four α isoforms, α1 to α4 , have been described (Kaplan, 2002). These isoforms are highly conserved with more than 77% identical primary amino acid sequences between each other. The α1 is the main isoform found in most tissues and other isoforms are tissue-specific (Blanco and Mercer, 1998). The β subunit has four isoforms and contains glycosylation sites. It controls the heterodimer assembly and insertion into the plasma membrane. Mutation of Na,K-ATPase has been linked to human diseases. The loss-offunction mutations of α2 subunit have been identified to be associated with familial hemiplegic migraine type 2 (De Fusco et al., 2003; Vanmolkot et al., 2003; Segall et al., 2004). Missense mutation of α3 subunit causes dystoniaParkinsonism (de Carvalho Aguiar et al., 2004). Mice with deletion of either the α1 or α2 isoform fail to survive, suggesting their fundamental roles in organ development (Moseley et al., 2003; Barcroft et al., 2004). The Na,K-ATPase activity can be regulated by changes in affinity for its substrates. However, more recent reports have suggested that the Na,K-ATPase activity is regulated mostly by its trafficking and insertion into the plasma membrane (Bertorello and Sznajder, 2005). The biological function of Na,K-ATPase has been studied in the brain, heart, kidney and lung (Lichtstein and Rosen, 2001; Schwinger et al., 2003; Bertorello and Sznajder, 2005). In the lung alveolar epithelium, the best studied function of
7. Na,K-ATPase and ROS
133
the Na,K-ATPase is its role in alveolar fluid reabsorption (Mutlu and Sznajder, 2005).
II. NA,K-ATPase IN ALVEOLAR FLUID REABSORPTION Under physiological conditions there is a very thin layer of fluid lining the alveolar epithelium which allows for maintenance of surface tension, basic host defense properties, and gas exchange (Ware and Matthay, 2001). Patients with acute respiratory distress syndrome (ARDS) or congestive heart failure develop pulmonary edema as a consequence of increased permeability across the alveolarcapillary barrier (Fromm Jr. et al., 1995; Ware and Matthay, 2000). The accumulation of edema fluid causes a life-threatening impairment of gas exchange; therefore, the edema needs to be cleared for these patients to survive (Sznajder, 2001; Ware and Matthay, 2001). The edema is cleared by alveolar fluid reabsorption through active Na+ transport across the alveolar epithelium. Sodium is taken in on the apical surface of alveolar epithelial cells, partly through amiloride-sensitive Na+ channels. Subsequently, Na+ is actively extruded from the basolateral surface into the lung interstitium by the Na,K-ATPase, generating a transepithelial osmotic gradient. Then water follows the osmotic gradient created by the active Na+ transport into the interstitium space and the pulmonary circulation, leading to the reabsorption of alveolar fluid (Figure 1) (Matalon et al., 2002; Sznajder et al., 2002). The alveolar epithelium in the adult human lung consists of two morphologically distinct epithelial cells, type I (ATI) and type II (ATII) cells. Although the numbers of ATI and ATII cells are similar, about 95% of surface area is covered by ATI cells. Both ATI and ATII cells express Na,K-ATPase
FIGURE 1 Schematic representation of alveolar fluid reabsorption.
134
G. Zhou et al.
and contribute to active Na+ transport (Figure 1) (Borok and Verkman, 2002; Johnson et al., 2002, 2006; Ridge et al., 2003). The importance of the Na,K-ATPase in edema clearance is highlighted by experiments where overexpression of Na,K-ATPase β1 subunit in rat lungs results in a significant increase in alveolar fluid reabsorption (Factor et al., 1998, 1999; Machado-Aranda et al., 2005). Importantly, gene transfer of Na,K-ATPase can improve alveolar fluid reabsorption in lung injury models (Azzam et al., 2002; Factor et al., 2002). These studies suggest the potential therapeutic application of Na,K-ATPase gene transfer in treatment of ARDS patients (Adir et al., 2003; Mutlu et al., 2004).
III. ROLE OF REACTIVE OXYGEN SPECIES IN SIGNALING Reactive oxygen species (ROS) production has been associated with a number of systems, including the mitochondrial electron transport chain, NADPH oxidase, xanthine oxidase, glucose oxidase and lipooxygenase (Finkel, 1998; Thannickal and Fanburg, 2000). Accumulating evidence suggests that the primary ROS sources are the mitochondria and NADPH oxidase (Figure 2) (Hancock et al., 2001; Chandel and Budinger, 2007).
FIGURE 2 The generation of reactive oxygen species in cells by mitochondrial electron transport chain and NADPH oxidase.
7. Na,K-ATPase and ROS
135
A. Mitochondrial ROS In eukaryotes it has been estimated that 2–3% of the O2 consumed by mitochondria is incompletely reduced, yielding ROS (Chandel and Schumacker, 2000). Capture of an electron by O2 generates superoxide, which is then converted to hydrogen peroxide by superoxide dismutase (SOD) (Chandel and Schumacker, 2000). Superoxide can potentially be generated at complex I, complex III, and other electron transfer proteins (Figure 2). In complex III, superoxide is generated from the radical ubisemiquinone during the Q cycle, at two different sites, the Qi and Qo sites, where superoxide is released into the matrix and the intermembrane space, respectively. ROS do not appear to be generated by cytochrome oxidase itself (Guzy et al., 2005; Guzy and Schumacker, 2006).
B. NADPH Oxidase ROS Production The NADPH oxidase was initially discovered in neutrophils, serving as a host defense system against invading microorganisms (Bokoch and Knaus, 2003). The NADPH oxidase is a multi-protein complex consisting of membrane components and cytosolic components. In resting cells, p22-phox and gp91-phox form a heterodimer termed flavocytochrome b558 at the plasma membrane; upon stimulation, the cytosolic components (p40-phox, p47-phox and p67-phox) translocate to the plasma membrane and assemble the active enzyme with flavocytochrome b558 (Hancock et al., 2001). Flavocytochrome b558 contains an FAD group and two heme groups to enable the transfer of an electron from NADPH to oxygen, producing a superoxide anion, which is converted to hydrogen peroxide (Figure 2) (Herkert et al., 2004). Recent evidence suggests that the NADPH oxidase is ubiquitously expressed in mammalian plasma membrane. A family of gp91-phox-like proteins termed nonphagocytic NADPH oxidase proteins (NOX1 through NOX5) has been identified and p47-phox and p22-phox were also discovered in nonphagocytic mammalian cells (Bokoch and Knaus, 2003; Takeya and Sumimoto, 2006). The fact that nonphagocytic NADPH oxidases produce relatively lower amount of ROS than the phagocytic NADPH oxidase suggests that ROS may play an important role as signaling molecules rather than act as toxic agents (Gabbita et al., 2000; Thannickal, 2003).
C. ROS as Signaling Molecules ROS are increasingly considered as second messengers in mediating signal transduction when produced in low concentration (Thannickal, 2003). In many
136
G. Zhou et al.
ways, ROS are ideal as signaling molecules. They are small, ubiquitous and diffusive. They are produced in multiple sites and their production is regulated by multiple mechanisms (Gabbita et al., 2000). They can be inactivated by catalases, peroxidases and other mechanisms. A large number of signaling pathways appear to be regulated by ROS, including receptor tyrosine kinases, protein kinase C (PKC), Src kinase, Janus kinase (JAK) and mitogen-activated protein kinases (MAPK) (Thannickal and Fanburg, 2000). Growth factors induce dimerization or oligomerization of their cognate receptors, leading to autophosphorylation in their cytoplasmic kinase domain and activation. This effect occurs in parallel with ROS production upon ligand binding and appears to be mediated by ROS (Thannickal and Fanburg, 2000). Similarly, exogenous H2 O2 has been shown to induce similar effects on phosphorylation and activation of the platelet-derived growth factor (PDGF) and epidermal growth factor receptors (Rhee et al., 2000). H2 O2 induces tyrosine phosphorylation of various isoforms of PKC (α, βI , γ , δ, ε and ζ ), leading to its activation even in the absence of receptor-mediated stimulation of phospholipase C (Konishi et al., 1997; Sun et al., 2000). Activation of the JAK-STAT pathway by PDGF appears to be redox sensitive (Simon et al., 1998). In fibroblast cells, H2 O2 -induced activation of p21Ras requires activation of Src kinase and JAK as well as recruitment of phosphatidylinositol 3 -kinase to the plasma membrane, where it interacts directly with p21Ras (Deora et al., 1998). Also, ROS activate ERK, which participates in Src kinases and p21Ras activation (Muller et al., 1997; Aikawa et al., 1997). ROS activate apoptosis signal-regulating kinase 1 (ASK1), resulting in activation of p38 and JNK (Zhang et al., 2003; Zhou et al., 2004). ROS activate signaling mainly through two pathways. On one hand, ROS alter the intracellular redox state. The cytosol normally maintains its redox state by the buffering capacity of intracellular thiols, primarily glutathione (GSH) and thioredoxin (TRX). Reduced GSH and TRX are maintained by their respective reductases. Both thiols can counteract intracellular oxidative stress by reducing H2 O2 (Thannickal and Fanburg, 2000). On the other hand, ROS mediate signaling via direct modification of cysteine residues in target proteins, altering their structure and function (Rhee et al., 2000).
IV. REGULATION OF NA,K-ATPase AND ALVEOLAR FLUID REABSORPTION BY ROS A. Hypoxia Alveolar hypoxia may occur during acute lung injury as a consequence of alveolar flooding, impairing oxygen transfer from the airspace into the pulmonary circulation (Ware and Matthay, 2000, 2001). Hypoxia has been shown to impair alveolar fluid clearance by inhibiting transepithelial active Na+ transport
7. Na,K-ATPase and ROS
137
FIGURE 3 Time- and dose-dependent generation of mitochondrial ROS during hypoxia. Reproduced with permission from Chandel et al. (1998). Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc. Natl. Acad. Sci. USA 95 (20), 11715–11720.
(Vivona et al., 2001; Litvan et al., 2006). It has been demonstrated that exposure of rats to moderate hypoxia results in a significant decrease in alveolar fluid clearance, which was associated with a decrease in ENaC activity as well as a decrease in Na,K-ATPase activity due to decreased protein abundance at the basolateral membrane (Tomlinson et al., 1999; Carpenter et al., 2003; Litvan et al., 2006). In cultured alveolar epithelial cells, hypoxia-mediated downregulation of Na,KATPase is time- and O2 concentration-dependent (Planes et al., 1996; Wodopia et al., 2000; Dada et al., 2003). Short term exposure to hypoxia decreases Na,KATPase activity and the amount of plasma membrane Na,K-ATPase α1 subunit without significant change in its total amount, suggesting the endocytosis of Na,K-ATPase during hypoxia (Dada et al., 2003). Exposure of cells and tissues to hypoxia (pO2 = 5–50 Torr) increases the production of mitochondrial ROS in a dose-dependent manner (Figure 3) (Chandel et al., 1998), while cellular respiration does not become limited until the pO2 falls below 5–7 Torr. The current reasoning is that hypoxia does not change the apparent Km of the cytochrome oxidase, but reversibly decreases its Vmax (Chandel and Schumacker, 2000). This decrease in Vmax is not sufficient to limit normal respiration but affects the mitochondrial redox state by increasing the reduction state of cytochrome c (the electron donor to cytochrome oxidase), resulting in the ROS leaking from the mitochondria (Chandel and Schumacker, 2000). Accordingly, alveolar epithelial cells treated with mitochondrial inhibitors such as
138
G. Zhou et al.
antimycin A, which inhibit sites distal to complex III, increase ROS production during normoxia or hypoxia (Dada et al., 2003). In contrast, inhibitors such as rotenone, diphenyleneiodonium chloride, which inhibit sites more proximal to complex III, inhibit ROS generation by blocking the flux of electrons before complex III (Guzy and Schumacker, 2006). The role of mitochondrial ROS during hypoxia is also supported by experiments carried out in mitochondrial DNA deficient cells (ρ 0 cells) (King and Attardi, 1989). The mammalian mitochondrial DNA encodes 13 polypeptides which are critical catalytic subunits for complex I, complex III, complex IV and the F1F0 ATP synthase (Anderson et al., 1981). These cells lack a competent electron transport chain and are incapable of generating ROS during hypoxia (Chandel and Schumacker, 1999). Treatment of cells with H2 O2 caused the endocytosis of plasma membrane Na,K-ATPase, and thus a decrease in Na,K-ATPase activity (Dada et al., 2003). Interestingly, ROS scavengers prevent the hypoxia-induced decrease in Na,KATPase activity and its protein abundance (Dada et al., 2003). The source of ROS in this process was further assessed in ρ 0 -A549 cells, where hypoxia failed to induce Na,K-ATPase endocytosis and decrease Na,K-ATPase activity. In animal studies overexpression of manganese SOD inhibited mitochondrial ROS production and blocked the decrease of Na,K-ATPase activity and alveolar fluid reabsorption during hypoxia (Litvan et al., 2006). Moreover, H2 O2 induced Na,KATPase endocytosis in ρ 0 -A549 cells, suggesting ROS act as messengers downstream of mitochondrion. Together, these studies suggest a role of mitochondrial ROS in hypoxia-mediated endocytosis of Na,K-ATPase. The endocytosis of Na,K-ATPase during hypoxia is triggered by the phosphorylation of its α1 subunit by PKCζ , which is activated by ROS (Dada et al., 2003). Endocytosis of Na,K-ATPase was reported to be clathrin dependent (Khundmiri et al., 2004). In lung alveolar epithelial cells, hypoxia-induced endocytosis of Na,KATPase requires the binding of adaptor protein AP-2 to the tyrosine-based motif (Tyr-537) located in the Na,K-ATPase α1 subunit, leading to the incorporation of Na,K-ATPase into clathrin vesicles. This process again requires ROS signaling (Figure 4) (Chen et al., 2006). Trafficking of clathrin vesicles requires the actin cytoskeleton in mammalian cells. The activation of Rho proteins leads to rearrangement of actin cytoskeleton, thus regulating endocytic process (Ridley, 2006). Most recently, it has been suggested that during hypoxia, mitochondrial ROS promote formation of actin stress fibers in alveolar epithelial cells by activation of the small GTPase RhoA, contributing to hypoxia-induced endocytosis of Na,K-ATPase (Dada et al., 2004). Prolonged hypoxia decreases the total Na,K-ATPase and plasma membrane Na,K-ATPase (Comellas et al., 2006; Litvan et al., 2006). Treatment of alveolar cells with the EUK-134 (combined SOD/catalase mimetic) or overexpression of glutathione peroxidase prevented the hypoxia-mediated Na,K-ATPase degradation. Furthermore, hypoxia-mediated Na,K-ATPase degradation was prevented in
7. Na,K-ATPase and ROS
139
FIGURE 4 Schematic representation of endocytosis of plasma membrane Na,K-ATPase.
ρ 0 cells and cells with suppression of Rieske iron sulfur protein (which prevents the generation of ROS from the ubisemiquinone at Qi and Qo sites), suggesting that mitochondrial ROS are critical for Na,K-ATPase degradation (Comellas et al., 2006). Both lysosome and proteosome inhibitors prevented the degradation of Na,K-ATPase (Comellas et al., 2006), yet the exact location of the plasma membrane Na,K-ATPase degradation during hypoxia has not been determined. B. Hyperoxia Adult rats exposed to 100% oxygen develop a lethal lung injury (Factor et al., 2000; He et al., 2005). The alveolar epithelium becomes more permeable to solutes and alveolar edema accumulates (Olivera et al., 1995; Carvalho et al., 1998). Moreover, there is an impairment in active Na+ transport and the ability to clear edema, associated with a parallel decrease in Na,K-ATPase activity in ATII cells isolated from rats exposed to 95% O2 (Olivera et al., 1995). Cells exposed to hyperoxia have a decrease in the plasma membrane Na, K-ATPase abundance (Hawkins et al., 2006), probably related to the increased ROS production. Several studies suggest that hyperoxia can stimulate superoxide production from the mitochondria (Freeman and Crapo, 1981; Li et al., 2004; Xu et al., 2006). However, other groups of investigators have reported NADPH oxidase as the primary source of ROS in hyperoxic environments (Buccellato et al., 2004; Parinandi et al., 2003; Brueckl et al., 2006; Thannickal, 2003). Parinandi et al. reported that kinase activation was required for the assembly of the NADPH oxidase to generate the bulk of ROS during hyperoxia (Parinandi et al., 2003). These
140
G. Zhou et al.
studies suggest that the mitochondrial ROS may act as a trigger to initiate the signaling to assemble the NADPH oxidase, which then amplifies the ROS signal (Parinandi et al., 2003).
C. Other Stimuli Particulate matter contributes to human diseases, especially pulmonary and cardiovascular diseases (Nel, 2005; Cascio, 2005; Brunekreef and Holgate, 2002). In the lung, long term exposure to particulate matter has been linked to obstructive lung diseases and cancer (Pope 3rd et al., 2002). However, the mechanisms involved are not clear. ROS have been implicated to play a role in the development of these diseases caused by exposure to particulate matter (Li et al., 2003). Recently, Mutlu and coworkers reported that exposure to particulate matter (diameter less than 10 µm) significantly decreases alveolar fluid reabsorption in mice as well as Na,K-ATPase activity and its abundance at the plasma membrane in alveolar epithelial cells (Mutlu et al., 2006). Pretreatment with the antioxidant EUK-134 rescued the decreased Na,K-ATPase due to particulate matter, suggesting a role for ROS (Mutlu et al., 2006). Patients with acute lung injury may have elevated concentrations of thrombin, a coagulation protease, in plasma and bronchoalveolar lavage fluids (Idell, 2003). An increased amount of thrombin is frequently associated with elevated ROS levels in endothelial cells and platelets (Herkert et al., 2004). Intravascular thrombin inhibits active Na+ transport in isolated-perfused rabbit lungs, leading to decreased alveolar fluid clearance (Vadasz et al., 2005). Thrombin downregulates plasma membrane Na,K-ATPase protein abundance and activity without affecting the amount of ENaC α and β subunits. These thrombin-induced effects can be prevented by inhibition of ROS production from NADPH oxidase, but not from mitochondria (Vadasz et al., 2005).
V. DOPAMINE AND β-ADRENERGIC AGONISTS IMPROVE ROS-MEDIATED DECREASE IN ALVEOLAR FLUID REABSORPTION The impaired alveolar fluid reabsorption by hypoxia and hyperoxia can be reversed by treatment with dopamine (DA) and the β-adrenergic agonists (terbutaline and isoproterenol (ISO)) (Vivona et al., 2001; Litvan et al., 2006; Saldias et al., 1999a, 1999b). The improvement of alveolar fluid reabsorption by DA and ISO is associated with parallel increases in Na,K-ATPase protein abundance at the basolateral membrane (Ridge et al., 2002; Litvan et al., 2006). This increase in plasma membrane Na,K-ATPase abundance is mediated by the exocytosis of Na,K-ATPase from late endosomal compartments into the basolateral membrane (Pesce et al., 2000; Ridge et al., 2002; Lecuona et al., 2003).
7. Na,K-ATPase and ROS
141
VI. SUMMARY Alveolar fluid reabsorption is critical for patients with ARDS or congestive heart failure to have better outcomes. Alveolar fluid reabsorption is effected by Na,K-ATPase and Na+ channels. Hypoxia, hyperoxia, particulate matter and thrombin impair alveolar fluid reabsorption via ROS-mediated downregulation of Na,K-ATPase activity in the alveolar epithelium. More recent studies suggest that mitochondria- and/or NADPH oxidase-derived ROS are the common mediator of Na,K-ATPase downregulation in these conditions. ROS activates PKCζ , which phosphorylates Na,K-ATPase at Ser-18, leading to its endocytosis from the plasma membrane of alveolar epithelial cells. Antioxidants prevent endocytosis of Na,K-ATPase, resulting in restoration of the basal level of alveolar fluid reabsorption. Dopamine and isoproterenol can improve the rate of alveolar fluid reabsorption inhibited by hypoxia or hyperoxia, suggesting their potential as therapeutic drugs. However, further studies into the mechanisms by which Na,K-ATPase is regulated are warranted to provide insights for the design of novel therapeutic agents. Acknowledgements This work was supported in part by grants from the National Institutes of Health HL-071643, HL-48129 and Parker B. Francis Foundation fellowship (to G.Z.).
References Adir, Y., Factor, P., Dumasius, V., Ridge, K.M., Sznajder, J.I. (2003). Na,K-ATPase gene transfer increases liquid clearance during ventilation-induced lung injury. Am. J. Respir. Crit. Care Med. 168, 1445–1448. Aikawa, R., Komuro, I., Yamazaki, T., Zou, Y., Kudoh, S., Tanaka, M., Shiojima, I., Hiroi, Y., Yazaki, Y. (1997). Oxidative stress activates extracellular signal-regulated kinases through Src and Ras in cultured cardiac myocytes of neonatal rats. J. Clin. Invest. 100, 1813–1821. Anderson, S., Bankier, A.T., Barrell, B.G., de Bruijn, M.H., Coulson, A.R., Drouin, J., Eperon, I.C., Nierlich, D.P., Roe, B.A., Sanger, F., Schreier, P.H., Smith, A.J., Staden, R., Young, I.G. (1981). Sequence and organization of the human mitochondrial genome. Nature 290, 457–465. Azzam, Z.S., Dumasius, V., Saldias, F.J., Adir, Y., Sznajder, J.I., Factor, P. (2002). Na,K-ATPase overexpression improves alveolar fluid clearance in a rat model of elevated left atrial pressure. Circulation 105, 497–501. Barcroft, L.C., Moseley, A.E., Lingrel, J.B., Watson, A.J. (2004). Deletion of the Na/K-ATPase alpha1-subunit gene (Atp1a1) does not prevent cavitation of the preimplantation mouse embryo. Mech. Dev. 121, 417–426. Bertorello, A.M., Sznajder, J.I. (2005). The dopamine paradox in lung and kidney epithelia: Sharing the same target but operating different signaling networks. Am. J. Respir. Cell Mol. Biol. 33, 432– 437. Blanco, G., Mercer, R.W. (1998). Isozymes of the Na-K-ATPase: Heterogeneity in structure, diversity in function. Am. J. Physiol. 275, F633–F650. Bokoch, G.M., Knaus, U.G. (2003). NADPH oxidases: Not just for leukocytes anymore! Trends Biochem. Sci. 28, 502–508. Borok, Z., Verkman, A.S. (2002). Lung edema clearance: 20 years of progress: Invited review: Role of aquaporin water channels in fluid transport in lung and airways. J. Appl. Physiol. 93, 2199–2206.
142
G. Zhou et al.
Brueckl, C., Kaestle, S., Kerem, A., Habazettl, H., Krombach, F., Kuppe, H., Kuebler, W.M. (2006). Hyperoxia-induced reactive oxygen species formation in pulmonary capillary endothelial cells in situ. Am. J. Respir. Cell Mol. Biol. 34, 453–463. Brunekreef, B., Holgate, S.T. (2002). Air pollution and health. Lancet 360, 1233–1242. Buccellato, L.J., Tso, M., Akinci, O.I., Chandel, N.S., Budinger, G.R. (2004). Reactive oxygen species are required for hyperoxia-induced Bax activation and cell death in alveolar epithelial cells. J. Biol. Chem. 279, 6753–6760. Carpenter, T.C., Schomberg, S., Nichols, C., Stenmark, K.R., Weil, J.V. (2003). Hypoxia reversibly inhibits epithelial sodium transport but does not inhibit lung ENaC or Na-K-ATPase expression. Am. J. Physiol. Lung Cell Mol. Physiol. 284, L77–L83. Carvalho, C.R., de Paula Pinto Schettino, G., Maranhao, B., Bethlem, E.P. (1998). Hyperoxia and lung disease. Curr. Opin. Pulm. Med. 4, 300–304. Cascio, W.E. (2005). Cardiopulmonary health effects of air pollution: Is a mechanism emerging? Am. J. Respir. Crit. Care Med. 172, 1482–1484. Chandel, N.S., Budinger, G.R. (2007). The cellular basis for diverse responses to oxygen. Free Radic. Biol. Med. 42, 165–174. Chandel, N.S., Maltepe, E., Goldwasser, E., Mathieu, C.E., Simon, M.C., Schumacker, P.T. (1998). Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc. Natl. Acad. Sci. USA 95, 11715–11720. Chandel, N.S., Schumacker, P.T. (1999). Cells depleted of mitochondrial DNA (rho0) yield insight into physiological mechanisms. FEBS Lett. 454, 173–176. Chandel, N.S., Schumacker, P.T. (2000). Cellular oxygen sensing by mitochondria: Old questions, new insight. J. Appl. Physiol. 88, 1880–1889. Chen, Z., Krmar, R.T., Dada, L., Efendiev, R., Leibiger, I.B., Pedemonte, C.H., Katz, A.I., Sznajder, J.I., Bertorello, A.M. (2006). Phosphorylation of adaptor protein-2 mu2 is essential for Na+ ,K+ ATPase endocytosis in response to either G protein-coupled receptor or reactive oxygen species. Am. J. Respir. Cell Mol. Biol. 35, 127–132. Comellas, A.P., Dada, L.A., Lecuona, E., Pesce, L.M., Chandel, N.S., Quesada, N., Budinger, G.R., Strous, G.J., Ciechanover, A., Sznajder, J.I. (2006). Hypoxia-mediated degradation of Na,KATPase via mitochondrial reactive oxygen species and the ubiquitin-conjugating system. Circ. Res. 98, 1314–1322. Dada, L.A., Chandel, N.S., Ridge, K.M., Pedemonte, C., Bertorello, A.M., Sznajder, J.I. (2003). Hypoxia-induced endocytosis of Na,K-ATPase in alveolar epithelial cells is mediated by mitochondrial reactive oxygen species and PKC-zeta. J. Clin. Invest. 111, 1057–1064. Dada, L.A., Santos, B.F., Lecuona, E., Sznajder, J.I. (2004). The actin cytoskeleton is required for hypoxia-mediated Na,K-ATPase endocytosis in alveolar epithelial cells. Am. J. Respir. Crit. Care Med. 169, A412. de Carvalho Aguiar, P., Sweadner, K.J., Penniston, J.T., Zaremba, J., Liu, L., Caton, M., Linazasoro, G., Borg, M., Tijssen, M.A., Bressman, S.B., Dobyns, W.B., Brashear, A., Ozelius, L.J. (2004). Mutations in the Na+ /K+ -ATPase alpha3 gene ATP1A3 are associated with rapid-onset dystonia parkinsonism. Neuron 43, 169–175. De Fusco, M., Marconi, R., Silvestri, L., Atorino, L., Rampoldi, L., Morgante, L., Ballabio, A., Aridon, P., Casari, G. (2003). Haploinsufficiency of ATP1A2 encoding the Na+ /K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat. Genet. 33, 192–196. Deora, A.A., Win, T., Vanhaesebroeck, B., Lander, H.M. (1998). A redox-triggered ras-effector interaction. Recruitment of phosphatidylinositol 3 -kinase to Ras by redox stress. J. Biol. Chem. 273, 29923–29928. Factor, P., Dumasius, V., Saldias, F., Brown, L.A., Sznajder, J.I. (2000). Adenovirus-mediated transfer of an Na+ /K+ -ATPase beta1 subunit gene improves alveolar fluid clearance and survival in hyperoxic rats. Hum. Gene Ther. 11, 2231–2242.
7. Na,K-ATPase and ROS
143
Factor, P., Dumasius, V., Saldias, F., Sznajder, J.I. (1999). Adenoviral-mediated overexpression of the NA,K-ATPase beta1 subunit gene increases lung edema clearance and improves survival during acute hyperoxic lung injury in rats. Chest 116, 24S–25S. Factor, P., Mendez, M., Mutlu, G.M., Dumasius, V. (2002). Acute hyperoxic lung injury does not impede adenoviral-mediated alveolar gene transfer. Am. J. Respir. Crit. Care Med. 165, 521–526. Factor, P., Saldias, F., Ridge, K., Dumasius, V., Zabner, J., Jaffe, H.A., Blanco, G., Barnard, M., Mercer, R., Perrin, R., Sznajder, J.I. (1998). Augmentation of lung liquid clearance via adenovirusmediated transfer of a Na,K-ATPase beta1 subunit gene. J. Clin. Invest. 102, 1421–1430. Finkel, T. (1998). Oxygen radicals and signaling. Curr. Opin. Cell Biol. 10, 248–253. Freeman, B.A., Crapo, J.D. (1981). Hyperoxia increases oxygen radical production in rat lungs and lung mitochondria. J. Biol. Chem. 256, 10986–10992. Fromm Jr., R.E., Varon, J., Gibbs, L.R. (1995). Congestive heart failure and pulmonary edema for the emergency physician. J. Emerg. Med. 13, 71–87. Gabbita, S.P., Robinson, K.A., Stewart, C.A., Floyd, R.A., Hensley, K. (2000). Redox regulatory mechanisms of cellular signal transduction. Arch. Biochem. Biophys. 376, 1–13. Guzy, R.D., Hoyos, B., Robin, E., Chen, H., Liu, L., Mansfield, K.D., Simon, M.C., Hammerling, U., Schumacker, P.T. (2005). Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab. 1, 401–408. Guzy, R.D., Schumacker, P.T. (2006). Oxygen sensing by mitochondria at complex III: The paradox of increased reactive oxygen species during hypoxia. Exp. Physiol. 91, 807–819. Hancock, J.T., Desikan, R., Neill, S.J. (2001). Role of reactive oxygen species in cell signalling pathways. Biochem. Soc. Trans. 29, 345–350. Hawkins, K.A., Welch, L.C., Dada, L.A., Sznajder, J.I., Budinger, G.R. (2006). The overexpression of catalase targeted to the mitochondria prevents hyperoxia-mediated endocytosis of the Na,KATPase in alveolar epithelial cells. Proc. Am. Thor. Soc. 3, A838. He, C.H., Waxman, A.B., Lee, C.G., Link, H., Rabach, M.E., Ma, B., Chen, Q., Zhu, Z., Zhong, M., Nakayama, K., Nakayama, K.I., Homer, R., Elias, J.A. (2005). Bcl-2-related protein A1 is an endogenous and cytokine-stimulated mediator of cytoprotection in hyperoxic acute lung injury. J. Clin. Invest. 115, 1039–1048. Herkert, O., Djordjevic, T., BelAiba, R.S., Gorlach, A. (2004). Insights into the redox control of blood coagulation: Role of vascular NADPH oxidase-derived reactive oxygen species in the thrombogenic cycle. Antioxid. Redox Signal. 6, 765–776. Idell, S. (2003). Coagulation, fibrinolysis, and fibrin deposition in acute lung injury. Crit. Care Med. 31, S213–S220. Johnson, M.D., Bao, H.F., Helms, M.N., Chen, X.J., Tigue, Z., Jain, L., Dobbs, L.G., Eaton, D.C. (2006). Functional ion channels in pulmonary alveolar type I cells support a role for type I cells in lung ion transport. Proc. Natl. Acad. Sci. USA 103, 4964–4969. Johnson, M.D., Widdicombe, J.H., Allen, L., Barbry, P., Dobbs, L.G. (2002). Alveolar epithelial type I cells contain transport proteins and transport sodium, supporting an active role for type I cells in regulation of lung liquid homeostasis. Proc. Natl. Acad. Sci. USA 99, 1966–1971. Kaplan, J.H. (2002). Biochemistry of Na,K-ATPase. Annu. Rev. Biochem. 71, 511–535. Khundmiri, S.J., Bertorello, A.M., Delamere, N.A., Lederer, E.D. (2004). Clathrin-mediated endocytosis of Na+ ,K+ -ATPase in response to parathyroid hormone requires ERK-dependent phosphorylation of ser-11 within the {alpha}1-subunit. J. Biol. Chem. 279, 17418–17427. King, M.P., Attardi, G. (1989). Human cells lacking mtDNA: Eepopulation with exogenous mitochondria by complementation. Science 246, 500–503. Konishi, H., Tanaka, M., Takemura, Y., Matsuzaki, H., Ono, Y., Kikkawa, U., Nishizuka, Y. (1997). Activation of protein kinase C by tyrosine phosphorylation in response to H2 O2 . Proc. Natl. Acad. Sci. USA 94, 11233–11237. Lecuona, E., Ridge, K., Pesce, L., Batlle, D., Sznajder, J.I. (2003). The GTP-binding protein RhoA mediates Na,K-ATPase exocytosis in alveolar epithelial cells. Mol. Biol. Cell 14, 3888–3897.
144
G. Zhou et al.
Li, J., Gao, X., Qian, M., Eaton, J.W. (2004). Mitochondrial metabolism underlies hyperoxic cell damage. Free Radic. Biol. Med. 36, 1460–1470. Li, N., Hao, M., Phalen, R.F., Hinds, W.C., Nel, A.E. (2003). Particulate air pollutants and asthma. A paradigm for the role of oxidative stress in PM-induced adverse health effects. Clin. Immunol. 109, 250–265. Lichtstein, D., Rosen, H. (2001). Endogenous digitalis-like Na+ ,K+ -ATPase inhibitors, and brain function. Neurochem. Res. 26, 971–978. Litvan, J., Briva, A., Wilson, M.S., Budinger, G.R., Sznajder, J.I., Ridge, K.M. (2006). Beta-adrenergic receptor stimulation and adenoviral overexpression of superoxide dismutase prevent the hypoxiamediated decrease in Na,K-ATPase and alveolar fluid reabsorption. J. Biol. Chem. 281, 19892– 19898. Machado-Aranda, D., Adir, Y., Young, J.L., Briva, A., Budinger, G.R.S., Yeldandi, A.V., Sznajder, J.I., Dean, D.A. (2005). Gene Transfer of the Na+ ,K+ -ATPase {beta}1 subunit using electroporation increases lung liquid clearance. Am. J. Respir. Crit. Care Med. 171, 204–211. Matalon, S., Lazrak, A., Jain, L., Eaton, D.C. (2002). Lung edema clearance: 20 years of progress: Invited review: Biophysical properties of sodium channels in lung alveolar epithelial cells. J. Appl. Physiol. 93, 1852–1859. Moseley, A.E., Lieske, S.P., Wetzel, R.K., James, P.F., He, S., Shelly, D.A., Paul, R.J., Boivin, G.P., Witte, D.P., Ramirez, J.M., Sweadner, K.J., Lingrel, J.B. (2003). The Na,K-ATPase alpha 2 isoform is expressed in neurons, and its absence disrupts neuronal activity in newborn mice. J. Biol. Chem. 278, 5317–5324. Muller, J.M., Cahill, M.A., Rupec, R.A., Baeuerle, P.A., Nordheim, A. (1997). Antioxidants as well as oxidants activate c-fos via Ras-dependent activation of extracellular-signal-regulated kinase 2 and Elk-1. Eur. J. Biochem. 244, 45–52. Mutlu, G.M., Dumasius, V., Burhop, J., McShane, P.J., Meng, F.J., Welch, L., Dumasius, A., Mohebahmadi, N., Thakuria, G., Hardiman, K., Matalon, S., Hollenberg, S., Factor, P. (2004). Upregulation of alveolar epithelial active Na+ transport is dependent on beta2-adrenergic receptor signaling. Circ. Res. 94, 1091–1100. Mutlu, G.M., Snyder, C., Bellmeyer, A., Wang, H., Hawkins, K., Soberanes, S., Welch, L.C., Ghio, A.J., Chandel, N.S., Kamp, D., Sznajder, J.I., Budinger, G.R. (2006). Airborne particulate matter inhibits alveolar fluid reabsorption in mice via oxidant generation. Am. J. Respir. Cell Mol. Biol. 34, 670–676. Mutlu, G.M., Sznajder, J.I. (2005). Mechanisms of pulmonary edema clearance. Am. J. Physiol. Lung Cell. Mol. Physiol. 289, L685–L695. Nel, A. (2005). Atmosphere. Air pollution-related illness: Effects of particles. Science 308, 804–806. Olivera, W.G., Ridge, K.M., Sznajder, J.I. (1995). Lung liquid clearance and Na,K-ATPase during acute hyperoxia and recovery in rats. Am. J. Respir. Crit. Care Med. 152, 1229–1234. Parinandi, N.L., Kleinberg, M.A., Usatyuk, P.V., Cummings, R.J., Pennathur, A., Cardounel, A.J., Zweier, J.L., Garcia, J.G., Natarajan, V. (2003). Hyperoxia-induced NAD(P)H oxidase activation and regulation by MAP kinases in human lung endothelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 284, L26–L38. Pesce, L., Guerrero, C., Comellas, A., Ridge, K.M., Sznajder, J.I. (2000). beta-agonists regulate Na,KATPase via novel MAPK/ERK and rapamycin-sensitive pathways. FEBS Lett. 486, 310–314. Planes, C., Friedlander, G., Loiseau, A., Amiel, C., Clerici, C. (1996). Inhibition of Na-K-ATPase activity after prolonged hypoxia in an alveolar epithelial cell line. Am. J. Physiol. Lung Cell Mol. Physiol. 271, L70–L78. Pope 3rd, C.A., Burnett, R.T., Thun, M.J., Calle, E.E., Krewski, D., Ito, K., Thurston, G.D. (2002). Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA 287, 1132–1141. Rhee, S.G., Bae, Y.S., Lee, S.R., Kwon, J. (2000). Hydrogen peroxide: A key messenger that modulates protein phosphorylation through cysteine oxidation, in: Science’s Stke: Signal Transduction Knowledge Environment 2000, PE1.
7. Na,K-ATPase and ROS
145
Ridge, K.M., Dada, L., Lecuona, E., Bertorello, A.M., Katz, A.I., Mochly-Rosen, D., Sznajder, J.I. (2002). Dopamine-induced exocytosis of Na,K-ATPase is dependent on activation of protein kinase C-epsilon and -delta. Mol. Biol. Cell 13, 1381–1389. Ridge, K.M., Olivera, W.G., Saldias, F., Azzam, Z., Horowitz, S., Rutschman, D.H., Dumasius, V., Factor, P., Sznajder, J.I. (2003). Alveolar type 1 cells express the {alpha}2 Na,K-ATPase, which contributes to lung liquid clearance. Circ. Res. 92, 453–460. Ridley, A.J. (2006). Rho GTPases and actin dynamics in membrane protrusions and vesicle trafficking. Trends Cell Biol. 16, 522–529. Saldias, F.J., Comellas, A., Ridge, K.M., Lecuona, E., Sznajder, J.I. (1999a). Isoproterenol improves ability of lung to clear edema in rats exposed to hyperoxia. J. Appl. Physiol. 87, 30–35. Saldias, F.J., Lecuona, E., Comellas, A.P., Ridge, K.M., Sznajder, J.I. (1999b). Dopamine restores lung ability to clear edema in rats exposed to hyperoxia. Am. J. Respir. Crit. Care Med. 159, 626–633. Schwinger, R.H., Bundgaard, H., Muller-Ehmsen, J., Kjeldsen, K. (2003). The Na,K-ATPase in the failing human heart. Cardiovasc. Res. 57, 913–920. Segall, L., Scanzano, R., Kaunisto, M.A., Wessman, M., Palotie, A., Gargus, J.J., Blostein, R. (2004). Kinetic alterations due to a missense mutation in the Na,K-ATPase alpha2 subunit cause familial hemiplegic migraine type 2. J. Biol. Chem. 279, 43692–43696. Simon, A.R., Rai, U., Fanburg, B.L., Cochran, B.H. (1998). Activation of the JAK-STAT pathway by reactive oxygen species. Am. J. Physiol. 275, C1640–C1652. Sun, X., Wu, F., Datta, R., Kharbanda, S., Kufe, D. (2000). Interaction between protein kinase C delta and the c-Abl tyrosine kinase in the cellular response to oxidative stress. J. Biol. Chem. 275, 7470–7473. Sznajder, J.I. (2001). Alveolar edema must be cleared for the acute respiratory distress syndrome patient to survive. Am. J. Respir. Crit. Care Med. 163, 1293–1294. Sznajder, J.I., Factor, P., Ingbar, D.H. (2002). Invited review: Lung edema clearance: Role of Na(+)K(+)-ATPase. J. Appl. Physiol. 93, 1860–1866. Takeya, R., Sumimoto, H. (2006). Regulation of novel superoxide-producing NAD(P)H oxidases. Antioxid. Redox Signal 8, 1523–1532. Thannickal, V.J. (2003). The paradox of reactive oxygen species: Injury, signaling, or both? Am. J. Physiol. Lung Cell. Mol. Physiol. 284, L24–L25. Thannickal, V.J., Fanburg, B.L. (2000). Reactive oxygen species in cell signaling. Am. J. Physiol. Lung Cell Mol. Physiol. 279, L1005–L1028. Therien, A.G., Blostein, R. (2000). Mechanisms of sodium pump regulation. Am. J. Physiol. Cell Physiol. 279, C541–C566. Tomlinson, L.A., Carpenter, T.C., Baker, E.H., Bridges, J.B., Weil, J.V. (1999). Hypoxia reduces airway epithelial sodium transport in rats. Am. J. Physiol. Lung Cell Mol. Physiol. 277, L881–L886. Vadasz, I., Morty, R.E., Olschewski, A., Konigshoff, M., Kohstall, M.G., Ghofrani, H.A., Grimminger, F., Seeger, W. (2005). Thrombin impairs alveolar fluid clearance by promoting endocytosis of Na+ ,K+ -ATPase. Am. J. Respir. Cell Mol. Biol. 33, 343–354. Vanmolkot, K.R., Kors, E.E., Hottenga, J.J., Terwindt, G.M., Haan, J., Hoefnagels, W.A., Black, D.F., Sandkuijl, L.A., Frants, R.R., Ferrari, M.D., van den Maagdenberg, A.M. (2003). Novel mutations in the Na+ ,K+ -ATPase pump gene ATP1A2 associated with familial hemiplegic migraine and benign familial infantile convulsions. Ann. Neurol. 54, 360–366. Vivona, M.L., Matthay, M., Chabaud, M.B., Friedlander, G., Clerici, C. (2001). Hypoxia reduces alveolar epithelial sodium and fluid transport in rats: Reversal by beta-adrenergic agonist treatment. Am. J. Respir. Cell Mol. Biol. 25, 554–561. Ware, L.B., Matthay, M.A. (2000). The acute respiratory distress syndrome. N. Engl. J. Med. 342, 1334–1349. Ware, L.B., Matthay, M.A. (2001). Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 163, 1376–1383.
146
G. Zhou et al.
Wodopia, R., Ko, H.S., Billian, J., Wiesner, R., Bartsch, P., Mairbaurl, H. (2000). Hypoxia decreases proteins involved in epithelial electrolyte transport in A549 cells and rat lung. Am. J. Physiol. Lung Cell Mol. Physiol. 279, L1110–L1119. Xu, D., Guthrie, J.R., Mabry, S., Sack, T.M., Truog, W.E. (2006). Mitochondrial aldehyde dehydrogenase attenuates hyperoxia-induced cell death through activation of ERK/MAPK and PI3K-Akt pathways in lung epithelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 291, L966–L975. Zhang, R., He, X., Liu, W., Lu, M., Hsieh, J.T., Min, W. (2003). AIP1 mediates TNF-alpha-induced ASK1 activation by facilitating dissociation of ASK1 from its inhibitor 14-3-3. J. Clin. Invest. 111, 1933–1943. Zhou, G., Golden, T., Aragon, I.V., Honkanen, R.E. (2004). Ser/Thr protein phosphatase 5 inactivates hypoxia-induced activation of an apoptosis signal-regulating kinase 1/MKK-4/JNK signaling cascade. J. Biol. Chem. 279, 46595–46605.
CHAPTER 8 Reactive Oxygen Species and Endothelial Permeability Masuko Ushio-Fukai, Randall S. Frey, Tohru Fukai and Asrar B. Malik Department of Pharmacology and the Center for Lung and Vascular Biology, University of Illinois, Chicago, IL 60605, USA
I. II. III. IV. V. VI. VII. VIII. IX. X.
Introduction Generation and Metabolism of ROS ROS Generating System in ECs (NADPH Oxidase) Regulation of Adherens Junctions (AJs) by Phosphorylation and by Rho GTPase ROS-generating Stimulants which Regulate Endothelial Permeability ROS Reducing Factors/Proteins which Block Endothelial Permeability Molecular Targets of ROS Regulating Endothelial Permeability Mediators/Regulators of ROS-dependent Endothelial Permeability Functional Significance of ROS-dependent Endothelial Permeability in Vivo Summary and Conclusions References
Abstract Alterations in endothelial permeability are a defining feature of diverse processes including arteriosclerosis, inflammation, ischemia/reperfusion injury, angiogenesis, pulmonary edema in acute lung injury and adult respiratory distress syndrome. Endothelial monolayer permeability increases as a result of both disruption of endothelial cell–cell contacts and EC contraction. Disruption of endothelial cell–cell junctions occurs concomitantly with the redistribution and tyrosine phosphorylation of the VE-cadherin-containing adherens junction (AJ) protein complexes. Little is known about mechanisms of how endothelial permeability is regulated. Reactive oxygen species (ROS) including superoxide (O− 2 ) and hydrogen peroxide (H2 O2 ) generated by activated polymorphonuclear leukocyte (PMNs) and endothelial cells (ECs) impair endothelial barrier integrity by promoting loss of cell–cell adhesions and reorganization of actin cytoskeleton. These responses are involved in promoting transendothelial migration of PMNs and endothelial permeability. Major source of ROS in PMNs and ECs is NADPH oxidase. Phagocyte Current Topics in Membranes, Volume 61 Copyright © 2008, Elsevier Inc. All rights reserved
1063-5823/08 $35.00 DOI: 10.1016/S1063-5823(08)00208-1
148
M. Ushio-Fukai et al.
NADPH oxidase consists of membrane-bound gp91phox and p22hox as well as cytosolic components such as p47phox, p67phox and small GTPase Rac. Recently, several novel homologues of gp91phox (Nox2) of NADPH oxidase (Nox) have been cloned in non-phagocytic cells. In ECs Nox1, Nox2, Nox4 and Nox5 are functionally expressed. NADPH oxidase in ECs is activated by inflammatory cytokines, thrombogenic agents, growth factors, G-protein coupled receptor agonists and shear stress. ROS derived from NADPH oxidase function as signaling molecules to activate various redox signaling pathways through modulating activity of kinases and phosphatases, which may contribute to increase in endothelial permeability. Understanding mechanisms by which ROS regulate endothelial permeability is important for the development of novel therapeutic approaches against various diseases such as inflammation, atherogenesis and acute lung injury.
I. INTRODUCTION The endothelium lining the vasculature forms the size-selective and a semipermeable barrier to circulating cells, plasma albumin, macromolecules and bioactive agents between the blood and interstitial tissue. During an inflammatory or thrombogenic response, endothelial monolayer permeability increases as a result of both disruption of endothelial cell–cell contacts and EC contraction. Disruption of endothelial cell–cell junctions occurs mobilization concomitantly with the redistribution of the adherens junction (AJ) protein complexes at the sites of intercellular gap formation. EC contraction occurs by intracellular calcium, Rho GTPase activation, myosin light chain (MLC) phosphorylation, actin microfilament reorganization, and focal adhesion complex (FA) formation. Maintenance of endothelial cell (EC) barrier integrity is critical for preventing development of inflammatory diseases such as atherosclerosis, ischemia-reperfusion injury, diabetes, sepsis and pulmonary edema in acute lung injury (ALI), and adult respiratory distress syndrome (ARDS). Thus, understanding mechanisms of how endothelial permeability is regulated is critically important. Reactive oxygen species (ROS) including superoxide (O− 2 ), hydrogen peroxide (H2 O2 ) and other metalolites have been shown to play a central role in host defense by killing microbes in phagocytic cells such as neutrophils and macrophages. The major source of ROS in phagocytes is the NADPH oxidase, which catalyzes the NADPH-dependent reduction of molecular oxygen to generate large amounts of O− 2 . Accumulating evidence suggest that non-phagocytic cells including EC also produce ROS. Although excess amount of ROS is cytotoxic and induces cell death, ROS at low levels function as signaling molecules to mediate various biological functions such as cell proliferation, migration, differentiation and gene expression. Of note, ROS generated by activated polymorphonuclear leukocytes (PMN) or ECs at sits of inflammation and injury are
8. Reactive Oxygen Species and Endothelial Permeability
149
FIGURE 1 Signaling pathways of ROS-mediated increase in endothelial permeability. ICAM-1-dependent PMN binding to ECs and various inflammatory stimuli such as thrombin cytokine, shear stress, acute hypoxia, angiotensin II, advanced glycation end products (AGEs) and VEGF simulate ROS production via activation of NADPH oxidase in ECs. ROS are involved in activation of Src, Pyk2, FAK, PKC and PAK or in oxidative inactivation of PTPs, thereby phosphorylating VE-cadherin and β-catenin. Furthermore, H2 O2 activates TRPM2 channel to increase intracellular Ca2+ to promote loss of cell–cell adhesions at AJs, which may contribute to endothelial barrier dysfunction and increase in endothelial permeability. Moreover, ROS mediate NF-kB-dependent ICAM-1 expression, and thus creating positive-feedback loop whereby PMN-induced ROS in ECs promote PMN endothelial adhesivity through increasing expression of adhesion molecules.
involved in disruption of cell–cell junctions, adhesion molecule expression and leukocyte transendothelial migration, which contribute to endothelial barrier dysfunction and endothelial permeability. ROS are produced following activation of neutrophils, thrombogenic and edemic agents, cytokines, growth factors, Gprotein coupled receptor agonists and shear stress, and play an important role in the pathophysiology of vascular disorders and lung injury (Figures 1 and 2). Signal transduction activated by ROS, “redox signaling” has been an emerging area of investigation.
150
M. Ushio-Fukai et al.
FIGURE 2 Role of ROS in endothelial barrier function and inflammatory response in ALI, diabetes and atherosclerosis. In inflammatory state, LPS binding to TLR4 receptor induces NADPH oxidase activation and production of ROS in PMNs as well as ECs, thereby stimulating phosphorylation of AJs complex proteins and MyD88-dependent NF-κB signaling in ECs. These responses play an important role for loss of endothelial barrier integrity and expression of ICAM-1 in cell surface. Adhesion of PMNs to ECs is mediated by binding of constitutive ICAM-1 to CD18 integrin and provides the appropriate coupling required for PMNs to transmit oxidant signals to ECs. Furthermore, various inflammatory stimulants such as thrombin, TNFα, VEGF also stimulates NADPH oxidase activation and production of ROS in ECs, and thus promoting loss of cell–cell adhesions and initiation of NF-kB signaling in ECs, which contribute to increase in vascular permeability. These inflammatory responses are prevented by endogenous growth factor such as PEDF and anticoagulant serine protease such as APC with antioxidant properties. Finally, increased endothelial permeability and/or ROS itself could promote infiltration of inflammatory cells in the tissue via expression of adhesion molecules such as ICAM-1 in ECs, which may participate in tissue repair and remodeling. Thus, ROS produced by PMN and ECs play an important role in various inflammatory diseases such as ALI, diabetes and atherosclerosis through increase in vascular permeability.
ROS are generated from a number of sources including the mitochondrial electron transport system, xanthine oxidase, the cytochrome p450, the NADPH oxidase, uncoupled NO synthase (NOS) and myeloperoxidase. The NADPH oxidase has emerged as major sources of ROS in ECs. The prototype phagocyte NADPH oxidase is composed of membrane-bound gp91phox and p22hox as well
8. Reactive Oxygen Species and Endothelial Permeability
151
as cytosolic components such as p47phox, p67phox and small GTPase Rac. Recently, several human homologs of gp91phox (also termed as Nox2) have been identified in non-phagocytic cells. Pro-inflammatory cytokines induce oxidant production via activation of NADPH oxidase and stable adhesion of PMNs to ECs, which in turn promotes microvascular lung injury and pulmonary edema formation (Malik and Lo, 1996) (Figure 2). The overall objective of this review is to summarize the recent information on role of ROS and oxidant signaling in regulating EC permeability. Understanding molecular mechanisms by which ROS regulate endothelial barrier function may lead to development of novel therapeutic strategies for preventing tissue damage due to inflammation, sepsis or other causes of acute lung injury. II. GENERATION AND METABOLISM OF ROS ROS are formed as intermediates in reduction-oxidation (redox) processes, leading from oxygen to water (Fridovich, 1978). The reduction of oxygen by one electron increases the formation of O− 2 , which can be either dismutated to H2 O2 spontaneously or in a reaction catalyzed by superoxide dismutase (SOD). Further reactions lead to the formation of hydroxyl radicals (· OH), especially in the presence of metal ions through the Fenton or Haber–Weiss reactions (Fridovich, 1978; · Deby and Goutier, 1990). O− 2 reacts with nitric oxide (NO ) at a near diffusion− limited rate to form peroxynitrite (ONOO ), which is a potent oxidant. NO· is protective and thus loss of NO· bioavailability via these reactions contributes to endothelial dysfunction and various pathophysiologies. Mammalian peroxidases such as myeloperoxidase (MPO) are activated by H2 O2 to form a highly reac− · tive radical that can oxidize NO· to NO− 2 and react with NO2 to form NO2 . · NO2 can, in turn, participate in nitrating events, such as the formation of nitrotyrosines. Under homeostatic conditions, antioxidant defenses are critical to modulate the steady state balance. ROS are all produced to varying degrees, and are tightly regulated by anti-oxidants such as SOD, catalase, thioredoxin, glutathione peroxidase and other small molecules. Under normal conditions, the rate of ROS production is balanced by the rate of elimination. However, a mismatch between ROS formation and the ability to defend against them by antioxidants results in increased bioavailability of ROS leading to a state of oxidative stress, a risk factor of various inflammatory diseases (Griendling et al., 2000; Landmesser et al., 2005). III. ROS GENERATING SYSTEM IN ECS (NADPH OXIDASE) There are several other enzymatic sources of ROS in mammalian cells, depending on the tissue and environmental context which include the mitochondrial electron transport chain, xanthine oxidase, cytochrome p450, and uncoupled
152
M. Ushio-Fukai et al.
eNOS (Griendling et al., 2000; Li and Shah, 2004). There may be complex intereactions among different sources of ROS and feedback and feedforward regulation of ROS accumulation (Li and Shah, 2004). In ECs a major source of ROS is NADPH oxidase (Babior, 2000) which is activated by growth factors, cytokines, shear stress, hypoxia, and G-protein coupled agonists (Griendling et al., 2000). The prototype phagocytic NADPH oxidase consists of the membrane bound cytochrome b558 comprising the catalytic subunit gp91phox (Nox2) and regulatory subunit p22phox , as well as cytosolic subunits, p40phox , p47phox and p67phox , and the GTPase, Rac (DeLeo and Quinn, 1996). Superoxide production is induced by assembly of the cytosolic and membrane-bound subunits, which is mediated through the phosphorylation of p47phox (Bokoch and Knaus, 2003). The neutrophil NADPH oxidase is normally quiescent in basal state but releases large amounts of O·− 2 in bursts upon activation during phagocytosis via the one electronreduction of oxygen by NADPH, which participate in host defense by killing invading microbes (Babior, 1995; Lambeth, 2004). By contrast, the non-phagocytic NADPH oxidase(s) continuously produce low levels of O·− 2 intracellularly in basal state, yet it can be further stimulated acutely by various agonists and growth factors. Several human homologs of gp91phox (also termed as Nox2) have been identified including Nox1, Nox3, Nox4, Nox5, Dual oxidases (Duox1/2) (Lambeth, 2004; Cheng et al., 2001; Geiszt et al., 2000; Geiszt, 2006). All Nox family members share the common binding sites for FAD, heme, and NADPH and 6 transmembrane domains. Each Nox is encoded by different genes (Lambeth, 2004; Lassegue and Clempus, 2003). Recently, isoforms of p47phox and p67phox were discovered. These were termed as NoxO1 (for Nox organizer 1) and NoxA1 (for Nox activator 1), which substitute for p47phox and p67phox respectively (Banfi et al., 2003; Geiszt et al., 2003). An important difference between p47phox and NoxO1 is that the latter lacks the p47phox domain that is regulated by phosphorylation; therefore NoxO1 may influence oxidase activity quite differently from p47phox . In ECs, all the phagocytic NADPH oxidase subunits including Nox2, p22phox, Rac1, p47phox as well as Nox1, Nox4 and Nox5 are expressed, and various Nox enzymes contribute to ROS production at different degree, location and EC types (Li and Shah, 2004; Babior, 2000). In porcine pulmonary artery ECs, histochemical data showed the presence of Nox2 and p22phox well as p47phox and p67phox (Hohler et al., 2000). In human umbilical vein ECs, RT-PCR demonstrated the presence of mRNA for all the Nox enzymes (Jones et al., 1996). ECs cultured from rat aorta express mRNA for Nox4 in addition to Nox2 and a membrane preparation demonstrated that ROS production is inhibited by Nox4 antisense oligonucleotide (Datla et al., 2007). In addition, Nox5 is expressed in human microvascular ECs (BelAiba et al., 2007). To our knowledge, expression of Nox3, Duox, NoxO1 and NoxA1 in ECs has not been demonstrated.
8. Reactive Oxygen Species and Endothelial Permeability
153
IV. REGULATION OF ADHERENS JUNCTIONS (AJS) BY PHOSPHORYLATION AND BY RHO GTPASE Endothelial AJs maintain endothelial barrier integrity by connecting adjacent ECs and their association with the cytoskeleton, allowing the cells to form a tight barrier between the vessel lumen and the stroma. Vascular endothelial cadherin (VE-cadherin) is an essential transmembrane homophilic adhesion molecule in endothelial AJs that control cell–cell adhesion in ECs (Dejana et al., 1995). The cytoplasmic domain of VE-cadherin binds to cytosolic proteins either β-catenin, plakoglobin or p120catenin which couple to the actin cytoskeleton through αcatenin (Bazzoni and Dejana, 2004). Some studies have shown that interaction of α-catenin with β-catenin or with actin is mutually exclusive (Drees et al., 2005; Yamada et al., 2005). The linkage between VE-cadherin-based AJ complex and actin cytoskeleton contributes to the strong adhesion and the endothelial barrier integrity (Figure 1). Phosphorylation states of AJ proteins can alter the interactions between components of AJ proteins. In order to maintain endothelial barrier function, VEcadherin function is tightly regulated through mechanisms that involve protein phosphorylation and cytoskeletal dynamics (Esser et al., 1998; Lampugnani et al., 1997; Lilien and Balsamo, 2005; Alema and Salvatore, 2007). Tyrosine phosphorylation of AJ components which is related to the impairment of cell–cell adhesion is regulated by the state of confluence of the cells. Tyrosine phosphorylation of VE-cadherin, β-catenin and p120 occurs in looser AJs at early cell contacts, while is reduced by the formation of mature and cytoskeleton-connected junctions in tightly confluent cells (Lampugnani et al., 1997). Thus, changes in phospho-tyrosine content parallels to changes in the molecular organization of cell–cell contacts. Of note, ROS production is also dependent on cell density. ROS levels are increased and decreased at low and high confluent cells, respectively (Pani et al., 2000), which is consistent with the idea that ROS are involved in disruption of cell–cell contacts in ECs (Figure 1). Rho-like small GTPases are key molecular switches that control cytoskeletal dynamics and cadherin function. VE-cadherin colocalizes with actin stress fibers at cell–cell junctions in ECs. Inhibition of VE-cadherin-mediated adhesion induces reorganization of the actin cytoskeleton and loss of cell–cell adhesion, which contributes to increased monolayer permeability and neutrophil transendothelial migration. Modulation of the actin cytoskeleton strongly affects VE-cadherin distribution. Cytoskeletal reorganization resulting from the inactivation of p21Rho causes a diffuse localization of VE-cadherin, which is accompanied by the reduced cell–cell adhesion. Thus, monolayer permeability is modulated by VE-cadherin-mediated cell–cell adhesion, which is in turn controlled by the dynamics of the actin cytoskeleton through Rho GTPases (Hordijk et al., 1999).
154
M. Ushio-Fukai et al.
V. ROS-GENERATING STIMULANTS WHICH REGULATE ENDOTHELIAL PERMEABILITY Thrombin Thrombin proteolytically cleaves and activates the protease-activated receptors PAR1 that are present on EC surface, leading to disassembly of AJs and reorganization of the actin cytoskeleton, which results in increased endothelial permeability and barrier disruption (Mehta and Malik, 2006). With the use of an intact lung model, thrombin is shown to increase pulmonary vascular resistance in conjunction with a rise in the capillary filtration coefficient and lung water content (Horgan et al., 1987; Malik and Horgan, 1987). Thrombin increases ROS production albeit to a slower kinetics than that of TNFα (Coughlin, 2000; Lum and Malik, 1996; Tiruppathi et al., 2002). Thrombin stimulates ROS production in a Nox5-dependent manner in human ECs (BelAiba et al., 2007) or through upregulating p22phox of NADPH oxidase in human EC line (Djordjevic et al., 2005). The nonreceptor protein-tyrosine phosphatase (PTP) SHP2 co-precipitates with VE-cadherin complexes in confluent, quiescent HUVECs. Thrombin stimulates SHP2 tyrosine phosphorylation and its dissociation from VE-cadherin complexes, thereby regulating the tyrosine phosphorylation of AJs complex proteins, which contributes to increased endothelial permeability (Ukropec et al., 2000). Although it remains unknown how ROS regulate thrombin-induced increase in endothelial permeability, it is possible that ROS are involved in SHP-2 phosphorylation or oxidative inactivation of this PTP, thereby promoting tyrosine phosphorylation of AJs proteins and barrier dysfunction. PAR1 stimulates RhoA through heterotrimeric G proteins Gα12/13 binding to the guanine nucleotide exchange factor p115RhoGEF that facilitates its GEF activity, leading to RhoA activation (Kozasa et al., 1998). Gαq-mediated stimulation of PKCα activates RhoA by phosphorylating Rho guanosine diphosphate (GDP) dissociation inhibitor (Rho GDI) and p115RhoGEF (Mehta et al., 2001; Holinstat et al., 2003; Knezevic et al., 2007). Downstream of RhoA, Rho-associated kinase (ROCK) and LIM kinase induce reorganization of actin and microtubule cytoskeleton, thereby increasing acto-myosin contractility (Yang et al., 1998; Gorovoy et al., 2005; Essler et al., 1998) by phosphorylating MLC phosphatase, MYPT1, which in turn increasing MLC phosphorylation (Birukova et al., 2004d). These responses result in endothelial barrier dysfunction and pulmonary edema associated with ALI. By contrast, H2O2-induced MLC phosphorylation and actin rearrangement are mediated through MLCK-dependent pathway in bovine pulmonary artery ECs (Zhao and Davis, 1998). Independent of Rho activation, activation of atypical PKCzeta is also involved in thrombin-induced endothelial permeability in HUVECs (Li et al., 2004). Of interest, angiopoietin-1 protects endothelial barrier integrity at least in part through inhibition of thrombin-induced activation of both PKCzeta and Rho (Li et al., 2004).
8. Reactive Oxygen Species and Endothelial Permeability
155
TNF-α TNF-α is an inflammatory cytokine, and is released from activated monocytes and macrophages sequestered in the microcirculation (Hocking et al., 1990) and is increased in bronchoalveolar lavage fluid from patients with ARDS (Malik et al., 1989; Suter et al., 1992). TNF-a increases ROS production and stimulates lung vascular barrier dysfunction upon engaging TNF-α receptor-1, leading to increased endothelial permeability in cultured EC and in vivo (Lum and Malik, 1996; Hocking et al., 1990; Horvath et al., 1988; Ferro et al., 2000; Partridge et al., 1993). In addition, TNF-α upregulates ICAM-1 and E-selectin expression (Lo et al., 1992; Rahman et al., 1998, 2000), thereby promoting neutrophil adhesion to endothelium and ROS generation (Rahman et al., 1998), which in turn increases endothelial permeability. Mechanically, TNF-α induces reorganization of the actin cytoskeleton and increases formation of intercellular gaps and EC monolayer permeability through promoting loss of cell–cell junctions by activation of Rho, Rac, and Cdc42 (Wojciak-Stothard et al., 1998) or by tyrosine phosphorylation of VE-cadherin (Nwariaku et al., 2002). Nwariaku et al. (2004) reported that TNF-α-induced loss of endothelial junctional integrity is mediated through PAK1-NADPH oxidase-JNK-VE-cadherin phosphorylation pathway. Thus, PAK1 is a potential therapeutic target for oxidant stress-dependent inflammatory diseases which are associated with increased endothelial permeability. Transforming Growth Factor-β1 (TGF-β1) TGF-β1 is a cytokine critically involved in acute lung injury and EC barrier dysfunction. TGF-β1-induced decrease in pulmonary endothelial monolayer integrity is associated with disassembly of the adherens junction. This response may be due to activation of a MLC kinase (MLCK)-dependent signaling cascade (Hurst et al., 1999). Mechanically, TGF-β1-mediated adherens junction disassembly is associated with interaction of TGF-beta type II receptor with Smad3 and Smad4 (Tian and Phillips, 2002). TGF-β1 induces barrier dysfunction, which is linked to increased actin stress fiber formation, MLC phosphorylation, EC contraction, and gap formation, which is abolished by inhibition of Rho and Rhokinase, and by MT stabilization with taxol (Birukova et al., 2005). Thus, MT dynamics plays an important role in the TGF-β1-mediated Rho regulation, EC barrier dysfunction, and actin remodeling. Lu et al. (2006) reported that TGF-β1 induces endothelial barrier dysfunction through Smad2-dependent p38 activation, resulting in RhoA activation. TGF-β itself induces ROS production as part of its signal-transduction pathway (Koli et al., 2008). However, role of TGF-β-induced ROS in EC barrier dysfunction remains unclear. Vascular Endothelial Growth Factor (VEGF) VEGF is one of the potent angiogenesis factor (Ferrara and Davis-Smyth, 1997) and vascular permeabilizing agents, also named vascular permeability fac-
156
M. Ushio-Fukai et al.
tor (Dvorak et al., 1995). Lung endothelial damage is a characteristic morphological feature of ischemia-reperfusion injury. Pretreatment with adenovirus encoding soluble VEGF receptor type II (VEGFR2) prevents I/R-mediated increase in lung vascular permeability in rats. Activation of the stress protein response with geldanamycin or pyrrolidine dithiocarbamate prevents the development of pulmonary edema by inhibiting VEGF-induced phosphorylation of VE-cadherin and the formation of actin stress fibers in a model of lung ischemia-reperfusion injury in rats (Godzich et al., 2006). Hence it plays a key role in the pathogenesis of ALI/ARDS (Medford and Millar, 2006). Endothelial AJ is a downstream target of VEGFR2 signaling linked to increase of vascular permeability in cultured EC monolayers (Godzich et al., 2006). VEGF induces tyrosine phosphorylation of AJ components, leading to loss of cell–cell contacts, which contributes to increase in vascular permeability and angiogenesis (Esser et al., 1998). VEGF stimulation promotes association of cSrc with VEGFR2, which is required for Src-dependent tyrosine phosphorylation of VE-cadherin at Tyr685 and loss of VE-cadherin-mediated cell–cell adhesion, thereby promoting vascular permeability and angiogenesis (Chou et al., 2002; Lambeng et al., 2005; Wallez et al., 2007). Furthermore, VEGF activation of redox-sensitive protein kinase C (PKC)βII increases phosphorylation of tight junction protein occluding, thereby increasing endothelial permeability (Harhaj et al., 2006). Thus, regulation of PKC activity by ROS and tight junction protein modification may have therapeutic implications. Formation of FAs involved in EC contraction also regulates EC permeability. VEGF stimulates tyrosine phosphorylation and recruitment of focal adhesion kinases (FAK) and paxillin to new FAs in ECs (Abedi and Zachary, 1997). VEGF-stimulated FA complex assembly in human microvascular ECs is mediated through activation of FAK and Pyk2 (Avraham et al., 2003) which are targets of ROS. Rho-ROCK pathway contributes to VEGF-induced microvascular endothelial hyperpermeability. MLC phosphorylation and actin stress fiber formation occur concomitantly with the increase in permeability upon VEGF stimulation (Sun et al., 2006). VEGF also promotes Src-mediated phosphorylation of FAK on Tyr861, leading to the formation of a FAK/αvβ5 signaling complex involved in increase in vascular permeability, which is significantly reduced in pp60csrc-deficient mice (Eliceiri et al., 2002). Thus, Src-mediated coupling of FAK to integrin αvβ5 is required for VEGF-stimulated vascular permeability. Taken together, cSrc is a potential molecular target regulating VEGF-induced loss of cell–cell contacts and formation of FAs, which contribute to increase in endothelial permeability. VEGF rapidly increases ROS production via activation of Rac1-dependent NADPH oxidase in ECs (Colavitti et al., 2002; Abid et al., 2007; Ushio-Fukai, 2007; Ushio-Fukai et al., 2002). Resveratrol, a polyphenolic compound in grapes inhibit ROS-dependent Src kinase activation and VE-cadherin tyrosine phosphorylation (Lin et al., 2003). Green tea catechins with antioxidant properties inhibit
8. Reactive Oxygen Species and Endothelial Permeability
157
VEGF-induced phosphorylation of VE-cadherin and Akt as well as tube formation in human microvascular ECs presumably through inhibition of cSrc (Tang et al., 2003). Thus, cSrc is a downstream target of VEGF-induced ROS and involved in tyrosine phosphorylation of VE-cadherin, thereby promoting disruption of cell–cell contacts in confluent ECs and endothelial permeability (Lin et al., 2003). VEGF-induced increase in endothelial permeability is also mediated through eNOS-dependent mechanism of transcytosis in caveolae. Localization of Flk-1/KDR and eNOS with caveolin-1 suggests that VEGF signaling occurs within the caveolar compartment (Feng et al., 1999). Of note, NADPH oxidase is also localized in Cav1-enriched caveolae fraction in ECs (Yang and Rizzo, 2006), suggesting that peroxinitrite formed by reaction of eNOS-derived NO and NADPH oxidase-derived O− 2 may be involved in this process. VEGF also mediates airway inflammation and remodeling in asthma of lung through regulating MMP-9 expression (Lee et al., 2006). NADPH oxidase-derived ROS stimulate induction of MMP-9 expression, which may be relevant in oxidative stress-dependent inflammatory diseases (Zalba et al., 2007). VEGF also stimulates rapid endocytosis of VE-cadherin through beta-arrestin, thereby disrupting the endothelial barrier function (Gavard and Gutkind, 2006). This process is initiated by activation of Rac1 through the Src-dependent phosphorylation of Vav2, a guanine nucleotide-exchange factor, which in turn, promotes the p21-activated kinase (PAK)-mediated phosphorylation of the intracellular tail of VE-cadherin. This results in the recruitment of beta-arrentin2 to serine-phosphorylated VE-cadherin, thereby promoting its internalization into clathrin-coated vesicles and the consequent disassembly of intercellular junctions. Given that Rac1 is a critical component of NADPH oxidase, and that Src-dependent VE-cadherin phosphorylation is ROS-dependent, it is likely that NADPH oxidase-derived ROS may be involved in this mechanism. Understanding this novel signaling mechanism may help to identify new therapeutic targets for the treatment of many human diseases that are characterized by vascular leakage. Lysophosphatidylcholine (LysoPC) LysoPC, a major component of oxidized low density lipoprotein (oxLDL), evokes diverse biological and pathophysiological responses through ROS production and increases endothelial permeability (Essler et al., 1999; Yan et al., 2005). In human coronary artery ECs, lysoPC increases endothelial monolayer permeability and reduces the expression of tight junction molecules including zonula occludens-1, occludin, claudin-1, and junctional adhesion molecule through increase in oxidative stress and activation of c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinase (p38MAPK). The antioxidant can effectively block LysoPC-induced endothelial permeability, suggesting an involvement of ROS. Another mechanism for oxidized LDL-induced increased endothelial
158
M. Ushio-Fukai et al.
permeability includes its effect on lysyl oxidase, a key enzyme involved in extracellular matrix (ECM) synthesis. Hypoxia NADPH oxidases have been shown to serve as oxygen sensors in the lung. Chronic hypoxia induces vascular remodeling with medial hypertrophy leading to the development of pulmonary hypertension. NOX1, NOXA1, NOXO1, p22phox, p47phox, p40phox, p67phox, NOX2, and NOX4 are present in mouse lung tissue. Mice maintained for 21 days under hypoxic (10% O2 ) or normoxic (21% O2 ) conditions show upregulation of NOX4 mRNA by hypoxia in homogenized lung tissue (Mittal et al., 2007). In lungs from patients with idiopathic pulmonary arterial hypertension (IPAH), expression of NOX4 is upregulated mainly in the vessel media (Mittal et al., 2007). EC grown to confluence under hypoxia (5% O2 ) form a tighter monolayer than ECs grown under normoxia (21% O2 ). This tighter barrier in hypoxic cells appears to be due, in part, to the inhibition of RhoA activity (Solodushko et al., 2007). Conversely, severe acute hypoxia disrupts the EC barrier and increases EC permeability (Wojciak-Stothard et al., 2005; Ogawa et al., 1990) due to an increase of ROS (Wojciak-Stothard et al., 2005). Hypoxia/reoxygenation Hypoxia/reoxygenation-induced changes in endothelial permeability are accompanied by endothelial actin cytoskeletal and adherens junction remodeling, which is mediated through coordinated actions of the Rho GTPases Rac1 and RhoA. Rac1 and RhoA are rapidly activated by changes in oxygen tension, and their activity depends on NADPH oxidase- and PI3 kinase-dependent production of ROS. Rac1 acts upstream of RhoA, and its transient inhibition by acute hypoxia leads to activation of RhoA, followed by stress fiber formation, dispersion of adherens junctions, and increased endothelial permeability. Reoxygenation strongly activates Rac1 and restores cortical localization of F-actin and VE-cadherin. This effect is due to Rac1-mediated inhibition of RhoA, which can be prevented by activators of RhoA and lysophosphatidic acid (Wojciak-Stothard et al., 2005). Thus, Rho GTPases act as mediators coupling cellular redox state to endothelial function. Polymorphonuclear Leukocyte (PMN) Lung inflammatory disease is characterized by increased PMN infiltration and vascular permeability. Leukocyte transendothelial migration occurs through intercellular gaps between ECs or transcellular pathway which is dependent on caveolae/caveolin-1. PMN adhesion to activated EC during acute inflammation promotes formation of intercellular gaps between ECs by loss of endothelial cell– cell adhesion, resulting in increased EC permeability and PMN transendothelial migration (Ionescu et al., 2003; Del Maschio et al., 1996). Mechanically, activated neutrophils induce hyperpermeability through tyrosine phosphorylation
8. Reactive Oxygen Species and Endothelial Permeability
159
of AJs proteins in coronary venular ECs (Tinsley et al., 1999). ROS produced from primed leukocytes are involved in the pathogenesis of lung injury. p47phox KO mice show greater alveolar neurtrophilic leucocyosis and have a decreased number of macrophages in bronchoalveolar lavage after acid or saline aspiration. NF-kappaB activation and resultant ICAM-1 expression in ECs occur secondary to oxidants generation by the PMN NADPH oxidase complex. The functional relevance of the PMN NADPH oxidase in mediating TNFα-induced ICAM-1dependent endothelial adhesivity is evident by reduced adhesion of p47phox-/PMN in co-culture experiments (Fan et al., 2002). Thus, oxidant signaling by PMN NADPH oxidase complex is an important determinant of TNFalphainduced NF-kB activation and ICAM-1 expression in ECs. Moreover, augmented NF-kB activation and the TLR2 upregulation in ECs are secondary to oxidant signaling generated by PMN NADPH oxidase. LPS induces TLR2 up-regulation through TLR4- and MyD88-dependent signaling. The functional relevance of NADPH oxidase in mediating TLR4-induced TLR2 expression in ECs is evident by markedly elevated and stable ICAM-1 expression as well as augmented PMN migration in response to sequential challenge with LPS and peptidoglycan (Fan et al., 2003). Thus, PMN NADPH oxidase-derived oxidant signaling is an important determinant of the cross-talk between TLR4 and TLR2 and EC activation (Figures 1 and 2). ICAM-1 and VCAM-1 Endothelial activation is an early step during leukocyte/endothelial adhesion and leukocyte transendothelial migration in inflammatory state. Leukocyte adhesion is mediated totally and transendothelial migration partially by heterotypic interactions between the β1 and β2 integrins on the leukocytes and their ligands, Ig-like cell adhesion molecules VCAM-1 and ICAM-1 on the endothelium. Both integrins and Ig-CAMs are known to have signaling capacities. Clustered ICAM-1 and VCAM-1 are in very close proximity on the EC surface in particular following adhesion of leukocytes that use β1 and β2 integrins for transmigration, suggesting that the signaling induced by these molecules may be interconnected. Whether ROS are involved in cross-talk between ICAM-1 and VCAM-1-induced signaling events remain unknown. ICAM-1 Five ICAMs have been discovered thus far and are members of the Ig supergene family and are receptors for the β2 family of integrins on leukocytes (Hopkins et al., 2004; Hubbard and Rothlein, 2000). ICAM-1 is one of the main integrin ligand and specifically involved in the leukocyte migration across the endothelial barrier. ICAM-1 knockout mice show impaired inflammatory and immune responses (Sligh et al., 1993). Antisense oligonucleotides to ICAM-1 decreases leukocyte adhesion and inflammation (Rijcken et al., 2002). ICAM-1 is normally present in low levels on ECs, but its expression is dramatically in-
160
M. Ushio-Fukai et al.
creased in response to various proinflammatory stimuli including TNF-α, IL-1β, and LPS (Myers et al., 1992), phorbol myristate acetate (Wertheimer et al., 1992), thrombin (Rahman et al., 2004) and shear stress (Tzima et al., 2002). ICAM-1 is localized at the apical surface of ECs on activation and is organized in microdomains along with VCAM-1 at around adherent leukocytes. The cytoplasmic C-terminus of ICAM-1 associates to the actin-binding ERM proteins (ezrin, radixin, moesin) as well as to α-actinin (Carpen et al., 1992; Etienne-Manneville et al., 2000). ICAM-1 acts as a signal transducer in ECs. ICAM-1 cross-linking activates the p60src kinase to phosphorylate cortactin (Durieu-Trautmann et al., 1994), and releases intracellular calcium and activates the Rho GTPase, which contributes to regulating actin cytoskeleton and EC contractility (Lorenzon et al., 1998). Moreover, ICAM-1 activates p60src via the activation of xanthine oxidase, leading to tyrosine phosphorylation of ezrin and p38 MAPK (Wang et al., 2003). These effects are mediated by the C-terminus of ICAM-1 and are required for increase in endothelial permeability and enhanced lymphocytes and leukocyte transendothelial migration (Greenwood et al., 2002; Yang et al., 2005; Lyck et al., 2003). ICAM-1 activation also induces tyrosine phosphorylation of focal adhesion signaling proteins including FAK, paxillin, and p130Cas in parallel to Rho activation. Tyrosine-phosphorylated Cas associates with the adaptor protein Crk and the GTP exchange factor C3G. In addition, tyrosine phosphorylation of FAK, paxillin, and Cas as well as Crk and JNK activation are blocked by pretreatment of the cells with inhibition of Rho (Etienne et al., 1998). Thus, activation of ICAM-1 may couple Rho to phosphorylation of FAs proteins, thereby promoting leukocyte transmigration. Moreover, ICAM-1 engagement activates tyrosine kinases, Src and proline-rich tyrosine kinase 2 (Pyk2), which induces phosphorylation of VE-cadherin on Tyr658 and Tyr731, respectively, which correspond to the p120-catenin and β-catenin binding sites, respectively (Allingham et al., 2007). Importantly, both Src and Pyk2 are activated by ROS. PMN adhesion to EC is increased in ROS-treated HUVEC (Sellak et al., 1994) which is inhibited by anti-ICAM-1, anti-CD11a, anti-CD11b, and anti-CD18 antibodies (Sellak et al., 1994). EC surface expression of ICAM-1 increases ROS production (Lo et al., 1993). Inhibition of endogenous catalase in ROS-treated EC augments the PMN adhesion, whereas catalase treatment blocks the ROS-induced PMN adhesion, indicating that oxidant-antioxidant balance at the EC interface is a critical factor modulating PMN-EC adhesive interactions (Lo et al., 1993) (Figures 1 and 2). VCAM-1 The main β1-integrin ligand on the endothelium, VCAM-1, is, in contrast to ICAM-1, absent in resting cells but greatly up-regulated by inflammatory stimuli. Similarly to ICAM-1, VCAM-1 not only acts as an adhesion receptor, but also as a signal transducer upon binding of leukocytes. The cytoplasmic domain of VCAM-1 is only 19 amino acids long and comprises a type I PDZ-binding motif.
8. Reactive Oxygen Species and Endothelial Permeability
161
However, whether specific interactions are mediated by this motif is unknown; to date, only ezrin and moesin have been shown to associate with the cytoplasmic domain of VCAM-1 (Barreiro et al., 2002). VCAM-1 cross-linking induces the Rac1-dependent ROS production, activation of p38 MAPK and changes in the actin cytoskeleton (i.e. stress fiber formation), which contribute to increased endothelial permeability and leukocyte transendothelial migration (van Wetering et al., 2003). Of note, VCAM1-induced Rac1-mediated ROS production is involved in phosphorylation of Pyk2 that controls endothelial integrity through the phosphorylation of β-catenin (van Buul et al., 2005). ROS may inactivate VEcadherin either by proteolytic breakdown or by reducing its homophilic adhesion through reduction of its link to the actin cytoskeleton. Moreover, VCAM-1 activation of endothelial NADPH oxidase induces transient activation of PKCα via oxidation, which is necessary for VCAM-1-dependent transendothelial cell migration (Abdala-Valencia and Cook-Mills, 2006). Integrins Adhesions of cells to extracellular matrix and adjacent cells are mediated by integrins and VE-cadherin, respectively. Understanding how they are coordinated to regulate endothelial integrity is essential. Integrins transmit signals from “outside in” as well as “inside out”, thus acting as signal transducing molecules as well as mechano-sensors. Integrin engagement by fibronectin-coated beads leads to disruption of the VE-cadherin-containing AJs (Wang et al., 2006), which is accompanied by increases of tyrosine phosphorylation of β-catenin and p120ctn, as well as the dissociation of α-catenin from VE-cadherin. A membrane-targeted Src reporter with the fluorescence resonance energy transfer in live cells shows that the integrin engagement induces activation of Src at adherens junctions, which is subsequently disrupted as well as significant alteration of cortical actin filaments at AJs. Given that integrin engagement activates cSrc through ROS production (Giannoni et al., 2005), ROS may be involved in disruption of VE-cadherin containing AJs via modulation of the actin cytoskeleton networks. Integrin αvβ5 regulates lung vascular permeability and pulmonary endothelial barrier function (Su et al., 2007). A function-blocking antibody against the alphavbeta5 prevents lung vascular permeability in two different models of ALI: ischemia-reperfusion in rats, which is mediated by VEGF, and ventilation-induced lung injury in mice which is mediated at least in part by TGF-β. Mice lacking β3 show enhanced angiogenesis and vascular leak in response to VEGF (Reynolds et al., 2002; Taverna et al., 2004). Mice lacking β5 show less edema in models of ischemic stroke or pulmonary ischemia-reperfusion or ventilator-induced lung injury (Su et al., 2007). Beta1 integrins can also influence the disruption of vascular permeability during inflammation, since β1 integrins can influence the ability of circulating cells to arrest, adhere, and extravasate at sites of injury and vascular leak (Sixt et al., 2006). Thus, several integrins regulate pulmonary endothelial permeability, and seem to be potentially attractive therapeutic targets for ALI.
162
M. Ushio-Fukai et al.
Shear Stress Shear stress plays an important role in atherosclerosis development. The disassembly of AJs in response to shear is important for the endothelial permeability barrier and other aspects of endothelial cell function (Noria et al., 1999). ECs exhibit profound changes in cell shape in response to shear stress that may require disassembly/reassembly of AJs complexes that mediate cell–cell adhesion (Seebach et al., 2000). In response to shear in endothelial monolayers, α-catenin that links β-catenin-bound cadherin to the actin cytoskeleton is dissociated from VE-cadherin complexes. This is associated with increased tyrosine phosphorylation of β-catenin bound to VE-cadherin and loss of SHP-2 from VE-cadherin complexes (Ukropec et al., 2002). Thus, the functional interaction of α-catenin with VE-cadherin-bound β-catenin is modulated by the extent of tyrosine phosphorylation of β-catenin that is regulated by SHP-2 associated with VE-cadherin complexes. Acute laminar shear stress induces cortical cytoskeletal remodeling, which is associated with transient peripheral translocation of cortactin, an actin-binding protein involved in the regulation of actin polymerization. This cortactin translocation is mediated through Rac1 and PAK1, but not Src, MLCK or ROCK (Birukov et al., 2002). In contrast, Shikata et al. (2005) reported that shear stress induces peripheral accumulation of FAs, activation of Rac1 without affecting Rho and FAK phosphorylation, thereby increasing transendothelial electrical resistance (TER) in human pulmonary EC, which is further promoted by barrier-protective phospholipid sphingosine 1-phosphate (S1P). Oscillatory shear stress increases ROS levels in ECs, whereas laminar shear stress blocks this response. Recently, Mowbray et al. (2008) reported that laminar shear upregulates mechanosensitive antioxidant, peroxiredoxin-1 in EC. Thus, effects of shear stress on endothelial barrier integrity seem to be dependent on extent and duration of shear as well as cell types. Advanced glycation end products (AGEs) The formation of AGEs is an important biochemical abnormality that accompanies diabetes mellitus and inflammation (Basta et al., 2004). Interaction between AGEs and their receptor (RAGE) evokes generation of ROS in EC, which may contribute to increase in endothelial permeability and vascular inflammation. The increase in permeability is accompanied by alterations of the physical integrity of the endothelium, as shown by the destruction of organized actin structures and alterations of cellular morphology (Esposito et al., 1989; Wautier et al., 1996). sRAGE, the extracellular ligand-binding domain of RAGE, blocks AGEs from binding to RAGE, and suppresses accelerated atherosclerotic lesion formation and decreases vascular hyperpermeability (Wautier et al., 1996; Park et al., 1998; Bucciarelli et al., 2002; Goova et al., 2001). Levels of AGEs and RAGE are increased in streptozotocin-treated (diabetic) apolipoprotein Enull mice that have advanced atherosclerosis (Esser et al., 1998). Blockade of
8. Reactive Oxygen Species and Endothelial Permeability
163
RAGE by sRAGE in mice with diabetes reduces atherosclerotic lesion area, supporting the notion that RAGE is a crucial for the development and acceleration of atherosclerosis and that sRAGE is an effective intervention (Park et al., 1998; Bucciarelli et al., 2002). Angiotensin II (Ang II) Vascular inflammation is involved in the initiation and progression of atherosclerosis, hypertension- and diabetes-induced vascular complications. Angiotensin II (Ang II), the key effector of the renin-angiotensin system, plays a central role in the regulation of blood pressure and also capable of inducing inflammatory response in the vascular wall, which includes increase in vascular permeability, infiltration of leukocytes, and tissue remodeling. Ang II increases vascular permeability via AT1 receptors, whereas stimulation of AT2 receptors exerts an opposite effect (Victorino et al., 2002). In both hypertensive and normotensive humans, ACE inhibitors produce pulmonary vasodilation and an increase in capillary volume that are blocked by cyclooxygenase inhibitors (Linz et al., 1995; Swartz and Williams, 1982). In addition, ACE inhibitors improve pulmonary diffusion in chronic heart failure, which is prevented by aspirin, a prostaglandin inhibitor (Guazzi et al., 1997). These suggest an importance of prostaglandin in Ang II-related alveolar-capillary membrane diffusing capacity or capillary permeability. Ang II-induced VEGF may contribute to the pathogenesis via the up-regulation of vascular permeability (Cheng et al., 2005). Importantly, Ang II is a potent stimulator for ROS production via activation of NADPH oxidase in vasculature (Griendling et al., 2000). Given that both Ang II and VEGF stimulate ROS production in the vessel wall, it is tempting to speculate that Ang II-induced increase in vascular permeability is due to an increase in ROS. 4-Hydroxy-2-nonenal (4-HNE) 4-HNE is one of the major biologically active aldehydes formed during inflammation and oxidative stress, and is implicated in a number of cardiovascular and pulmonary disorders involved in vascular endothelial permeability. In bovine lung microvascular ECs, 4-HNE induces ROS generation, thereby increasing EC permeability by modulating cell–cell adhesion through focal adhesion, adherens and tight junction proteins as well as integrin signal transduction (Usatyuk et al., 2006). This mechanism may lead dramatic alteration in endothelial cell barrier dysfunction during heart infarction, brain stroke, and lung diseases. Microparticles Endothelium-derived microparticles (EMPs) are shown as a new marker of EC dysfunction. Increased levels of circulating microparticles have been observed in inflammatory disorders and diabetes mellitus. Endothelium-derived EMPs induce attenuation of endothelium-mediated vasodilation and eNOS-derived NO production, and promote pulmonary edema, thereby contributing to acute lung
164
M. Ushio-Fukai et al.
injury (Densmore et al., 2006). Mezentsev et al. (2005) showed that EMPs impair angiogenesis-related responses in vitro, which is partially inhibited by cell-permeable SOD mimetic Mn-TBAP. Thus, EMPs-induced ROS seem to contribute to impairment of endothelial function and edema formation. Thus, EMPs may represent new therapeutic targets. Rac1 Activation of Rac1 stimulates generation of ROS, which are capable of activating Pyk2 (van Wetering et al., 2003; Frank et al., 2000) and Src (Allingham et al., 2007). Rac1-induced ROS disrupt VE-cadherin-mediated cell–cell adhesion through increase in tyrosine phosphorylation of α-catenin, a component the VE-cadherin-catenin complex in HUVECs (van Wetering et al., 2002). Inhibition of VE-cadherin function induced by VE-cadherin-blocking antibodies activates Rac1, thereby increasing production of ROS, which subsequently promotes intercellular gap formation in HUVECs. This loss of cell–cell contacts is due to increase in tyrosine phosphorylation of VE-cadherin-associated beta-catenin by Pyk2 (van Buul et al., 2005) that regulates cell adhesion (Lakkakorpi et al., 1999) and phosphatidylinositol 3-kinase/Akt pathways (Rocic et al., 2001). Thus, Rac-mediated production of ROS regulate VE-cadherin function and may play an important role in the (patho)physiology associated with inflammation and endothelial damage. In other ECs such as human pulmonary artery ECs, disruption of AJs by thrombin-induced signaling pathways is associated with an increase in RhoA activity and inactivation of Rac1, whereas reassembly of AJs is associated with activation of Cdc42 and Rac1 and inhibition of RhoA (Mehta and Malik, 2006; Kouklis et al., 2004). Activation of Rac1 counteracts RhoA activity, providing a mechanism for small GTPase coordination of AJ integrity (Noren et al., 2001; Noren et al., 2003). RhoA inactivation at cell–cell adhesion sites depends on both the activity and cortical localization of the GTPase activating protein (GAP) p190RhoGAP that stimulates GTP hydrolysis of RhoA (Wildenberg et al., 2006). Activation of p190RhoGAP is mediated through tyrosine phosphorylation by FAK (Holinstat et al., 2006) and Src (Noren et al., 2003). Src-induced phosphorylation of p190RhoGAP at Tyr1105 facilitates p190RhoGAP activity toward RhoA (Chang et al., 1995; Roof et al., 1998). Platelet-derived growth factor activates Rac and leads to translocation of p190RhoGAP to AJs, where it couples to the cadherin complex by interacting with p120-catenin (Wildenberg et al., 2006). A p120-catenin plays an indispensable role in the subcellular localization and function of p190RhoGAP. Thus, p120-catenin provides a platform for the physical interaction between p190RhoGAP and RhoA, and linking the cadherin-catenins complex to RhoA inhibition spatially coordinates the cross-talk between Rho GTPase signaling pathways at AJs (Wildenberg et al., 2006).
8. Reactive Oxygen Species and Endothelial Permeability
165
VI. ROS REDUCING FACTORS/PROTEINS WHICH BLOCK ENDOTHELIAL PERMEABILITY Pigment Epithelium-Derived Factor (PEDF) PEDF decreases ROS generation in AGE-elicited, VEGF-mediated vascular hyperpermeability by downregulation of mRNA levels of p22phox and gp91phox of NADPH oxidase (Yamagishi et al., 2006). This leads to blockade of the AGEinduced Ras activation and NF-kappaB-dependent VEGF gene induction in ECs. Thus, PEDF inhibits AGE signaling to vascular permeability by suppression of NADPH oxidase-mediated ROS generation and subsequent VEGF expression. Thus, PEDF is an important endogenous growth factor with antioxidant properties and may function to block ROS-mediated microvascular permeability during inflammation. Activated Protein C (APC) APC is an important natural anticoagulant serine protease that is proteolytically generated from protein C by the modulation of thrombin activity in the presence of thrombomodulin on an endothelial surface. Recent studies have demonstrated that, APC has anti-inflammatory and cytoprotective effects and improves sepsis survival through an unknown mechanism. Yamaji et al. (2005) demonstrated that APC has antioxidant properties and inhibits lipid peroxidation and advanced glycation end products formation. Thus, APC may prevent ROS-related chronic disorders including atherosclerosis and diabetes as well as acute shock conditions. Finigan et al. (2005) reported that APC inhibits thrombin-induced TER reductions and increases cortical MLC phosphorylation which is related to EC barrer protection. APC receptor ligation induces sphingosine 1-phosphate receptor transactivation, thereby resulting in EC cytoskeletal rearrangement and barrier protection. Thus, APC may restore vascular integrity after edemagenic agonists and treatment of patients with severe sepsis (Finigan et al., 2005).
VII. MOLECULAR TARGETS OF ROS REGULATING ENDOTHELIAL PERMEABILITY Tyrosine phosphorylation of VE-cadherin and AJs components through ROS is at least due to activation of kinases, Ca2+ channels and oxidative inactivation of phosphatases, which may contribute to ROS-dependent in crease in endothelial permeability. Several molecular targets of ROS involved in regulating EC permeability are listed as shown below (Figure 1). cSrc Src-family tyrosine kinases play a pivotal role in the disorganization of cadherin-dependent cell–cell contacts and have been shown as targets of ROS.
166
M. Ushio-Fukai et al.
Src associates with VE-cadherin and induces tyrosine phosphorylation of VEcadherin on Y685 in angiogenic tissues (Wallez et al., 2007). Csk, a negative regulator of Src family kinase, binds to pTyr685 of VE-cadherin, which is involved in cell density-dependent inhibition of cell growth (Baumeister et al., 2005). The Src family kinases, c-Src, Fyn, Yes bind to p120-catenin and modulate the stability of AJs; so does the kinase Fer (Kim and Wong, 1995). Tyrosine phopshorylation of β-catenin at Tyr142 by Fer or Fyn interferes with its binding to α-catenin, which in turn results in loss of AJs (Piedra et al., 2003; Ozawa and Kemler, 1998). Src-dependent phosphorylation of the RacGEF Vav2 is involved in PAK-mediated phosphorylation of VE-cadherin on Ser665, which contributes to β-arrestin-mediated endocytosis of VE-cadherin in response to VEGF (Gavard and Gutkind, 2006). This response is involved in loss of cell–cell contacts and increase in barrier permeability. Resveratrol, a polyphenolic compound found in grapes, prevents VEGF-induced ROS production, thereby inhibiting Src activation and tyrosine phosphorylation of VE-cadherin and β-catenin (Lin et al., 2003). Given that resveratrol promotes retention of VE-cadherin at cell–cell contacts, this may due to inhibition of ROS-dependent increase in endothelial permeability. Pyk2 Pyk2 is redox-sensitive, Ca2+ -dependent protein tyrosine kinase and it is activated and recruited to cell–cell junctions following the loss of VE-cadherin homotypic adhesion. Inhibition of Pyk2 activity by the expression of CRNK (CADTK/CAKbeta-related non-kinase), an N-terminal deletion mutant that acts in a dominant negative fashion, not only abolishes the increase in β-catenin tyrosine phosphorylation but also prevents the loss of endothelial cell–cell contact (van Buul et al., 2005). Loss of VE-cadherin function promotes Rac-mediated production of ROS, which activate Pyk2 which induce tyrosine phosphorylation of β-catenin, thereby reducing cell–cell adhesion in ECs. This Rac-ROS-Pyk2mediated signaling is important for modulation of endothelial integrity. FAK H2 O2 stimulates tyrosine phosphorylation of FAK, paxillin, beta-catenin, and VE-cadherin as well as distribution of cell–cell adhesions, which in turn decreases TER in bovine pulmonary artery ECs (Usatyuk and Natarajan, 2005). These H2 O2 -mediated responses are inhibited by overexpression of FAK-related non-kinase (FRNK), suggesting that FAK is a target of H2 O2 to transfer ROSdependent signal to endothelial barrier function by regulating cell–cell contacts. Furthermore, low dose H2 O2 increases FAK production in pulmonary microvascular ECs, which may contribute to H2 O2 -mediated cytoskeletal reorganization and cell growth/proliferation (Yang et al., 2004). In rat lung microvascular EC, H2 O2 elicits biphasic responses; initial decrease in TER, followed by recovery to baseline, indicating opening and resealing effects of H2 O2 on EC junction.
8. Reactive Oxygen Species and Endothelial Permeability
167
FAK mutant that inhibits FAK activity blocks H2 O2 -induced junctional recovery effects without affecting initial junctional separation (Quadri and Bhattacharya, 2007). Thus FAK rather plays a critical role in H2 O2 -induced remodeling of AJs to reseal the barrier in these ECs. Integrin-induced ROS induce oxidative inactivation of the low molecular weight PTPs, thereby increasing phosphorylation of FAK. Accordingly, FAK phosphorylation and other downstream events, including activation of MAPK and Src, focal adhesion formation, and cell spreading, are all attenuated by inhibition of ROS (Chiarugi et al., 2003). Thus, redox circuitry exists whereby cell adhesion induces oxidative inhibition of PTPs to promote phosphorylation of the downstream signaling of FAK, which results in increasing cell matrix adhesion and spreading onto fibronectin. p21-Activated Kinase (PAK) PAK is phosphorylated on Ser141 following Rac1 activation, and p-PAK translocates to endothelial cell–cell junctions in response to serum, VEGF, bFGF, TNFalpha, histamine, and thrombin. PAK activation and translocation increase permeability across the cell monolayer in response to these factors. Permeability correlates with PAK-induced myosin phosphorylation, formation of actin stress fibers, and the appearance of paracellular pores. Inhibition of myosin phosphorylation blocks the increase in permeability (Stockton et al., 2004). These data suggest that PAK is a central regulator of endothelial permeability induced by multiple growth factors and cytokines via an effect on cell contractility. Thus, PAK may be a potential therapeutic target for the treatment of pathophysiologies which are dependent on vascular leak, such as ischemia and inflammation. Given that PAK is downstream of Rac and phosphorylates p47phox (Knaus et al., 1995; Martyn et al., 2005), PAK-mediated responses may be mediated through ROS. c-Jun N-Terminal Kinase (JNK) TNF-alpha induces complex signaling events in ECs, leading to inflammatory gene transcription and junctional permeability increases. TNFα-induced H2 O2 activates JNK by inhibiting IKK (Pantano et al., 2003). Involvement of TRAF4 and p47phox of NADPH oxidase in oxidative activation of JNK in response to TNFα has been also reported in ECs (Xu et al., 2002; Gu et al., 2002; Li et al., 2002). TNF activates RhoA and Rho kinase, which is required for JNKdependent IL-6 production and increase in permeability in human pulmonary microvascular ECs (Mong et al., 2008). Knockdown of the basic-region leucine zipper protein, c-Jun, by a catalytic DNA molecule, Dz13, suppresses vascular permeability and transendothelial emigration of leukocytes in murine models of vascular permeability, inflammation, acute inflammation and rheumatoid arthritis (Fahmy et al., 2006). Mechanistic studies showed that Dz13 blocks cytokineinducible endothelial c-Jun, E-selectin, ICAM-1, VCAM-1 and VE-cadherin expression but has no effect on JAM-1, PECAM-1, p-JNK-1 or c-Fos. These findings implicate c-Jun as a potential target for anti-inflammatory therapies.
168
M. Ushio-Fukai et al.
Protein Kinase C (PKC) PKC is activated in response to various inflammatory mediators and contributes significantly to the endothelial barrier breakdown (Lynch et al., 1990). PKC activation can directly increase permeability of macromolecules across the endothelial or epithelial barriers by phosphorylating cytoskeletal proteins including caldesmon, vimentin, talin and vinculin (Stasek Jr. et al., 1992; Yuan et al., 2007), or by regulating expression or activity of various growth factors including VEGF (Yuan et al., 2007). PKC-mediated endothelial barrier regulation is in part dependent on caveolin-1 (Waschke et al., 2006). The Ca2+ -dependent PKC isoform PKCα plays a crucial role in initiating endothelial cell contraction and disassembly of VE-cadherin junctions. PKC phosphorylates caldesmon77 and vimentin, an event which occurs in concert with agonist-mediated EC contraction, which enhances albumin permeability and barrier dysfunction in bovine pulmonary artery ECs (Stasek Jr. et al., 1992). PKC is a target for redox modification by oxidants and antioxidants. Oxidants selectively oxidize N-terminal regulatory domain contains zinc-binding, cysteine-rich motifs and thus stimulate PKC activity. In contrast, antioxidants such as selenocompounds, polyphenolic agents such as curcumin, and vitamin E analogues react with C-terminal catalytic domain that contains several reactive cysteines, thereby inhibiting PKC activity (Gopalakrishna and Jaken, 2000). In ECs H2 O2 increases PKC activity and diacylglycerol formation (Taher et al., 1993), thereby promoting endothelial permeability (Siflinger-Birnboim et al., 1992). Myosin Light Chain Kinase (MLCK) Inflammatory mediators-induced actin reorganization requires activation of both MLCK and PKC. The high molecular weight endothelial MLCK isoform is stably associated with a complex containing p60srcand cortactin, an actin-binding protein and downstream of p60src. Cortactin-EC MLCK interaction plays an important role in endothelial cortical actin-based cytoskeletal rearrangement (Dudek et al., 2002). H2 O2 -induced MLC phosphorylation and actin rearrangement are dependent on MLCK in EC (Zhao and Davis, 1998). Phosphatase Protein tyrosine phosphorylation is controlled by the tightly regulated balance between protein tyrosine kinases and PTPs (Tonks, 2005). PTPs are considered as negative regulators for signaling process initiated by PTK activation. The reversible oxidative inhibition of PTPs by ROS is an important mechanism through which ROS increase tyrosine phosphorylation signaling events (Lee et al., 1998; Finkel, 1999; Meng et al., 2002; Chiarugi and Cirri, 2003). The PTP activity is dependent on the reactive cysteine residues (Cys-SH) with a low pKa at their active site (Zhang and Dixon, 1993; Lohse et al., 1997) that are readily susceptible to reversible oxidation by H2 O2 (Wu et al., 1998). Kinases and phosphatases cooperate at sites of cell–cell adhesion, thereby regulating AJ integrity or disas-
8. Reactive Oxygen Species and Endothelial Permeability
169
sembly both in the steady sate and in response to inflammatory agents (Shasby, 2007). They are recruited to the cell surface through interaction with AJs components, which in turn providing spatiotemporal control of cell–cell adhesion dynamics by modulating interactions between cadherin and catenins. A complex interdependence between AJs components and the activities of kinases and phosphatases contributes to the establishment, maintenance, and disassembly of cell–cell contact in the endothelium. The tyrosine phosphatase inhibitor, sodium orthovanadate induces MLC tyrosine phosphorylation, which decreases electrical resistance across bovine EC monolayers and increases albumin permeability (Gilbert-McClain et al., 1998). Diperoxovanadate stimulates tyrosine phosphorylation, phosphorylation of Src and cortactin, actin remodeling, and endothelial barrier dysfunction in BPAECs through increase in cytosolic Ca2+ (Usatyuk et al., 2003). PTP1B interacts with cadherin and dephosphorylates β-catenin at Tyr654, which is involved in stabilizing the cadherin-β-catenin complex (Xu et al., 2004). Phosphorylation of PTP1B on Tyr152 by Fer is required for interaction with cadherin (Xu et al., 2004). Thus, the presence of both PTP1B and Fer in the cadherinbeta-catenin-120-catenin complex increases the integrity of AJs in the basal state. Endothelial receptor-type phosphatases including Vascular endothelial (VE)-PTP, PTPmu and PTPmicro associate with VE-cadherin through extracellular domain, which inhibits tyrosine phosphorylation of VE-cadherin and stabilizes AJs, independently of its enzymatic activity (Nawroth et al., 2002; Hellberg et al., 2002; Sui et al., 2005). SHP2 associates selectively with β-catenin in VE-cadherin complexes (Ukropec et al., 2000). Thrombin promotes SHP2 tyrosine phosphorylation and dissociation from VE-cadherin complexes. Thus, thrombin regulates tyrosine phosphorylation of VE-cadherin-associated β-catenin, and p120-catenin by modulating the quantity of SHP2 associated with VE-cadherin complexes. Such changes in adherens junction complex composition likely underlie thrombininduced increase in endothelial monolayer permeability. Confluent ECs respond poorly to the proliferative signals of VEGF (Grazia Lampugnani et al., 2003), which is due to the expression of VE-cadherin. In sparse cells or in VE-cadherin-null cells, this phenomenon does not occur and the receptor is fully activated by the growth factor. VE-cadherin truncated in beta-catenin but not p120 binding domain is unable to associate with VEGFR2, and beta-catenin-null ECs are not contact inhibited by VE-cadherin and are still responsive to VEGF. Thus, VE-cadherin-beta-catenin complex participates in contact inhibition of VEGF signaling. Upon stimulation with VEGF, VEGFR2 associates with the complex at cell–cell contacts, where VEGFR2 signaling is inactivated by high cell density-enhanced PTP 1 (DEP-1)/CD148. Thus, it is likely that agonist-induced ROS may inhibit PTPs which negatively regulates tyrosine phosphorylation of VE-cadherin-containing AJs complex, thereby promoting junctional separation and increase in EC permeability.
170
M. Ushio-Fukai et al.
Ca2+ Channels Inflammatory mediators stimulate endothelial permeability by increasing the intracellular Ca2+ concentration ([Ca2+ ]i). The rise in [Ca2+ ]i activates key signaling pathways that mediate cytoskeletal reorganization (through myosinlight-chain-dependent contraction) and the disassembly of VE-cadherin at the AJs. Recent studies have identified members of Drosophila transient receptor potential (TRP) gene family of channels that encode functional store-operated cation channels (SOCs) in ECs. Canonical TRP channel (TRPC) homologue TRPC1 is the predominant isoform expressed in human vascular ECs. The malfunction and dysregulation of TRPCs (TRPC1, TRPC4, TRPP1, TRPP2, TRPV4) is associated with endothelial barrier dysfunction. Thus, endothelial TRP channels play an important role in signaling agonist-induced increases in endothelial permeability (Tiruppathi et al., 2006; Ahmmed and Malik, 2005; Kwan et al., 2007). PKCa phosphorylation of TRPC1 is important for Ca2+ Ca2+ entry in human ECs and is involved in thrombin-induced increase in EC permeability (Ahmmed et al., 2004). RhoA induces association of IP3 receptor with TRPC1, thereby activating SOCs and resultant increase in endothelial permeability (Mehta et al., 2003). Vanilloid TRPC, TRPV4 is involved in disruption of the alveolar septal barrier and pathogenesis of acute lung injury (Alvarez et al., 2006; Townsley et al., 2006). H2 O2 activates ROS sensitive channel, transient receptor potential melastatin (TRPM)2, an oxidant-activated channel belonging to the TRP family of cation channels, thereby increasing [Ca2+ ]i and endothelial permeability (Hecquet et al., 2007) (Figure 1). Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1, CD31) PECAM-1 is a critical modulator of neutrophil-EC transmigration. On stimulation by a vasoactive substance or shear stress, PECAM-1 is tyrosine phosphorylated, enabling recruitment of SHP-2 and tyrosine-phosphorylated β-catenin to its cytoplasmic domain, facilitating dephosphorylation of β-catenin to reconstitute the adherens junctions. In addition, PECAM-1 modulates the levels of β-catenin by regulating the activity of GSK-3β, which in turn affects the serine phosphorylation of β-catenin and its proteosomal degradation, regulating the reformation of AJs (Biswas et al., 2006). PECAM-1-null mice exhibit prolonged and increased permeability after inflammatory insults. In PECAM-1-null ECs, β-catenin is tyrosine phosphorylated, coinciding with a sustained increase in permeability (Biswas et al., 2006). SHP-2 association with β-catenin is diminished; β-catenin/GSK-3β association and β-catenin serine phosphorylation levels are increased; and GSK3β serine phosphorylation (inactivation) in response to histamine or shear stress is blunted. These suggest that lack of PECAM-1 prevents the dephosphorylation of AJs component, promoting a sustained increase in permeability. Thus, PECAM-1 serves as a critical dynamic regulator of endothelial barrier permeability. Of note, ROS support the PECAM-1/SHP-2 formation and induce oxidative inactivation of SHP-2, thereby promoting tyrosine phosphorylation of PECAM-1 (Maas et
8. Reactive Oxygen Species and Endothelial Permeability
171
al., 2003). In HUVEC and REN cells (a PECAM-1-negative EC-like cell line) stably transfected with PECAM-1, H2 O2 activates a calcium-permeant, nonselective cation current, and a transient rise in [Ca2+ ]i. Thus, PECAM-1 may function as a sensor of oxidative stress during the pro